1	Journal	NNP	O	Journal	_	0	SENT_1	[p1l41t81r128b110],
2	of	IN	O	of	_	0	SENT_1	[p1l138t81r164b103],
3	the	DT	O	the	det	5	SENT_1	[p1l171t81r207b103],
4	American	NNP	ORGANIZATION	American	nn	5	SENT_1	[p1l217t81r333b103],
5	College	NNP	ORGANIZATION	College	prep_of	1	SENT_1	[p1l344t81r432b111],
6	of	IN	ORGANIZATION	of	_	0	SENT_1	[p1l443t81r470b103],
7	Cardiology	NNP	ORGANIZATION	Cardiology	nn	8	SENT_1	[p1l477t81r607b111],
8	Vol	NNP	ORGANIZATION	Vol	prep_of	1	SENT_1	[p1l1854t81r1902b103],
9	.	.	O	.	_	0	SENT_1	[p1l1854t81r1902b103],

1	54	CD	NUMBER	54	_	0	SENT_2	[p1l1914t81r1948b108],
2	,	,	O	,	_	0	SENT_2	[p1l1914t81r1948b108],
3	No.	NN	O	no.	appos	1	SENT_2	[p1l1960t82r2003b103],
4	17	CD	NUMBER	17	num	3	SENT_2	[p1l2016t82r2049b108],
5	,	,	O	,	_	0	SENT_2	[p1l2016t82r2049b108],
6	2009	CD	DATE	2009	num	7	SENT_2	[p1l2061t82r2118b104],
7	©	CD	DATE	©	appos	1	SENT_2	[p1l44t115r66b136],
8	2009	CD	DATE	2009	dep	28	SENT_2	[p1l77t116r134b137],
9	by	IN	O	by	_	0	SENT_2	[p1l145t115r173b144],
10	the	DT	O	the	det	12	SENT_2	[p1l183t115r219b136],
11	American	NNP	ORGANIZATION	American	nn	12	SENT_2	[p1l229t114r344b136],
12	College	NNP	ORGANIZATION	College	prep_by	8	SENT_2	[p1l356t115r444b144],
13	of	IN	ORGANIZATION	of	_	0	SENT_2	[p1l455t115r482b136],
14	Cardiology	NNP	ORGANIZATION	Cardiology	nn	16	SENT_2	[p1l489t115r619b144],
15	Foundation	NNP	ORGANIZATION	Foundation	nn	16	SENT_2	[p1l628t115r765b136],
16	ISSN	NNP	ORGANIZATION	ISSN	prep_of	12	SENT_2	[p1l1785t114r1850b136],
17	0735-1097/09	CD	DURATION	0735-1097/09	num	16	SENT_2	[p1l1861t114r2039b136],
18	/	:	O	/	punct	19	SENT_2	[p1l1861t114r2039b136],
19	21336.00	CD	NUMBER	21336.00	dep	12	SENT_2	[p1l2040t115r2118b137],
20	Published	VBN	O	publish	partmod	19	SENT_2	[p1l44t147r159b169],
21	by	IN	O	by	_	0	SENT_2	[p1l169t147r197b176],
22	Elsevier	NNP	ORGANIZATION	Elsevier	nn	23	SENT_2	[p1l207t147r300b169],
23	Inc.	NNP	ORGANIZATION	Inc.	agent	20	SENT_2	[p1l310t147r353b169],
24	doi	FW	O	doi	dep	23	SENT_2	[p1l1758t147r2117b176],
25	:10.1016	CD	NUMBER	:10.1016	dep	24	SENT_2	[p1l1758t147r2117b176],
26	/	:	O	/	punct	19	SENT_2	[p1l1758t147r2117b176],
27	j.	NN	O	j.	nn	28	SENT_2	[p1l1758t147r2117b176],
28	jacc	NN	O	jacc	rcmod	7	SENT_2	[p1l1758t147r2117b176],
29	.2009.04.053	CD	NUMBER	.2009.04.053	dep	28	SENT_2	[p1l1758t147r2117b176],

1	Genetics	NNP	O	Genetics	_	0	SENT_3	[p1l1533t235r1708b265],
2	and	CC	O	and	_	0	SENT_3	[p1l1724t236r1793b265],
3	statin	NN	O	statin	nn	4	SENT_3	[p1l1810t235r1929b265],
4	Effects	NNS	O	effect	conj_and	1	SENT_3	[p1l1947t235r2089b265],

1	The	DT	O	the	det	6	SENT_4	[p1l117t357r232b415],
2	SLC01B1	NN	O	slc01b1	nn	3	SENT_4	[p1l260t356r555b415],
3	*	NN	O	*	npadvmod	6	SENT_4	[p1l567t357r636b415],
4	5	CD	NUMBER	5	number	5	SENT_4	[p1l567t357r636b415],
5	Genetic	JJ	O	genetic	amod	3	SENT_4	[p1l658t356r895b415],
6	Variant	JJ	O	variant	dep	7	SENT_4	[p1l922t357r1151b415],
7	Is	VBZ	O	be	_	0	SENT_4	[p1l1182t357r1233b415],

1	Associated	NNP	O	Associated	_	0	SENT_5	[p1l117t457r457b515],
2	With	IN	O	with	dep	1	SENT_5	[p1l488t457r631b515],
3	Statin-Induced	JJ	O	statin-induced	amod	5	SENT_5	[p1l660t456r1122b515],
4	Side	NN	O	side	nn	5	SENT_5	[p1l1151t456r1287b515],
5	Effects	NNS	O	effect	pobj	2	SENT_5	[p1l1318t456r1533b515],

1	Deepak	NNP	PERSON	Deepak	nn	46	SENT_6	[p1l119t591r262b637],
2	Voora	NNP	PERSON	Voora	nn	46	SENT_6	[p1l277t591r398b633],
3	,	,	O	,	_	0	SENT_6	[p1l277t591r398b633],
4	MD	NNP	O	MD	dep	46	SENT_6	[p1l416t591r547b633],
5	,	,	O	,	_	0	SENT_6	[p1l416t591r547b633],
6	*	CD	NUMBER	*	appos	4	SENT_6	[p1l416t591r547b633],
7	:	:	O	:	_	0	SENT_6	[p1l416t591r547b633],
8	lI	NNP	O	lI	nn	11	SENT_6	[p1l416t591r547b633],
9	Svati	NNP	PERSON	Svati	nn	11	SENT_6	[p1l566t591r654b625],
10	H.	NNP	PERSON	H.	nn	11	SENT_6	[p1l671t591r717b625],
11	Shah	NNP	PERSON	Shah	dep	4	SENT_6	[p1l739t591r839b633],
12	,	,	O	,	_	0	SENT_6	[p1l739t591r839b633],
13	MD	NNP	O	MD	appos	11	SENT_6	[p1l857t591r948b633],
14	,	,	O	,	_	0	SENT_6	[p1l857t591r948b633],
15	MHS	NNP	ORGANIZATION	MHS	nn	39	SENT_6	[p1l966t591r1147b633],
16	,	,	O	,	_	0	SENT_6	[p1l966t591r1147b633],
17	*	NN	O	*	nn	19	SENT_6	[p1l966t591r1147b633],
18	'	''	O	'	_	0	SENT_6	[p1l966t591r1147b633],
19	l	NN	O	l	dep	39	SENT_6	[p1l966t591r1147b633],
20	‘	CD	NUMBER	‘	dep	19	SENT_6	[p1l966t591r1147b633],
21	:	:	O	:	_	0	SENT_6	[p1l966t591r1147b633],
22	lI	NNP	O	lI	nn	24	SENT_6	[p1l966t591r1147b633],
23	Ivan	NNP	PERSON	Ivan	nn	24	SENT_6	[p1l1163t591r1243b625],
24	Spasojevic	NNP	PERSON	Spasojevic	dep	19	SENT_6	[p1l1262t591r1457b637],
25	,	,	O	,	_	0	SENT_6	[p1l1262t591r1457b637],
26	PHD	NNP	O	PHD	appos	24	SENT_6	[p1l1476t591r1602b633],
27	,	,	O	,	_	0	SENT_6	[p1l1476t591r1602b633],
28	i	FW	O	i	nn	29	SENT_6	[p1l1476t591r1602b633],
29	Shazia	FW	PERSON	shazia	appos	24	SENT_6	[p1l1621t591r1739b625],
30	Ali	NNP	PERSON	Ali	nn	37	SENT_6	[p1l1754t590r1822b633],
31	,	,	O	,	_	0	SENT_6	[p1l1754t590r1822b633],
32	PHARMD	NNP	LOCATION	PHARMD	appos	37	SENT_6	[p1l1841t591r2047b633],
33	,	,	O	,	_	0	SENT_6	[p1l1841t591r2047b633],
34	§	NNP	O	§	appos	37	SENT_6	[p1l1841t591r2047b633],
35	Carol	NNP	PERSON	Carol	nn	37	SENT_6	[p1l120t646r222b680],
36	R.	NNP	PERSON	R.	nn	37	SENT_6	[p1l240t646r278b680],
37	Reed	NNP	PERSON	Reed	dep	29	SENT_6	[p1l298t646r401b688],
38	,	,	O	,	_	0	SENT_6	[p1l298t646r401b688],
39	MD	NNP	O	MD	appos	11	SENT_6	[p1l418t646r537b688],
40	,1	CD	NUMBER	,1	num	41	SENT_6	[p1l418t646r537b688],
41	l	NN	O	l	tmod	39	SENT_6	[p1l418t646r537b688],
42	Benjamin	NNP	PERSON	Benjamin	nn	44	SENT_6	[p1l555t646r732b692],
43	A.	NNP	PERSON	A.	nn	44	SENT_6	[p1l747t645r790b680],
44	Salisbury	NNP	PERSON	Salisbury	dep	39	SENT_6	[p1l811t646r985b692],
45	,	,	O	,	_	0	SENT_6	[p1l811t646r985b692],
46	PHD	NNP	O	PHD	_	0	SENT_6	[p1l1004t646r1133b688],
47	,1	CD	NUMBER	,1	num	48	SENT_6	[p1l1004t646r1133b688],
48	l	NN	O	l	tmod	46	SENT_6	[p1l1004t646r1133b688],
49	Geoffrey	NNP	PERSON	Geoffrey	nn	51	SENT_6	[p1l1151t646r1310b692],
50	S.	NNP	PERSON	S.	nn	51	SENT_6	[p1l1327t646r1357b680],
51	Ginsburg	NNP	PERSON	Ginsburg	dep	46	SENT_6	[p1l1378t646r1560b692],
52	,	,	O	,	_	0	SENT_6	[p1l1378t646r1560b692],
53	MD	NNP	O	MD	appos	51	SENT_6	[p1l1577t646r1669b688],
54	,	,	O	,	_	0	SENT_6	[p1l1577t646r1669b688],
55	PHD	NNP	O	PHD	appos	51	SENT_6	[p1l1688t646r1839b686],
56	*	CD	NUMBER	*	num	55	SENT_6	[p1l1688t646r1839b686],
57	i	FW	O	i	nn	59	SENT_6	[p1l1688t646r1839b686],
58	§	FW	O	§	nn	59	SENT_6	[p1l1688t646r1839b686],
59	Dur/Jam	NN	O	dur/jam	dep	55	SENT_6	[p1l118t703r275b741],
60	,	,	O	,	_	0	SENT_6	[p1l118t703r275b741],
61	Norz	NNP	O	Norz	appos	51	SENT_6	[p1l294t703r399b737],
62	‘	CD	NUMBER	‘	num	61	SENT_6	[p1l294t703r399b737],
63	/	:	O	/	punct	64	SENT_6	[p1l294t703r399b737],
64	3	CD	NUMBER	3	dep	61	SENT_6	[p1l294t703r399b737],
65	Carolina	NNP	ORGANIZATION	Carolina	dep	64	SENT_6	[p1l419t703r581b741],
66	;	:	O	;	_	0	SENT_6	[p1l419t703r581b741],
67	and	CC	O	and	_	0	SENT_6	[p1l598t703r667b736],
68	New	NNP	LOCATION	New	nn	69	SENT_6	[p1l677t703r762b736],
69	Haven	NNP	LOCATION	Haven	dep	46	SENT_6	[p1l777t703r905b741],
70	,	,	O	,	_	0	SENT_6	[p1l777t703r905b741],
71	Connecticut	NNP	LOCATION	Connecticut	appos	69	SENT_6	[p1l929t703r1131b736],

1	Objectives	NNS	O	objective	nsubj	9	SENT_7	[p1l194t834r368b867],
2	We	PRP	O	we	nsubj	3	SENT_7	[p1l494t838r539b861],
3	sought	VBD	O	seek	rcmod	1	SENT_7	[p1l550t838r646b866],
4	to	TO	O	to	aux	5	SENT_7	[p1l657t839r684b861],
5	identify	VB	O	identify	xcomp	3	SENT_7	[p1l696t837r800b866],
6	single	JJ	O	single	amod	8	SENT_7	[p1l810t838r893b866],
7	nucleotide	NN	O	nucleotide	nn	8	SENT_7	[p1l906t838r1052b860],
8	polymorphisms	NNS	O	polymorphism	dobj	5	SENT_7	[p1l1065t838r1282b866],
9	associated	VBN	O	associate	_	0	SENT_7	[p1l1293t838r1444b860],
10	with	IN	O	with	_	0	SENT_7	[p1l1456t838r1514b860],
11	mild	JJ	O	mild	amod	14	SENT_7	[p1l1527t838r1587b860],
12	statin-induced	JJ	O	statin-induced	amod	14	SENT_7	[p1l1598t838r1798b861],
13	side	NN	O	side	nn	14	SENT_7	[p1l1810t838r1868b860],
14	effects	NNS	O	effect	prep_with	9	SENT_7	[p1l1879t837r1982b861],
15	.	.	O	.	_	0	SENT_7	[p1l1879t837r1982b861],

1	Background	NN	MISC	background	nsubj	6	SENT_8	[p1l195t877r392b910],
2	Statin-induced	JJ	MISC	statin-induced	amod	4	SENT_8	[p1l493t880r697b904],
3	side	JJ	O	side	amod	4	SENT_8	[p1l709t881r767b904],
4	effects	NNS	O	effect	dep	1	SENT_8	[p1l778t880r874b904],
5	can	MD	O	can	aux	6	SENT_8	[p1l885t886r934b904],
6	interfere	VB	O	interfere	_	0	SENT_8	[p1l948t880r1067b904],
7	with	IN	O	with	_	0	SENT_8	[p1l1078t880r1135b904],
8	therapy	NN	O	therapy	prep_with	6	SENT_8	[p1l1148t881r1262b909],
9	.	.	O	.	_	0	SENT_8	[p1l1148t881r1262b909],

1	Single	JJ	O	single	amod	3	SENT_9	[p1l1273t880r1360b909],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_9	[p1l1373t880r1519b904],
3	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_9	[p1l1532t881r1749b909],
4	in	IN	O	in	_	0	SENT_9	[p1l1761t881r1783b904],
5	cytochrome	NN	O	cytochrome	nn	7	SENT_9	[p1l1796t880r1961b909],
6	P450	NN	O	p450	nn	7	SENT_9	[p1l1974t880r2050b904],
7	enzymes	NNS	O	enzyme	prep_in	3	SENT_9	[p1l2061t886r2104b904, p1l494t929r583b952],
8	impair	VBP	O	impair	_	0	SENT_9	[p1l595t924r685b952],
9	statin	NN	O	statin	nn	10	SENT_9	[p1l695t924r774b947],
10	metabolism	NN	O	metabolism	dobj	8	SENT_9	[p1l788t924r963b951],
11	;	:	O	;	_	0	SENT_9	[p1l788t924r963b951],
12	the	DT	O	the	det	15	SENT_9	[p1l975t924r1020b947],
13	reduced	VBN	O	reduce	amod	15	SENT_9	[p1l1033t924r1144b947],
14	function	NN	O	function	nn	15	SENT_9	[p1l1156t923r1271b947],
15	SLCO1B1	NN	O	slco1b1	dep	10	SENT_9	[p1l1282t923r1455b947],
16	*	CD	NUMBER	*	number	17	SENT_9	[p1l1282t923r1455b947],
17	5	CD	NUMBER	5	num	18	SENT_9	[p1l1282t923r1455b947],
18	allele	NN	O	allele	dep	15	SENT_9	[p1l1466t924r1542b947],
19	impairs	VBZ	O	impair	rcmod	18	SENT_9	[p1l1554t924r1659b952],
20	statin	JJ	O	statin	amod	21	SENT_9	[p1l1670t924r1748b947],
21	clearance	NN	O	clearance	dobj	19	SENT_9	[p1l1761t924r1898b947],
22	and	CC	O	and	_	0	SENT_9	[p1l1910t924r1961b947],
23	is	VBZ	O	be	auxpass	24	SENT_9	[p1l1974t924r1995b947],
24	associated	VBN	O	associate	rcmod	18	SENT_9	[p1l2006t924r2103b947, p1l494t968r555b991],
25	with	IN	O	with	_	0	SENT_9	[p1l567t968r625b991],
26	simvastatin-induced	JJ	O	simvastatin-induced	amod	27	SENT_9	[p1l637t968r922b991],
27	myopathy	NN	O	myopathy	prep_with	24	SENT_9	[p1l936t968r1074b997],
28	with	IN	O	with	_	0	SENT_9	[p1l1085t968r1143b991],
29	creatine	NN	O	creatine	nn	30	SENT_9	[p1l1155t968r1270b991],
30	kinase	NN	O	kinase	prep_with	24	SENT_9	[p1l1282t968r1374b991],
31	(	CD	NUMBER	(	num	34	SENT_9	[p1l1386t968r1444b997],
32	CK	NN	O	ck	nn	34	SENT_9	[p1l1386t968r1444b997],
33	)	NN	O	)	nn	34	SENT_9	[p1l1386t968r1444b997],
34	elevation	NN	O	elevation	dobj	19	SENT_9	[p1l1455t968r1591b991],
35	.	.	O	.	_	0	SENT_9	[p1l1455t968r1591b991],

1	Methods	NNS	O	method	nsubj	17	SENT_10	[p1l195t1008r339b1034],
2	The	DT	O	the	det	6	SENT_10	[p1l493t1011r544b1034],
3	STRENGTH	NN	O	strength	nn	6	SENT_10	[p1l555t1011r707b1034],
4	(	CD	NUMBER	(	num	6	SENT_10	[p1l720t1011r812b1040],
5	Statin	NN	O	statin	nn	6	SENT_10	[p1l720t1011r812b1040],
6	Response	NN	O	response	nsubj	12	SENT_10	[p1l826t1011r963b1040],
7	Examined	VBN	O	examine	partmod	6	SENT_10	[p1l976t1011r1113b1034],
8	by	IN	O	by	_	0	SENT_10	[p1l1127t1011r1157b1040],
9	Genetic	JJ	ORGANIZATION	genetic	amod	11	SENT_10	[p1l1168t1011r1275b1034],
10	Haplotype	NN	ORGANIZATION	haplotype	nn	11	SENT_10	[p1l1288t1011r1429b1040],
11	Markers	NNS	ORGANIZATION	marker	agent	7	SENT_10	[p1l1441t1011r1565b1040],
12	)	VBP	O	)	rcmod	1	SENT_10	[p1l1441t1011r1565b1040],
13	study	NN	O	study	dobj	12	SENT_10	[p1l1576t1011r1652b1040],
14	was	VBD	O	be	cop	17	SENT_10	[p1l1663t1017r1718b1034],
15	a	DT	O	a	det	17	SENT_10	[p1l1730t1017r1745b1034],
16	pharmacogenetics	NNS	O	pharmacogenetic	nn	17	SENT_10	[p1l1758t1011r2021b1040],
17	study	NN	O	study	_	0	SENT_10	[p1l2031t1011r2107b1040],
18	of	IN	O	of	_	0	SENT_10	[p1l494t1054r521b1078],
19	statin	NN	O	statin	nn	20	SENT_10	[p1l531t1054r610b1078],
20	efficacy	NN	O	efficacy	prep_of	17	SENT_10	[p1l623t1054r731b1083],
21	and	CC	O	and	_	0	SENT_10	[p1l742t1054r793b1078],
22	safety	NN	O	safety	prep_of	17	SENT_10	[p1l805t1054r898b1083],
23	.	.	O	.	_	0	SENT_10	[p1l805t1054r898b1083],

1	Subjects	NNS	O	subject	nsubj	2	SENT_11	[p1l910t1054r1031b1084],
2	(	VBP	O	(	_	0	SENT_11	[p1l1042t1054r1067b1083],
3	n	NN	O	n	dobj	2	SENT_11	[p1l1042t1054r1067b1083],
4	=	JJ	O	=	amod	6	SENT_11	[p1l1083t1062r1103b1070],
5	509	CD	NUMBER	509	num	6	SENT_11	[p1l1117t1054r1184b1083],
6	)	NN	O	)	nsubjpass	8	SENT_11	[p1l1117t1054r1184b1083],
7	were	VBD	O	be	auxpass	8	SENT_11	[p1l1195t1060r1263b1078],
8	randomized	VBN	O	randomize	rcmod	3	SENT_11	[p1l1276t1054r1441b1078],
9	to	TO	O	to	_	0	SENT_11	[p1l1453t1056r1480b1078],
10	atorvastatin	NN	O	atorvastatin	nn	12	SENT_11	[p1l1492t1054r1660b1078],
11	10	CD	NUMBER	10	num	12	SENT_11	[p1l1673t1054r1709b1078],
12	mg	NN	O	mg	prep_to	8	SENT_11	[p1l1722t1057r1773b1083],
13	,	,	O	,	_	0	SENT_11	[p1l1722t1057r1773b1083],
14	simvastatin	NN	O	simvastatin	nn	16	SENT_11	[p1l1785t1054r1948b1078],
15	20	CD	NUMBER	20	num	16	SENT_11	[p1l1961t1054r1998b1078],
16	mg	NN	O	mg	dobj	2	SENT_11	[p1l2011t1057r2061b1083],
17	,	,	O	,	_	0	SENT_11	[p1l2011t1057r2061b1083],
18	or	CC	O	or	_	0	SENT_11	[p1l2074t1060r2101b1078],
19	pravastatin	NN	O	pravastatin	nn	21	SENT_11	[p1l495t1099r652b1127],
20	10	CD	NUMBER	10	num	21	SENT_11	[p1l665t1098r702b1121],
21	mg	NN	O	mg	dobj	2	SENT_11	[p1l714t1101r759b1127],
22	followed	VBN	O	follow	partmod	21	SENT_11	[p1l769t1098r887b1121],
23	by	IN	O	by	_	0	SENT_11	[p1l901t1099r931b1127],
24	80	CD	NUMBER	80	num	25	SENT_11	[p1l942t1098r979b1121],
25	mg	NN	O	mg	agent	22	SENT_11	[p1l992t1101r1043b1127],
26	,	,	O	,	_	0	SENT_11	[p1l992t1101r1043b1127],
27	80	CD	NUMBER	80	num	28	SENT_11	[p1l1055t1098r1092b1121],
28	mg	NN	O	mg	agent	22	SENT_11	[p1l1105t1101r1156b1127],
29	,	,	O	,	_	0	SENT_11	[p1l1105t1101r1156b1127],
30	and	CC	O	and	_	0	SENT_11	[p1l1168t1099r1219b1121],
31	40	CD	NUMBER	40	num	32	SENT_11	[p1l1232t1098r1269b1121],
32	mg	NN	O	mg	agent	22	SENT_11	[p1l1282t1101r1332b1127],
33	,	,	O	,	_	0	SENT_11	[p1l1282t1101r1332b1127],
34	respectively	RB	O	respectively	advmod	22	SENT_11	[p1l1346t1099r1519b1127],
35	.	.	O	.	_	0	SENT_11	[p1l1346t1099r1519b1127],

1	We	PRP	O	we	nsubj	2	SENT_12	[p1l1531t1099r1576b1121],
2	defined	VBD	O	define	_	0	SENT_12	[p1l1588t1098r1692b1121],
3	a	DT	O	a	det	6	SENT_12	[p1l1705t1104r1720b1121],
4	composite	JJ	O	composite	amod	6	SENT_12	[p1l1732t1099r1879b1127],
5	adverse	JJ	O	adverse	amod	6	SENT_12	[p1l1891t1099r2001b1121],
6	event	NN	O	event	npadvmod	23	SENT_12	[p1l2013t1100r2089b1122],
7	(	CD	NUMBER	(	num	8	SENT_12	[p1l494t1141r570b1170],
8	CAE	NNP	O	CAE	npadvmod	21	SENT_12	[p1l494t1141r570b1170],
9	)	CD	NUMBER	)	num	8	SENT_12	[p1l494t1141r570b1170],
10	as	IN	O	as	_	0	SENT_12	[p1l582t1147r613b1164],
11	discontinuation	NN	O	discontinuation	prep_as	8	SENT_12	[p1l625t1141r841b1164],
12	for	IN	O	for	_	0	SENT_12	[p1l853t1141r892b1164],
13	any	DT	O	any	det	15	SENT_12	[p1l903t1147r952b1170],
14	side	JJ	O	side	amod	15	SENT_12	[p1l963t1141r1020b1164],
15	effect	NN	O	effect	prep_for	11	SENT_12	[p1l1032t1141r1120b1169],
16	,	,	O	,	_	0	SENT_12	[p1l1032t1141r1120b1169],
17	myalgia	NN	O	myalgium	prep_for	11	SENT_12	[p1l1133t1141r1251b1170],
18	,	,	O	,	_	0	SENT_12	[p1l1133t1141r1251b1170],
19	or	CC	O	or	_	0	SENT_12	[p1l1263t1147r1291b1164],
20	CK	NNP	O	CK	prep_for	11	SENT_12	[p1l1302t1141r1340b1164],
21	>	JJR	O	>	amod	6	SENT_12	[p1l1353t1141r1421b1164],
22	3	CD	NUMBER	3	dep	21	SENT_12	[p1l1353t1141r1421b1164],
23	>	JJR	O	>	acomp	2	SENT_12	[p1l1353t1141r1421b1164],
24	<	JJR	O	<	amod	26	SENT_12	[p1l1353t1141r1421b1164],
25	upper	JJ	O	upper	amod	26	SENT_12	[p1l1437t1147r1517b1170],
26	limit	NN	O	limit	dobj	2	SENT_12	[p1l1529t1141r1590b1164],
27	of	IN	O	of	_	0	SENT_12	[p1l1602t1141r1629b1164],
28	normal	JJ	O	normal	prep_of	26	SENT_12	[p1l1641t1141r1738b1164],
29	during	IN	O	during	_	0	SENT_12	[p1l1751t1141r1841b1170],
30	follow-up	NN	O	follow-up	prep_during	2	SENT_12	[p1l1850t1141r1986b1170],
31	.	.	O	.	_	0	SENT_12	[p1l1850t1141r1986b1170],

1	We	PRP	O	we	nsubj	2	SENT_13	[p1l1998t1141r2043b1164],
2	sequenced	VBD	O	sequence	_	0	SENT_13	[p1l2054t1147r2095b1164, p1l494t1185r614b1213],
3	CYP2D6	NN	O	cyp2d6	dobj	2	SENT_13	[p1l627t1184r749b1212],
4	,	,	O	,	_	0	SENT_13	[p1l627t1184r749b1212],
5	CYP2C8	NN	O	cyp2c8	appos	3	SENT_13	[p1l762t1184r883b1212],
6	,	,	O	,	_	0	SENT_13	[p1l762t1184r883b1212],
7	CYP2C9	NN	O	cyp2c9	conj_and	5	SENT_13	[p1l896t1184r1016b1212],
8	,	,	O	,	_	0	SENT_13	[p1l896t1184r1016b1212],
9	CYP3A4	NN	O	cyp3a4	conj_and	5	SENT_13	[p1l1029t1184r1151b1212],
10	,	,	O	,	_	0	SENT_13	[p1l1029t1184r1151b1212],
11	and	CC	O	and	_	0	SENT_13	[p1l1163t1185r1214b1208],
12	SLCO1B1	NN	O	slco1b1	conj_and	5	SENT_13	[p1l1225t1184r1360b1208],
13	and	CC	O	and	_	0	SENT_13	[p1l1372t1185r1423b1208],
14	tested	VBN	O	test	conj_and	2	SENT_13	[p1l1435t1185r1522b1208],
15	7	CD	NUMBER	7	num	18	SENT_13	[p1l1535t1185r1552b1207],
16	reduced	VBN	O	reduce	amod	18	SENT_13	[p1l1565t1185r1676b1208],
17	function	NN	O	function	nn	18	SENT_13	[p1l1688t1184r1803b1208],
18	alleles	NNS	O	allele	dobj	14	SENT_13	[p1l1815t1185r1906b1208],
19	for	IN	O	for	_	0	SENT_13	[p1l1917t1184r1955b1208],
20	association	NN	O	association	prep_for	18	SENT_13	[p1l1966t1185r2081b1208, p1l494t1228r546b1251],
21	with	IN	O	with	_	0	SENT_13	[p1l558t1228r616b1251],
22	the	DT	O	the	det	23	SENT_13	[p1l628t1228r673b1251],
23	CAE	NNP	O	CAE	prep_with	20	SENT_13	[p1l685t1228r747b1251],
24	.	.	O	.	_	0	SENT_13	[p1l685t1228r747b1251],

1	Results	NNS	O	result	nsubj	4	SENT_14	[p1l195t1295r319b1322],
2	The	DT	O	the	det	3	SENT_14	[p1l493t1299r544b1322],
3	CAE	NNP	O	CAE	dep	1	SENT_14	[p1l556t1298r611b1322],
4	occurred	VBD	O	occur	_	0	SENT_14	[p1l623t1299r744b1322],
5	in	IN	O	in	_	0	SENT_14	[p1l757t1299r780b1322],
6	99	CD	NUMBER	99	num	7	SENT_14	[p1l792t1298r829b1322],
7	subjects	NNS	O	subject	prep_in	4	SENT_14	[p1l840t1299r958b1328],
8	(	JJ	O	(	amod	7	SENT_14	[p1l969t1298r1016b1327],
9	54	CD	NUMBER	54	num	10	SENT_14	[p1l969t1298r1016b1327],
10	discontinuations	NNS	O	discontinuation	tmod	8	SENT_14	[p1l1028t1299r1268b1326],
11	,	,	O	,	_	0	SENT_14	[p1l1028t1299r1268b1326],
12	49	CD	NUMBER	49	num	13	SENT_14	[p1l1281t1298r1318b1322],
13	myalgias	NNS	O	myalgia	appos	10	SENT_14	[p1l1331t1298r1464b1327],
14	,	,	O	,	_	0	SENT_14	[p1l1331t1298r1464b1327],
15	and	CC	O	and	_	0	SENT_14	[p1l1476t1299r1527b1322],
16	9	CD	NUMBER	9	num	18	SENT_14	[p1l1540t1298r1557b1322],
17	CK	NN	O	ck	nn	18	SENT_14	[p1l1569t1298r1607b1322],
18	elevations	NNS	O	elevation	conj_and	7	SENT_14	[p1l1618t1298r1780b1327],
19	)	CD	NUMBER	)	dep	18	SENT_14	[p1l1618t1298r1780b1327],
20	.	.	O	.	_	0	SENT_14	[p1l1618t1298r1780b1327],

1	Sex	NN	O	sex	nsubjpass	3	SENT_15	[p1l1791t1298r1842b1322],
2	was	VBD	O	be	auxpass	3	SENT_15	[p1l1852t1304r1908b1322],
3	associated	VBN	O	associate	_	0	SENT_15	[p1l1919t1298r2070b1322],
4	with	IN	O	with	_	0	SENT_15	[p1l494t1342r551b1365],
5	CAE	NNP	O	CAE	prep_with	3	SENT_15	[p1l564t1341r620b1365],
6	(	CD	PERCENT	(	num	5	SENT_15	[p1l631t1342r748b1370],
7	percent	NN	PERCENT	percent	nn	8	SENT_15	[p1l631t1342r748b1370],
8	female	NN	O	female	dobj	3	SENT_15	[p1l758t1341r858b1365],
9	in	IN	O	in	_	0	SENT_15	[p1l871t1342r893b1364],
10	CAE	NNP	ORGANIZATION	CAE	prep_in	8	SENT_15	[p1l906t1341r961b1365],
11	vs.	CC	O	vs.	prep	10	SENT_15	[p1l972t1347r1008b1365],
12	no	DT	O	no	det	14	SENT_15	[p1l1021t1347r1054b1365],
13	CAE	NN	ORGANIZATION	ca	nn	14	SENT_15	[p1l1066t1341r1121b1365],
14	groups	NNS	O	group	dep	11	SENT_15	[p1l1132t1344r1235b1370],
15	,	,	O	,	_	0	SENT_15	[p1l1132t1344r1235b1370],
16	66	CD	PERCENT	66	num	17	SENT_15	[p1l1248t1341r1310b1365],
17	%	NN	PERCENT	%	appos	8	SENT_15	[p1l1248t1341r1310b1365],
18	vs.	CC	O	vs.	prep	17	SENT_15	[p1l1321t1347r1357b1365],
19	50	CD	PERCENT	50	num	20	SENT_15	[p1l1370t1341r1440b1369],
20	%	NN	PERCENT	%	dep	18	SENT_15	[p1l1370t1341r1440b1369],
21	,	,	O	,	_	0	SENT_15	[p1l1370t1341r1440b1369],
22	p	NN	O	p	dep	23	SENT_15	[p1l1454t1347r1469b1370],
23	<	JJR	O	<	appos	8	SENT_15	[p1l1482t1344r1504b1363],
24	0.01	CD	NUMBER	0.01	num	25	SENT_15	[p1l1518t1341r1600b1370],
25	)	NN	O	)	dep	23	SENT_15	[p1l1518t1341r1600b1370],
26	.	.	O	.	_	0	SENT_15	[p1l1518t1341r1600b1370],

1	SLCO1B1	NN	O	slco1b1	nsubjpass	5	SENT_16	[p1l1611t1341r1784b1365],
2	*	CD	NUMBER	*	num	3	SENT_16	[p1l1611t1341r1784b1365],
3	5	CD	NUMBER	5	dep	1	SENT_16	[p1l1611t1341r1784b1365],
4	was	VBD	O	be	auxpass	5	SENT_16	[p1l1795t1347r1850b1365],
5	associated	VBN	O	associate	_	0	SENT_16	[p1l1862t1342r2012b1365],
6	with	IN	O	with	_	0	SENT_16	[p1l2024t1342r2082b1365],
7	CAE	NNP	ORGANIZATION	CAE	nn	9	SENT_16	[p1l494t1385r550b1409],
8	(	CD	PERCENT	(	num	9	SENT_16	[p1l561t1386r678b1414],
9	percent	NN	PERCENT	percent	prep_with	5	SENT_16	[p1l561t1386r678b1414],
10	with	IN	O	with	_	0	SENT_16	[p1l689t1386r747b1408],
11	21	CD	NUMBER	21	num	12	SENT_16	[p1l761t1385r805b1408],
12	allele	NN	O	allele	prep_with	5	SENT_16	[p1l816t1386r892b1408],
13	in	IN	O	in	_	0	SENT_16	[p1l904t1386r927b1408],
14	CAE	NNP	ORGANIZATION	CAE	prep_in	12	SENT_16	[p1l939t1385r995b1408],
15	vs.	CC	O	vs.	prep	14	SENT_16	[p1l1006t1391r1041b1408],
16	no	DT	O	no	det	18	SENT_16	[p1l1055t1391r1088b1408],
17	CAE	NN	ORGANIZATION	ca	nn	18	SENT_16	[p1l1100t1385r1155b1408],
18	groups	NNS	O	group	dep	15	SENT_16	[p1l1166t1388r1269b1414],
19	,	,	O	,	_	0	SENT_16	[p1l1166t1388r1269b1414],
20	37	CD	PERCENT	37	num	21	SENT_16	[p1l1281t1385r1344b1408],
21	%	NN	PERCENT	%	conj_and	14	SENT_16	[p1l1281t1385r1344b1408],
22	vs.	CC	O	vs.	prep	21	SENT_16	[p1l1355t1391r1391b1408],
23	25	CD	PERCENT	25	num	24	SENT_16	[p1l1404t1385r1474b1413],
24	%	NN	PERCENT	%	dep	22	SENT_16	[p1l1404t1385r1474b1413],
25	,	,	O	,	_	0	SENT_16	[p1l1404t1385r1474b1413],
26	p	NN	O	p	conj_and	14	SENT_16	[p1l1487t1391r1502b1414],
27	=	JJ	O	=	amod	29	SENT_16	[p1l1517t1393r1537b1401],
28	0.03	CD	NUMBER	0.03	tmod	27	SENT_16	[p1l1551t1385r1626b1414],
29	)	NN	O	)	dep	26	SENT_16	[p1l1551t1385r1626b1414],
30	and	CC	O	and	_	0	SENT_16	[p1l1638t1386r1689b1408],
31	those	DT	O	those	conj_and	14	SENT_16	[p1l1701t1386r1779b1409],
32	with	IN	O	with	_	0	SENT_16	[p1l1790t1386r1848b1408],
33	CAE	NN	ORGANIZATION	ca	prep_with	31	SENT_16	[p1l1861t1385r1916b1409],
34	with	IN	O	with	_	0	SENT_16	[p1l1927t1386r1985b1408],
35	no	DT	O	no	det	38	SENT_16	[p1l1998t1391r2031b1408],
36	significant	JJ	O	significant	amod	38	SENT_16	[p1l2042t1386r2091b1414, p1l495t1428r599b1451],
37	CK	NN	O	ck	nn	38	SENT_16	[p1l611t1428r649b1451],
38	elevation	NN	O	elevation	prep_with	5	SENT_16	[p1l660t1428r787b1451],
39	(	CD	NUMBER	(	num	41	SENT_16	[p1l800t1428r826b1457],
40	p	NN	O	p	nn	41	SENT_16	[p1l800t1428r826b1457],
41	s	NNS	O	s	dep	38	SENT_16	[p1l839t1431r862b1449],
42	0.03	CD	NUMBER	0.03	num	43	SENT_16	[p1l875t1428r958b1457],
43	)	NN	O	)	dep	41	SENT_16	[p1l875t1428r958b1457],
44	.	.	O	.	_	0	SENT_16	[p1l875t1428r958b1457],

1	Furthermore	RB	O	furthermore	advmod	4	SENT_17	[p1l972t1428r1154b1456],
2	,	,	O	,	_	0	SENT_17	[p1l972t1428r1154b1456],
3	there	EX	O	there	expl	4	SENT_17	[p1l1166t1428r1240b1451],
4	was	VBD	O	be	_	0	SENT_17	[p1l1251t1434r1306b1451],
5	evidence	NN	O	evidence	nsubj	4	SENT_17	[p1l1317t1428r1442b1451],
6	for	IN	O	for	_	0	SENT_17	[p1l1453t1428r1492b1451],
7	a	DT	O	a	det	11	SENT_17	[p1l1503t1434r1518b1451],
8	gene-dose	NN	O	gene-dose	nn	11	SENT_17	[p1l1530t1428r1675b1457],
9	effect	NN	O	effect	nn	11	SENT_17	[p1l1687t1428r1767b1451],
10	(	CD	PERCENT	(	num	11	SENT_17	[p1l1779t1428r1895b1457],
11	percent	NN	PERCENT	percent	prep_for	5	SENT_17	[p1l1779t1428r1895b1457],
12	with	IN	O	with	_	0	SENT_17	[p1l1906t1428r1964b1451],
13	CAE	NNP	ORGANIZATION	CAE	prep_with	11	SENT_17	[p1l1977t1428r2032b1451],
14	in	IN	O	in	_	0	SENT_17	[p1l2045t1428r2067b1451],
15	those	DT	O	those	prep_in	13	SENT_17	[p1l494t1472r571b1496],
16	with	IN	O	with	_	0	SENT_17	[p1l582t1472r640b1496],
17	o	NN	O	o	prep_with	15	SENT_17	[p1l653t1472r678b1500],
18	,	,	O	,	_	0	SENT_17	[p1l653t1472r678b1500],
19	1	CD	NUMBER	1	conj_or	17	SENT_17	[p1l691t1472r715b1500],
20	,	,	O	,	_	0	SENT_17	[p1l691t1472r715b1500],
21	or	CC	O	or	_	0	SENT_17	[p1l728t1478r755b1496],
22	2	CD	NUMBER	2	num	23	SENT_17	[p1l766t1472r783b1495],
23	alleles	NNS	O	allele	prep_with	15	SENT_17	[p1l795t1472r893b1496],
24	:	:	O	:	_	0	SENT_17	[p1l795t1472r893b1496],
25	19	CD	PERCENT	19	num	26	SENT_17	[p1l907t1472r976b1500],
26	%	NN	PERCENT	%	conj_and	5	SENT_17	[p1l907t1472r976b1500],
27	,	,	O	,	_	0	SENT_17	[p1l907t1472r976b1500],
28	27	CD	PERCENT	27	num	29	SENT_17	[p1l989t1472r1059b1500],
29	%	NN	PERCENT	%	appos	26	SENT_17	[p1l989t1472r1059b1500],
30	,	,	O	,	_	0	SENT_17	[p1l989t1472r1059b1500],
31	and	CC	O	and	_	0	SENT_17	[p1l1071t1472r1122b1496],
32	50	CD	PERCENT	50	num	33	SENT_17	[p1l1135t1472r1205b1500],
33	%	NN	PERCENT	%	conj_and	5	SENT_17	[p1l1135t1472r1205b1500],
34	,	,	O	,	_	0	SENT_17	[p1l1135t1472r1205b1500],
35	trend	NN	O	trend	nn	36	SENT_17	[p1l1217t1472r1290b1496],
36	p	NN	O	p	appos	33	SENT_17	[p1l1304t1478r1319b1501],
37	=	JJ	O	=	amod	39	SENT_17	[p1l1333t1480r1353b1488],
38	0.01	CD	NUMBER	0.01	tmod	37	SENT_17	[p1l1368t1472r1450b1501],
39	)	NN	O	)	dep	36	SENT_17	[p1l1368t1472r1450b1501],
40	.	.	O	.	_	0	SENT_17	[p1l1368t1472r1450b1501],

1	Finally	RB	O	finally	advmod	6	SENT_18	[p1l1464t1472r1560b1501],
2	,	,	O	,	_	0	SENT_18	[p1l1464t1472r1560b1501],
3	the	DT	O	the	det	5	SENT_18	[p1l1572t1472r1617b1496],
4	CAE	NNP	ORGANIZATION	CAE	nn	5	SENT_18	[p1l1629t1472r1684b1496],
5	risk	NN	O	risk	nsubj	6	SENT_18	[p1l1697t1472r1747b1496],
6	appeared	VBD	O	appear	_	0	SENT_18	[p1l1758t1472r1890b1501],
7	to	TO	O	to	aux	9	SENT_18	[p1l1902t1474r1929b1496],
8	be	VB	O	be	cop	9	SENT_18	[p1l1942t1472r1974b1496],
9	greatest	JJS	O	greatest	xcomp	6	SENT_18	[p1l1986t1474r2102b1501],
10	in	IN	O	in	_	0	SENT_18	[p1l495t1517r518b1540],
11	those	DT	O	those	det	12	SENT_18	[p1l530t1517r607b1540],
12	carriers	NNS	O	carrier	prep_in	9	SENT_18	[p1l619t1517r725b1540],
13	assigned	VBN	O	assign	partmod	12	SENT_18	[p1l736t1517r860b1546],
14	to	TO	O	to	_	0	SENT_18	[p1l872t1518r899b1540],
15	simvastatin	NN	O	simvastatin	prep_to	13	SENT_18	[p1l910t1517r1082b1540],
16	.	.	O	.	_	0	SENT_18	[p1l910t1517r1082b1540],

1	Conclusions	NNS	O	conclusion	nn	2	SENT_19	[p1l194t1557r395b1584],
2	SLCO1B1	NN	O	slco1b1	nsubjpass	10	SENT_19	[p1l493t1560r666b1585],
3	*	CD	NUMBER	*	number	4	SENT_19	[p1l493t1560r666b1585],
4	5	CD	NUMBER	5	num	5	SENT_19	[p1l493t1560r666b1585],
5	genotype	NN	O	genotype	dep	2	SENT_19	[p1l677t1562r807b1590],
6	and	CC	O	and	_	0	SENT_19	[p1l818t1561r869b1584],
7	female	JJ	O	female	amod	8	SENT_19	[p1l881t1561r980b1584],
8	sex	NN	O	sex	conj_and	2	SENT_19	[p1l991t1567r1039b1584],
9	were	VBD	O	be	auxpass	10	SENT_19	[p1l1049t1567r1116b1584],
10	associated	VBN	O	associate	_	0	SENT_19	[p1l1128t1561r1279b1584],
11	mild	JJ	O	mild	amod	14	SENT_19	[p1l1293t1561r1352b1584],
12	statin-induced	JJ	O	statin-induced	amod	14	SENT_19	[p1l1364t1561r1563b1584],
13	side	NN	O	side	nn	14	SENT_19	[p1l1575t1561r1633b1584],
14	effects	NNS	O	effect	dobj	10	SENT_19	[p1l1645t1561r1747b1584],
15	.	.	O	.	_	0	SENT_19	[p1l1645t1561r1747b1584],

1	These	DT	O	these	det	2	SENT_20	[p1l1759t1561r1842b1584],
2	findings	NNS	O	finding	nsubj	3	SENT_20	[p1l1853t1561r1965b1590],
3	expand	VBP	O	expand	_	0	SENT_20	[p1l1976t1561r2077b1590],
4	the	DT	O	the	det	5	SENT_20	[p1l494t1605r539b1629],
5	results	NNS	O	result	dobj	3	SENT_20	[p1l551t1605r644b1629],
6	of	IN	O	of	_	0	SENT_20	[p1l656t1605r682b1629],
7	a	DT	O	a	det	11	SENT_20	[p1l693t1611r709b1629],
8	recent	JJ	O	recent	amod	11	SENT_20	[p1l722t1607r810b1629],
9	genome-wide	JJ	O	genome-wide	amod	11	SENT_20	[p1l821t1605r1011b1634],
10	association	NN	O	association	nn	11	SENT_20	[p1l1023t1605r1182b1629],
11	study	NN	O	study	prep_of	5	SENT_20	[p1l1194t1605r1270b1634],
12	of	IN	O	of	_	0	SENT_20	[p1l1281t1605r1308b1629],
13	statin	NN	O	statin	nn	14	SENT_20	[p1l1318t1605r1396b1629],
14	myopathy	NN	O	myopathy	prep_of	11	SENT_20	[p1l1410t1605r1549b1634],
15	with	IN	O	with	_	0	SENT_20	[p1l1559t1605r1617b1629],
16	CK	NN	O	ck	nn	29	SENT_20	[p1l1629t1605r1668b1629],
17	>	JJR	O	>	amod	29	SENT_20	[p1l1680t1605r1749b1629],
18	3	CD	NUMBER	3	npadvmod	19	SENT_20	[p1l1680t1605r1749b1629],
19	>	JJR	O	>	dep	17	SENT_20	[p1l1680t1605r1749b1629],
20	<	JJR	O	<	dep	21	SENT_20	[p1l1680t1605r1749b1629],
21	normal	JJ	O	normal	dep	19	SENT_20	[p1l1765t1605r1862b1629],
22	to	TO	O	to	_	0	SENT_20	[p1l1874t1607r1901b1629],
23	milder	JJR	O	milder	amod	27	SENT_20	[p1l1914t1605r2010b1633],
24	,	,	O	,	_	0	SENT_20	[p1l1914t1605r2010b1633],
25	statininduced	JJ	O	statininduced	dep	23	SENT_20	[p1l2022t1605r2111b1629, p1l495t1650r613b1677],
26	,	,	O	,	_	0	SENT_20	[p1l2022t1605r2111b1629, p1l495t1650r613b1677],
27	muscle	NN	O	muscle	prep_to	17	SENT_20	[p1l626t1650r727b1672],
28	side	NN	O	side	nn	29	SENT_20	[p1l737t1650r795b1672],
29	effects	NNS	O	effect	prep_with	3	SENT_20	[p1l807t1649r909b1672],
30	.	.	O	.	_	0	SENT_20	[p1l807t1649r909b1672],

1	(	NN	O	(	nn	2	SENT_21	[p1l952t1650r971b1678],
2	J	NN	O	j	nsubj	5	SENT_21	[p1l952t1650r971b1678],
3	Am	VBP	O	be	cop	5	SENT_21	[p1l983t1650r1030b1672],
4	Coll	NNP	O	Coll	nn	5	SENT_21	[p1l1043t1649r1093b1672],
5	Cardiol	NNP	O	Cardiol	_	0	SENT_21	[p1l1106t1649r1203b1672],
6	2009	CD	DATE	2009	dep	5	SENT_21	[p1l1216t1649r1492b1678],
7	;	:	O	;	_	0	SENT_21	[p1l1216t1649r1492b1678],
8	54:1609	CD	NUMBER	54:1609	number	9	SENT_21	[p1l1216t1649r1492b1678],
9	—	CD	NUMBER	—	dep	5	SENT_21	[p1l1216t1649r1492b1678],
10	16	CD	NUMBER	16	num	11	SENT_21	[p1l1216t1649r1492b1678],
11	)	NN	O	)	dep	9	SENT_21	[p1l1216t1649r1492b1678],
12	©	CD	NUMBER	©	num	13	SENT_21	[p1l1503t1649r1527b1673],
13	2009	CD	DATE	2009	dep	5	SENT_21	[p1l1538t1649r1614b1673],
14	by	IN	O	by	dep	13	SENT_21	[p1l1627t1650r1657b1678],
15	the	DT	O	the	det	17	SENT_21	[p1l1667t1650r1712b1672],
16	American	NNP	O	American	nn	17	SENT_21	[p1l1723t1650r1858b1672],
17	College	NNP	O	College	pobj	14	SENT_21	[p1l1871t1649r1975b1678],
18	of	IN	O	of	dep	13	SENT_21	[p1l1986t1649r2013b1672],

1	Cardiology	NNP	O	Cardiology	nn	2	SENT_22	[p1l927t1713r1229b1771],
2	Foundation	NNP	O	Foundation	_	0	SENT_22	[p1l1254t1713r1573b1760],

1	Statins	NNS	MISC	statin	nsubjpass	4	SENT_23	[p1l13t2041r239b2104],
2	are	VBP	O	be	auxpass	4	SENT_23	[p1l268t2065r363b2104],
3	widely	RB	O	widely	advmod	4	SENT_23	[p1l386t2041r609b2126],
4	prescribed	VBN	O	prescribe	_	0	SENT_23	[p1l630t2041r977b2126],
5	medications	NNS	O	medication	dobj	4	SENT_23	[p1l1002t2041r1406b2104],
6	for	IN	O	for	_	0	SENT_23	[p1l1433t2041r1529b2104],
7	the	DT	O	the	det	8	SENT_23	[p1l1552t2041r1657b2104],
8	prevention	NN	O	prevention	prep_for	4	SENT_23	[p1l1682t2044r2043b2126],
9	of	IN	O	of	_	0	SENT_23	[p1l10t2142r86b2205],
10	myocardial	JJ	O	myocardial	amod	11	SENT_23	[p1l127t2142r496b2227],
11	infarction	NN	O	infarction	prep_of	8	SENT_23	[p1l547t2142r875b2205],
12	and	CC	O	and	_	0	SENT_23	[p1l928t2142r1049b2205],
13	stroke	NN	O	stroke	conj_and	11	SENT_23	[p1l1102t2142r1322b2219],
14	,	,	O	,	_	0	SENT_23	[p1l1102t2142r1322b2219],
15	and	CC	O	and	_	0	SENT_23	[p1l1378t2142r1499b2205],
16	their	PRP$	O	they	poss	17	SENT_23	[p1l1550t2142r1709b2205],
17	use	NN	O	use	nsubj	19	SENT_23	[p1l1758t2167r1864b2205],
18	also	RB	O	also	advmod	19	SENT_23	[p1l1918t2142r2042b2205],
19	reduces	VBZ	O	reduce	conj_and	4	SENT_23	[p1l9t2243r258b2306],
20	cardiovascular	JJ	O	cardiovascular	amod	22	SENT_23	[p1l300t2243r774b2306],
21	mortality	NN	O	mortality	nn	22	SENT_23	[p1l813t2243r1124b2328],
22	M	NN	O	m	iobj	19	SENT_23	[p1l1163t2241r1272b2320],
23	+	CC	O	+	nsubj	41	SENT_23	[p1l1163t2241r1272b2320],
24	Despite	IN	O	despite	_	0	SENT_23	[p1l1316t2244r1577b2328],
25	their	PRP$	O	they	poss	27	SENT_23	[p1l1617t2243r1776b2306],
26	proven	JJ	O	proven	amod	27	SENT_23	[p1l1813t2267r2043b2329],
27	eﬂicacy	NN	O	eﬂicacy	prep_despite	41	SENT_23	[p1l10t2344r269b2429],
28	,	,	O	,	_	0	SENT_23	[p1l10t2344r269b2429],
29	25	CD	PERCENT	25	number	33	SENT_23	[p1l294t2344r441b2408],
30	%	NN	PERCENT	%	dep	33	SENT_23	[p1l294t2344r441b2408],
31	to	TO	O	to	dep	33	SENT_23	[p1l465t2360r531b2407],
32	50	CD	PERCENT	50	number	33	SENT_23	[p1l556t2344r701b2408],
33	%	NN	PERCENT	%	appos	27	SENT_23	[p1l556t2344r701b2408],
34	of	IN	O	of	_	0	SENT_23	[p1l726t2344r803b2407],
35	patients	NNS	O	patient	prep_of	33	SENT_23	[p1l814t2347r1078b2429],
36	with	IN	O	with	_	0	SENT_23	[p1l1101t2344r1255b2407],
37	coronary	JJ	O	coronary	amod	39	SENT_23	[p1l1280t2368r1575b2429],
38	artery	NN	O	artery	nn	39	SENT_23	[p1l1597t2360r1790b2429],
39	disease	NN	O	disease	prep_with	35	SENT_23	[p1l1812t2344r2043b2407],
40	are	VBP	O	be	cop	41	SENT_23	[p1l11t2469r107b2508],
41	noncompliant	JJ	O	noncompliant	rcmod	22	SENT_23	[p1l143t2445r615b2531],
42	with	IN	O	with	_	0	SENT_23	[p1l645t2445r799b2509],
43	statin	NN	O	statin	nn	44	SENT_23	[p1l836t2448r1020b2508],
44	medications	NNS	O	medication	prep_with	41	SENT_23	[p1l1055t2445r1459b2508],
45	after	IN	O	after	_	0	SENT_23	[p1l1498t2445r1649b2508],
46	1	CD	DURATION	1	num	47	SENT_23	[p1l1687t2449r1717b2508],
47	year	NN	NUMBER	year	prep_after	41	SENT_23	[p1l1754t2469r1893b2530],
48	܄	CD	NUMBER	܄	number	49	SENT_23	[p1l1930t2443r2039b2522],
49	M	NN	O	m	dobj	19	SENT_23	[p1l1930t2443r2039b2522],
50	+	CC	O	+	cc	49	SENT_23	[p1l1930t2443r2039b2522],
51	Although	IN	O	although	mark	54	SENT_23	[p1l7t2545r336b2631],
52	a	DT	O	a	det	54	SENT_23	[p1l364t2571r396b2609],
53	multifactorial	JJ	O	multifactorial	amod	54	SENT_23	[p1l423t2546r879b2609],
54	problem	NN	O	problem	advcl	57	SENT_23	[p1l903t2546r1204b2631],
55	,	,	O	,	_	0	SENT_23	[p1l903t2546r1204b2631],
56	many	JJ	O	many	nsubj	57	SENT_23	[p1l1234t2571r1420b2631],
57	believe	VBP	O	believe	rcmod	49	SENT_23	[p1l1441t2546r1671b2609],
58	that	IN	O	that	_	0	SENT_23	[p1l1699t2546r1833b2609],
59	statin	NN	O	statin	prep_that	57	SENT_23	[p1l1860t2549r2043b2609],

1	From	IN	O	from	dep	71	SENT_24	[p1l9t2865r139b2909],
2	the	DT	O	the	det	20	SENT_24	[p1l157t2865r230b2909],
3	*	CD	NUMBER	*	num	4	SENT_24	[p1l248t2865r478b2909],
4	Division	NN	O	division	nn	20	SENT_24	[p1l248t2865r478b2909],
5	of	IN	O	of	_	0	SENT_24	[p1l497t2865r551b2909],
6	Cardiovascular	NNP	O	Cardiovascular	nn	7	SENT_24	[p1l563t2865r930b2909],
7	Medicine	NNP	O	Medicine	prep_of	4	SENT_24	[p1l946t2865r1195b2919],
8	,	,	O	,	_	0	SENT_24	[p1l946t2865r1195b2919],
9	Duke	NNP	ORGANIZATION	Duke	nn	12	SENT_24	[p1l1215t2865r1349b2909],
10	University	NNP	ORGANIZATION	University	nn	12	SENT_24	[p1l1367t2866r1624b2924],
11	Medical	NNP	ORGANIZATION	Medical	nn	12	SENT_24	[p1l1639t2865r1841b2909],
12	Center	NNP	ORGANIZATION	Center	appos	7	SENT_24	[p1l1860t2865r2042b2919],
13	,	,	O	,	_	0	SENT_24	[p1l1860t2865r2042b2919],
14	Durham	NNP	LOCATION	Durham	appos	7	SENT_24	[p1l9t2938r231b2992],
15	,	,	O	,	_	0	SENT_24	[p1l9t2938r231b2992],
16	North	NNP	LOCATION	North	nn	17	SENT_24	[p1l277t2938r428b2982],
17	Carolina	NNP	LOCATION	Carolina	appos	14	SENT_24	[p1l473t2938r700b2992],
18	;	:	O	;	_	0	SENT_24	[p1l473t2938r700b2992],
19	'	''	O	'	_	0	SENT_24	[p1l745t2938r946b2989],
20	l‘Center	NN	O	l‘center	pobj	1	SENT_24	[p1l745t2938r946b2989],
21	for	IN	O	for	_	0	SENT_24	[p1l989t2938r1059b2982],
22	Human	JJ	ORGANIZATION	human	amod	23	SENT_24	[p1l1102t2938r1290b2982],
23	Genetics	NNP	ORGANIZATION	Genetics	prep_for	20	SENT_24	[p1l1335t2938r1566b2992],
24	,	,	O	,	_	0	SENT_24	[p1l1335t2938r1566b2992],
25	Duke	NNP	ORGANIZATION	Duke	nn	28	SENT_24	[p1l1612t2938r1746b2982],
26	University	NNP	ORGANIZATION	University	nn	28	SENT_24	[p1l1789t2939r2046b2997],
27	Medical	NNP	ORGANIZATION	Medical	nn	28	SENT_24	[p1l8t3011r210b3055],
28	Center	NNP	ORGANIZATION	Center	conj_and	20	SENT_24	[p1l246t3011r428b3065],
29	,	,	O	,	_	0	SENT_24	[p1l246t3011r428b3065],
30	Durham	NNP	LOCATION	Durham	appos	28	SENT_24	[p1l465t3011r688b3065],
31	,	,	O	,	_	0	SENT_24	[p1l465t3011r688b3065],
32	North	NNP	LOCATION	North	nn	33	SENT_24	[p1l724t3011r875b3055],
33	Carolina	NNP	LOCATION	Carolina	conj_and	20	SENT_24	[p1l912t3011r1139b3065],
34	;	:	O	;	_	0	SENT_24	[p1l912t3011r1139b3065],
35	:	:	O	:	_	0	SENT_24	[p1l1176t3011r1508b3071],
36	lIDepartment	NN	O	lidepartment	conj_and	20	SENT_24	[p1l1176t3011r1508b3071],
37	of	IN	O	of	_	0	SENT_24	[p1l1542t3011r1597b3055],
38	Medicine	NNP	O	Medicine	prep_of	36	SENT_24	[p1l1623t3011r1872b3065],
39	,	,	O	,	_	0	SENT_24	[p1l1623t3011r1872b3065],
40	Duke	NNP	ORGANIZATION	Duke	nn	43	SENT_24	[p1l1909t3011r2043b3055],
41	University	NNP	ORGANIZATION	University	nn	43	SENT_24	[p1l8t3085r265b3143],
42	Medical	NNP	ORGANIZATION	Medical	nn	43	SENT_24	[p1l295t3084r497b3128],
43	Center	NNP	ORGANIZATION	Center	appos	36	SENT_24	[p1l531t3084r713b3138],
44	,	,	O	,	_	0	SENT_24	[p1l531t3084r713b3138],
45	Durham	NNP	LOCATION	Durham	nn	48	SENT_24	[p1l749t3084r971b3138],
46	,	,	O	,	_	0	SENT_24	[p1l749t3084r971b3138],
47	North	NNP	LOCATION	North	appos	48	SENT_24	[p1l1006t3084r1157b3128],
48	Carolina	NNP	LOCATION	Carolina	appos	43	SENT_24	[p1l1192t3084r1419b3138],
49	;	:	O	;	_	0	SENT_24	[p1l1192t3084r1419b3138],
50	§	NNP	ORGANIZATION	§	nn	51	SENT_24	[p1l1457t3084r1696b3135],
51	Institute	NNP	ORGANIZATION	Institute	pobj	1	SENT_24	[p1l1457t3084r1696b3135],
52	for	IN	ORGANIZATION	for	_	0	SENT_24	[p1l1730t3084r1799b3128],
53	Genome	NNP	ORGANIZATION	Genome	nn	54	SENT_24	[p1l1833t3084r2043b3128],
54	Sciences	NNPS	ORGANIZATION	Sciences	prep_for	51	SENT_24	[p1l11t3157r214b3201],
55	&	CC	ORGANIZATION	&	_	0	SENT_24	[p1l242t3158r294b3201],
56	Policy	NNP	ORGANIZATION	Policy	prep_for	51	SENT_24	[p1l315t3157r480b3216],
57	,	,	O	,	_	0	SENT_24	[p1l315t3157r480b3216],
58	Duke	NNP	ORGANIZATION	Duke	nn	61	SENT_24	[p1l508t3157r642b3201],
59	University	NNP	ORGANIZATION	University	nn	61	SENT_24	[p1l668t3158r925b3216],
60	Medical	NNP	ORGANIZATION	Medical	nn	61	SENT_24	[p1l947t3157r1150b3201],
61	Center	NNP	ORGANIZATION	Center	pobj	1	SENT_24	[p1l1176t3157r1359b3211],
62	,	,	O	,	_	0	SENT_24	[p1l1176t3157r1359b3211],
63	Durham	NNP	LOCATION	Durham	nn	66	SENT_24	[p1l1387t3157r1609b3211],
64	,	,	O	,	_	0	SENT_24	[p1l1387t3157r1609b3211],
65	North	NNP	LOCATION	North	appos	66	SENT_24	[p1l1637t3157r1788b3201],
66	Carolina	NNP	LOCATION	Carolina	appos	61	SENT_24	[p1l1815t3157r2042b3211],
67	;	:	O	;	_	0	SENT_24	[p1l1815t3157r2042b3211],
68	and	CC	O	and	_	0	SENT_24	[p1l10t3230r97b3274],
69	1lPGxHealth	NN	O	1lpgxhealth	pobj	1	SENT_24	[p1l129t3230r451b3284],
70	,	,	O	,	_	0	SENT_24	[p1l129t3230r451b3284],
71	LLC	NNP	ORGANIZATION	LLC	_	0	SENT_24	[p1l483t3230r616b3284],
72	,	,	O	,	_	0	SENT_24	[p1l483t3230r616b3284],
73	New	NNP	LOCATION	New	nn	74	SENT_24	[p1l647t3231r761b3274],
74	Haven	NNP	LOCATION	Haven	appos	71	SENT_24	[p1l788t3231r957b3284],
75	,	,	O	,	_	0	SENT_24	[p1l788t3231r957b3284],
76	Connecticut	NNP	LOCATION	Connecticut	dep	71	SENT_24	[p1l990t3230r1294b3274],
77	.	.	O	.	_	0	SENT_24	[p1l990t3230r1294b3274],

1	This	DT	O	this	det	2	SENT_25	[p1l1324t3229r1433b3274],
2	work	NN	O	work	nsubjpass	4	SENT_25	[p1l1461t3230r1585b3274],
3	was	VBD	O	be	auxpass	4	SENT_25	[p1l1609t3247r1695b3274],
4	supported	VBN	O	support	_	0	SENT_25	[p1l1726t3230r1961b3290],
5	by	IN	O	by	_	0	SENT_25	[p1l1989t3230r2046b3289],
6	institutional	JJ	O	institutional	amod	7	SENT_25	[p1l9t3303r296b3347],
7	funds	NNS	O	fund	agent	4	SENT_25	[p1l312t3303r441b3347],
8	from	IN	O	from	_	0	SENT_25	[p1l458t3303r572b3347],
9	the	DT	O	the	det	11	SENT_25	[p1l588t3303r662b3347],
10	Duke	NNP	ORGANIZATION	Duke	nn	11	SENT_25	[p1l679t3303r809b3347],
11	Institute	NNP	ORGANIZATION	Institute	prep_from	4	SENT_25	[p1l826t3304r1026b3347],
12	for	IN	ORGANIZATION	for	_	0	SENT_25	[p1l1043t3303r1110b3347],
13	Genome	NNP	ORGANIZATION	Genome	nn	16	SENT_25	[p1l1126t3303r1331b3347],
14	Sciences	NNPS	ORGANIZATION	Sciences	nn	16	SENT_25	[p1l1350t3303r1545b3347],
15	8c	NN	O	8c	nn	16	SENT_25	[p1l1563t3304r1614b3347],
16	Policy	NN	O	policy	prep_for	11	SENT_25	[p1l1626t3303r1782b3362],
17	.	.	O	.	_	0	SENT_25	[p1l1626t3303r1782b3362],

1	Dr.	NNP	O	Dr.	nn	2	SENT_26	[p1l1802t3304r1880b3347],
2	Voora	NNP	PERSON	Voora	nsubjpass	4	SENT_26	[p1l1899t3304r2045b3348],
3	was	VBD	O	be	auxpass	4	SENT_26	[p1l6t3393r93b3420],
4	supported	VBN	O	support	_	0	SENT_26	[p1l119t3376r354b3436],
5	by	IN	O	by	_	0	SENT_26	[p1l376t3376r434b3435],
6	an	DT	O	a	det	9	SENT_26	[p1l456t3393r510b3420],
7	NIH	NNP	MISC	NIH	nn	9	SENT_26	[p1l534t3377r651b3420],
8	T32	NN	MISC	t32	nn	9	SENT_26	[p1l675t3375r774b3421],
9	training	NN	O	training	agent	4	SENT_26	[p1l800t3378r987b3435],
10	grant	NN	O	grant	nn	13	SENT_26	[p1l1010t3387r1134b3435],
11	(	CD	NUMBER	(	num	13	SENT_26	[p1l1159t3375r1576b3430],
12	T32HL007101	NN	O	t32hl007101	nn	13	SENT_26	[p1l1159t3375r1576b3430],
13	)	NN	O	)	dep	9	SENT_26	[p1l1159t3375r1576b3430],
14	.	.	O	.	_	0	SENT_26	[p1l1159t3375r1576b3430],

1	Dr.	NNP	O	Dr.	nn	2	SENT_27	[p1l1603t3377r1682b3420],
2	Shah	NNP	PERSON	Shah	nsubj	3	SENT_27	[p1l1711t3376r1829b3420],
3	received	VBD	O	receive	_	0	SENT_27	[p1l1853t3376r2044b3420],
4	unrestricted	JJ	O	unrestricted	amod	6	SENT_27	[p1l8t3449r290b3493],
5	research	NN	O	research	nn	6	SENT_27	[p1l322t3449r513b3493],
6	funding	NN	O	funding	dobj	3	SENT_27	[p1l545t3449r732b3508],
7	from	IN	O	from	_	0	SENT_27	[p1l763t3449r876b3493],
8	Medtronic	NNP	ORGANIZATION	Medtronic	nn	10	SENT_27	[p1l907t3449r1174b3503],
9	,	,	ORGANIZATION	,	_	0	SENT_27	[p1l907t3449r1174b3503],
10	Inc.	NNP	ORGANIZATION	Inc.	prep_from	3	SENT_27	[p1l1208t3450r1297b3493],
11	.	.	O	.	_	0	SENT_27	[p1l1208t3450r1297b3493],

1	This	DT	O	this	det	2	SENT_28	[p1l1330t3448r1439b3493],
2	trial	NN	O	trial	nsubjpass	4	SENT_28	[p1l1472t3449r1566b3493],
3	was	VBD	O	be	auxpass	4	SENT_28	[p1l1595t3466r1682b3493],
4	conducted	VBN	O	conduct	_	0	SENT_28	[p1l1715t3449r1959b3493],
5	by	IN	O	by	_	0	SENT_28	[p1l1989t3449r2047b3508],
6	Genaissance	NNP	ORGANIZATION	Genaissance	nn	7	SENT_28	[p1l10t3522r302b3566],
7	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	agent	4	SENT_28	[p1l331t3522r729b3576],
8	,	,	O	,	_	0	SENT_28	[p1l331t3522r729b3576],
9	which	WDT	O	which	nsubj	13	SENT_28	[p1l757t3522r902b3566],
10	is	VBZ	O	be	cop	13	SENT_28	[p1l931t3524r964b3566],
11	now	RB	DATE	now	advmod	13	SENT_28	[p1l994t3539r1096b3566],
12	a	DT	O	a	det	13	SENT_28	[p1l1123t3539r1146b3566],
13	part	NN	O	part	rcmod	7	SENT_28	[p1l1172t3534r1267b3582],
14	of	IN	O	of	_	0	SENT_28	[p1l1295t3522r1349b3566],
15	Clinical	JJ	ORGANIZATION	clinical	amod	16	SENT_28	[p1l1370t3522r1555b3566],
16	Data	NNS	ORGANIZATION	datum	prep_of	13	SENT_28	[p1l1583t3523r1711b3576],
17	,	,	ORGANIZATION	,	_	0	SENT_28	[p1l1583t3523r1711b3576],
18	Inc.	NNP	ORGANIZATION	Inc.	appos	16	SENT_28	[p1l1741t3523r1846b3576],
19	,	,	O	,	_	0	SENT_28	[p1l1741t3523r1846b3576],
20	and	CC	O	and	_	0	SENT_28	[p1l1877t3522r1962b3566],
21	all	DT	O	all	det	22	SENT_28	[p1l1991t3522r2044b3566],
22	analyses	NNS	O	analysis	nsubjpass	24	SENT_28	[p1l10t3595r197b3654],
23	were	VBD	O	be	auxpass	24	SENT_28	[p1l212t3612r323b3639],
24	performed	VBN	O	perform	conj_and	4	SENT_28	[p1l339t3595r587b3655],
25	by	IN	O	by	_	0	SENT_28	[p1l602t3595r659b3654],
26	investigators	NNS	O	investigator	agent	24	SENT_28	[p1l673t3597r968b3654],
27	at	IN	O	at	_	0	SENT_28	[p1l987t3606r1029b3639],
28	Duke	NNP	ORGANIZATION	Duke	nn	29	SENT_28	[p1l1045t3595r1175b3639],
29	University	NNP	ORGANIZATION	University	prep_at	26	SENT_28	[p1l1191t3596r1447b3654],
30	.	.	O	.	_	0	SENT_28	[p1l1191t3596r1447b3654],

1	Two	CD	NUMBER	two	num	2	SENT_29	[p1l1464t3594r1575b3639],
2	authors	NNS	O	author	nsubj	10	SENT_29	[p1l1594t3595r1767b3639],
3	(	CD	NUMBER	(	dep	2	SENT_29	[p1l1786t3594r1904b3648],
4	Drs.	NNP	O	Drs.	nn	5	SENT_29	[p1l1786t3594r1904b3648],
5	Reed	NNP	PERSON	Reed	dep	2	SENT_29	[p1l1925t3595r2044b3639],
6	and	CC	O	and	_	0	SENT_29	[p1l10t3668r95b3712],
7	Salisbury	NNP	LOCATION	Salisbury	nn	8	SENT_29	[p1l114t3667r343b3727],
8	)	NNP	O	)	dep	2	SENT_29	[p1l114t3667r343b3727],
9	are	VBP	O	be	cop	10	SENT_29	[p1l363t3685r430b3712],
10	employees	NNS	O	employee	_	0	SENT_29	[p1l448t3668r691b3728],
11	and	CC	O	and	_	0	SENT_29	[p1l710t3668r795b3712],
12	shareholders	NNS	O	shareholder	conj_and	10	SENT_29	[p1l812t3668r1106b3712],
13	of	IN	O	of	_	0	SENT_29	[p1l1125t3668r1179b3712],
14	Clinical	JJ	ORGANIZATION	clinical	amod	15	SENT_29	[p1l1188t3668r1374b3712],
15	Data	NNS	ORGANIZATION	datum	prep_of	10	SENT_29	[p1l1390t3669r1519b3722],
16	,	,	ORGANIZATION	,	_	0	SENT_29	[p1l1390t3669r1519b3722],
17	Inc.	NNP	ORGANIZATION	Inc.	appos	15	SENT_29	[p1l1537t3669r1626b3712],
18	.	.	O	.	_	0	SENT_29	[p1l1537t3669r1626b3712],

1	Paul	NNP	PERSON	Paul	nn	2	SENT_30	[p1l1646t3668r1751b3712],
2	Thompson	NNP	PERSON	Thompson	nsubj	6	SENT_30	[p1l1765t3667r2042b3728],
3	,	,	O	,	_	0	SENT_30	[p1l1765t3667r2042b3728],
4	MD	NNP	O	MD	appos	2	SENT_30	[p1l8t3742r126b3795],
5	,	,	O	,	_	0	SENT_30	[p1l8t3742r126b3795],
6	served	VBD	O	serve	_	0	SENT_30	[p1l151t3741r297b3785],
7	as	IN	O	as	_	0	SENT_30	[p1l320t3758r362b3785],
8	Guest	NNP	O	Guest	nn	9	SENT_30	[p1l386t3741r528b3785],
9	Editor	NNP	O	Editor	prep_as	6	SENT_30	[p1l550t3741r705b3785],
10	for	IN	O	for	_	0	SENT_30	[p1l725t3741r792b3785],
11	this	DT	O	this	det	12	SENT_30	[p1l813t3741r898b3785],
12	article	NN	O	article	prep_for	6	SENT_30	[p1l922t3741r1076b3785],
13	.	.	O	.	_	0	SENT_30	[p1l922t3741r1076b3785],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_31	[p2l67t18r343b77],
2	received	VBD	O	receive	_	0	SENT_31	[p2l364t17r555b61],
3	January	NNP	DATE	January	dobj	2	SENT_31	[p2l570t18r755b76],
4	13	CD	DATE	13	num	3	SENT_31	[p2l777t19r844b71],
5	,	,	DATE	,	_	0	SENT_31	[p2l777t19r844b71],
6	2009	CD	DATE	2009	num	3	SENT_31	[p2l866t19r998b71],
7	;	:	O	;	_	0	SENT_31	[p2l866t19r998b71],
8	revised	VBN	O	revise	amod	9	SENT_31	[p2l1021t17r1184b61],
9	manuscript	NN	O	manuscript	dep	3	SENT_31	[p2l1206t19r1470b77],
10	received	VBN	O	receive	partmod	9	SENT_31	[p2l1490t17r1682b61],
11	April	NNP	DATE	April	tmod	10	SENT_31	[p2l1701t16r1827b77],
12	9	CD	DATE	9	num	11	SENT_31	[p2l1849t19r1889b71],
13	,	,	DATE	,	_	0	SENT_31	[p2l1849t19r1889b71],
14	2009	CD	DATE	2009	num	11	SENT_31	[p2l1911t19r2042b71],
15	,	,	O	,	_	0	SENT_31	[p2l1911t19r2042b71],

1	accepted	VBN	O	accept	_	0	SENT_32	[p2l10t90r212b150],
2	April	NNP	DATE	April	tmod	1	SENT_32	[p2l232t89r359b150],
3	13	CD	DATE	13	num	2	SENT_32	[p2l382t93r450b144],
4	,	,	DATE	,	_	0	SENT_32	[p2l382t93r450b144],
5	2009	CD	DATE	2009	num	2	SENT_32	[p2l473t93r603b135],
6	.	.	O	.	_	0	SENT_32	[p2l473t93r603b135],

1	noncompliance	NN	O	noncompliance	nsubjpass	4	SENT_33	[p2l54t467r581b554],
2	is	VBZ	O	be	auxpass	4	SENT_33	[p2l625t470r675b532],
3	primarily	RB	O	primarily	advmod	4	SENT_33	[p2l718t467r1038b554],
4	caused	VBN	O	cause	_	0	SENT_33	[p2l1079t467r1306b532],
5	by	IN	O	by	_	0	SENT_33	[p2l1346t467r1430b554],
6	side	JJ	O	side	amod	8	SENT_33	[p2l1471t467r1603b532],
7	effects	NNS	O	effect	nn	8	SENT_33	[p2l1647t467r1856b532],
8	D	NN	O	d	agent	4	SENT_33	[p2l1904t465r2017b546],
9	In	IN	O	in	_	0	SENT_33	[p2l2064t468r2140b531],
10	numerous	JJ	O	numerous	amod	12	SENT_33	[p2l54t599r394b639],
11	placebo	NN	O	placebo	nn	12	SENT_33	[p2l436t574r1088b661],
12	—	NN	O	—	prep_in	4	SENT_33	[p2l436t574r1088b661],
13	controlled	VBN	O	control	partmod	12	SENT_33	[p2l436t574r1088b661],
14	clinical	JJ	O	clinical	amod	15	SENT_33	[p2l1130t574r1373b639],
15	trials	NNS	O	trial	dobj	13	SENT_33	[p2l1413t574r1601b653],
16	,	,	O	,	_	0	SENT_33	[p2l1413t574r1601b653],
17	statins	NNS	O	statin	nsubj	18	SENT_33	[p2l1647t577r1865b639],
18	have	VBP	O	have	ccomp	4	SENT_33	[p2l1908t574r2063b639],
19	a	DT	O	a	det	22	SENT_33	[p2l2107t600r2141b639],
20	well-deﬁned	JJ	O	well-deﬁned	amod	22	SENT_33	[p2l50t681r486b746],
21	safety	NN	O	safety	nn	22	SENT_33	[p2l536t681r733b768],
22	proﬁle	NN	O	proﬁle	dobj	18	SENT_33	[p2l778t681r999b768],
23	with	IN	O	with	_	0	SENT_33	[p2l1046t681r1204b745],
24	a	DT	O	a	det	28	SENT_33	[p2l1255t706r1288b745],
25	small	JJ	O	small	amod	28	SENT_33	[p2l1338t681r1517b745],
26	but	CC	O	but	_	0	SENT_33	[p2l1564t681r1680b745],
27	real	JJ	O	real	conj_but	25	SENT_33	[p2l1727t681r1851b745],
28	risk	NN	O	risk	prep_with	22	SENT_33	[p2l1899t681r2028b745],
29	of	IN	O	of	_	0	SENT_33	[p2l2074t681r2152b745],
30	predominantly	RB	O	predominantly	advmod	31	SENT_33	[p2l52t788r565b875],
31	musculoskeletal	JJ	O	musculoskeletal	amod	33	SENT_33	[p2l617t788r1163b852],
32	side	JJ	O	side	amod	33	SENT_33	[p2l1217t788r1348b852],
33	effects	NNS	O	effect	prep_of	28	SENT_33	[p2l1405t788r1613b852],
34	of	IN	O	of	_	0	SENT_33	[p2l1670t788r1749b852],
35	increasing	VBG	O	increase	prepc_of	33	SENT_33	[p2l1791t791r2142b875],
36	severity	NN	O	severity	dobj	35	SENT_33	[p2l55t898r317b982],
37	,	,	O	,	_	0	SENT_33	[p2l55t898r317b982],
38	for	IN	O	for	_	0	SENT_33	[p2l344t895r439b959],
39	example	NN	O	example	prep_for	35	SENT_33	[p2l463t895r752b982],
40	,	,	O	,	_	0	SENT_33	[p2l463t895r752b982],
41	myalgia	NN	O	myalgium	nn	44	SENT_33	[p2l781t895r1054b982],
42	,	,	O	,	_	0	SENT_33	[p2l781t895r1054b982],
43	creatine	NN	O	creatine	dep	44	SENT_33	[p2l1082t898r1339b959],
44	kinase	NN	O	kinase	iobj	35	SENT_33	[p2l1365t895r1570b959],
45	(	CD	NUMBER	(	num	48	SENT_33	[p2l1598t893r1768b974],
46	CK	NN	O	ck	nn	48	SENT_33	[p2l1598t893r1768b974],
47	)	NN	O	)	nn	48	SENT_33	[p2l1598t893r1768b974],
48	elevations	NNS	O	elevation	dobj	35	SENT_33	[p2l1796t895r2137b974],
49	,	,	O	,	_	0	SENT_33	[p2l1796t895r2137b974],
50	and	CC	O	and	_	0	SENT_33	[p2l55t1003r176b1067],
51	rhabdomyolysis	NN	O	rhabdomyolysis	npadvmod	61	SENT_33	[p2l211t1003r728b1090],
52	In	IN	O	in	_	0	SENT_33	[p2l915t1004r989b1066],
53	clinical	JJ	O	clinical	amod	54	SENT_33	[p2l1027t1003r1258b1067],
54	practice	NN	O	practice	prep_in	61	SENT_33	[p2l1291t1006r1548b1090],
55	the	DT	O	the	det	56	SENT_33	[p2l1585t1003r1689b1067],
56	incidence	NN	O	incidence	nsubj	61	SENT_33	[p2l1726t1003r2038b1067],
57	of	IN	O	of	_	0	SENT_33	[p2l2076t1003r2152b1067],
58	mild	JJ	O	mild	amod	60	SENT_33	[p2l54t1110r207b1174],
59	statin	NN	O	statin	nn	60	SENT_33	[p2l233t1110r712b1174],
60	—	NN	O	—	prep_of	56	SENT_33	[p2l233t1110r712b1174],
61	induced	VBD	O	induce	conj_and	4	SENT_33	[p2l233t1110r712b1174],
62	side	JJ	O	side	amod	63	SENT_33	[p2l738t1110r864b1174],
63	effects	NNS	O	effect	nsubjpass	76	SENT_33	[p2l891t1110r1090b1174],
64	appears	VBZ	O	appear	ccomp	61	SENT_33	[p2l1117t1135r1362b1197],
65	to	TO	O	to	aux	67	SENT_33	[p2l1389t1126r1454b1174],
66	be	VB	O	be	cop	67	SENT_33	[p2l1478t1110r1556b1174],
67	greater	JJR	O	greater	xcomp	64	SENT_33	[p2l1580t1126r1810b1197],
68	than	IN	O	than	_	0	SENT_33	[p2l1834t1110r1984b1174],
69	that	DT	O	that	prep_than	67	SENT_33	[p2l2009t1110r2142b1174],
70	seen	VBN	O	see	partmod	69	SENT_33	[p2l55t1242r196b1281],
71	in	IN	O	in	_	0	SENT_33	[p2l233t1219r297b1280],
72	controlled	JJ	O	controlled	amod	73	SENT_33	[p2l334t1216r669b1281],
73	trials	NNS	O	trial	prep_in	70	SENT_33	[p2l704t1216r862b1281],
74	and	CC	O	and	_	0	SENT_33	[p2l901t1216r1023b1281],
75	is	VBZ	O	be	auxpass	76	SENT_33	[p2l1058t1219r1106b1281],
76	estimated	VBN	O	estimate	ccomp	61	SENT_33	[p2l1145t1216r1464b1281],
77	at	IN	O	at	_	0	SENT_33	[p2l1501t1233r1561b1281],
78	5	CD	PERCENT	5	number	82	SENT_33	[p2l1596t1216r1700b1281],
79	%	NN	PERCENT	%	dep	82	SENT_33	[p2l1596t1216r1700b1281],
80	to	TO	O	to	dep	82	SENT_33	[p2l1736t1233r1801b1281],
81	10	CD	PERCENT	10	number	82	SENT_33	[p2l1843t1220r1984b1281],
82	%	NN	PERCENT	%	num	83	SENT_33	[p2l1843t1220r1984b1281],
83	m	NN	O	m	prep_at	76	SENT_33	[p2l2023t1214r2135b1294],

1	See	VB	O	see	_	0	SENT_34	[p2l880t1428r981b1481],
2	page	NN	O	page	dobj	1	SENT_34	[p2l1008t1441r1138b1490],
3	1617	CD	DATE	1617	num	2	SENT_34	[p2l1169t1429r1309b1480],

1	This	DT	O	this	det	2	SENT_35	[p2l51t1635r211b1701],
2	discrepancy	NN	O	discrepancy	nsubj	4	SENT_35	[p2l241t1637r644b1724],
3	is	VBZ	O	be	cop	4	SENT_35	[p2l668t1640r717b1701],
4	unexplained	JJ	O	unexplained	_	0	SENT_35	[p2l745t1637r1182b1724],
5	.	.	O	.	_	0	SENT_35	[p2l745t1637r1182b1724],

1	However	RB	O	however	advmod	6	SENT_36	[p2l1215t1638r1549b1716],
2	,	,	O	,	_	0	SENT_36	[p2l1215t1638r1549b1716],
3	it	PRP	O	it	nsubj	6	SENT_36	[p2l1579t1640r1628b1701],
4	is	VBZ	O	be	cop	6	SENT_36	[p2l1654t1640r1703b1701],
5	the	DT	O	the	det	6	SENT_36	[p2l1733t1637r1840b1701],
6	consensus	NN	O	consensus	_	0	SENT_36	[p2l1869t1662r2137b1701, p2l55t1769r154b1808],
7	that	IN	O	that	complm	12	SENT_36	[p2l189t1744r327b1808],
8	these	DT	O	these	det	9	SENT_36	[p2l359t1744r534b1808],
9	symptoms	NNS	O	symptom	nsubjpass	12	SENT_36	[p2l570t1761r920b1831],
10	can	MD	O	can	aux	12	SENT_36	[p2l956t1769r1071b1808],
11	be	VB	O	be	auxpass	12	SENT_36	[p2l1102t1744r1180b1808],
12	caused	VBN	O	cause	ccomp	6	SENT_36	[p2l1216t1744r1442b1808],
13	by	IN	O	by	_	0	SENT_36	[p2l1473t1744r1557b1831],
14	statins	NNS	O	statin	agent	12	SENT_36	[p2l1588t1747r1827b1823],
15	,	,	O	,	_	0	SENT_36	[p2l1588t1747r1827b1823],
16	often	RB	O	often	advmod	12	SENT_36	[p2l1863t1744r2041b1808],
17	in	IN	O	in	_	0	SENT_36	[p2l2074t1747r2140b1807],
18	the	DT	O	the	det	19	SENT_36	[p2l53t1851r161b1915],
19	absence	NN	O	absence	prep_in	12	SENT_36	[p2l203t1851r466b1915],
20	of	IN	O	of	_	0	SENT_36	[p2l507t1850r586b1915],
21	CK	NN	O	ck	nn	22	SENT_36	[p2l615t1850r740b1915],
22	elevations	NNS	O	elevation	prep_of	19	SENT_36	[p2l778t1851r1115b1915],
23	This	DT	O	this	det	24	SENT_36	[p2l1314t1849r1473b1915],
24	consensus	NN	O	consensus	nsubjpass	26	SENT_36	[p2l1516t1876r1856b1915],
25	is	VBZ	O	be	auxpass	26	SENT_36	[p2l1898t1853r1947b1915],
26	supported	VBN	O	support	rcmod	22	SENT_36	[p2l1990t1876r2137b1938, p2l52t1957r279b2045],
27	by	IN	O	by	_	0	SENT_36	[p2l313t1958r397b2045],
28	observations	NNS	O	observation	agent	26	SENT_36	[p2l431t1958r857b2022],
29	that	WDT	O	that	nsubj	30	SENT_36	[p2l895t1957r1033b2022],
30	statin	VBP	O	statin	rcmod	28	SENT_36	[p2l1070t1957r1571b2022],
31	—	NN	O	—	nsubj	32	SENT_36	[p2l1070t1957r1571b2022],
32	induced	VBD	O	induce	ccomp	30	SENT_36	[p2l1070t1957r1571b2022],
33	side	JJ	O	side	amod	34	SENT_36	[p2l1609t1957r1740b2022],
34	effects	NNS	O	effect	nsubj	35	SENT_36	[p2l1779t1957r1988b2022],
35	appear	VBP	O	appear	ccomp	32	SENT_36	[p2l2028t1983r2137b2045, p2l52t2089r200b2152],
36	to	TO	O	to	aux	43	SENT_36	[p2l227t2081r293b2129],
37	be	VB	O	be	cop	43	SENT_36	[p2l321t2064r399b2129],
38	a	DT	O	a	det	43	SENT_36	[p2l430t2090r464b2129],
39	class	NN	O	class	nn	43	SENT_36	[p2l492t2064r643b2129],
40	effect	NN	O	effect	nn	43	SENT_36	[p2l673t2064r855b2129],
41	(	CD	NUMBER	(	number	42	SENT_36	[p2l884t2062r998b2143],
42	5	CD	NUMBER	5	num	43	SENT_36	[p2l884t2062r998b2143],
43	)	NN	O	)	xcomp	35	SENT_36	[p2l884t2062r998b2143],
44	,	,	O	,	_	0	SENT_36	[p2l884t2062r998b2143],
45	improve	VB	O	improve	appos	43	SENT_36	[p2l1029t2067r1311b2152],
46	with	IN	O	with	_	0	SENT_36	[p2l1337t2064r1495b2129],
47	Withdrawal	NN	O	withdrawal	prep_with	45	SENT_36	[p2l1519t2064r1910b2129],
48	of	IN	O	of	_	0	SENT_36	[p2l1937t2064r2015b2129],
49	the	DT	O	the	det	50	SENT_36	[p2l2032t2064r2139b2129],
50	drug	NN	O	drug	prep_of	47	SENT_36	[p2l54t2171r231b2258],
51	,	,	O	,	_	0	SENT_36	[p2l54t2171r231b2258],
52	and	CC	O	and	_	0	SENT_36	[p2l267t2171r392b2236],
53	recur	VBP	O	recur	ccomp	32	SENT_36	[p2l424t2196r598b2236],
54	with	IN	O	with	_	0	SENT_36	[p2l625t2171r783b2236],
55	rechallenge	NN	O	rechallenge	prep_with	53	SENT_36	[p2l815t2171r1206b2258],
56	of	IN	O	of	_	0	SENT_36	[p2l1239t2171r1317b2236],
57	the	DT	O	the	det	58	SENT_36	[p2l1338t2171r1446b2236],
58	drug	NN	O	drug	prep_of	55	SENT_36	[p2l1480t2171r1638b2258],
59	@	IN	O	@	prep	53	SENT_36	[p2l1672t2169r1784b2250],

1	Although	IN	O	although	mark	9	SENT_37	[p2l138t2276r475b2365],
2	the	DT	O	the	det	3	SENT_37	[p2l534t2278r642b2343],
3	mechanisms	NNS	O	mechanism	nsubj	9	SENT_37	[p2l702t2278r1125b2343],
4	for	IN	O	for	_	0	SENT_37	[p2l1185t2278r1284b2343],
5	these	DT	O	these	det	7	SENT_37	[p2l1341t2278r1517b2343],
6	side	JJ	O	side	amod	7	SENT_37	[p2l1578t2278r1709b2343],
7	effects	NNS	O	effect	prep_for	3	SENT_37	[p2l1769t2278r1979b2343],
8	are	VBP	O	be	cop	9	SENT_37	[p2l2040t2303r2139b2343],
9	unclear	JJ	O	unclear	advcl	16	SENT_37	[p2l52t2385r322b2464],
10	,	,	O	,	_	0	SENT_37	[p2l52t2385r322b2464],
11	certain	JJ	O	certain	amod	13	SENT_37	[p2l360t2388r593b2449],
12	patient	NN	O	patient	nn	13	SENT_37	[p2l626t2388r870b2472],
13	characteristics	NNS	O	characteristic	nsubjpass	16	SENT_37	[p2l904t2385r1387b2449],
14	have	VBP	O	have	aux	16	SENT_37	[p2l1424t2385r1579b2450],
15	been	VBN	O	be	auxpass	16	SENT_37	[p2l1612t2385r1775b2449],
16	identiﬁed	VBN	O	identiﬁed	_	0	SENT_37	[p2l1810t2385r2141b2449],
17	1610	CD	DATE	1610	dobj	16	SENT_37	[p2l14t2487r160b2540],
18	Voora	NNP	O	Voora	tmod	16	SENT_37	[p2l328t2487r493b2540],
19	et	FW	O	et	nn	20	SENT_37	[p2l516t2489r573b2540],
20	al.	FW	O	al.	dep	18	SENT_37	[p2l588t2487r655b2540],
21	.	.	O	.	_	0	SENT_37	[p2l588t2487r655b2540],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_38	[p2l332t2577r858b2639],
2	of	IN	O	of	_	0	SENT_38	[p2l877t2576r933b2629],
3	Statin	NN	O	statin	nn	5	SENT_38	[p2l949t2576r1116b2629],
4	Side	NN	O	side	nn	5	SENT_38	[p2l1136t2576r1259b2629],
5	Eﬁects	NNS	O	eﬁects	prep_of	1	SENT_38	[p2l1280t2576r1468b2629],
6	and	CC	O	and	_	0	SENT_38	[p2l81t2922r191b2971],
7	Acronyms	NNS	MISC	acronym	prep_of	1	SENT_38	[p2l219t2922r530b2983],
8	as	IN	O	as	_	0	SENT_38	[p2l967t2932r1030b2972],
9	lower	JJR	O	lower	amod	11	SENT_38	[p2l1070t2906r1267b2972],
10	body	NN	O	body	nn	11	SENT_38	[p2l1303t2906r1480b2995],
11	mass	NN	O	mass	prep_as	7	SENT_38	[p2l1517t2932r1706b2987],
12	,	,	O	,	_	0	SENT_38	[p2l1517t2932r1706b2987],
13	female	JJ	O	female	amod	14	SENT_38	[p2l1749t2906r1981b2972],
14	sex	NN	O	sex	appos	11	SENT_38	[p2l2023t2932r2147b2987],
15	,	,	O	,	_	0	SENT_38	[p2l2023t2932r2147b2987],
16	that	WDT	O	that	nsubj	17	SENT_38	[p2l965t2799r1107b2865],
17	contribute	VBP	O	contribute	rcmod	11	SENT_38	[p2l1144t2799r1507b2865],
18	to	TO	O	to	_	0	SENT_38	[p2l1546t2816r1614b2865],
19	the	DT	O	the	det	20	SENT_38	[p2l1654t2799r1765b2865],
20	risk	NN	O	risk	prep_to	17	SENT_38	[p2l1803t2799r1950b2880],
21	,	,	O	,	_	0	SENT_38	[p2l1803t2799r1950b2880],
22	such	JJ	O	such	amod	20	SENT_38	[p2l1993t2799r2150b2865],
23	and	CC	O	and	_	0	SENT_38	[p2l967t3013r1095b3079],
24	hepatic	JJ	O	hepatic	conj_and	22	SENT_38	[p2l1129t3013r1385b3103],
25	or	CC	O	or	_	0	SENT_38	[p2l1421t3039r1493b3079],
26	renal	JJ	O	renal	amod	28	SENT_38	[p2l1526t3013r1701b3079],
27	dysfunction	NN	O	dysfunction	nn	28	SENT_38	[p2l1736t3013r2150b3102],
28	(	NN	O	(	prep_as	7	SENT_38	[p2l968t3118r1084b3201],
29	7	CD	NUMBER	7	num	30	SENT_38	[p2l968t3118r1084b3201],
30	)	NN	O	)	dep	28	SENT_38	[p2l968t3118r1084b3201],
31	.	.	O	.	_	0	SENT_38	[p2l968t3118r1084b3201],

1	Several	JJ	O	several	amod	2	SENT_39	[p2l1128t3120r1378b3187],
2	authors	NNS	O	author	nsubj	4	SENT_39	[p2l1414t3120r1675b3186],
3	have	VBP	O	have	aux	4	SENT_39	[p2l1713t3120r1872b3187],
4	identified	VBN	O	identify	_	0	SENT_39	[p2l1909t3120r2147b3186, p2l965t3227r1096b3293],
5	that	IN	O	that	complm	12	SENT_39	[p2l1151t3227r1292b3293],
6	these	DT	O	these	det	8	SENT_39	[p2l1346t3227r1526b3293],
7	side	JJ	O	side	amod	8	SENT_39	[p2l1584t3227r1718b3293],
8	effects	NNS	O	effect	nsubj	12	SENT_39	[p2l1775t3227r1989b3293],
9	are	VBP	O	be	cop	12	SENT_39	[p2l2048t3253r2149b3293],
10	dose	NN	O	dose	nn	12	SENT_39	[p2l966t3334r1122b3400],
11	dependent	JJ	O	dependent	amod	12	SENT_39	[p2l1149t3334r1523b3424],
12	(	NN	O	(	ccomp	4	SENT_39	[p2l1549t3332r1666b3415],
13	8	CD	NUMBER	8	num	14	SENT_39	[p2l1549t3332r1666b3415],
14	)	NN	O	)	dep	12	SENT_39	[p2l1549t3332r1666b3415],
15	,	,	O	,	_	0	SENT_39	[p2l1549t3332r1666b3415],
16	are	VBP	O	be	auxpass	17	SENT_39	[p2l1696t3360r1797b3400],
17	increased	VBN	O	increase	conj_and	12	SENT_39	[p2l1823t3334r2151b3400],
18	by	IN	O	by	_	0	SENT_39	[p2l963t3441r1050b3531],
19	concomitant	JJ	O	concomitant	amod	20	SENT_39	[p2l1070t3444r1516b3507],
20	drugs	NNS	O	drug	agent	17	SENT_39	[p2l1539t3441r1731b3531],
21	that	WDT	O	that	nsubj	22	SENT_39	[p2l1756t3441r1897b3507],
22	impair	VBP	O	impair	rcmod	20	SENT_39	[p2l1919t3444r2152b3531],
23	statin	NN	O	statin	nn	24	SENT_39	[p2l966t3552r1160b3614],
24	disposition	NN	O	disposition	dobj	22	SENT_39	[p2l1219t3548r1607b3638],
25	and	CC	O	and	_	0	SENT_39	[p2l1666t3548r1794b3614],
26	metabolism	NN	O	metabolism	dobj	22	SENT_39	[p2l1852t3548r2147b3614, p2l964t3655r1111b3721],
27	(	CD	NUMBER	(	number	28	SENT_39	[p2l1149t3653r1266b3736],
28	8	CD	NUMBER	8	num	29	SENT_39	[p2l1149t3653r1266b3736],
29	)	NN	O	)	dep	26	SENT_39	[p2l1149t3653r1266b3736],
30	,	,	O	,	_	0	SENT_39	[p2l1149t3653r1266b3736],
31	and	CC	O	and	_	0	SENT_39	[p2l1305t3655r1433b3721],
32	are	VBP	O	be	auxpass	33	SENT_39	[p2l1468t3681r1568b3721],
33	associated	VBN	O	associate	ccomp	4	SENT_39	[p2l1605t3655r1958b3721],
34	with	IN	O	with	_	0	SENT_39	[p2l1988t3655r2150b3722],
35	elevated	JJ	O	elevated	amod	36	SENT_39	[p2l966t3762r1252b3829],
36	levels	NNS	O	level	prep_with	33	SENT_39	[p2l1286t3762r1475b3829],
37	of	IN	O	of	_	0	SENT_39	[p2l1514t3762r1595b3828],
38	statin	NN	O	statin	nn	39	SENT_39	[p2l1621t3766r1814b3828],
39	metabo	NN	O	metabo	prep_of	36	SENT_39	[p2l1852t3762r2147b3828, p2l2t2796r888b3020],

1	AE	NN	O	ae	_	0	SENT_40	[p2l79t3087r148b3127],
2	=	JJ	O	=	amod	4	SENT_40	[p2l175t3100r211b3119],
3	adverse	JJ	O	adverse	amod	4	SENT_40	[p2l238t3087r437b3128],
4	event	NN	O	event	dep	1	SENT_40	[p2l459t3088r601b3128],

1	CAE	NN	O	ca	_	0	SENT_41	[p2l81t3207r187b3248],
2	=	JJ	O	=	amod	5	SENT_41	[p2l214t3220r250b3238],
3	composite	JJ	O	composite	amod	5	SENT_41	[p2l277t3207r544b3258],
4	adverse	JJ	O	adverse	amod	5	SENT_41	[p2l566t3207r766b3248],
5	event	NN	O	event	dep	1	SENT_41	[p2l80t3293r222b3333],

1	CK	NN	O	ck	_	0	SENT_42	[p2l81t3412r154b3453],
2	=	JJ	O	=	amod	4	SENT_42	[p2l180t3425r216b3444],
3	creatine	NN	O	creatine	nn	4	SENT_42	[p2l243t3412r454b3453],
4	kinase	NN	O	kinase	dep	1	SENT_42	[p2l477t3412r644b3453],

1	FDR	NNP	O	FDR	_	0	SENT_43	[p2l82t3533r185b3573],
2	=	JJ	O	=	amod	5	SENT_43	[p2l213t3546r248b3565],
3	false	JJ	O	false	amod	5	SENT_43	[p2l275t3532r397b3574],
4	discovery	NN	O	discovery	nn	5	SENT_43	[p2l419t3532r662b3583],
5	rate	NN	O	rate	dep	1	SENT_43	[p2l685t3534r785b3574],

1	LDL	NN	O	ldl	_	0	SENT_44	[p2l82t3653r175b3693],
2	=	JJ	O	=	amod	4	SENT_44	[p2l201t3666r237b3685],
3	low-density	JJ	O	low-density	amod	4	SENT_44	[p2l265t3653r554b3704],
4	lipoprotein	NN	O	lipoprotein	dep	1	SENT_44	[p2l82t3737r352b3788],

1	MAF	NN	O	maf	_	0	SENT_45	[p3l83t33r200b74],
2	=	JJ	O	=	dep	1	SENT_45	[p3l224t47r260b65],
3	'	''	O	'	_	0	SENT_45	[p3l288t33r431b74],
4	"	``	O	"	punct	2	SENT_45	[p3l288t33r431b74],
5	i	FW	O	i	dep	2	SENT_45	[p3l288t33r431b74],
6	"	``	O	"	punct	7	SENT_45	[p3l288t33r431b74],
7	°	NN	O	°	dep	1	SENT_45	[p3l288t33r431b74],
8	'	''	O	'	_	0	SENT_45	[p3l288t33r431b74],
9	a	DT	O	a	det	11	SENT_45	[p3l452t33r588b74],
10	"	``	O	"	punct	11	SENT_45	[p3l452t33r588b74],
11	°	NN	O	°	dep	7	SENT_45	[p3l452t33r588b74],
12	'	''	O	'	_	0	SENT_45	[p3l452t33r588b74],
13	°	CD	NUMBER	°	num	14	SENT_45	[p3l452t33r588b74],
14	lites	NNS	O	lite	dep	1	SENT_45	[p3l964t45r1105b111],
15	o	NN	O	o	dep	14	SENT_45	[p3l1135t42r1250b125],
16	!	.	O	!	_	0	SENT_45	[p3l1135t42r1250b125],

1	G	NN	O	g	_	0	SENT_46	[p3l1135t42r1250b125],
2	+	CC	O	+	nsubj	3	SENT_46	[p3l1135t42r1250b125],
3	Furthermore	RB	O	furthermore	rcmod	1	SENT_46	[p3l1280t45r1755b125],
4	,	,	O	,	_	0	SENT_46	[p3l1280t45r1755b125],
5	SNPS	NNS	O	snp	dep	3	SENT_46	[p3l1786t45r1984b111],
6	that	WDT	O	that	dobj	8	SENT_46	[p3l2010t45r2152b111],
7	frequencies	NNS	O	frequency	nsubj	8	SENT_46	[p3l80t118r378b169],
8	_	VBP	O	_	rcmod	5	SENT_46	[p3l968t155r978b165],
9	,	,	O	,	_	0	SENT_46	[p3l1159t155r1169b165],
10	,	,	O	,	_	0	SENT_46	[p3l1575t155r1586b165],
11	,	,	O	,	_	0	SENT_46	[p3l1644t155r1654b165],

1	impair	VB	O	impair	_	0	SENT_47	[p3l965t178r1211b241],
2	the	DT	O	the	det	3	SENT_47	[p3l1277t152r1393b218],
3	activity	NN	O	activity	dobj	1	SENT_47	[p3l1463t169r1738b241],
4	of	IN	O	of	_	0	SENT_47	[p3l1802t152r1885b218],
5	drugmetabolizing	VBG	O	drugmetabolize	prepc_of	3	SENT_47	[p3l1942t152r2147b241, p3l966t259r1430b348],
6	enzymes	NNS	O	enzyme	dobj	5	SENT_47	[p3l1483t285r1781b348],
7	(	CD	NUMBER	(	number	8	SENT_47	[p3l1840t257r1933b340],
8	9	CD	NUMBER	9	num	9	SENT_47	[p3l1840t257r1933b340],
9	)	NN	O	)	nsubjpass	12	SENT_47	[p3l1840t257r1933b340],
10	have	VBP	O	have	aux	12	SENT_47	[p3l1990t259r2149b326],
11	been	VBN	O	be	auxpass	12	SENT_47	[p3l963t366r1131b432],
12	associated	VBN	O	associate	rcmod	6	SENT_47	[p3l1176t366r1530b432],
13	with	IN	O	with	_	0	SENT_47	[p3l1571t366r1733b433],
14	the	DT	O	the	det	15	SENT_47	[p3l1777t366r1887b432],
15	development	NN	O	development	prep_with	12	SENT_47	[p3l1934t366r2147b433, p3l966t492r1240b565],

1	of	IN	O	of	_	0	SENT_48	[p3l1288t475r1368b541],
2	musculoskeletal	JJ	O	musculoskeletal	amod	4	SENT_48	[p3l1406t475r1966b541],
3	side	JJ	O	side	amod	4	SENT_48	[p3l2015t475r2149b541],
4	effects	NNS	O	effect	pobj	1	SENT_48	[p3l10t583r245b649],
5	.	.	O	.	_	0	SENT_48	[p3l10t583r245b649],

1	In	IN	O	in	_	0	SENT_49	[p3l274t584r351b648],
2	particular	JJ	O	particular	prep_in	20	SENT_49	[p3l375t583r733b672],
3	,	,	O	,	_	0	SENT_49	[p3l375t583r733b672],
4	the	DT	O	the	det	13	SENT_49	[p3l760t583r871b649],
5	*	NN	O	*	nn	13	SENT_49	[p3l896t583r964b649],
6	5	CD	NUMBER	5	num	13	SENT_49	[p3l896t583r964b649],
7	allele	NN	O	allele	nn	13	SENT_49	[p3l994t583r1171b649],
8	(	CD	NUMBER	(	num	13	SENT_49	[p3l1200t581r1628b664],
9	Val174Ala	NN	O	val174alum	nn	13	SENT_49	[p3l1200t581r1628b664],
10	,	,	O	,	_	0	SENT_49	[p3l1200t581r1628b664],
11	rs414905	NN	O	rs414905	dep	13	SENT_49	[p3l1656t583r1979b649],
12	6	CD	NUMBER	6	num	13	SENT_49	[p3l1988t581r2053b663],
13	)	NN	O	)	nsubj	20	SENT_49	[p3l1988t581r2053b663],
14	in	IN	O	in	_	0	SENT_49	[p3l2082t586r2150b648],
15	the	DT	O	the	det	19	SENT_49	[p3l9t689r120b755],
16	hepatic	JJ	O	hepatic	amod	19	SENT_49	[p3l182t689r438b778],
17	drug	NN	O	drug	nn	19	SENT_49	[p3l500t689r663b778],
18	transporter	NN	O	transporter	nn	19	SENT_49	[p3l722t706r1114b779],
19	SLCOZBJ	NN	O	slcozbj	prep_in	20	SENT_49	[p3l1177t692r1536b756],
20	interferes	VBZ	O	interfere	_	0	SENT_49	[p3l1600t689r1929b755],
21	with	IN	O	with	_	0	SENT_49	[p3l1988t689r2150b755],
22	localization	NN	O	localization	prep_with	20	SENT_49	[p3l8t796r416b863],
23	of	IN	O	of	_	0	SENT_49	[p3l444t796r524b863],
24	the	DT	O	the	det	25	SENT_49	[p3l538t797r649b863],
25	transporter	NN	O	transporter	prep_of	22	SENT_49	[p3l676t813r1069b886],
26	to	TO	O	to	_	0	SENT_49	[p3l1094t814r1162b863],
27	the	DT	O	the	det	29	SENT_49	[p3l1190t796r1301b863],
28	plasma	NN	O	plasma	nn	29	SENT_49	[p3l1327t797r1575b886],
29	membrane	NN	O	membrane	prep_to	25	SENT_49	[p3l1602t797r1977b863],
30	(	CD	NUMBER	(	number	31	SENT_49	[p3l2008t794r2146b877],
31	10	CD	NUMBER	10	num	32	SENT_49	[p3l2008t794r2146b877],
32	)	NN	O	)	dobj	20	SENT_49	[p3l2008t794r2146b877],
33	and	CC	O	and	_	0	SENT_49	[p3l11t903r139b969],
34	leads	VBZ	O	lead	conj_and	20	SENT_49	[p3l167t903r340b969],
35	to	TO	O	to	_	0	SENT_49	[p3l372t920r440b969],
36	greater	JJR	O	greater	amod	39	SENT_49	[p3l471t920r717b992],
37	systemic	JJ	O	systemic	amod	39	SENT_49	[p3l747t906r1044b992],
38	statin	NN	O	statin	nn	39	SENT_49	[p3l1075t906r1268b969],
39	concentrations	NNS	O	concentration	prep_to	34	SENT_49	[p3l1299t906r1817b969],
40	(	VBP	O	(	dep	39	SENT_49	[p3l1852t901r2146b984],
41	11-13	CD	NUMBER	11-13	num	42	SENT_49	[p3l1852t901r2146b984],
42	)	CD	NUMBER	)	dobj	40	SENT_49	[p3l1852t901r2146b984],
43	.	.	O	.	_	0	SENT_49	[p3l1852t901r2146b984],

1	The	DT	O	the	det	2	SENT_50	[p3l7t1009r154b1077],
2	*	NN	O	*	nsubj	23	SENT_50	[p3l192t1010r260b1077],
3	5	CD	NUMBER	5	num	4	SENT_50	[p3l192t1010r260b1077],
4	allele	NN	O	allele	nsubjpass	6	SENT_50	[p3l303t1010r480b1077],
5	was	VBD	O	be	auxpass	6	SENT_50	[p3l515t1037r645b1077],
6	identiﬁed	VBN	O	identiﬁed	rcmod	2	SENT_50	[p3l685t1010r1024b1077],
7	in	IN	O	in	_	0	SENT_50	[p3l1062t1013r1129b1076],
8	a	DT	O	a	det	13	SENT_50	[p3l1169t1037r1203b1077],
9	genome	NN	O	genome	nn	13	SENT_50	[p3l1239t1010r1725b1100],
10	—	CD	NUMBER	—	num	13	SENT_50	[p3l1239t1010r1725b1100],
11	wide	JJ	O	wide	amod	13	SENT_50	[p3l1239t1010r1725b1100],
12	association	NN	O	association	nn	13	SENT_50	[p3l1766t1013r2150b1077],
13	study	NN	O	study	prep_in	6	SENT_50	[p3l11t1117r201b1206],
14	as	IN	O	as	_	0	SENT_50	[p3l235t1143r298b1183],
15	a	DT	O	a	det	17	SENT_50	[p3l338t1143r372b1183],
16	dominant	JJ	O	dominant	amod	17	SENT_50	[p3l408t1117r754b1183],
17	cause	NN	O	cause	prep_as	13	SENT_50	[p3l789t1143r974b1183],
18	of	IN	O	of	_	0	SENT_50	[p3l1012t1117r1092b1183],
19	severe	JJ	O	severe	amod	21	SENT_50	[p3l1118t1143r1327b1183],
20	statin-induced	JJ	O	statin-induced	amod	21	SENT_50	[p3l1366t1117r1881b1183],
21	myopathy	NN	O	myopathy	prep_of	17	SENT_50	[p3l1917t1143r2147b1206, p3l11t1224r164b1313],
22	(	RB	O	(	advmod	23	SENT_50	[p3l203t1222r492b1305],
23	defined	VBN	O	define	_	0	SENT_50	[p3l203t1222r492b1305],
24	as	IN	O	as	_	0	SENT_50	[p3l533t1251r596b1290],
25	CK	NN	O	ck	prep_as	23	SENT_50	[p3l640t1224r767b1291],
26	>	JJR	O	>	npadvmod	29	SENT_50	[p3l810t1228r1031b1291],
27	10	CD	NUMBER	10	number	28	SENT_50	[p3l810t1228r1031b1291],
28	>	JJR	O	>	amod	26	SENT_50	[p3l810t1228r1031b1291],
29	<	JJR	O	<	amod	25	SENT_50	[p3l810t1228r1031b1291],
30	the	DT	O	the	det	32	SENT_50	[p3l1080t1224r1190b1290],
31	upper	JJ	O	upper	amod	32	SENT_50	[p3l1230t1250r1435b1314],
32	limit	NN	O	limit	dobj	23	SENT_50	[p3l1472t1224r1643b1290],
33	of	IN	O	of	_	0	SENT_50	[p3l1682t1224r1762b1290],
34	normal	JJ	O	normal	amod	42	SENT_50	[p3l1791t1224r2043b1290],
35	in	IN	O	in	_	0	SENT_50	[p3l2082t1227r2150b1290],
36	those	DT	O	those	prep_in	34	SENT_50	[p3l9t1332r196b1398],
37	with	IN	O	with	_	0	SENT_50	[p3l217t1332r379b1398],
38	symptoms	NNS	O	symptom	prep_with	36	SENT_50	[p3l404t1349r763b1421],
39	and	CC	O	and	_	0	SENT_50	[p3l790t1332r918b1398],
40	>	JJR	O	>	conj_and	34	SENT_50	[p3l947t1335r1053b1398],
41	3	CD	NUMBER	3	dep	34	SENT_50	[p3l947t1335r1053b1398],
42	X	NN	O	x	prep_of	32	SENT_50	[p3l1069t1341r1122b1394],
43	in	IN	O	in	_	0	SENT_50	[p3l1155t1335r1223b1397],
44	those	DT	O	those	nsubj	50	SENT_50	[p3l1247t1332r1434b1398],
45	Without	IN	O	without	_	0	SENT_50	[p3l1455t1332r1736b1398],
46	symptoms	NNS	O	symptom	prep_without	50	SENT_50	[p3l1760t1330r2147b1421],
47	)	RB	O	)	advmod	46	SENT_50	[p3l1760t1330r2147b1421],
48	in	IN	O	in	_	0	SENT_50	[p3l9t1441r77b1503],
49	patients	NNS	O	patient	prep_in	46	SENT_50	[p3l110t1441r389b1528],
50	taking	VBG	O	take	prepc_in	23	SENT_50	[p3l424t1438r648b1527],
51	80	CD	NUMBER	80	num	52	SENT_50	[p3l683t1441r765b1505],
52	mg	NN	O	mg	dobj	50	SENT_50	[p3l801t1464r914b1527],
53	of	IN	O	of	_	0	SENT_50	[p3l947t1438r1027b1504],
54	simvastatin	NN	O	simvastatin	prep_of	52	SENT_50	[p3l1050t1441r1448b1504],
55	(	CD	NUMBER	(	num	54	SENT_50	[p3l1485t1436r1645b1519],
56	14	CD	NUMBER	14	num	57	SENT_50	[p3l1485t1436r1645b1519],
57	)	NN	O	)	dep	54	SENT_50	[p3l1485t1436r1645b1519],
58	.	.	O	.	_	0	SENT_50	[p3l1485t1436r1645b1519],

1	Whether	IN	O	whether	complm	16	SENT_51	[p3l1680t1438r2007b1505],
2	the	DT	O	the	det	5	SENT_51	[p3l2039t1438r2149b1504],
3	SLCO1B	NN	O	slco1b	nn	5	SENT_51	[p3l12t1549r450b1612],
4	]	CD	NUMBER	]	num	5	SENT_51	[p3l12t1549r450b1612],
5	*	NN	O	*	nsubj	16	SENT_51	[p3l12t1549r450b1612],
6	5	CD	NUMBER	5	dep	5	SENT_51	[p3l12t1549r450b1612],
7	and	CC	O	and	_	0	SENT_51	[p3l473t1545r601b1612],
8	other	JJ	O	other	amod	9	SENT_51	[p3l626t1545r813b1612],
9	SNPS	NNS	O	snp	nsubj	16	SENT_51	[p3l841t1545r1038b1612],
10	in	IN	O	in	_	0	SENT_51	[p3l1065t1548r1133b1611],
11	drug	NN	O	drug	prep_in	9	SENT_51	[p3l1159t1545r1825b1635],
12	—	CD	NUMBER	—	num	11	SENT_51	[p3l1159t1545r1825b1635],
13	metabolizing	VBG	O	metabolize	partmod	11	SENT_51	[p3l1159t1545r1825b1635],
14	enzymes	NNS	O	enzyme	dobj	13	SENT_51	[p3l1849t1572r2149b1635],
15	are	VBP	O	be	cop	16	SENT_51	[p3l11t1678r112b1718],
16	responsible	JJ	O	responsible	ccomp	28	SENT_51	[p3l138t1652r534b1741],
17	for	IN	O	for	_	0	SENT_51	[p3l560t1652r661b1718],
18	milder	JJ	O	milder	amod	20	SENT_51	[p3l686t1652r917b1718],
19	side	JJ	O	side	amod	20	SENT_51	[p3l943t1652r1077b1718],
20	effects	NNS	O	effect	prep_for	16	SENT_51	[p3l1105t1652r1319b1718],
21	caused	VBN	O	cause	partmod	20	SENT_51	[p3l1347t1652r1580b1718],
22	by	IN	O	by	_	0	SENT_51	[p3l1603t1652r1690b1741],
23	statins	NNS	O	statin	agent	21	SENT_51	[p3l1713t1655r1936b1718],
24	other	JJ	O	other	nsubj	28	SENT_51	[p3l1964t1652r2152b1718],
25	than	IN	O	than	_	0	SENT_51	[p3l9t1759r168b1825],
26	simvastatin	NN	O	simvastatin	prep_than	24	SENT_51	[p3l203t1762r601b1825],
27	is	VBZ	O	be	cop	28	SENT_51	[p3l634t1762r685b1825],
28	unknown	JJ	O	unknown	_	0	SENT_51	[p3l718t1759r1072b1825],
29	.	.	O	.	_	0	SENT_51	[p3l718t1759r1072b1825],

1	Therefore	RB	O	therefore	advmod	4	SENT_52	[p3l96t1865r473b1948],
2	,	,	O	,	_	0	SENT_52	[p3l96t1865r473b1948],
3	we	PRP	O	we	nsubj	4	SENT_52	[p3l498t1893r597b1933],
4	sought	VBD	O	seek	_	0	SENT_52	[p3l625t1867r863b1956],
5	to	TO	O	to	aux	6	SENT_52	[p3l887t1884r955b1933],
6	test	VB	O	test	xcomp	4	SENT_52	[p3l982t1884r1108b1933],
7	the	DT	O	the	det	8	SENT_52	[p3l1131t1867r1242b1933],
8	hypothesis	NN	O	hypothesis	dobj	6	SENT_52	[p3l1269t1867r1643b1956],
9	that	IN	O	that	complm	26	SENT_52	[p3l1670t1867r1812b1933],
10	common	JJ	O	common	amod	12	SENT_52	[p3l1838t1893r2150b1933],
11	genetic	JJ	O	genetic	amod	12	SENT_52	[p3l8t1976r262b2062],
12	polymorphisms	NNS	O	polymorphism	nsubjpass	26	SENT_52	[p3l310t1973r858b2063],
13	that	WDT	O	that	nsubj	14	SENT_52	[p3l909t1973r1051b2039],
14	lead	VBP	O	lead	rcmod	12	SENT_52	[p3l1097t1973r1241b2039],
15	to	TO	O	to	_	0	SENT_52	[p3l1289t1990r1357b2039],
16	reduced	VBN	O	reduce	amod	17	SENT_52	[p3l1408t1973r1687b2039],
17	function	NN	O	function	prep_to	14	SENT_52	[p3l1735t1973r2033b2039],
18	in	IN	O	in	_	0	SENT_52	[p3l2082t1976r2150b2038],
19	drug	NN	O	drug	prep_in	17	SENT_52	[p3l10t2082r173b2171],
20	metabolizing	VBG	O	metabolize	partmod	19	SENT_52	[p3l205t2082r669b2171],
21	or	CC	O	or	_	0	SENT_52	[p3l701t2107r774b2148],
22	transporting	VBG	O	transport	partmod	19	SENT_52	[p3l804t2085r1244b2171],
23	enzymes	NNS	O	enzyme	dobj	20	SENT_52	[p3l1276t2108r1574b2171],
24	would	MD	O	would	aux	26	SENT_52	[p3l1605t2082r1827b2148],
25	be	VB	O	be	auxpass	26	SENT_52	[p3l1857t2082r1938b2148],
26	associated	VBN	O	associate	ccomp	6	SENT_52	[p3l1973t2108r2148b2148, p3l10t2188r218b2254],
27	with	IN	O	with	_	0	SENT_52	[p3l267t2188r430b2254],
28	mild	JJ	O	mild	amod	31	SENT_52	[p3l484t2188r646b2254],
29	statin-induced	JJ	O	statin-induced	amod	31	SENT_52	[p3l700t2188r1215b2254],
30	side	NN	O	side	nn	31	SENT_52	[p3l1269t2188r1404b2254],
31	effects	NNS	O	effect	prep_with	26	SENT_52	[p3l1459t2188r1695b2269],
32	,	,	O	,	_	0	SENT_52	[p3l1459t2188r1695b2269],
33	particularly	RB	O	particularly	advmod	31	SENT_52	[p3l1751t2188r2154b2278],
34	those	DT	O	those	dep	31	SENT_52	[p3l9t2295r196b2362],
35	Without	IN	O	without	_	0	SENT_52	[p3l227t2295r509b2362],
36	CK	NN	O	ck	nn	37	SENT_52	[p3l543t2295r670b2362],
37	elevations	NNS	O	elevation	prep_without	26	SENT_52	[p3l702t2295r1068b2362],
38	.	.	O	.	_	0	SENT_52	[p3l702t2295r1068b2362],

1	We	PRP	O	we	nsubj	2	SENT_53	[p3l1102t2296r1233b2362],
2	tested	VBD	O	test	_	0	SENT_53	[p3l1267t2295r1477b2362],
3	this	DT	O	this	det	4	SENT_53	[p3l1510t2295r1637b2362],
4	hypothesis	NN	O	hypothesis	nsubj	29	SENT_53	[p3l1672t2295r2047b2385],
5	in	IN	O	in	_	0	SENT_53	[p3l2082t2298r2150b2361],
6	the	DT	O	the	det	7	SENT_53	[p3l9t2402r120b2468],
7	context	NN	O	context	prep_in	4	SENT_53	[p3l153t2419r413b2468],
8	of	IN	O	of	_	0	SENT_53	[p3l443t2402r524b2468],
9	a	DT	O	a	det	12	SENT_53	[p3l544t2428r579b2468],
10	large	JJ	O	large	amod	12	SENT_53	[p3l607t2402r777b2491],
11	pharmacogenetics	NNS	O	pharmacogenetic	nn	12	SENT_53	[p3l808t2402r1446b2491],
12	trial	NN	O	trial	prep_of	7	SENT_53	[p3l1479t2402r1621b2468],
13	of	IN	O	of	_	0	SENT_53	[p3l1651t2402r1732b2468],
14	3	CD	NUMBER	3	num	17	SENT_53	[p3l1752t2405r1788b2468],
15	commercially	RB	O	commercially	advmod	16	SENT_53	[p3l1824t2428r2147b2468, p3l10t2509r193b2598],
16	available	JJ	O	available	amod	17	SENT_53	[p3l225t2509r525b2576],
17	statins	NNS	O	statin	prep_of	12	SENT_53	[p3l561t2512r806b2590],
18	,	,	O	,	_	0	SENT_53	[p3l561t2512r806b2590],
19	the	DT	O	the	det	23	SENT_53	[p3l843t2509r954b2575],
20	STRENGTH	NN	O	strength	nn	23	SENT_53	[p3l993t2507r1502b2576],
21	(	CD	NUMBER	(	num	23	SENT_53	[p3l1541t2507r1780b2590],
22	Statin	NN	O	statin	nn	23	SENT_53	[p3l1541t2507r1780b2590],
23	Response	NN	O	response	appos	17	SENT_53	[p3l1816t2510r2149b2599],
24	Examined	VBN	O	examine	partmod	23	SENT_53	[p3l11t2617r374b2683],
25	by	IN	O	by	_	0	SENT_53	[p3l396t2617r483b2706],
26	Genetic	JJ	O	genetic	amod	28	SENT_53	[p3l506t2617r787b2683],
27	Haplotype	NN	O	haplotype	nn	28	SENT_53	[p3l813t2617r1186b2706],
28	Markers	NNS	O	marker	agent	24	SENT_53	[p3l1211t2615r1536b2697],
29	)	VBP	O	)	ccomp	2	SENT_53	[p3l1211t2615r1536b2697],
30	study	NN	O	study	dobj	29	SENT_53	[p3l1567t2617r1772b2706],
31	,	,	O	,	_	0	SENT_53	[p3l1567t2617r1772b2706],
32	where	WRB	O	where	advmod	36	SENT_53	[p3l1797t2617r2013b2683],
33	the	DT	O	the	det	35	SENT_53	[p3l2038t2617r2149b2683],
34	main	JJ	O	main	amod	35	SENT_53	[p3l10t2728r187b2791],
35	objectives	NNS	O	objective	nsubj	36	SENT_53	[p3l229t2725r570b2814],
36	were	VBD	O	be	rcmod	30	SENT_53	[p3l609t2751r776b2791],
37	to	TO	O	to	aux	38	SENT_53	[p3l817t2742r886b2791],
38	identify	VB	O	identify	xcomp	36	SENT_53	[p3l928t2725r1203b2814],
39	genetic	JJ	O	genetic	amod	40	SENT_53	[p3l1239t2728r1493b2814],
40	associations	NNS	O	association	dobj	38	SENT_53	[p3l1535t2728r1949b2791],
41	with	IN	O	with	_	0	SENT_53	[p3l1988t2725r2150b2791],
42	statin	NN	O	statin	nn	43	SENT_53	[p3l11t2835r204b2899],
43	safety	NN	O	safety	prep_with	38	SENT_53	[p3l239t2832r441b2922],
44	and	CC	O	and	_	0	SENT_53	[p3l472t2832r600b2899],
45	efficacy	NN	O	efficacy	prep_with	38	SENT_53	[p3l633t2832r904b2922],
46	.	.	O	.	_	0	SENT_53	[p3l633t2832r904b2922],

1	SNP	NN	O	snp	_	0	SENT_54	[p3l80t239r187b280],
2	=	JJ	O	=	amod	5	SENT_54	[p3l214t252r250b270],
3	single	JJ	O	single	amod	5	SENT_54	[p3l276t239r428b290],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_54	[p3l452t239r720b280],
5	polymorphism	NN	O	polymorphism	dep	1	SENT_54	[p3l82t323r436b374],

1	Methods	NNS	O	method	_	0	SENT_55	[p3l12t3083r379b3145],

1	Study	NNP	O	Study	_	0	SENT_56	[p4l12t53r228b143],
2	population	NN	O	population	dep	1	SENT_56	[p4l263t53r694b143],
3	.	.	O	.	_	0	SENT_56	[p4l263t53r694b143],

1	The	DT	O	the	det	3	SENT_57	[p4l743t52r890b120],
2	STRENGTH	NN	O	strength	nn	3	SENT_57	[p4l935t52r1445b120],
3	study	NN	O	study	nsubj	7	SENT_57	[p4l1487t54r1677b143],
4	was	VBD	O	be	cop	7	SENT_57	[p4l1709t80r1839b120],
5	a	DT	O	a	det	7	SENT_57	[p4l1882t80r1916b120],
6	pharmacogenetic	JJ	O	pharmacogenetic	amod	7	SENT_57	[p4l1954t54r2148b143, p4l10t165r454b251],
7	study	NN	O	study	_	0	SENT_57	[p4l481t162r671b251],
8	of	IN	O	of	_	0	SENT_57	[p4l694t162r774b228],
9	statin	NN	O	statin	nn	10	SENT_57	[p4l789t165r983b228],
10	eﬂicacy	NN	O	eﬂicacy	prep_of	7	SENT_57	[p4l1009t162r1266b251],
11	and	CC	O	and	_	0	SENT_57	[p4l1290t162r1418b228],
12	safety	NN	O	safety	conj_and	7	SENT_57	[p4l1444t162r1647b251],
13	(	CD	NUMBER	(	number	14	SENT_57	[p4l1672t160r1832b242],
14	15	CD	NUMBER	15	num	15	SENT_57	[p4l1672t160r1832b242],
15	)	NN	O	)	dep	12	SENT_57	[p4l1672t160r1832b242],
16	.	.	O	.	_	0	SENT_57	[p4l1672t160r1832b242],

1	In	IN	O	in	_	0	SENT_58	[p4l1862t163r1940b227],
2	brief	NN	O	brief	prep_in	7	SENT_58	[p4l1964t162r2147b243],
3	,	,	O	,	_	0	SENT_58	[p4l1964t162r2147b243],
4	it	PRP	O	it	nsubj	7	SENT_58	[p4l9t271r60b334],
5	was	VBD	O	be	cop	7	SENT_58	[p4l83t294r213b334],
6	a	DT	O	a	det	7	SENT_58	[p4l245t294r280b334],
7	16-week	JJ	DURATION	16-week	_	0	SENT_58	[p4l311t268r630b349],
8	,	,	O	,	_	0	SENT_58	[p4l311t268r630b349],
9	randomized	VBN	O	randomize	partmod	7	SENT_58	[p4l662t268r1104b349],
10	,	,	O	,	_	0	SENT_58	[p4l662t268r1104b349],
11	open	JJ	O	open	amod	14	SENT_58	[p4l1137t268r1513b357],
12	—	NN	O	—	nn	14	SENT_58	[p4l1137t268r1513b357],
13	label	NN	O	label	nn	14	SENT_58	[p4l1137t268r1513b357],
14	study	NN	O	study	dobj	9	SENT_58	[p4l1542t268r1732b357],
15	of	IN	O	of	_	0	SENT_58	[p4l1757t268r1837b334],
16	3	CD	NUMBER	3	num	17	SENT_58	[p4l1855t271r1891b334],
17	statins	NNS	O	statin	prep_of	14	SENT_58	[p4l1925t271r2149b334],
18	tested	VBN	O	test	partmod	17	SENT_58	[p4l9t375r218b441],
19	in	IN	O	in	_	0	SENT_58	[p4l261t378r329b441],
20	509	CD	NUMBER	509	num	21	SENT_58	[p4l372t375r500b442],
21	outpatients	NNS	O	outpatient	prep_in	18	SENT_58	[p4l547t378r942b465],
22	with	IN	O	with	_	0	SENT_58	[p4l983t375r1146b442],
23	hypercholesterolemia	NN	O	hypercholesterolemia	prep_with	18	SENT_58	[p4l1189t375r1947b465],
24	conducted	VBN	O	conduct	partmod	23	SENT_58	[p4l1990t401r2148b441, p4l10t483r248b549],
25	between	IN	O	between	_	0	SENT_58	[p4l290t483r585b549],
26	2001	CD	DATE	2001	prep_between	24	SENT_58	[p4l628t486r800b550],
27	and	CC	DATE	and	_	0	SENT_58	[p4l851t483r979b549],
28	2002	CD	DATE	2002	prep_between	24	SENT_58	[p4l1021t486r1217b550],
29	.	.	O	.	_	0	SENT_58	[p4l1021t486r1217b550],

1	Subjects	NNS	O	subject	nsubjpass	4	SENT_59	[p4l1270t483r1557b572],
2	were	VBD	O	be	auxpass	4	SENT_59	[p4l1600t508r1767b549],
3	randomly	RB	O	randomly	advmod	4	SENT_59	[p4l1812t483r2154b572],
4	assigned	VBN	O	assign	_	0	SENT_59	[p4l11t589r307b678],
5	to	TO	O	to	_	0	SENT_59	[p4l341t606r410b655],
6	8	CD	DURATION	8	num	7	SENT_59	[p4l449t592r484b655],
7	weeks	NNS	NUMBER	week	prep_to	4	SENT_59	[p4l518t589r730b655],
8	of	IN	O	of	_	0	SENT_59	[p4l768t589r848b655],
9	10	CD	NUMBER	10	prep_of	7	SENT_59	[p4l874t592r955b655],
10	mg/day	JJ	O	mg/day	amod	11	SENT_59	[p4l992t589r1261b678],
11	atorvastatin	NN	O	atorvastatin	dobj	4	SENT_59	[p4l1294t592r1725b670],
12	,	,	O	,	_	0	SENT_59	[p4l1294t592r1725b670],
13	20	CD	NUMBER	20	num	15	SENT_59	[p4l1761t592r1848b656],
14	mg/day	JJ	O	mg/day	amod	15	SENT_59	[p4l1884t589r2154b678],
15	simvastatin	NN	O	simvastatin	conj_or	11	SENT_59	[p4l11t699r428b777],
16	,	,	O	,	_	0	SENT_59	[p4l11t699r428b777],
17	or	CC	O	or	_	0	SENT_59	[p4l466t722r539b762],
18	10	CD	NUMBER	10	num	19	SENT_59	[p4l575t700r656b763],
19	mg	NN	O	mg	conj_or	11	SENT_59	[p4l692t696r836b785],
20	/	:	O	/	punct	22	SENT_59	[p4l692t696r836b785],
21	day	NN	DURATION	day	nn	22	SENT_59	[p4l838t696r961b785],
22	pravastatin	NN	O	pravastatin	dep	11	SENT_59	[p4l991t699r1378b786],
23	followed	VBN	O	follow	partmod	22	SENT_59	[p4l1412t696r1717b763],
24	by	IN	O	by	_	0	SENT_59	[p4l1749t696r1835b785],
25	8	CD	DURATION	8	num	26	SENT_59	[p4l1868t700r1903b763],
26	weeks	NNS	NUMBER	week	agent	23	SENT_59	[p4l1936t696r2149b763],
27	of	IN	O	of	_	0	SENT_59	[p4l10t804r91b870],
28	80	CD	NUMBER	80	num	30	SENT_59	[p4l118t807r200b870],
29	mg/day	JJ	O	mg/day	amod	30	SENT_59	[p4l238t803r508b893],
30	atorvastatin	NN	O	atorvastatin	prep_of	26	SENT_59	[p4l543t807r974b885],
31	,	,	O	,	_	0	SENT_59	[p4l543t807r974b885],
32	80	CD	NUMBER	80	num	34	SENT_59	[p4l1017t807r1098b870],
33	mg/day	JJ	O	mg/day	amod	34	SENT_59	[p4l1137t803r1407b893],
34	simvastatin	NN	O	simvastatin	conj_and	30	SENT_59	[p4l1441t807r1859b885],
35	,	,	O	,	_	0	SENT_59	[p4l1441t807r1859b885],
36	and	CC	O	and	_	0	SENT_59	[p4l1900t804r2028b870],
37	40	CD	NUMBER	40	num	38	SENT_59	[p4l2064t807r2149b870],
38	mg	NN	O	mg	conj_and	30	SENT_59	[p4l10t912r154b1001],
39	/	:	O	/	punct	22	SENT_59	[p4l10t912r154b1001],
40	day	NN	DURATION	day	nn	41	SENT_59	[p4l157t912r280b1001],
41	pravastatin	NN	O	pravastatin	dep	11	SENT_59	[p4l308t915r715b1001],
42	,	,	O	,	_	0	SENT_59	[p4l308t915r715b1001],
43	respectively	RB	O	respectively	advmod	41	SENT_59	[p4l751t912r1178b1001],
44	.	.	O	.	_	0	SENT_59	[p4l751t912r1178b1001],

1	The	DT	O	the	det	4	SENT_60	[p4l96t1018r243b1086],
2	following	VBG	O	follow	amod	4	SENT_60	[p4l269t1019r606b1108],
3	57	CD	NUMBER	57	num	4	SENT_60	[p4l629t1019r715b1086],
4	subjects	NNS	O	subject	nsubjpass	6	SENT_60	[p4l741t1019r1014b1108],
5	were	VBD	O	be	auxpass	6	SENT_60	[p4l1037t1045r1204b1086],
6	excluded	VBN	O	exclude	_	0	SENT_60	[p4l1231t1019r1540b1086],
7	from	IN	O	from	_	0	SENT_60	[p4l1564t1019r1735b1085],
8	all	DT	O	all	det	9	SENT_60	[p4l1762t1019r1842b1086],
9	analyses	NNS	O	analysis	prep_from	6	SENT_60	[p4l1868t1019r2148b1108],
10	as	IN	O	as	mark	15	SENT_60	[p4l11t1153r74b1193],
11	the	DT	O	the	det	12	SENT_60	[p4l106t1127r217b1193],
12	result	NN	O	result	nsubj	15	SENT_60	[p4l248t1127r443b1193],
13	of	IN	O	of	_	0	SENT_60	[p4l473t1127r554b1193],
14	incomplete	JJ	O	incomplete	prep_of	12	SENT_60	[p4l572t1127r965b1216],
15	follow	VBP	O	follow	advcl	6	SENT_60	[p4l996t1127r1362b1216],
16	—	RB	O	—	advmod	15	SENT_60	[p4l996t1127r1362b1216],
17	up	RB	O	up	advmod	15	SENT_60	[p4l996t1127r1362b1216],
18	:	:	O	:	_	0	SENT_60	[p4l996t1127r1362b1216],
19	10	CD	NUMBER	10	nsubj	20	SENT_60	[p4l1401t1130r1482b1193],
20	withdrew	VBD	O	withdraw	parataxis	6	SENT_60	[p4l1511t1127r1852b1193],
21	consent	NN	O	consent	dobj	20	SENT_60	[p4l1880t1144r2152b1193],
22	before	IN	O	before	_	0	SENT_60	[p4l7t1233r229b1299],
23	drug	NN	O	drug	nn	24	SENT_60	[p4l282t1233r445b1322],
24	administration	NN	O	administration	prep_before	20	SENT_60	[p4l496t1233r1035b1314],
25	,	,	O	,	_	0	SENT_60	[p4l496t1233r1035b1314],
26	21	CD	NUMBER	21	num	28	SENT_60	[p4l1088t1236r1170b1300],
27	discontinued	VBN	O	discontinue	amod	28	SENT_60	[p4l1228t1233r1685b1299],
28	therapy	NN	O	therapy	nsubj	32	SENT_60	[p4l1735t1233r2003b1322],
29	for	IN	O	for	_	0	SENT_60	[p4l2050t1233r2152b1299],
30	reasons	NNS	O	reason	prep_for	28	SENT_60	[p4l9t1366r267b1406],
31	not	RB	O	not	neg	32	SENT_60	[p4l298t1357r416b1406],
32	related	VBN	O	relate	dep	6	SENT_60	[p4l442t1340r683b1406],
33	to	TO	O	to	_	0	SENT_60	[p4l710t1357r778b1406],
34	symptoms	NNS	O	symptom	prep_to	32	SENT_60	[p4l810t1357r1190b1430],
35	,	,	O	,	_	0	SENT_60	[p4l810t1357r1190b1430],
36	13	CD	NUMBER	13	nsubjpass	38	SENT_60	[p4l1226t1344r1303b1407],
37	were	VBD	O	be	auxpass	38	SENT_60	[p4l1332t1366r1499b1407],
38	lost	VBN	O	lose	ccomp	6	SENT_60	[p4l1528t1340r1655b1406],
39	to	TO	O	to	aux	40	SENT_60	[p4l1681t1357r1750b1406],
40	follow	VB	O	follow	xcomp	38	SENT_60	[p4l1780t1340r2147b1430],
41	—	RB	O	—	advmod	40	SENT_60	[p4l1780t1340r2147b1430],
42	up	RB	O	up	advmod	40	SENT_60	[p4l1780t1340r2147b1430],
43	,	,	O	,	_	0	SENT_60	[p4l1780t1340r2147b1430],
44	7	CD	NUMBER	7	nsubjpass	46	SENT_60	[p4l11t1449r51b1514],
45	were	VBD	O	be	auxpass	46	SENT_60	[p4l87t1473r255b1514],
46	removed	VBN	O	remove	ccomp	6	SENT_60	[p4l295t1448r601b1514],
47	for	IN	O	for	_	0	SENT_60	[p4l640t1448r741b1514],
48	protocol	NN	O	protocol	nn	49	SENT_60	[p4l779t1448r1076b1537],
49	violations	NNS	O	violation	prep_for	46	SENT_60	[p4l1111t1448r1453b1514],
50	or	CC	O	or	_	0	SENT_60	[p4l1497t1473r1569b1514],
51	noncompliance	NN	O	noncompliance	conj_or	49	SENT_60	[p4l1608t1448r2149b1537],
52	with	IN	O	with	_	0	SENT_60	[p4l6t1556r168b1622],
53	study	NN	O	study	nn	54	SENT_60	[p4l202t1556r392b1645],
54	drug	NN	O	drug	prep_with	49	SENT_60	[p4l423t1556r603b1645],
55	,	,	O	,	_	0	SENT_60	[p4l423t1556r603b1645],
56	1	CD	NUMBER	1	conj_or	49	SENT_60	[p4l644t1559r676b1621],
57	for	IN	O	for	_	0	SENT_60	[p4l714t1556r815b1622],
58	pregnancy	NN	O	pregnancy	prep_for	56	SENT_60	[p4l845t1582r1229b1645],
59	,	,	O	,	_	0	SENT_60	[p4l845t1582r1229b1645],
60	and	CC	O	and	_	0	SENT_60	[p4l1267t1556r1395b1622],
61	5	CD	NUMBER	5	prep_for	46	SENT_60	[p4l1427t1556r1465b1622],
62	for	IN	O	for	_	0	SENT_60	[p4l1502t1556r1602b1622],
63	other	JJ	O	other	amod	64	SENT_60	[p4l1635t1556r1822b1622],
64	reasons	NNS	O	reason	prep_for	61	SENT_60	[p4l1853t1582r2131b1622],
65	.	.	O	.	_	0	SENT_60	[p4l1853t1582r2131b1622],

1	JACC	NNP	O	JACC	nn	2	SENT_61	[p4l1480t1805r1594b1856],
2	Vol	NNP	O	Vol	_	0	SENT_61	[p4l1615t1806r1698b1856],
3	.	.	O	.	_	0	SENT_61	[p4l1615t1806r1698b1856],

1	54	CD	NUMBER	54	_	0	SENT_62	[p4l1722t1806r1796b1865],
2	,	,	O	,	_	0	SENT_62	[p4l1722t1806r1796b1865],
3	No.	NN	O	no.	appos	1	SENT_62	[p4l1821t1806r1893b1856],
4	17	CD	NUMBER	17	num	3	SENT_62	[p4l1919t1806r1991b1865],
5	,	,	O	,	_	0	SENT_62	[p4l1919t1806r1991b1865],
6	2009	CD	DATE	2009	appos	1	SENT_62	[p4l2016t1805r2139b1856],
7	October	NNP	DATE	October	tmod	6	SENT_62	[p4l1478t1894r1657b1945],
8	20	CD	DATE	20	num	7	SENT_62	[p4l1677t1894r1750b1953],
9	,	,	O	,	_	0	SENT_62	[p4l1677t1894r1750b1953],
10	2009160946	CD	NUMBER	2009160946	num	7	SENT_62	[p4l1775t1894r2139b1945],

1	Follow-up	JJ	O	follow-up	_	0	SENT_63	[p4l10t2113r421b2203],
2	,	,	O	,	_	0	SENT_63	[p4l10t2113r421b2203],
3	laboratory	JJ	O	laboratory	amod	4	SENT_63	[p4l455t2113r840b2203],
4	testing	NN	O	testing	conj_and	1	SENT_63	[p4l868t2118r1143b2203],
5	,	,	O	,	_	0	SENT_63	[p4l868t2118r1143b2203],
6	and	CC	O	and	_	0	SENT_63	[p4l1180t2113r1316b2180],
7	deﬁnition	NN	O	deﬁnition	conj_and	1	SENT_63	[p4l1348t2113r1713b2180],
8	of	IN	O	of	_	0	SENT_63	[p4l1747t2113r1830b2180],
9	primary	JJ	O	primary	amod	10	SENT_63	[p4l1851t2118r2144b2203],
10	outcome	NN	O	outcome	prep_of	7	SENT_63	[p4l10t2236r351b2286],
11	.	.	O	.	_	0	SENT_63	[p4l10t2236r351b2286],

1	In-person	JJ	O	in-person	amod	2	SENT_64	[p4l402t2221r753b2309],
2	visits	NNS	O	visit	nsubjpass	8	SENT_64	[p4l776t2223r952b2286],
3	with	IN	O	with	_	0	SENT_64	[p4l976t2220r1138b2286],
4	a	DT	O	a	det	6	SENT_64	[p4l1166t2246r1200b2286],
5	research	NN	O	research	nn	6	SENT_64	[p4l1225t2220r1512b2286],
6	coordinator	NN	O	coordinator	prep_with	2	SENT_64	[p4l1540t2220r1951b2286],
7	were	VBD	O	be	auxpass	8	SENT_64	[p4l1972t2246r2139b2286],
8	scheduled	VBN	O	schedule	_	0	SENT_64	[p4l11t2326r359b2392],
9	every	DT	SET	every	det	11	SENT_64	[p4l409t2352r592b2415],
10	other	JJ	SET	other	amod	11	SENT_64	[p4l638t2326r824b2392],
11	week	NN	SET	week	tmod	8	SENT_64	[p4l869t2326r1054b2392],
12	to	TO	O	to	aux	13	SENT_64	[p4l1099t2343r1167b2392],
13	assess	VB	O	assess	xcomp	8	SENT_64	[p4l1220t2352r1415b2392],
14	for	IN	O	for	mark	17	SENT_64	[p4l1466t2326r1567b2392],
15	adverse	JJ	O	adverse	amod	16	SENT_64	[p4l1616t2326r1871b2392],
16	events	NNS	O	event	nsubj	17	SENT_64	[p4l1923t2343r2138b2392],
17	(	VBP	O	(	advcl	13	SENT_64	[p4l12t2431r220b2513],
18	AES	NN	O	ae	nn	19	SENT_64	[p4l12t2431r220b2513],
19	)	NN	O	)	dobj	17	SENT_64	[p4l12t2431r220b2513],
20	and	CC	O	and	_	0	SENT_64	[p4l264t2433r391b2499],
21	compliance	NN	O	compliance	dobj	17	SENT_64	[p4l429t2433r848b2522],
22	.	.	O	.	_	0	SENT_64	[p4l429t2433r848b2522],

1	Any	DT	O	any	det	2	SENT_65	[p4l888t2431r1043b2522],
2	symptom	NN	O	symptom	nsubjpass	38	SENT_65	[p4l1079t2450r1425b2522],
3	,	,	O	,	_	0	SENT_65	[p4l1079t2450r1425b2522],
4	physical	JJ	O	physical	amod	5	SENT_65	[p4l1466t2433r1750b2522],
5	sign	NN	O	sign	nsubjpass	38	SENT_65	[p4l1788t2436r1948b2522],
6	,	,	O	,	_	0	SENT_65	[p4l1788t2436r1948b2522],
7	syndrome	NN	O	syndrome	nsubjpass	38	SENT_65	[p4l1992t2459r2137b2522, p4l10t2539r256b2620],
8	,	,	O	,	_	0	SENT_65	[p4l1992t2459r2137b2522, p4l10t2539r256b2620],
9	or	CC	O	or	_	0	SENT_65	[p4l285t2565r357b2605],
10	disease	NN	O	disease	conj_or	2	SENT_65	[p4l381t2539r623b2605],
11	that	WDT	O	that	nsubj	24	SENT_65	[p4l649t2539r790b2605],
12	either	CC	O	either	advmod	13	SENT_65	[p4l814t2539r1018b2605],
13	emerged	VBD	O	emerge	rcmod	10	SENT_65	[p4l1042t2539r1343b2628],
14	during	IN	O	during	_	0	SENT_65	[p4l1369t2539r1602b2628],
15	the	DT	O	the	det	16	SENT_65	[p4l1625t2539r1735b2605],
16	study	NN	O	study	prep_during	13	SENT_65	[p4l1762t2539r1952b2628],
17	or	CC	O	or	_	0	SENT_65	[p4l1973t2565r2063b2620],
18	,	,	O	,	_	0	SENT_65	[p4l1973t2565r2063b2620],
19	if	IN	O	if	mark	20	SENT_65	[p4l2091t2539r2151b2604],
20	present	JJ	DATE	present	parataxis	13	SENT_65	[p4l8t2663r267b2735],
21	at	IN	O	at	_	0	SENT_65	[p4l299t2663r362b2712],
22	screening	NN	O	screening	prep_at	20	SENT_65	[p4l394t2649r744b2735],
23	,	,	O	,	_	0	SENT_65	[p4l394t2649r744b2735],
24	worsened	VBN	O	worsen	conj_or	13	SENT_65	[p4l776t2646r1113b2712],
25	during	IN	O	during	_	0	SENT_65	[p4l1146t2646r1379b2735],
26	the	DT	O	the	det	27	SENT_65	[p4l1409t2646r1519b2712],
27	study	NN	O	study	prep_during	24	SENT_65	[p4l1553t2646r1758b2735],
28	,	,	O	,	_	0	SENT_65	[p4l1553t2646r1758b2735],
29	regardless	RB	O	regardless	_	0	SENT_65	[p4l1793t2646r2138b2735],
30	of	IN	O	of	_	0	SENT_65	[p4l10t2752r90b2818],
31	the	DT	O	the	det	33	SENT_65	[p4l117t2752r228b2818],
32	suspected	VBN	O	suspect	amod	33	SENT_65	[p4l269t2752r606b2841],
33	cause	NN	O	cause	prep_regardless_of	24	SENT_65	[p4l646t2778r830b2818],
34	of	IN	O	of	_	0	SENT_65	[p4l871t2752r951b2818],
35	the	DT	O	the	det	36	SENT_65	[p4l978t2752r1088b2818],
36	event	NN	O	event	prep_of	33	SENT_65	[p4l1130t2769r1317b2818],
37	was	VBD	O	be	auxpass	38	SENT_65	[p4l1351t2778r1480b2818],
38	documented	VBN	O	document	_	0	SENT_65	[p4l1523t2752r1960b2818],
39	as	IN	O	as	_	0	SENT_65	[p4l2001t2778r2064b2818],
40	a	DT	O	a	det	43	SENT_65	[p4l2107t2778r2141b2818],
41	potential	JJ	O	potential	amod	43	SENT_65	[p4l8t2859r323b2948],
42	adverse	JJ	O	adverse	amod	43	SENT_65	[p4l363t2859r618b2925],
43	event	NN	O	event	prep_as	38	SENT_65	[p4l659t2876r863b2925],
44	.	.	O	.	_	0	SENT_65	[p4l659t2876r863b2925],

1	Symptoms	NNS	O	symptom	nsubjpass	5	SENT_66	[p4l910t2859r1282b2948],
2	may	MD	O	may	aux	5	SENT_66	[p4l1324t2885r1472b2948],
3	have	VB	O	have	aux	5	SENT_66	[p4l1508t2859r1666b2925],
4	been	VBN	O	be	auxpass	5	SENT_66	[p4l1704t2859r1870b2925],
5	volunteered	VBN	O	volunteer	_	0	SENT_66	[p4l1906t2859r2137b2925, p4l9t2965r225b3031],
6	spontaneously	RB	O	spontaneously	advmod	5	SENT_66	[p4l253t2965r755b3054],
7	by	IN	O	by	_	0	SENT_66	[p4l777t2965r863b3054],
8	the	DT	O	the	det	21	SENT_66	[p4l887t2965r997b3031],
9	subject	JJ	O	subject	amod	21	SENT_66	[p4l1027t2965r1269b3054],
10	or	CC	O	or	_	0	SENT_66	[p4l1296t2991r1368b3031],
11	discovered	VBN	O	discover	amod	21	SENT_66	[p4l1395t2965r1765b3031],
12	as	IN	O	as	_	0	SENT_66	[p4l1793t2991r1856b3031],
13	a	DT	O	a	det	14	SENT_66	[p4l1887t2991r1921b3031],
14	result	NN	O	result	prep_as	11	SENT_66	[p4l1947t2965r2142b3031],
15	of	IN	O	of	_	0	SENT_66	[p4l10t3071r90b3137],
16	general	JJ	O	general	prep_of	14	SENT_66	[p4l126t3071r382b3160],
17	questioning	VBG	O	question	partmod	16	SENT_66	[p4l431t3074r846b3160],
18	by	IN	O	by	_	0	SENT_66	[p4l891t3071r977b3160],
19	the	DT	O	the	det	20	SENT_66	[p4l1022t3071r1132b3137],
20	study	NN	O	study	agent	17	SENT_66	[p4l1183t3071r1372b3160],
21	staff	NN	O	staff	agent	5	SENT_66	[p4l1419t3071r1572b3137],
22	or	CC	O	or	_	0	SENT_66	[p4l1609t3097r1681b3137],
23	by	IN	O	by	_	0	SENT_66	[p4l1726t3071r1813b3160],
24	physical	JJ	O	physical	amod	25	SENT_66	[p4l1856t3071r2141b3160],
25	examination	NN	O	examination	conj_or	21	SENT_66	[p4l10t3180r463b3242],
26	.	.	O	.	_	0	SENT_66	[p4l10t3180r463b3242],

1	At	IN	O	at	_	0	SENT_67	[p5l96t26r191b94],
2	each	DT	O	each	det	3	SENT_67	[p5l231t28r387b94],
3	visit	NN	O	visit	prep_at	7	SENT_67	[p5l423t31r571b94],
4	the	DT	O	the	det	5	SENT_67	[p5l609t28r720b94],
5	subject	NN	O	subject	nsubjpass	7	SENT_67	[p5l762t28r1005b117],
6	was	VBD	O	be	auxpass	7	SENT_67	[p5l1040t54r1170b94],
7	asked	VBN	O	ask	ccomp	10	SENT_67	[p5l1213t28r1426b109],
8	,	,	O	,	_	0	SENT_67	[p5l1213t28r1426b109],
9	“	CD	NUMBER	“	nsubj	10	SENT_67	[p5l1469t28r1687b94],
10	Have	VBP	O	have	_	0	SENT_67	[p5l1469t28r1687b94],
11	you	PRP	O	you	nsubj	12	SENT_67	[p5l1725t54r1853b117],
12	experienced	VBD	O	experience	ccomp	10	SENT_67	[p5l1894t31r2137b117, p5l10t134r212b200],
13	any	DT	O	any	det	14	SENT_67	[p5l248t160r371b223],
14	problems	NNS	O	problem	dobj	12	SENT_67	[p5l401t134r726b223],
15	since	IN	O	since	_	0	SENT_67	[p5l765t137r936b200],
16	your	PRP$	O	you	poss	18	SENT_67	[p5l969t160r1129b223],
17	last	JJ	O	last	amod	18	SENT_67	[p5l1161t134r1281b200],
18	visit	NN	O	visit	prep_since	12	SENT_67	[p5l1311t134r1521b200],
19	?	.	O	?	_	0	SENT_67	[p5l1311t134r1521b200],

1	”	NN	O	”	nsubj	13	SENT_68	[p5l1311t134r1521b200],
2	To	TO	O	to	aux	3	SENT_68	[p5l1554t132r1659b200],
3	avoid	VB	O	avoid	infmod	1	SENT_68	[p5l1697t134r1883b200],
4	vague	JJ	O	vague	acomp	3	SENT_68	[p5l1915t160r2137b223],
5	,	,	O	,	_	0	SENT_68	[p5l1915t160r2137b223],
6	ambiguous	JJ	O	ambiguous	nsubj	13	SENT_68	[p5l11t240r413b329],
7	,	,	O	,	_	0	SENT_68	[p5l11t240r413b329],
8	or	CC	O	or	_	0	SENT_68	[p5l477t266r549b306],
9	colloquial	JJ	O	colloquial	amod	10	SENT_68	[p5l608t240r951b329],
10	expressions	NNS	O	expression	nsubj	13	SENT_68	[p5l1011t243r1427b329],
11	,	,	O	,	_	0	SENT_68	[p5l1011t243r1427b329],
12	staff	NN	O	staff	appos	10	SENT_68	[p5l1492t240r1644b306],
13	recorded	VBD	O	record	_	0	SENT_68	[p5l1692t240r2000b306],
14	all	DT	O	all	det	15	SENT_68	[p5l2061t240r2141b306],
15	symptoms	NNS	O	symptom	dobj	13	SENT_68	[p5l11t363r368b435],
16	in	IN	O	in	_	0	SENT_68	[p5l408t349r475b411],
17	standard	JJ	O	standard	amod	19	SENT_68	[p5l515t346r817b412],
18	medical	JJ	O	medical	amod	19	SENT_68	[p5l855t346r1128b412],
19	terminology	NN	O	terminology	prep_in	13	SENT_68	[p5l1165t346r1598b435],
20	in	IN	O	in	_	0	SENT_68	[p5l1632t349r1700b411],
21	addition	NN	O	addition	prep_in	19	SENT_68	[p5l1739t346r2033b412],
22	to	TO	O	to	_	0	SENT_68	[p5l2070t363r2138b412],
23	the	DT	O	the	det	24	SENT_68	[p5l9t453r119b519],
24	subject	JJ	O	subject	poss	27	SENT_68	[p5l177t453r465b542],
25	’s	POS	O	’s	_	0	SENT_68	[p5l177t453r465b542],
26	own	JJ	O	own	amod	27	SENT_68	[p5l522t479r671b519],
27	words	NNS	O	word	prep_to	13	SENT_68	[p5l722t453r954b519],
28	.	.	O	.	_	0	SENT_68	[p5l722t453r954b519],

1	For	IN	O	for	_	0	SENT_69	[p5l1015t454r1140b519],
2	example	NN	O	example	prep_for	6	SENT_69	[p5l1194t453r1502b542],
3	,	,	O	,	_	0	SENT_69	[p5l1194t453r1502b542],
4	symptoms	NNS	O	symptom	nsubjpass	6	SENT_69	[p5l1562t470r1919b542],
5	were	VBD	O	be	auxpass	6	SENT_69	[p5l1973t479r2139b519],
6	recorded	VBN	O	record	_	0	SENT_69	[p5l9t559r316b625],
7	as	IN	O	as	_	0	SENT_69	[p5l350t585r413b625],
8	“	NN	O	“	nn	9	SENT_69	[p5l448t559r805b648],
9	myalgia	NN	O	myalgium	prep_as	6	SENT_69	[p5l448t559r805b648],
10	,	,	O	,	_	0	SENT_69	[p5l448t559r805b648],
11	”	CD	NUMBER	”	num	14	SENT_69	[p5l448t559r805b648],
12	“	NN	O	“	nn	14	SENT_69	[p5l840t559r1112b625],
13	muscle	NN	O	muscle	nn	14	SENT_69	[p5l840t559r1112b625],
14	cramps	NNS	O	cramp	prep_as	6	SENT_69	[p5l1147t559r1450b648],
15	,	,	O	,	_	0	SENT_69	[p5l1147t559r1450b648],
16	”	CD	NUMBER	”	conj_or	9	SENT_69	[p5l1147t559r1450b648],
17	or	CC	O	or	_	0	SENT_69	[p5l1484t585r1557b625],
18	“	CD	NUMBER	“	num	21	SENT_69	[p5l1588t559r1905b625],
19	elevated	JJ	O	elevated	amod	21	SENT_69	[p5l1588t559r1905b625],
20	creatine	NN	O	creatine	nn	21	SENT_69	[p5l1937t576r2137b625, p5l9t669r114b732],
21	phosphokinase	NN	O	phosphokinase	prep_as	6	SENT_69	[p5l157t666r715b755],
22	”	RB	O	”	advmod	24	SENT_69	[p5l157t666r715b755],
23	as	IN	O	as	dep	24	SENT_69	[p5l761t692r824b732],
24	appropriate	JJ	O	appropriate	amod	21	SENT_69	[p5l871t669r1292b755],
25	.	.	O	.	_	0	SENT_69	[p5l871t669r1292b755],

1	At	IN	O	at	_	0	SENT_70	[p5l1337t664r1432b732],
2	both	CC	O	both	preconj	4	SENT_70	[p5l1472t666r1636b732],
3	the	DT	O	the	dep	4	SENT_70	[p5l1678t666r1789b732],
4	first	JJ	ORDINAL	first	prep_at	22	SENT_70	[p5l1833t666r1970b732],
5	and	CC	O	and	_	0	SENT_70	[p5l2013t666r2140b732],
6	ﬁnal	JJ	O	ﬁnal	amod	8	SENT_70	[p5l9t772r164b838],
7	visit	NN	O	visit	nn	8	SENT_70	[p5l197t775r344b838],
8	(	NN	O	(	conj_and	4	SENT_70	[p5l382t770r591b852],
9	week	NN	DURATION	week	dep	22	SENT_70	[p5l382t770r591b852],
10	16	CD	NUMBER	16	num	9	SENT_70	[p5l628t775r707b838],
11	or	CC	O	or	_	0	SENT_70	[p5l747t798r819b838],
12	at	IN	O	at	conj_or	9	SENT_70	[p5l856t789r919b838],
13	time	NN	O	time	pobj	12	SENT_70	[p5l955t775r1112b838],
14	of	IN	O	of	_	0	SENT_70	[p5l1151t772r1231b838],
15	termination	NN	O	termination	prep_of	13	SENT_70	[p5l1256t770r1699b852],
16	)	CD	NUMBER	)	num	15	SENT_70	[p5l1256t770r1699b852],
17	a	DT	O	a	det	20	SENT_70	[p5l1742t798r1776b838],
18	thorough	JJ	O	thorough	amod	20	SENT_70	[p5l1812t772r2140b861],
19	physical	JJ	O	physical	amod	20	SENT_70	[p5l8t879r292b968],
20	examination	NN	O	examination	nsubjpass	22	SENT_70	[p5l343t882r777b945],
21	was	VBD	O	be	auxpass	22	SENT_70	[p5l824t905r953b945],
22	performed	VBN	O	perform	_	0	SENT_70	[p5l1004t879r1375b968],
23	and	CC	O	and	_	0	SENT_70	[p5l1426t879r1554b945],
24	any	DT	O	any	det	26	SENT_70	[p5l1605t905r1728b968],
25	signiﬁcant	JJ	O	signiﬁcant	amod	26	SENT_70	[p5l1776t879r2141b968],
26	change	NN	O	change	conj_and	22	SENT_70	[p5l10t985r256b1074],
27	that	WDT	O	that	nsubj	28	SENT_70	[p5l283t985r424b1051],
28	occurred	VBD	O	occur	rcmod	26	SENT_70	[p5l449t985r753b1051],
29	during	IN	O	during	_	0	SENT_70	[p5l779t985r1013b1074],
30	the	DT	O	the	det	31	SENT_70	[p5l1037t985r1147b1051],
31	trial	NN	O	trial	prep_during	28	SENT_70	[p5l1174t985r1315b1051],
32	recorded	VBN	O	record	partmod	31	SENT_70	[p5l1340t985r1647b1051],
33	as	IN	O	as	_	0	SENT_70	[p5l1674t1011r1737b1051],
34	a	DT	O	a	det	36	SENT_70	[p5l1767t1011r1801b1051],
35	potential	JJ	O	potential	amod	36	SENT_70	[p5l1825t985r2140b1074],
36	AE	NN	O	ae	prep_as	32	SENT_70	[p5l7t1089r151b1157],
37	.	.	O	.	_	0	SENT_70	[p5l7t1089r151b1157],

1	Finally	RB	O	finally	advmod	26	SENT_71	[p5l218t1091r480b1180],
2	,	,	O	,	_	0	SENT_71	[p5l218t1091r480b1180],
3	in	IN	O	in	_	0	SENT_71	[p5l545t1094r613b1156],
4	addition	NN	O	addition	_	0	SENT_71	[p5l676t1091r969b1157],
5	to	TO	O	to	_	0	SENT_71	[p5l1031t1108r1098b1157],
6	these	DT	O	these	det	7	SENT_71	[p5l1162t1091r1341b1157],
7	assessments	NNS	O	assessment	prep_in_addition_to	26	SENT_71	[p5l1405t1108r1839b1172],
8	,	,	O	,	_	0	SENT_71	[p5l1405t1108r1839b1172],
9	at	IN	O	at	_	0	SENT_71	[p5l1905t1108r1969b1157],
10	the	DT	O	the	det	12	SENT_71	[p5l2029t1091r2139b1157],
11	following	VBG	O	follow	amod	12	SENT_71	[p5l9t1197r344b1286],
12	intervals	NNS	O	interval	prep_at	26	SENT_71	[p5l381t1197r674b1263],
13	routine	JJ	O	routine	amod	15	SENT_71	[p5l714t1200r967b1263],
14	laboratory	NN	O	laboratory	nn	15	SENT_71	[p5l1004t1197r1366b1286],
15	analyses	NNS	O	analysis	nsubjpass	26	SENT_71	[p5l1401t1197r1681b1286],
16	for	IN	O	for	_	0	SENT_71	[p5l1720t1197r1821b1263],
17	chemistries	NNS	O	chemistry	prep_for	15	SENT_71	[p5l1859t1197r2136b1263, p5l9t1306r178b1383],
18	,	,	O	,	_	0	SENT_71	[p5l1859t1197r2136b1263, p5l9t1306r178b1383],
19	liver	NN	O	liver	nn	21	SENT_71	[p5l203t1303r356b1369],
20	function	NN	O	function	nn	21	SENT_71	[p5l378t1303r675b1368],
21	studies	NNS	O	study	prep_for	15	SENT_71	[p5l701t1303r960b1383],
22	,	,	O	,	_	0	SENT_71	[p5l701t1303r960b1383],
23	and	CC	O	and	_	0	SENT_71	[p5l988t1303r1116b1368],
24	CK	NN	O	ck	prep_for	15	SENT_71	[p5l1141t1303r1268b1369],
25	were	VBD	O	be	auxpass	26	SENT_71	[p5l1286t1328r1452b1369],
26	measured	VBN	O	measure	_	0	SENT_71	[p5l1478t1303r1830b1368],
27	:	:	O	:	_	0	SENT_71	[p5l1478t1303r1830b1368],
28	baseline	NN	O	baseline	dep	31	SENT_71	[p5l1857t1303r2139b1368],
29	and	CC	O	and	_	0	SENT_71	[p5l11t1409r138b1474],
30	weeks	NNS	DURATION	week	dep	31	SENT_71	[p5l167t1409r378b1475],
31	6	CD	NUMBER	6	parataxis	26	SENT_71	[p5l414t1412r473b1489],
32	,	,	O	,	_	0	SENT_71	[p5l414t1412r473b1489],
33	8	CD	NUMBER	8	appos	31	SENT_71	[p5l512t1412r570b1489],
34	,	,	O	,	_	0	SENT_71	[p5l512t1412r570b1489],
35	12	CD	NUMBER	12	num	33	SENT_71	[p5l610t1412r711b1489],
36	,	,	O	,	_	0	SENT_71	[p5l610t1412r711b1489],
37	and	CC	NUMBER	and	_	0	SENT_71	[p5l748t1409r876b1474],
38	16	CD	NUMBER	16	appos	31	SENT_71	[p5l912t1412r1012b1475],
39	.	.	O	.	_	0	SENT_71	[p5l912t1412r1012b1475],

1	For	IN	O	for	_	0	SENT_72	[p5l99t1517r228b1582],
2	this	DT	O	this	det	3	SENT_72	[p5l258t1516r390b1582],
3	analysis	NN	O	analysis	prep_for	7	SENT_72	[p5l426t1516r727b1605],
4	,	,	O	,	_	0	SENT_72	[p5l426t1516r727b1605],
5	we	PRP	O	we	nsubj	39	SENT_72	[p5l759t1542r859b1582],
6	prospectively	RB	O	prospectively	advmod	7	SENT_72	[p5l891t1516r1376b1605],
7	deﬁned	VBD	O	deﬁned	_	0	SENT_72	[p5l1406t1516r1675b1582],
8	the	DT	O	the	det	10	SENT_72	[p5l1707t1516r1821b1582],
9	primary	JJ	O	primary	amod	10	SENT_72	[p5l1853t1519r2144b1605],
10	outcome	NN	O	outcome	dobj	7	SENT_72	[p5l10t1639r324b1688],
11	as	IN	O	as	_	0	SENT_72	[p5l365t1648r430b1688],
12	a	DT	O	a	det	15	SENT_72	[p5l473t1648r507b1688],
13	composite	JJ	O	composite	amod	15	SENT_72	[p5l547t1625r920b1711],
14	adverse	JJ	O	adverse	amod	15	SENT_72	[p5l962t1622r1227b1688],
15	event	NN	O	event	prep_as	7	SENT_72	[p5l1268t1639r1462b1688],
16	(	CD	NUMBER	(	num	17	SENT_72	[p5l1503t1620r1752b1702],
17	CAE	NNP	O	CAE	dep	7	SENT_72	[p5l1503t1620r1752b1702],
18	)	CD	NUMBER	)	num	17	SENT_72	[p5l1503t1620r1752b1702],
19	of	IN	O	of	_	0	SENT_72	[p5l1797t1622r1878b1688],
20	any	DT	O	any	prep_of	17	SENT_72	[p5l1907t1648r2034b1711],
21	of	IN	O	of	_	0	SENT_72	[p5l2070t1622r2152b1688],
22	the	DT	O	the	prep_of	20	SENT_72	[p5l9t1729r123b1795],
23	following	VBG	O	follow	amod	22	SENT_72	[p5l151t1729r500b1818],
24	at	IN	O	at	_	0	SENT_72	[p5l527t1746r592b1795],
25	any	DT	O	any	det	27	SENT_72	[p5l619t1755r746b1818],
26	time	NN	O	time	nn	27	SENT_72	[p5l769t1732r932b1795],
27	point	NN	O	point	prep_at	22	SENT_72	[p5l959t1732r1155b1818],
28	in	IN	O	in	_	0	SENT_72	[p5l1180t1732r1250b1794],
29	the	DT	O	the	det	30	SENT_72	[p5l1277t1729r1391b1795],
30	study	NN	O	study	prep_in	27	SENT_72	[p5l1420t1729r1633b1818],
31	:	:	O	:	_	0	SENT_72	[p5l1420t1729r1633b1818],
32	1	CD	NUMBER	1	number	33	SENT_72	[p5l1669t1727r1733b1809],
33	)	CD	NUMBER	)	num	35	SENT_72	[p5l1669t1727r1733b1809],
34	premature	JJ	O	premature	amod	35	SENT_72	[p5l1763t1746r2139b1818],
35	discontinuation	NN	O	discontinuation	dep	39	SENT_72	[p5l10t1835r586b1901],
36	of	IN	O	of	_	0	SENT_72	[p5l642t1835r724b1901],
37	study	NN	O	study	nn	38	SENT_72	[p5l768t1835r964b1924],
38	drug	NN	O	drug	prep_of	35	SENT_72	[p5l1016t1835r1184b1924],
39	due	JJ	O	due	conj_and	7	SENT_72	[p5l1238t1835r1365b1901],
40	to	TO	O	to	_	0	SENT_72	[p5l1421t1852r1491b1901],
41	any	DT	O	any	det	43	SENT_72	[p5l1548t1861r1675b1924],
42	side	NN	O	side	nn	43	SENT_72	[p5l1727t1835r1867b1901],
43	eﬁect	NN	O	eﬁect	prep_to	39	SENT_72	[p5l1923t1835r2137b1916],
44	;	:	O	;	_	0	SENT_72	[p5l1923t1835r2137b1916],
45	2	CD	NUMBER	2	number	46	SENT_72	[p5l7t1939r78b2021],
46	)	CD	NUMBER	)	num	48	SENT_72	[p5l7t1939r78b2021],
47	myalgia/muscle	NN	O	myalgia/muscle	nn	48	SENT_72	[p5l133t1941r704b2030],
48	cramps	NNS	O	cramp	nsubj	49	SENT_72	[p5l756t1967r1013b2030],
49	(	VBD	O	(	conj_and	7	SENT_72	[p5l1068t1939r1514b2030],
50	irrespective	RB	O	irrespective	advmod	49	SENT_72	[p5l1068t1939r1514b2030],
51	of	IN	O	of	_	0	SENT_72	[p5l1566t1941r1648b2007],
52	CK	NN	O	ck	nn	53	SENT_72	[p5l1688t1941r1817b2007],
53	values	NNS	O	value	prep_of	50	SENT_72	[p5l1862t1939r2136b2022],
54	)	CD	NUMBER	)	tmod	50	SENT_72	[p5l1862t1939r2136b2022],
55	;	:	O	;	_	0	SENT_72	[p5l1862t1939r2136b2022],
56	and	CC	O	and	_	0	SENT_72	[p5l11t2047r142b2113],
57	3	CD	NUMBER	3	num	60	SENT_72	[p5l188t2045r256b2127],
58	)	NN	O	)	nn	60	SENT_72	[p5l188t2045r256b2127],
59	CK	NN	O	ck	nn	60	SENT_72	[p5l308t2047r436b2113],
60	elevations	NNS	O	elevation	dep	67	SENT_72	[p5l481t2047r841b2113],
61	>	JJR	O	>	npadvmod	64	SENT_72	[p5l894t2050r1072b2113],
62	3	CD	NUMBER	3	number	63	SENT_72	[p5l894t2050r1072b2113],
63	>	JJR	O	>	amod	61	SENT_72	[p5l894t2050r1072b2113],
64	<	JJR	O	<	amod	67	SENT_72	[p5l894t2050r1072b2113],
65	the	DT	O	the	det	67	SENT_72	[p5l1128t2047r1242b2113],
66	upper	JJ	O	upper	amod	67	SENT_72	[p5l1288t2073r1498b2136],
67	limit	NN	O	limit	conj_and	7	SENT_72	[p5l1542t2047r1719b2113],
68	of	IN	O	of	_	0	SENT_72	[p5l1764t2047r1846b2113],
69	normal	JJ	O	normal	amod	70	SENT_72	[p5l1881t2047r2141b2113],
70	(	NN	O	(	prep_of	67	SENT_72	[p5l12t2151r458b2242],
71	irrespective	RB	O	irrespective	_	0	SENT_72	[p5l12t2151r458b2242],
72	of	IN	O	of	_	0	SENT_72	[p5l496t2153r578b2219],
73	symptoms	NNS	O	symptom	prep_irrespective_of	70	SENT_72	[p5l603t2151r1026b2242],
74	)	CD	NUMBER	)	tmod	73	SENT_72	[p5l603t2151r1026b2242],
75	.	.	O	.	_	0	SENT_72	[p5l603t2151r1026b2242],

1	Candidate	NN	O	candidate	nn	3	SENT_73	[p5l11t2258r395b2325],
2	gene	NN	O	gene	nn	3	SENT_73	[p5l436t2285r609b2348],
3	selection	NN	O	selection	_	0	SENT_73	[p5l652t2258r1001b2341],
4	,	,	O	,	_	0	SENT_73	[p5l652t2258r1001b2341],
5	power	NN	O	power	nn	6	SENT_73	[p5l1045t2284r1273b2348],
6	calculation	NN	O	calculation	appos	3	SENT_73	[p5l1312t2258r1742b2341],
7	,	,	O	,	_	0	SENT_73	[p5l1312t2258r1742b2341],
8	and	CC	O	and	_	0	SENT_73	[p5l1787t2258r1923b2325],
9	SNP	NN	O	snp	nn	10	SENT_73	[p5l1966t2259r2139b2325],
10	selection	NN	O	selection	appos	3	SENT_73	[p5l11t2364r359b2431],
11	.	.	O	.	_	0	SENT_73	[p5l11t2364r359b2431],

1	As	IN	O	as	_	0	SENT_74	[p5l409t2363r503b2431],
2	part	NN	O	part	prep_as	14	SENT_74	[p5l552t2382r693b2454],
3	of	IN	O	of	_	0	SENT_74	[p5l740t2365r820b2431],
4	the	DT	O	the	det	6	SENT_74	[p5l855t2365r965b2431],
5	STRENGTH	NN	O	strength	nn	6	SENT_74	[p5l1016t2363r1524b2431],
6	protocol	NN	O	protocol	prep_of	2	SENT_74	[p5l1572t2365r1885b2454],
7	,	,	O	,	_	0	SENT_74	[p5l1572t2365r1885b2454],
8	>	JJR	O	>	nsubjpass	14	SENT_74	[p5l1941t2368r2139b2431],
9	160	CD	NUMBER	160	num	12	SENT_74	[p5l1941t2368r2139b2431],
10	potential	JJ	O	potential	amod	12	SENT_74	[p5l8t2472r323b2561],
11	candidate	NN	O	candidate	nn	12	SENT_74	[p5l360t2472r697b2538],
12	genes	NNS	O	gene	dep	8	SENT_74	[p5l733t2498r927b2561],
13	were	VBD	O	be	auxpass	14	SENT_74	[p5l961t2498r1128b2538],
14	sequenced	VBN	O	sequence	_	0	SENT_74	[p5l1166t2472r1528b2561],
15	or	CC	O	or	_	0	SENT_74	[p5l1564t2498r1636b2538],
16	genotyped	VBN	O	genotype	conj_or	14	SENT_74	[p5l1670t2472r2038b2561],
17	as	IN	O	as	mark	19	SENT_74	[p5l2075t2498r2138b2538],
18	previously	RB	DATE	previously	advmod	19	SENT_74	[p5l8t2578r368b2667],
19	described	VBN	O	describe	advcl	14	SENT_74	[p5l399t2578r731b2644],
20	(	CD	NUMBER	(	number	21	SENT_74	[p5l767t2576r926b2658],
21	15	CD	NUMBER	15	num	22	SENT_74	[p5l767t2576r926b2658],
22	)	NN	O	)	dobj	19	SENT_74	[p5l767t2576r926b2658],
23	.	.	O	.	_	0	SENT_74	[p5l767t2576r926b2658],

1	For	IN	O	for	_	0	SENT_75	[p5l965t2579r1091b2644],
2	the	DT	O	the	det	3	SENT_75	[p5l1122t2578r1233b2644],
3	purposes	NNS	O	purpose	prep_for	16	SENT_75	[p5l1266t2604r1574b2667],
4	of	IN	O	of	_	0	SENT_75	[p5l1610t2578r1690b2644],
5	this	DT	O	this	det	7	SENT_75	[p5l1711t2578r1838b2644],
6	focused	JJ	O	focused	amod	7	SENT_75	[p5l1874t2578r2140b2644],
7	analysis	NN	O	analysis	prep_of	3	SENT_75	[p5l11t2684r297b2773],
8	,	,	O	,	_	0	SENT_75	[p5l11t2684r297b2773],
9	from	IN	O	from	_	0	SENT_75	[p5l323t2684r493b2750],
10	this	DT	O	this	det	11	SENT_75	[p5l517t2684r643b2750],
11	list	NN	O	list	prep_from	3	SENT_75	[p5l666t2684r773b2750],
12	of	IN	O	of	_	0	SENT_75	[p5l795t2684r874b2750],
13	candidate	NN	O	candidate	nn	14	SENT_75	[p5l886t2684r1223b2750],
14	genes	NNS	O	gene	prep_of	11	SENT_75	[p5l1246t2710r1440b2773],
15	we	PRP	O	we	nsubj	16	SENT_75	[p5l1461t2710r1559b2750],
16	selected	VBD	O	select	_	0	SENT_75	[p5l1584t2684r1859b2750],
17	5	CD	NUMBER	5	num	18	SENT_75	[p5l1881t2684r1919b2750],
18	genes	NNS	O	gene	nsubj	19	SENT_75	[p5l1944t2710r2138b2773],
19	(	VBP	O	(	ccomp	16	SENT_75	[p5l12t2787r373b2869],
20	CYP2D6	NN	O	cyp2d6	dobj	19	SENT_75	[p5l12t2787r373b2869],
21	,	,	O	,	_	0	SENT_75	[p5l12t2787r373b2869],
22	CYP2C8	NN	O	cyp2c8	conj_and	20	SENT_75	[p5l436t2792r753b2869],
23	,	,	O	,	_	0	SENT_75	[p5l436t2792r753b2869],
24	CYPZC9	NN	O	cypzc9	conj_and	20	SENT_75	[p5l816t2792r1133b2869],
25	,	,	O	,	_	0	SENT_75	[p5l816t2792r1133b2869],
26	CYP3ﬂ4	NN	O	cyp3ﬂ4	conj_and	20	SENT_75	[p5l1196t2792r1509b2869],
27	,	,	O	,	_	0	SENT_75	[p5l1196t2792r1509b2869],
28	and	CC	O	and	_	0	SENT_75	[p5l1567t2789r1695b2854],
29	SLCOIBJ	NNP	O	SLCOIBJ	conj_and	20	SENT_75	[p5l1750t2787r2136b2869],
30	)	CD	NUMBER	)	num	29	SENT_75	[p5l1750t2787r2136b2869],

1	thought	VBN	O	think	_	0	SENT_76	[p5l9t2896r293b2985],
2	to	TO	O	to	aux	4	SENT_76	[p5l327t2913r394b2962],
3	be	VB	O	be	auxpass	4	SENT_76	[p5l429t2896r510b2962],
4	implicated	VBN	O	implicate	xcomp	1	SENT_76	[p5l547t2896r918b2985],
5	in	IN	O	in	_	0	SENT_76	[p5l954t2899r1021b2961],
6	statin	NN	O	statin	nn	7	SENT_76	[p5l1058t2899r1251b2962],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	4	SENT_76	[p5l1286t2896r1907b2985],
8	based	VBN	O	base	_	0	SENT_76	[p5l1943t2896r2140b2962],
9	on	IN	O	on	prepc_based_on	4	SENT_76	[p5l10t3028r98b3068],
10	information	NN	O	information	pobj	4	SENT_76	[p5l130t3002r553b3068],
11	compiled	VBN	O	compile	partmod	10	SENT_76	[p5l586t3002r911b3091],
12	by	IN	O	by	_	0	SENT_76	[p5l941t3002r1027b3091],
13	the	DT	O	the	det	15	SENT_76	[p5l1055t3002r1165b3068],
14	PharmGKB	NN	O	pharmgkb	nn	15	SENT_76	[p5l1199t3002r1627b3068],
15	database	NN	O	database	agent	11	SENT_76	[p5l1664t3002r1962b3068],
16	(	CD	NUMBER	(	number	17	SENT_76	[p5l1998t3000r2136b3082],
17	16	CD	NUMBER	16	num	18	SENT_76	[p5l1998t3000r2136b3082],
18	)	NN	O	)	dep	15	SENT_76	[p5l1998t3000r2136b3082],
19	and	CC	O	and	_	0	SENT_76	[p5l11t3109r138b3175],
20	recent	JJ	O	recent	amod	21	SENT_76	[p5l188t3126r405b3175],
21	reviews	NNS	O	review	agent	11	SENT_76	[p5l454t3112r710b3175],
22	of	IN	O	of	_	0	SENT_76	[p5l764t3109r843b3175],
23	statin	NN	O	statin	nn	25	SENT_76	[p5l884t3112r1076b3175],
24	pharmacogenetics	NNS	O	pharmacogenetic	nn	25	SENT_76	[p5l1127t3109r1761b3198],
25	pathways	NNS	O	pathway	prep_of	21	SENT_76	[p5l1813t3109r2138b3198],

1	(	NN	O	(	_	0	SENT_77	[p6l12t31r171b113],
2	17	CD	NUMBER	17	num	3	SENT_77	[p6l12t31r171b113],
3	)	NN	O	)	dep	1	SENT_77	[p6l12t31r171b113],
4	.	.	O	.	_	0	SENT_77	[p6l12t31r171b113],

1	The	DT	O	the	det	2	SENT_78	[p6l199t31r346b99],
2	percent	NN	O	percent	nsubj	7	SENT_78	[p6l371t50r634b122],
3	missing	VBG	O	miss	partmod	2	SENT_78	[p6l660t36r930b122],
4	genotypes	NNS	O	genotype	dobj	3	SENT_78	[p6l953t50r1303b122],
5	and	CC	O	and	_	0	SENT_78	[p6l1332t33r1460b99],
6	race	NN	O	race	dobj	3	SENT_78	[p6l1484t59r1623b99],
7	stratiﬁed	VBD	O	stratiﬁed	_	0	SENT_78	[p6l1651t33r1960b99],
8	tests	NNS	O	test	dobj	7	SENT_78	[p6l1985t50r2138b99],
9	for	IN	O	for	_	0	SENT_78	[p6l9t139r110b205],
10	Hardy	NNP	PERSON	Hardy	prep_for	7	SENT_78	[p6l135t139r756b228],
11	.	.	O	.	_	0	SENT_78	[p6l135t139r756b228],

1	—	NN	O	—	_	0	SENT_79	[p6l135t139r756b228],
2	.	.	O	.	_	0	SENT_79	[p6l135t139r756b228],

1	Weinberg	NNP	ORGANIZATION	Weinberg	nn	2	SENT_80	[p6l135t139r756b228],
2	Equilibrium	NNP	ORGANIZATION	Equilibrium	nsubjpass	4	SENT_80	[p6l782t139r1213b228],
3	were	VBD	O	be	auxpass	4	SENT_80	[p6l1237t165r1403b205],
4	evaluated	VBN	O	evaluate	_	0	SENT_80	[p6l1431t139r1760b205],
5	by	IN	O	by	_	0	SENT_80	[p6l1783t139r1870b228],
6	the	DT	O	the	det	7	SENT_80	[p6l1892t139r2002b205],
7	use	NN	O	use	agent	4	SENT_80	[p6l2028t165r2139b205],
8	of	IN	O	of	_	0	SENT_80	[p6l10t245r90b311],
9	Haploview	NNP	LOCATION	Haploview	nn	10	SENT_80	[p6l116t245r503b334],
10	software	NN	O	software	prep_of	7	SENT_80	[p6l538t245r831b311],
11	(	CD	NUMBER	(	number	12	SENT_80	[p6l872t243r1010b325],
12	18	CD	NUMBER	18	num	13	SENT_80	[p6l872t243r1010b325],
13	)	NN	O	)	dobj	4	SENT_80	[p6l872t243r1010b325],
14	as	IN	O	as	_	0	SENT_80	[p6l1052t271r1115b311],
15	a	DT	O	a	det	16	SENT_80	[p6l1155t271r1190b311],
16	means	NN	O	means	prep_as	13	SENT_80	[p6l1226t271r1447b311],
17	of	IN	O	of	_	0	SENT_80	[p6l1486t245r1566b311],
18	quality	NN	O	quality	nn	19	SENT_80	[p6l1592t245r1833b334],
19	control	NN	O	control	prep_of	16	SENT_80	[p6l1868t245r2135b311],
20	.	.	O	.	_	0	SENT_80	[p6l1868t245r2135b311],

1	The	DT	O	the	det	4	SENT_81	[p6l7t349r153b417],
2	average	JJ	O	average	amod	4	SENT_81	[p6l189t377r447b440],
3	call	NN	O	call	nn	4	SENT_81	[p6l481t351r598b417],
4	rate	NN	O	rate	nsubj	7	SENT_81	[p6l630t368r760b417],
5	was	VBD	O	be	cop	7	SENT_81	[p6l791t377r919b417],
6	98	CD	PERCENT	98	num	7	SENT_81	[p6l956t354r1125b417],
7	%	NN	PERCENT	%	_	0	SENT_81	[p6l956t354r1125b417],
8	.	.	O	.	_	0	SENT_81	[p6l956t354r1125b417],

1	We	PRP	O	we	nsubj	3	SENT_82	[p6l94t458r225b524],
2	prospectively	RB	O	prospectively	advmod	3	SENT_82	[p6l248t457r711b546],
3	deﬁned	VBD	O	deﬁned	_	0	SENT_82	[p6l731t457r992b523],
4	allele	NN	O	allele	nn	6	SENT_82	[p6l1016t457r1192b523],
5	frequency	NN	O	frequency	nn	6	SENT_82	[p6l1215t457r1562b546],
6	cutoffs	NNS	O	cutoff	dobj	3	SENT_82	[p6l1582t457r1809b523],
7	based	VBN	O	base	_	0	SENT_82	[p6l1832t457r2030b523],
8	on	IN	O	on	prepc_based_on	3	SENT_82	[p6l2053t483r2140b523],
9	power	NN	O	power	nn	10	SENT_82	[p6l8t589r227b652],
10	calculations	NNS	O	calculation	pobj	3	SENT_82	[p6l284t563r693b629],
11	performed	VBN	O	perform	partmod	10	SENT_82	[p6l751t563r1122b652],
12	by	IN	O	by	_	0	SENT_82	[p6l1177t563r1264b652],
13	using	VBG	O	use	agent	11	SENT_82	[p6l1317t566r1507b652],
14	the	DT	O	the	det	16	SENT_82	[p6l1563t563r1673b629],
15	QUANTO	NNP	O	QUANTO	nn	16	SENT_82	[p6l1734t561r2137b647],
16	program	NN	O	program	nsubj	19	SENT_82	[p6l8t695r309b758],
17	(	CD	NUMBER	(	number	18	SENT_82	[p6l337t667r496b749],
18	19	CD	NUMBER	19	num	19	SENT_82	[p6l337t667r496b749],
19	)	NN	O	)	xcomp	13	SENT_82	[p6l337t667r496b749],
20	.	.	O	.	_	0	SENT_82	[p6l337t667r496b749],

1	On	IN	O	on	_	0	SENT_83	[p6l527t669r642b735],
2	the	DT	O	the	det	3	SENT_83	[p6l667t669r777b735],
3	basis	NN	O	basis	prep_on	34	SENT_83	[p6l800t669r967b735],
4	of	IN	O	of	_	0	SENT_83	[p6l995t669r1074b735],
5	the	DT	O	the	det	7	SENT_83	[p6l1086t669r1197b735],
6	99	CD	NUMBER	99	num	7	SENT_83	[p6l1224t672r1305b735],
7	subjects	NNS	O	subject	prep_of	3	SENT_83	[p6l1334t669r1605b758],
8	with	IN	O	with	_	0	SENT_83	[p6l1628t669r1789b735],
9	the	DT	O	the	det	10	SENT_83	[p6l1814t669r1924b735],
10	CAB	NN	O	cab	prep_with	7	SENT_83	[p6l1951t667r2138b735],
11	included	VBD	O	include	rcmod	10	SENT_83	[p6l9t776r312b842],
12	in	IN	O	in	_	0	SENT_83	[p6l341t779r409b841],
13	our	PRP$	O	we	poss	15	SENT_83	[p6l440t802r556b842],
14	primary	JJ	O	primary	amod	15	SENT_83	[p6l583t779r864b865],
15	analysis	NN	O	analysis	prep_in	11	SENT_83	[p6l890t776r1177b865],
16	,	,	O	,	_	0	SENT_83	[p6l890t776r1177b865],
17	assuming	VBG	O	assume	xcomp	11	SENT_83	[p6l1211t779r1540b865],
18	a	DT	O	a	det	20	SENT_83	[p6l1569t802r1604b842],
19	relative	JJ	O	relative	amod	20	SENT_83	[p6l1632t776r1885b842],
20	risk	NN	O	risk	dobj	17	SENT_83	[p6l1915t776r2046b842],
21	of	IN	O	of	_	0	SENT_83	[p6l2072t776r2152b842],
22	2.0	CD	NUMBER	2.0	prep_of	20	SENT_83	[p6l8t885r116b948],
23	associated	VBN	O	associate	partmod	22	SENT_83	[p6l144t882r497b947],
24	with	IN	O	with	_	0	SENT_83	[p6l517t882r678b948],
25	the	DT	O	the	det	27	SENT_83	[p6l703t882r814b947],
26	risk	NN	O	risk	nn	27	SENT_83	[p6l840t882r970b947],
27	allele	NN	O	allele	prep_with	23	SENT_83	[p6l993t882r1169b947],
28	and	CC	O	and	_	0	SENT_83	[p6l1197t882r1324b947],
29	a	DT	O	a	det	31	SENT_83	[p6l1350t908r1384b947],
30	dominant	JJ	O	dominant	amod	31	SENT_83	[p6l1409t882r1753b947],
31	model	NN	O	model	prep_with	23	SENT_83	[p6l1778t882r2016b962],
32	,	,	O	,	_	0	SENT_83	[p6l1778t882r2016b962],
33	we	PRP	O	we	nsubj	34	SENT_83	[p6l2041t908r2139b948],
34	estimated	VBD	O	estimate	_	0	SENT_83	[p6l10t988r351b1054],
35	that	IN	O	that	complm	38	SENT_83	[p6l379t988r520b1054],
36	we	PRP	O	we	nsubj	38	SENT_83	[p6l543t1014r642b1054],
37	would	MD	O	would	aux	38	SENT_83	[p6l668t988r888b1054],
38	have	VB	O	have	ccomp	34	SENT_83	[p6l917t988r1075b1054],
39	50	CD	PERCENT	50	number	40	SENT_83	[p6l1105t988r1257b1054],
40	%	NN	PERCENT	%	amod	41	SENT_83	[p6l1105t988r1257b1054],
41	power	NN	O	power	dobj	38	SENT_83	[p6l1285t1014r1504b1077],
42	with	IN	O	with	_	0	SENT_83	[p6l1528t988r1689b1054],
43	minor	JJ	O	minor	amod	45	SENT_83	[p6l1719t991r1933b1054],
44	allele	NN	O	allele	nn	45	SENT_83	[p6l1962t988r2139b1054],
45	frequencies	NNS	O	frequency	prep_with	38	SENT_83	[p6l9t1094r405b1183],
46	(	CD	NUMBER	(	num	48	SENT_83	[p6l438t1092r693b1174],
47	MAF	NN	O	maf	nn	48	SENT_83	[p6l438t1092r693b1174],
48	)	NN	O	)	dep	45	SENT_83	[p6l438t1092r693b1174],
49	of	IN	O	of	_	0	SENT_83	[p6l726t1094r806b1160],
50	0.05	CD	NUMBER	0.05	prep_of	48	SENT_83	[p6l823t1094r994b1175],
51	,	,	O	,	_	0	SENT_83	[p6l823t1094r994b1175],
52	73	CD	PERCENT	73	num	54	SENT_83	[p6l1028t1095r1177b1160],
53	%	NN	PERCENT	%	nn	54	SENT_83	[p6l1028t1095r1177b1160],
54	power	NN	O	power	conj_and	45	SENT_83	[p6l1205t1120r1424b1183],
55	with	IN	O	with	_	0	SENT_83	[p6l1447t1094r1608b1160],
56	MAF	NN	O	maf	prep_with	54	SENT_83	[p6l1635t1092r1842b1159],
57	of	IN	O	of	_	0	SENT_83	[p6l1868t1094r1948b1160],
58	0.10	CD	NUMBER	0.10	prep_of	56	SENT_83	[p6l1965t1097r2136b1175],
59	,	,	O	,	_	0	SENT_83	[p6l1965t1097r2136b1175],
60	82	CD	PERCENT	82	num	62	SENT_83	[p6l12t1203r161b1267],
61	%	NN	PERCENT	%	nn	62	SENT_83	[p6l12t1203r161b1267],
62	power	NN	O	power	conj_and	45	SENT_83	[p6l190t1226r409b1289],
63	with	IN	O	with	_	0	SENT_83	[p6l434t1200r595b1266],
64	MAF	NN	O	maf	prep_with	62	SENT_83	[p6l624t1198r831b1265],
65	of	IN	O	of	_	0	SENT_83	[p6l859t1200r939b1266],
66	0.15	CD	NUMBER	0.15	prep_of	64	SENT_83	[p6l957t1200r1129b1281],
67	,	,	O	,	_	0	SENT_83	[p6l957t1200r1129b1281],
68	and	CC	PERCENT	and	_	0	SENT_83	[p6l1164t1200r1291b1266],
69	85	CD	PERCENT	85	number	70	SENT_83	[p6l1323t1200r1473b1266],
70	%	NN	PERCENT	%	amod	71	SENT_83	[p6l1323t1200r1473b1266],
71	power	NN	O	power	conj_and	45	SENT_83	[p6l1502t1226r1720b1289],
72	with	IN	O	with	_	0	SENT_83	[p6l1745t1200r1907b1266],
73	MAF	NN	O	maf	prep_with	71	SENT_83	[p6l1935t1198r2142b1265],
74	of	IN	O	of	_	0	SENT_83	[p6l10t1306r90b1371],
75	0.20	CD	NUMBER	0.20	prep_of	73	SENT_83	[p6l104t1309r274b1372],
76	.	.	O	.	_	0	SENT_83	[p6l104t1309r274b1372],

1	On	IN	O	on	_	0	SENT_84	[p6l306t1306r421b1372],
2	the	DT	O	the	det	3	SENT_84	[p6l446t1306r556b1371],
3	basis	NN	O	basis	prep_on	9	SENT_84	[p6l581t1306r747b1371],
4	of	IN	O	of	_	0	SENT_84	[p6l775t1306r855b1371],
5	these	DT	O	these	det	6	SENT_84	[p6l869t1306r1048b1371],
6	estimates	NNS	O	estimate	prep_of	3	SENT_84	[p6l1075t1309r1419b1386],
7	,	,	O	,	_	0	SENT_84	[p6l1075t1309r1419b1386],
8	we	PRP	O	we	nsubj	9	SENT_84	[p6l1445t1332r1542b1372],
9	chose	VBD	O	choose	_	0	SENT_84	[p6l1570t1306r1763b1371],
10	to	TO	O	to	aux	11	SENT_84	[p6l1789t1323r1857b1371],
11	include	VB	O	include	xcomp	9	SENT_84	[p6l1884t1306r2139b1371],
12	only	RB	O	only	advmod	14	SENT_84	[p6l10t1412r163b1501],
13	those	DT	O	those	det	14	SENT_84	[p6l190t1412r376b1478],
14	alleles	NNS	O	allele	npadvmod	17	SENT_84	[p6l411t1412r617b1478],
15	with	IN	O	with	_	0	SENT_84	[p6l647t1412r808b1478],
16	frequencies	NNS	O	frequency	prep_with	14	SENT_84	[p6l840t1412r1236b1501],
17	>	JJR	O	>	amod	22	SENT_84	[p6l1274t1415r1495b1478],
18	0.10	CD	NUMBER	0.10	dep	17	SENT_84	[p6l1274t1415r1495b1478],
19	in	IN	O	in	dep	18	SENT_84	[p6l1528t1415r1595b1477],
20	STRENGTH	NN	O	strength	pobj	19	SENT_84	[p6l1630t1410r2138b1478],
21	Caucasian	JJ	MISC	caucasian	amod	22	SENT_84	[p6l11t1518r370b1584],
22	patients	NNS	O	patient	dobj	11	SENT_84	[p6l402t1521r679b1607],
23	for	IN	O	for	_	0	SENT_84	[p6l713t1518r814b1584],
24	further	JJ	O	further	amod	25	SENT_84	[p6l845t1518r1091b1584],
25	analysis	NN	O	analysis	prep_for	11	SENT_84	[p6l1123t1518r1408b1607],
26	.	.	O	.	_	0	SENT_84	[p6l1123t1518r1408b1607],

1	Finally	RB	O	finally	advmod	5	SENT_85	[p6l1446t1518r1707b1607],
2	,	,	O	,	_	0	SENT_85	[p6l1446t1518r1707b1607],
3	because	IN	O	because	_	0	SENT_85	[p6l1741t1518r2011b1584],
4	we	PRP	O	we	prep_because	5	SENT_85	[p6l2041t1544r2139b1584],
5	JACC	VBP	O	jacc	_	0	SENT_85	[p6l9t1623r123b1673],
6	Vol	NN	O	vol	dobj	5	SENT_85	[p6l150t1623r232b1673],
7	.	.	O	.	_	0	SENT_85	[p6l150t1623r232b1673],

1	54	CD	NUMBER	54	_	0	SENT_86	[p6l263t1623r336b1682],
2	,	,	O	,	_	0	SENT_86	[p6l263t1623r336b1682],
3	No.	NN	O	no.	appos	1	SENT_86	[p6l368t1623r440b1673],
4	17	CD	NUMBER	17	num	3	SENT_86	[p6l472t1623r544b1682],
5	,	,	O	,	_	0	SENT_86	[p6l472t1623r544b1682],
6	2009	CD	DATE	2009	appos	1	SENT_86	[p6l574t1622r697b1673],
7	October	NNP	DATE	October	tmod	6	SENT_86	[p6l11t1711r190b1762],
8	20	CD	DATE	20	num	7	SENT_86	[p6l216t1711r289b1770],
9	,	,	O	,	_	0	SENT_86	[p6l216t1711r289b1770],
10	20092160946	CD	NUMBER	20092160946	num	7	SENT_86	[p6l320t1711r684b1762],

1	were	VBD	O	be	cop	3	SENT_87	[p6l7t1956r173b1996],
2	primarily	RB	O	primarily	advmod	3	SENT_87	[p6l200t1930r527b2019],
3	interested	JJ	O	interested	ccomp	13	SENT_87	[p6l550t1930r897b1996],
4	in	IN	O	in	_	0	SENT_87	[p6l923t1933r991b1995],
5	those	DT	O	those	det	6	SENT_87	[p6l1018t1930r1204b1996],
6	genes	NNS	O	gene	prep_in	3	SENT_87	[p6l1231t1956r1425b2019],
7	implicated	VBN	O	implicate	partmod	6	SENT_87	[p6l1454t1930r1826b2019],
8	in	IN	O	in	_	0	SENT_87	[p6l1852t1933r1920b1995],
9	statin	NN	O	statin	nn	10	SENT_87	[p6l1948t1933r2141b1996],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	7	SENT_87	[p6l9t2039r652b2128],
11	,	,	O	,	_	0	SENT_87	[p6l9t2039r652b2128],
12	we	PRP	O	we	nsubj	13	SENT_87	[p6l706t2065r804b2105],
13	limited	VBD	O	limit	_	0	SENT_87	[p6l859t2039r1111b2105],
14	our	PRP$	O	we	poss	15	SENT_87	[p6l1166t2065r1284b2105],
15	analysis	NN	O	analysis	dobj	13	SENT_87	[p6l1338t2039r1603b2128],
16	to	TO	O	to	_	0	SENT_87	[p6l1659t2056r1727b2105],
17	functional	JJ	O	functional	amod	48	SENT_87	[p6l1783t2039r2142b2105],
18	SNPS	NN	O	snp	dep	17	SENT_87	[p6l14t2147r210b2213],
19	(	CD	NUMBER	(	num	18	SENT_87	[p6l240t2145r389b2228],
20	i.e.	FW	O	i.e.	dep	18	SENT_87	[p6l240t2145r389b2228],
21	,	,	O	,	_	0	SENT_87	[p6l240t2145r389b2228],
22	those	DT	O	those	appos	18	SENT_87	[p6l417t2147r603b2213],
23	with	IN	O	with	_	0	SENT_87	[p6l625t2147r787b2213],
24	alleles	NNS	O	allele	prep_with	22	SENT_87	[p6l813t2147r1020b2213],
25	that	WDT	O	that	nsubjpass	36	SENT_87	[p6l1047t2147r1188b2213],
26	had	VBD	O	have	aux	29	SENT_87	[p6l1211t2147r1340b2213],
27	been	VBN	O	be	auxpass	29	SENT_87	[p6l1363t2147r1529b2213],
28	previously	RB	DATE	previously	advmod	29	SENT_87	[p6l1553t2147r1913b2236],
29	tested	VBN	O	test	rcmod	24	SENT_87	[p6l1934t2147r2142b2213],
30	in	FW	O	in	dep	29	SENT_87	[p6l10t2258r78b2320],
31	vivo	FW	O	vivo	pobj	30	SENT_87	[p6l126t2258r270b2321],
32	or	CC	O	or	_	0	SENT_87	[p6l324t2280r396b2321],
33	in	FW	O	in	nn	34	SENT_87	[p6l446t2258r514b2320],
34	vitro	FW	O	vitro	dep	29	SENT_87	[p6l562t2258r726b2321],
35	and	CC	O	and	_	0	SENT_87	[p6l780t2255r908b2321],
36	found	VBN	O	find	conj_and	29	SENT_87	[p6l959t2255r1167b2321],
37	to	TO	O	to	aux	38	SENT_87	[p6l1217t2272r1285b2321],
38	reduce	VB	O	reduce	xcomp	36	SENT_87	[p6l1338t2255r1568b2321],
39	the	DT	O	the	det	41	SENT_87	[p6l1621t2255r1731b2321],
40	enzymatic	JJ	O	enzymatic	amod	41	SENT_87	[p6l1784t2258r2141b2344],
41	function	NN	O	function	dobj	38	SENT_87	[p6l10t2362r307b2429],
42	of	IN	O	of	_	0	SENT_87	[p6l341t2363r421b2429],
43	the	DT	O	the	det	45	SENT_87	[p6l441t2363r551b2429],
44	protein	NN	O	protein	nn	45	SENT_87	[p6l584t2361r865b2452],
45	)	NN	O	)	prep_of	41	SENT_87	[p6l584t2361r865b2452],
46	(	CD	NUMBER	(	num	47	SENT_87	[p6l905t2361r1175b2443],
47	10,20	CD	NUMBER	10,20	dobj	29	SENT_87	[p6l905t2361r1175b2443],
48	)	NN	O	)	prep_to	13	SENT_87	[p6l905t2361r1175b2443],
49	.	.	O	.	_	0	SENT_87	[p6l905t2361r1175b2443],

1	Statin	NN	O	statin	_	0	SENT_88	[p6l13t2470r235b2537],
2	metabolite	NN	O	metabolite	nn	3	SENT_88	[p6l270t2469r667b2537],
3	measurements	NNS	O	measurement	dep	1	SENT_88	[p6l702t2487r1258b2537],
4	.	.	O	.	_	0	SENT_88	[p6l702t2487r1258b2537],

1	Simvastatin	NNP	O	Simvastatin	nn	4	SENT_89	[p6l1313t2470r1742b2537],
2	and	CC	O	and	_	0	SENT_89	[p6l1781t2471r1912b2537],
3	pravastatin	NN	O	pravastatin	conj_and	1	SENT_89	[p6l1948t2496r2138b2560, p6l12t2581r253b2645],
4	metabolites	NNS	O	metabolite	nsubjpass	6	SENT_89	[p6l301t2578r722b2645],
5	were	VBD	O	be	auxpass	6	SENT_89	[p6l766t2604r938b2645],
6	measured	VBN	O	measure	_	0	SENT_89	[p6l986t2578r1334b2645],
7	on	IN	O	on	_	0	SENT_89	[p6l1381t2605r1470b2645],
8	plasma	NN	O	plasma	prep_on	6	SENT_89	[p6l1516t2578r1771b2668],
9	collected	VBN	O	collect	partmod	8	SENT_89	[p6l1818t2578r2141b2645],
10	from	IN	O	from	_	0	SENT_89	[p6l10t2686r185b2752],
11	samples	NNS	O	sample	prep_from	9	SENT_89	[p6l214t2686r497b2776],
12	collected	VBN	O	collect	partmod	11	SENT_89	[p6l526t2686r850b2752],
13	the	DT	DATE	the	det	14	SENT_89	[p6l875t2686r989b2752],
14	day	NN	DATE	day	tmod	12	SENT_89	[p6l1017t2686r1143b2775],
15	after	IN	O	after	mark	24	SENT_89	[p6l1167t2686r1333b2752],
16	the	DT	O	the	det	22	SENT_89	[p6l1357t2686r1471b2752],
17	last	JJ	O	last	amod	22	SENT_89	[p6l1497t2686r1623b2752],
18	low	JJ	O	low	amod	22	SENT_89	[p6l1646t2686r1810b2753],
19	-	:	O	-	_	0	SENT_89	[p6l1646t2686r1810b2753],
20	or	CC	O	or	_	0	SENT_89	[p6l1840t2712r1914b2752],
21	highdose	JJ	O	highdose	conj_or	18	SENT_89	[p6l1938t2686r2138b2775, p6l11t2794r172b2861],
22	statin	NN	O	statin	nsubjpass	24	SENT_89	[p6l219t2797r420b2861],
23	was	VBD	O	be	auxpass	24	SENT_89	[p6l461t2821r594b2861],
24	taken	VBN	O	take	advcl	12	SENT_89	[p6l640t2794r859b2861],
25	.	.	O	.	_	0	SENT_89	[p6l640t2794r859b2861],

1	We	PRP	O	we	nsubj	3	SENT_90	[p6l905t2795r1037b2861],
2	randomly	RB	O	randomly	advmod	3	SENT_90	[p6l1082t2794r1434b2883],
3	chose	VBD	O	choose	_	0	SENT_90	[p6l1476t2794r1676b2861],
4	57	CD	NUMBER	57	num	5	SENT_90	[p6l1722t2794r1809b2861],
5	subjects	NNS	O	subject	dobj	3	SENT_90	[p6l1855t2794r2138b2883],
6	assigned	VBN	O	assign	partmod	5	SENT_90	[p6l12t2903r320b2992],
7	to	TO	O	to	_	0	SENT_90	[p6l367t2920r436b2969],
8	simvastatin	NN	O	simvastatin	prep_to	6	SENT_90	[p6l487t2906r901b2969],
9	and	CC	O	and	_	0	SENT_90	[p6l951t2903r1081b2969],
10	55	CD	NUMBER	55	dobj	3	SENT_90	[p6l1129t2903r1212b2969],
11	assigned	VBN	O	assign	partmod	10	SENT_90	[p6l1265t2903r1573b2992],
12	to	TO	O	to	_	0	SENT_90	[p6l1620t2920r1689b2969],
13	pravastatin	NN	O	pravastatin	prep_to	11	SENT_90	[p6l1738t2906r2141b2992],
14	with	IN	O	with	_	0	SENT_90	[p6l7t3011r174b3077],
15	available	JJ	O	available	amod	16	SENT_90	[p6l209t3011r522b3078],
16	samples	NNS	O	sample	prep_with	11	SENT_90	[p6l558t3011r865b3100],
17	,	,	O	,	_	0	SENT_90	[p6l558t3011r865b3100],
18	stratiﬁed	VBN	O	stratiﬁed	partmod	16	SENT_90	[p6l904t3011r1227b3077],
19	1:1	CD	NUMBER	1:1	dobj	18	SENT_90	[p6l1264t3015r1367b3077],
20	based	VBN	O	base	_	0	SENT_90	[p6l1404t3011r1609b3077],
21	on	IN	O	on	prepc_based_on	18	SENT_90	[p6l1644t3037r1733b3077],
22	SLCOJBZ	NNP	O	SLCOJBZ	nn	23	SENT_90	[p6l1770t3014r2137b3078],
23	genotype	NN	O	genotype	pobj	18	SENT_90	[p6l9t3136r342b3208],
24	and	CC	O	and	_	0	SENT_90	[p6l389t3119r520b3185],
25	sex	NN	O	sex	pobj	18	SENT_90	[p6l566t3145r693b3185],
26	.	.	O	.	_	0	SENT_90	[p6l566t3145r693b3185],

1	Metabolites	NNS	O	metabolite	nsubjpass	3	SENT_91	[p6l741t3119r1179b3185],
2	were	VBD	O	be	auxpass	3	SENT_91	[p6l1223t3145r1394b3185],
3	analyzed	VBN	O	analyze	_	0	SENT_91	[p6l1442t3119r1757b3208],
4	by	IN	O	by	_	0	SENT_91	[p6l1800t3119r1887b3208],
5	liquid	JJ	O	liquid	amod	6	SENT_91	[p6l1927t3119r2141b3208],
6	chromatography	NN	O	chromatography	agent	3	SENT_91	[p6l11t3227r619b3316],
7	tandem	JJ	O	tandem	amod	10	SENT_91	[p6l672t3227r946b3293],
8	mass	NN	O	mass	nn	10	SENT_91	[p6l1005t3253r1177b3293],
9	spectrometry	NN	O	spectrometry	nn	10	SENT_91	[p6l1237t3244r1718b3316],
10	system	NN	O	system	tmod	3	SENT_91	[p6l1772t3244r2015b3316],
11	as	IN	O	as	mark	13	SENT_91	[p6l2074t3253r2139b3293],
12	previously	RB	DATE	previously	advmod	13	SENT_91	[p6l9t3335r385b3424],
13	described	VBN	O	describe	dep	10	SENT_91	[p6l416t3335r762b3401],
14	(	NN	O	(	nn	16	SENT_91	[p6l799t3333r942b3415],
15	21	CD	NUMBER	21	num	16	SENT_91	[p6l799t3333r942b3415],
16	)	NN	O	)	dobj	13	SENT_91	[p6l799t3333r942b3415],
17	with	IN	O	with	_	0	SENT_91	[p6l976t3335r1142b3401],
18	modiﬁcations	NNS	O	modiﬁcations	prep_with	13	SENT_91	[p6l1177t3335r1675b3401],
19	(	CD	NUMBER	(	nsubj	20	SENT_91	[p6l1714t3333r1849b3415],
20	see	VBP	O	see	rcmod	18	SENT_91	[p6l1714t3333r1849b3415],
21	Online	NNP	O	Online	nn	22	SENT_91	[p6l1886t3335r2140b3401],
22	Methods	NNS	O	method	dobj	20	SENT_91	[p6l9t3444r340b3510],
23	for	IN	O	for	_	0	SENT_91	[p6l379t3444r484b3510],
24	details	NNS	O	detail	prep_for	20	SENT_91	[p6l521t3442r807b3524],
25	)	CD	NUMBER	)	dep	10	SENT_91	[p6l521t3442r807b3524],
26	.	.	O	.	_	0	SENT_91	[p6l521t3442r807b3524],

1	The	DT	O	the	det	3	SENT_92	[p6l847t3442r997b3510],
2	lower	JJR	O	lower	amod	3	SENT_92	[p6l1035t3444r1238b3510],
3	limits	NNS	O	limit	nsubj	12	SENT_92	[p6l1273t3444r1480b3510],
4	of	IN	O	of	_	0	SENT_92	[p6l1521t3444r1603b3510],
5	quantiﬁcation	NN	O	quantiﬁcation	prep_of	3	SENT_92	[p6l1629t3444r2140b3533],
6	in	IN	O	in	_	0	SENT_92	[p6l10t3555r80b3617],
7	plasma	NN	O	plasma	prep_in	5	SENT_92	[p6l108t3552r363b3641],
8	were	VBD	O	be	cop	12	SENT_92	[p6l388t3577r560b3618],
9	as	IN	O	as	mark	10	SENT_92	[p6l591t3578r656b3618],
10	follows	VBZ	O	follow	dep	12	SENT_92	[p6l687t3552r968b3618],
11	:	:	O	:	_	0	SENT_92	[p6l687t3552r968b3618],
12	0.018	CD	NUMBER	0.018	_	0	SENT_92	[p6l1003t3555r1228b3633],
13	,	,	O	,	_	0	SENT_92	[p6l1003t3555r1228b3633],
14	0.018	CD	NUMBER	0.018	dep	12	SENT_92	[p6l1260t3555r1485b3633],
15	,	,	O	,	_	0	SENT_92	[p6l1260t3555r1485b3633],
16	0.041	CD	NUMBER	0.041	num	14	SENT_92	[p6l1518t3555r1743b3633],
17	,	,	O	,	_	0	SENT_92	[p6l1518t3555r1743b3633],
18	and	CC	O	and	_	0	SENT_92	[p6l1777t3552r1908b3618],
19	0.041	CD	NUMBER	0.041	dep	12	SENT_92	[p6l1937t3555r2135b3618],
20	ng	NN	O	ng	dep	14	SENT_92	[p6l12t3659r134b3749],
21	/	:	O	/	punct	14	SENT_92	[p6l12t3659r134b3749],
22	ml	NN	O	ml	dep	14	SENT_92	[p6l138t3660r231b3725],
23	for	IN	O	for	_	0	SENT_92	[p6l261t3659r365b3726],
24	simvastatin	NN	O	simvastatin	nn	25	SENT_92	[p6l396t3662r809b3726],
25	acid	NN	O	acid	prep_for	22	SENT_92	[p6l842t3659r1008b3740],
26	,	,	O	,	_	0	SENT_92	[p6l842t3659r1008b3740],
27	simvastatin	NN	O	simvastatin	nn	28	SENT_92	[p6l1044t3662r1458b3726],
28	lactone	NN	O	lactone	appos	25	SENT_92	[p6l1487t3659r1772b3740],
29	,	,	O	,	_	0	SENT_92	[p6l1487t3659r1772b3740],
30	pravastatin	NN	O	pravastatin	dep	12	SENT_92	[p6l1805t3677r2138b3749, p7l10t19r110b83],

1	acid	NN	O	acid	_	0	SENT_93	[p7l179t16r345b97],
2	,	,	O	,	_	0	SENT_93	[p7l179t16r345b97],
3	and	CC	O	and	dep	1	SENT_93	[p7l416t16r547b83],
4	pravastatin	NN	O	pravastatin	nn	5	SENT_93	[p7l613t19r1016b106],
5	lactone	NN	O	lactone	dep	1	SENT_93	[p7l1082t16r1367b97],
6	,	,	O	,	_	0	SENT_93	[p7l1082t16r1367b97],
7	respectively	RB	O	respectively	dep	5	SENT_93	[p7l1436t16r1882b106],
8	.	.	O	.	_	0	SENT_93	[p7l1436t16r1882b106],

1	In	IN	O	in	_	0	SENT_94	[p7l1953t17r2033b82],
2	2	CD	NUMBER	2	num	3	SENT_94	[p7l2098t20r2139b84],
3	simvastatin	NN	O	simvastatin	prep_in	17	SENT_94	[p7l12t127r425b191],
4	and	CC	O	and	_	0	SENT_94	[p7l483t125r614b191],
5	6	CD	NUMBER	6	num	7	SENT_94	[p7l671t128r708b191],
6	pravastatin	NN	O	pravastatin	nn	7	SENT_94	[p7l765t127r1169b214],
7	samples	NNS	O	sample	prep_in	17	SENT_94	[p7l1226t124r1532b214],
8	,	,	O	,	_	0	SENT_94	[p7l1226t124r1532b214],
9	metabolites	NNS	O	metabolite	nsubj	17	SENT_94	[p7l1592t124r2013b191],
10	of	IN	O	of	_	0	SENT_94	[p7l2072t124r2153b191],
11	both	DT	O	both	preconj	12	SENT_94	[p7l8t233r178b300],
12	lactone	NN	O	lactone	prep_of	9	SENT_94	[p7l238t233r500b300],
13	and	CC	O	and	_	0	SENT_94	[p7l565t233r695b300],
14	acid	NN	O	acid	conj_and	12	SENT_94	[p7l758t233r903b300],
15	Were	VBD	O	be	cop	17	SENT_94	[p7l960t259r1132b300],
16	undetectable	JJ	O	undetectable	amod	17	SENT_94	[p7l1193t233r1660b300],
17	(	NN	O	(	_	0	SENT_94	[p7l1726t231r2143b322],
18	suggesting	VBG	O	suggest	partmod	17	SENT_94	[p7l1726t231r2143b322],
19	nonadherence	NN	O	nonadherence	nn	20	SENT_94	[p7l12t339r552b421],
20	)	NN	O	)	dobj	18	SENT_94	[p7l12t339r552b421],
21	and	CC	O	and	_	0	SENT_94	[p7l593t341r724b407],
22	were	VBD	O	be	auxpass	23	SENT_94	[p7l754t367r926b407],
23	excluded	VBN	O	exclude	conj_and	17	SENT_94	[p7l962t341r1302b407],
24	.	.	O	.	_	0	SENT_94	[p7l962t341r1302b407],

1	In	IN	O	in	_	0	SENT_95	[p7l1340t342r1419b406],
2	addition	NN	O	addition	prep_in	16	SENT_95	[p7l1456t341r1783b421],
3	,	,	O	,	_	0	SENT_95	[p7l1456t341r1783b421],
4	3	CD	NUMBER	3	number	6	SENT_95	[p7l1821t345r1857b407],
5	simva	NN	O	simva	dep	6	SENT_95	[p7l1898t344r2138b407],
6	—	NN	O	—	amod	7	SENT_95	[p7l1898t344r2138b407],
7	statin	NN	O	statin	nsubj	16	SENT_95	[p7l12t453r213b516],
8	and	CC	O	and	_	0	SENT_95	[p7l263t450r394b516],
9	1	CD	NUMBER	1	num	14	SENT_95	[p7l445t454r477b515],
10	pravastatin	NN	O	pravastatin	nn	14	SENT_95	[p7l529t453r933b539],
11	high	JJ	O	high	amod	14	SENT_95	[p7l981t450r1349b539],
12	—	NN	O	—	nn	14	SENT_95	[p7l981t450r1349b539],
13	dose	NN	O	dose	nn	14	SENT_95	[p7l981t450r1349b539],
14	measurements	NNS	O	measurement	conj_and	7	SENT_95	[p7l1399t467r1922b516],
15	were	VBD	O	be	cop	16	SENT_95	[p7l1968t476r2139b516],
16	<	JJR	O	<	_	0	SENT_95	[p7l15t558r196b625],
17	5	CD	PERCENT	5	num	18	SENT_95	[p7l15t558r196b625],
18	%	NN	PERCENT	%	nsubj	26	SENT_95	[p7l15t558r196b625],
19	of	IN	O	of	_	0	SENT_95	[p7l258t558r339b624],
20	their	PRP$	O	they	poss	25	SENT_95	[p7l389t558r562b624],
21	respective	JJ	O	respective	amod	25	SENT_95	[p7l621t561r982b647],
22	low	JJ	O	low	amod	25	SENT_95	[p7l1042t558r1376b624],
23	—	NN	O	—	nn	25	SENT_95	[p7l1042t558r1376b624],
24	dose	NN	O	dose	nn	25	SENT_95	[p7l1042t558r1376b624],
25	concentrations	NNS	O	concentration	prep_of	18	SENT_95	[p7l1439t561r1977b624],
26	(	VBP	O	(	ccomp	16	SENT_95	[p7l2043t556r2141b638],
27	in	IN	O	in	_	0	SENT_95	[p7l2043t556r2141b638],
28	contrast	NN	O	contrast	prep_in	26	SENT_95	[p7l11t683r306b732],
29	to	TO	O	to	_	0	SENT_95	[p7l336t683r406b732],
30	the	DT	O	the	det	31	SENT_95	[p7l440t666r554b732],
31	remainder	NN	O	remainder	prep_to	16	SENT_95	[p7l587t666r963b732],
32	of	IN	O	of	_	0	SENT_95	[p7l994t666r1076b732],
33	the	DT	O	the	det	34	SENT_95	[p7l1096t666r1210b732],
34	group	NN	O	group	prep_of	31	SENT_95	[p7l1242t692r1476b755],
35	,	,	O	,	_	0	SENT_95	[p7l1242t692r1476b755],
36	whose	WP$	O	whose	poss	38	SENT_95	[p7l1509t666r1737b732],
37	high	JJ	O	high	amod	38	SENT_95	[p7l1771t666r2139b755],
38	—	NN	O	—	dobj	44	SENT_95	[p7l1771t666r2139b755],
39	dose	NN	O	dose	nn	40	SENT_95	[p7l1771t666r2139b755],
40	measurements	NNS	O	measurement	nsubj	44	SENT_95	[p7l11t791r534b840],
41	were	VBD	O	be	cop	44	SENT_95	[p7l570t800r742b840],
42	4	LS	NUMBER	4	dep	44	SENT_95	[p7l780t777r857b839],
43	-	:	O	-	_	0	SENT_95	[p7l780t777r857b839],
44	to	TO	O	to	rcmod	34	SENT_95	[p7l898t791r967b840],
45	8-fold	JJ	O	8-fold	pobj	44	SENT_95	[p7l1010t774r1235b840],
46	greater	JJR	O	greater	dep	44	SENT_95	[p7l1271t791r1527b863],
47	than	IN	O	than	_	0	SENT_95	[p7l1563t774r1727b840],
48	their	PRP$	O	they	poss	50	SENT_95	[p7l1765t774r1939b840],
49	lowdose	NN	O	lowdose	nn	50	SENT_95	[p7l1974t774r2138b840, p7l11t883r172b949],
50	measurement	NN	O	measurement	prep_than	44	SENT_95	[p7l231t881r775b964],
51	)	RB	O	)	advmod	44	SENT_95	[p7l231t881r775b964],
52	,	,	O	,	_	0	SENT_95	[p7l231t881r775b964],
53	suggesting	VBG	O	suggest	xcomp	16	SENT_95	[p7l837t886r1224b972],
54	nonadherence	NN	O	nonadherence	dobj	53	SENT_95	[p7l1282t883r1795b949],
55	at	IN	O	at	_	0	SENT_95	[p7l1855t900r1920b949],
56	high	JJ	O	high	amod	57	SENT_95	[p7l1976t883r2141b972],
57	dose	NN	O	dose	prep_at	53	SENT_95	[p7l11t992r172b1057],
58	and	CC	O	and	_	0	SENT_95	[p7l238t992r369b1057],
59	therefore	RB	O	therefore	advmod	62	SENT_95	[p7l431t992r764b1057],
60	were	VBD	O	be	auxpass	62	SENT_95	[p7l825t1017r996b1057],
61	also	RB	O	also	advmod	62	SENT_95	[p7l1062t992r1198b1057],
62	excluded	VBN	O	exclude	conj_and	16	SENT_95	[p7l1264t992r1584b1057],
63	from	IN	O	from	_	0	SENT_95	[p7l1647t992r1822b1057],
64	further	JJ	O	further	amod	65	SENT_95	[p7l1886t992r2143b1057],
65	analysis	NN	O	analysis	prep_from	62	SENT_95	[p7l12t1101r311b1190],
66	.	.	O	.	_	0	SENT_95	[p7l12t1101r311b1190],

1	Statistical	JJ	O	statistical	amod	2	SENT_96	[p7l13t1207r382b1275],
2	analysis	NN	O	analysis	_	0	SENT_96	[p7l423t1207r731b1298],
3	.	.	O	.	_	0	SENT_96	[p7l423t1207r731b1298],

1	Continuous	JJ	O	continuous	amod	2	SENT_97	[p7l785t1208r1201b1275],
2	variables	NNS	O	variable	nsubjpass	4	SENT_97	[p7l1241t1209r1545b1275],
3	were	VBD	O	be	auxpass	4	SENT_97	[p7l1584t1234r1751b1275],
4	compared	VBN	O	compare	_	0	SENT_97	[p7l1795t1208r2141b1298],
5	with	IN	O	with	_	0	SENT_97	[p7l7t1316r168b1383],
6	the	DT	O	the	det	7	SENT_97	[p7l208t1316r318b1383],
7	use	NN	O	use	prep_with	4	SENT_97	[p7l358t1343r469b1383],
8	of	IN	O	of	_	0	SENT_97	[p7l511t1316r591b1383],
9	Student	NN	O	student	nn	12	SENT_97	[p7l622t1316r899b1383],
10	2	CD	NUMBER	2	num	12	SENT_97	[p7l939t1333r968b1382],
11	‘	NN	O	‘	nn	12	SENT_97	[p7l939t1333r968b1382],
12	tests	NNS	O	test	prep_of	7	SENT_97	[p7l1001t1333r1176b1397],
13	,	,	O	,	_	0	SENT_97	[p7l1001t1333r1176b1397],
14	categorical	JJ	O	categorical	amod	15	SENT_97	[p7l1220t1316r1596b1406],
15	variables	NNS	O	variable	nsubjpass	4	SENT_97	[p7l1631t1316r1935b1383],
16	were	VBD	O	be	auxpass	4	SENT_97	[p7l1973t1342r2139b1383],
17	compared	VBN	O	compare	_	0	SENT_97	[p7l11t1424r358b1514],
18	with	IN	O	with	_	0	SENT_97	[p7l380t1425r541b1491],
19	the	DT	O	the	det	20	SENT_97	[p7l567t1425r677b1491],
20	use	NN	O	use	prep_compared_with	4	SENT_97	[p7l703t1451r815b1491],
21	of	IN	O	of	_	0	SENT_97	[p7l842t1424r922b1491],
22	chi-square	JJ	O	chi-square	amod	23	SENT_97	[p7l937t1424r1303b1514],
23	tests	NNS	O	test	prep_of	20	SENT_97	[p7l1330t1442r1505b1505],
24	,	,	O	,	_	0	SENT_97	[p7l1330t1442r1505b1505],
25	and	CC	O	and	_	0	SENT_97	[p7l1535t1424r1663b1491],
26	trends	NNS	O	trend	nsubjpass	31	SENT_97	[p7l1688t1424r1905b1491],
27	across	IN	O	across	_	0	SENT_97	[p7l1934t1450r2139b1491],
28	ordinal	JJ	O	ordinal	amod	29	SENT_97	[p7l11t1532r261b1599],
29	variables	NNS	O	variable	prep_across	26	SENT_97	[p7l286t1532r590b1599],
30	were	VBD	O	be	auxpass	31	SENT_97	[p7l619t1558r785b1599],
31	assessed	VBN	O	assess	conj_and	4	SENT_97	[p7l818t1532r1100b1599],
32	With	IN	O	with	_	0	SENT_97	[p7l1126t1532r1287b1599],
33	the	DT	O	the	det	34	SENT_97	[p7l1318t1532r1428b1599],
34	Cochran	NNP	O	Cochran	prep_with	31	SENT_97	[p7l1461t1531r2140b1621],
35	.	.	O	.	_	0	SENT_97	[p7l1461t1531r2140b1621],

1	—	NN	O	—	_	0	SENT_98	[p7l1461t1531r2140b1621],
2	.	.	O	.	_	0	SENT_98	[p7l1461t1531r2140b1621],

1	Armitage	NN	PERSON	armitage	nn	2	SENT_99	[p7l1461t1531r2140b1621],
2	trend	NN	O	trend	nsubj	3	SENT_99	[p7l10t1640r209b1706],
3	test	NN	O	test	_	0	SENT_99	[p7l276t1657r427b1706],
4	.	.	O	.	_	0	SENT_99	[p7l276t1657r427b1706],

1	Triglycerides	NNS	MISC	triglyceride	nsubjpass	6	SENT_100	[p7l496t1638r992b1729],
2	and	CC	O	and	_	0	SENT_100	[p7l1063t1640r1196b1706],
3	CK	NN	O	ck	nn	4	SENT_100	[p7l1264t1640r1394b1707],
4	values	NNS	O	value	conj_and	1	SENT_100	[p7l1455t1640r1681b1707],
5	were	VBD	O	be	auxpass	6	SENT_100	[p7l1747t1666r1921b1706],
6	logtransformed	VBN	O	logtransform	_	0	SENT_100	[p7l1988t1640r2137b1729, p7l10t1748r441b1814],
7	to	TO	O	to	_	0	SENT_100	[p7l466t1765r534b1814],
8	approximate	JJ	O	approximate	amod	10	SENT_100	[p7l562t1751r999b1837],
9	normal	JJ	O	normal	amod	10	SENT_100	[p7l1026t1748r1277b1814],
10	distributions	NNS	O	distribution	prep_to	6	SENT_100	[p7l1302t1748r1765b1814],
11	.	.	O	.	_	0	SENT_100	[p7l1302t1748r1765b1814],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_101	[p7l1793t1748r2138b1814, p7l10t1860r134b1923],
2	models	NNS	O	model	nsubjpass	4	SENT_101	[p7l159t1857r407b1923],
3	Were	VBD	O	be	auxpass	4	SENT_101	[p7l428t1882r595b1923],
4	constructed	VBN	O	construct	_	0	SENT_101	[p7l619t1857r1028b1923],
5	by	IN	O	by	_	0	SENT_101	[p7l1049t1857r1135b1946],
6	the	DT	O	the	det	7	SENT_101	[p7l1153t1857r1264b1923],
7	use	NN	O	use	agent	4	SENT_101	[p7l1286t1883r1397b1923],
8	of	IN	O	of	_	0	SENT_101	[p7l1422t1857r1502b1923],
9	logistic	JJ	O	logistic	amod	10	SENT_101	[p7l1512t1857r1764b1946],
10	regression	NN	O	regression	prep_of	7	SENT_101	[p7l1786t1860r2141b1946],
11	for	IN	O	for	_	0	SENT_101	[p7l10t1964r111b2031],
12	categorical	JJ	O	categorical	amod	13	SENT_101	[p7l133t1964r510b2054],
13	variables	NNS	O	variable	prep_for	10	SENT_101	[p7l527t1964r851b2031],
14	.	.	O	.	_	0	SENT_101	[p7l527t1964r851b2031],

1	A	DT	O	a	nsubj	15	SENT_102	[p7l876t1963r943b2030],
2	generalized	VBN	O	generalize	csubjpass	12	SENT_102	[p7l963t1964r1365b2054],
3	linear	JJ	O	linear	amod	4	SENT_102	[p7l1386t1964r1586b2031],
4	model	NN	O	model	dobj	2	SENT_102	[p7l1608t1964r1828b2031],
5	with	IN	O	with	_	0	SENT_102	[p7l1846t1965r2007b2031],
6	the	DT	O	the	det	10	SENT_102	[p7l2030t1964r2140b2031],
7	least	JJS	O	least	amod	10	SENT_102	[p7l9t2073r167b2140],
8	square	JJ	O	square	amod	10	SENT_102	[p7l211t2099r433b2163],
9	means	NNS	O	means	nn	10	SENT_102	[p7l478t2100r698b2140],
10	method	NN	O	method	prep_with	2	SENT_102	[p7l744t2073r1017b2140],
11	was	VBD	O	be	auxpass	12	SENT_102	[p7l1055t2100r1185b2140],
12	used	VBN	O	use	dep	1	SENT_102	[p7l1229t2073r1388b2140],
13	to	TO	O	to	aux	14	SENT_102	[p7l1430t2090r1498b2140],
14	estimate	VB	O	estimate	xcomp	12	SENT_102	[p7l1544t2076r1836b2140],
15	percent	JJ	O	percent	_	0	SENT_102	[p7l1879t2091r2143b2163],
16	reduction	NN	O	reduction	dobj	15	SENT_102	[p7l10t2181r351b2247],
17	in	IN	O	in	_	0	SENT_102	[p7l414t2184r482b2247],
18	LDL	NN	O	ldl	prep_in	16	SENT_102	[p7l546t2182r733b2247],
19	by	IN	O	by	_	0	SENT_102	[p7l794t2181r881b2270],
20	genotype	NN	O	genotype	prep_by	15	SENT_102	[p7l938t2198r1282b2271],
21	.	.	O	.	_	0	SENT_102	[p7l938t2198r1282b2271],

1	For	IN	O	for	_	0	SENT_103	[p7l1350t2182r1476b2247],
2	changes	NNS	O	change	prep_for	16	SENT_103	[p7l1539t2181r1818b2270],
3	in	IN	O	in	_	0	SENT_103	[p7l1883t2184r1951b2247],
4	CK	NN	O	ck	prep_in	2	SENT_103	[p7l2016t2181r2143b2248],
5	throughout	IN	O	throughout	_	0	SENT_103	[p7l10t2289r413b2378],
6	the	DT	O	the	det	7	SENT_103	[p7l471t2289r581b2355],
7	study	NN	O	study	prep_throughout	4	SENT_103	[p7l644t2289r848b2378],
8	,	,	O	,	_	0	SENT_103	[p7l644t2289r848b2378],
9	a	DT	O	a	det	12	SENT_103	[p7l912t2315r947b2355],
10	repeated	VBN	O	repeat	amod	12	SENT_103	[p7l1005t2289r1305b2378],
11	measures	NNS	O	measure	nn	12	SENT_103	[p7l1365t2315r1683b2355],
12	analysis	NN	O	analysis	nsubjpass	16	SENT_103	[p7l1746t2289r2011b2378],
13	of	IN	O	of	_	0	SENT_103	[p7l2073t2289r2153b2355],
14	variance	NN	O	variance	prep_of	12	SENT_103	[p7l7t2400r296b2463],
15	was	VBD	O	be	auxpass	16	SENT_103	[p7l318t2423r447b2463],
16	used	VBN	O	use	_	0	SENT_103	[p7l472t2397r648b2463],
17	.	.	O	.	_	0	SENT_103	[p7l472t2397r648b2463],

1	To	TO	O	to	aux	2	SENT_104	[p7l674t2395r778b2463],
2	account	VB	O	account	purpcl	9	SENT_104	[p7l806t2414r1078b2463],
3	for	IN	O	for	_	0	SENT_104	[p7l1100t2397r1201b2463],
4	the	DT	O	the	det	6	SENT_104	[p7l1223t2397r1334b2463],
5	multiple	JJ	O	multiple	amod	6	SENT_104	[p7l1359t2397r1652b2486],
6	comparisons	NNS	O	comparison	prep_for	2	SENT_104	[p7l1678t2400r2138b2486],
7	,	,	O	,	_	0	SENT_104	[p7l1678t2400r2138b2486],
8	we	PRP	O	we	nsubj	9	SENT_104	[p7l7t2532r105b2572],
9	calculated	VBD	O	calculate	_	0	SENT_104	[p7l134t2506r483b2572],
10	the	DT	O	the	det	13	SENT_104	[p7l509t2506r619b2572],
11	false	JJ	O	false	amod	13	SENT_104	[p7l647t2506r801b2572],
12	discovery	NN	O	discovery	nn	13	SENT_104	[p7l829t2506r1157b2595],
13	rate	NN	O	rate	dobj	9	SENT_104	[p7l1180t2523r1311b2572],
14	(	CD	NUMBER	(	num	15	SENT_104	[p7l1341t2504r1577b2586],
15	FDR	NNP	O	FDR	tmod	9	SENT_104	[p7l1341t2504r1577b2586],
16	)	CD	NUMBER	)	num	15	SENT_104	[p7l1341t2504r1577b2586],
17	as	IN	O	as	mark	18	SENT_104	[p7l1610t2532r1673b2572],
18	described	VBN	O	describe	dep	15	SENT_104	[p7l1703t2506r2035b2572],
19	by	IN	O	by	_	0	SENT_104	[p7l2059t2506r2145b2595],
20	Benjamini	NNP	PERSON	Benjamini	prep_by	18	SENT_104	[p7l11t2614r377b2703],
21	and	CC	O	and	_	0	SENT_104	[p7l412t2614r539b2680],
22	Hochberg	NNP	PERSON	Hochberg	prep_by	18	SENT_104	[p7l572t2613r930b2703],
23	(	CD	NUMBER	(	number	24	SENT_104	[p7l965t2611r1124b2694],
24	22	CD	NUMBER	22	num	25	SENT_104	[p7l965t2611r1124b2694],
25	)	NN	O	)	dobj	18	SENT_104	[p7l965t2611r1124b2694],
26	.	.	O	.	_	0	SENT_104	[p7l965t2611r1124b2694],

1	Statin	NN	O	statin	nn	3	SENT_105	[p7l103t2721r310b2788],
2	metabolite	NN	O	metabolite	nn	3	SENT_105	[p7l339t2721r711b2788],
3	concentrations	NNS	O	concentration	nsubj	5	SENT_105	[p7l742t2724r1257b2788],
4	were	VBD	O	be	cop	5	SENT_105	[p7l1283t2747r1450b2788],
5	log	NN	O	log	_	0	SENT_105	[p7l1478t2721r1587b2811],
6	transformed	VBN	O	transform	partmod	5	SENT_105	[p7l1613t2721r2044b2788],
7	to	TO	O	to	aux	8	SENT_105	[p7l2071t2739r2139b2788],
8	approximate	JJ	O	approximate	xcomp	6	SENT_105	[p7l12t2832r449b2919],
9	a	DT	O	a	det	11	SENT_105	[p7l476t2856r510b2895],
10	normal	JJ	O	normal	amod	11	SENT_105	[p7l535t2829r786b2895],
11	distribution	NN	O	distribution	dobj	8	SENT_105	[p7l810t2829r1241b2895],
12	.	.	O	.	_	0	SENT_105	[p7l810t2829r1241b2895],

1	Generalized	NNP	O	Generalized	nn	3	SENT_106	[p7l1272t2829r1701b2896],
2	linear	JJ	O	linear	amod	3	SENT_106	[p7l1724t2829r1923b2895],
3	models	NNS	O	model	nsubjpass	5	SENT_106	[p7l1947t2829r2138b2895, p7l11t2937r98b3003],
4	were	VBD	O	be	auxpass	5	SENT_106	[p7l143t2962r309b3003],
5	constructed	VBN	O	construct	_	0	SENT_106	[p7l359t2937r767b3003],
6	to	TO	O	to	aux	7	SENT_106	[p7l813t2954r882b3003],
7	evaluate	VB	O	evaluate	xcomp	5	SENT_106	[p7l931t2937r1212b3003],
8	the	DT	O	the	det	9	SENT_106	[p7l1260t2937r1370b3003],
9	association	NN	O	association	dobj	7	SENT_106	[p7l1419t2940r1802b3003],
10	between	IN	O	between	_	0	SENT_106	[p7l1847t2937r2141b3003],
11	genotype	NN	O	genotype	prep_between	9	SENT_106	[p7l9t3062r329b3134],
12	(	CD	NUMBER	(	num	11	SENT_106	[p7l365t3043r600b3125],
13	coded	VBN	O	code	partmod	11	SENT_106	[p7l365t3043r600b3125],
14	as	IN	O	as	_	0	SENT_106	[p7l633t3071r695b3111],
15	1	CD	NUMBER	1	prep_as	13	SENT_106	[p7l733t3048r790b3126],
16	,	,	O	,	_	0	SENT_106	[p7l733t3048r790b3126],
17	2	CD	NUMBER	2	conj_or	15	SENT_106	[p7l823t3048r885b3126],
18	,	,	O	,	_	0	SENT_106	[p7l823t3048r885b3126],
19	3	CD	NUMBER	3	num	20	SENT_106	[p7l921t3043r987b3125],
20	)	NN	O	)	conj_or	15	SENT_106	[p7l921t3043r987b3125],
21	or	CC	O	or	_	0	SENT_106	[p7l1023t3071r1095b3111],
22	sex	NN	O	sex	conj_or	15	SENT_106	[p7l1127t3071r1232b3111],
23	and	CC	O	and	_	0	SENT_106	[p7l1264t3045r1391b3111],
24	the	DT	O	the	det	26	SENT_106	[p7l1422t3045r1532b3111],
25	log	NN	O	log	nn	26	SENT_106	[p7l1563t3045r2142b3134],
26	—	NN	O	—	conj_and	11	SENT_106	[p7l1563t3045r2142b3134],
27	transformed	VBN	O	transform	partmod	26	SENT_106	[p7l1563t3045r2142b3134],
28	drug	NN	O	drug	nn	30	SENT_106	[p7l11t3154r174b3243],
29	metabolite	NN	O	metabolite	nn	30	SENT_106	[p7l216t3154r588b3220],
30	concentrations	NNS	O	concentration	dobj	27	SENT_106	[p7l633t3157r1169b3220],
31	.	.	O	.	_	0	SENT_106	[p7l633t3157r1169b3220],

1	For	IN	O	for	_	0	SENT_107	[p7l1216t3155r1342b3220],
2	each	DT	O	each	det	3	SENT_107	[p7l1385t3154r1541b3220],
3	model	NN	O	model	prep_for	8	SENT_107	[p7l1584t3154r1823b3235],
4	,	,	O	,	_	0	SENT_107	[p7l1584t3154r1823b3235],
5	residual	JJ	O	residual	amod	6	SENT_107	[p7l1868t3154r2142b3220],
6	plots	NNS	O	plot	nsubjpass	8	SENT_107	[p7l9t3261r178b3351],
7	were	VBD	O	be	auxpass	8	SENT_107	[p7l219t3287r386b3328],
8	examined	VBN	O	examine	_	0	SENT_107	[p7l431t3261r769b3328],
9	to	TO	O	to	aux	10	SENT_107	[p7l811t3278r879b3328],
10	confirm	VB	O	confirm	xcomp	8	SENT_107	[p7l925t3261r1199b3328],
11	a	DT	O	a	det	13	SENT_107	[p7l1244t3288r1279b3328],
12	normal	JJ	O	normal	amod	13	SENT_107	[p7l1322t3262r1573b3328],
13	distribution	NN	O	distribution	dobj	10	SENT_107	[p7l1615t3261r2028b3328],
14	of	IN	O	of	_	0	SENT_107	[p7l2073t3261r2152b3328],
15	errors	NNS	O	error	prep_of	13	SENT_107	[p7l11t3395r230b3435],
16	.	.	O	.	_	0	SENT_107	[p7l11t3395r230b3435],

1	No	DT	O	no	det	3	SENT_108	[p7l267t3370r377b3435],
2	inﬂuential	JJ	O	inﬂuential	amod	3	SENT_108	[p7l412t3369r772b3435],
3	outliers	NNS	O	outlier	nsubjpass	5	SENT_108	[p7l805t3369r1063b3435],
4	were	VBD	O	be	auxpass	5	SENT_108	[p7l1094t3395r1260b3435],
5	observed	VBN	O	observe	_	0	SENT_108	[p7l1295t3369r1620b3435],
6	.	.	O	.	_	0	SENT_108	[p7l1295t3369r1620b3435],

1	A	DT	O	a	det	2	SENT_109	[p8l97t27r164b94],
2	p	NN	O	p	nsubjpass	7	SENT_109	[p8l221t55r263b118],
3	value	NN	O	value	dep	2	SENT_109	[p8l321t28r503b95],
4	<	JJR	O	<	dobj	3	SENT_109	[p8l569t28r787b95],
5	0.05	CD	NUMBER	0.05	advmod	3	SENT_109	[p8l569t28r787b95],
6	was	VBD	O	be	auxpass	7	SENT_109	[p8l846t55r976b95],
7	considered	VBN	O	consider	_	0	SENT_109	[p8l1038t28r1417b94],
8	signiﬁcant	NN	O	signiﬁcant	dobj	7	SENT_109	[p8l1478t28r1843b117],
9	for	IN	O	for	_	0	SENT_109	[p8l1901t28r2002b94],
10	all	DT	O	all	det	11	SENT_109	[p8l2062t28r2142b94],
11	analyses	NNS	O	analysis	prep_for	8	SENT_109	[p8l12t137r291b226],
12	except	IN	O	except	_	0	SENT_109	[p8l318t154r541b227],
13	for	IN	O	for	_	0	SENT_109	[p8l564t137r665b203],
14	interaction	NN	O	interaction	nn	15	SENT_109	[p8l688t140r1070b203],
15	tests	NNS	O	test	prep_except_for	7	SENT_109	[p8l1095t154r1269b218],
16	,	,	O	,	_	0	SENT_109	[p8l1095t154r1269b218],
17	where	WRB	O	where	advmod	19	SENT_109	[p8l1293t137r1508b204],
18	we	PRP	O	we	nsubj	19	SENT_109	[p8l1530t163r1628b203],
19	used	VBD	O	use	rcmod	15	SENT_109	[p8l1653t137r1812b203],
20	a	DT	O	a	det	22	SENT_109	[p8l1837t163r1872b203],
21	p	NN	O	p	nn	22	SENT_109	[p8l1894t163r1936b226],
22	value	NN	O	value	npadvmod	23	SENT_109	[p8l1959t137r2140b204],
23	<	JJR	O	<	acomp	19	SENT_109	[p8l15t248r191b312],
24	0.2	CD	NUMBER	0.2	tmod	19	SENT_109	[p8l15t248r191b312],
25	to	TO	O	to	aux	26	SENT_109	[p8l252t262r320b311],
26	allow	VB	O	allow	infmod	24	SENT_109	[p8l382t245r569b311],
27	greater	JJR	O	greater	amod	28	SENT_109	[p8l624t262r869b334],
28	power	NN	O	power	dobj	26	SENT_109	[p8l925t271r1144b334],
29	to	TO	O	to	aux	30	SENT_109	[p8l1201t262r1269b311],
30	detect	VB	O	detect	xcomp	26	SENT_109	[p8l1331t245r1544b311],
31	interactions	NNS	O	interaction	dobj	30	SENT_109	[p8l1601t248r2013b311],
32	as	IN	O	as	mark	33	SENT_109	[p8l2076t271r2139b311],
33	suggested	VBN	O	suggest	advcl	30	SENT_109	[p8l12t354r353b443],
34	by	IN	O	by	_	0	SENT_109	[p8l386t354r472b443],
35	Selvin	NNP	PERSON	Selvin	prep_by	33	SENT_109	[p8l507t354r719b420],
36	(	CD	NUMBER	(	num	35	SENT_109	[p8l758t352r895b434],
37	23	CD	NUMBER	23	num	38	SENT_109	[p8l758t352r895b434],
38	)	NN	O	)	dep	35	SENT_109	[p8l758t352r895b434],
39	and	CC	O	and	_	0	SENT_109	[p8l936t354r1063b420],
40	Frankel	NNP	PERSON	Frankel	dep	43	SENT_109	[p8l1099t354r1369b420],
41	et	FW	O	et	nn	43	SENT_109	[p8l1405t371r1468b420],
42	al.	FW	O	al.	nn	43	SENT_109	[p8l1504t354r1578b420],
43	(	FW	O	(	advcl	30	SENT_109	[p8l1621t352r1780b434],
44	24	CD	NUMBER	24	num	45	SENT_109	[p8l1621t352r1780b434],
45	)	NN	O	)	dep	24	SENT_109	[p8l1621t352r1780b434],
46	.	.	O	.	_	0	SENT_109	[p8l1621t352r1780b434],

1	We	PRP	O	we	nsubj	2	SENT_110	[p8l1817t355r1947b421],
2	used	VBD	O	use	_	0	SENT_110	[p8l1982t354r2141b420],
3	SAS	NNP	ORGANIZATION	SAS	nn	4	SENT_110	[p8l14t460r167b528],
4	version	NN	O	version	dobj	2	SENT_110	[p8l199t465r452b528],
5	9.1	CD	NUMBER	9.1	number	6	SENT_110	[p8l486t465r587b528],
6	(	CD	NUMBER	(	dep	4	SENT_110	[p8l627t459r810b542],
7	SAS	NNP	ORGANIZATION	SAS	nn	14	SENT_110	[p8l627t459r810b542],
8	Institute	NNP	ORGANIZATION	Institute	nn	14	SENT_110	[p8l845t462r1165b542],
9	,	,	O	,	_	0	SENT_110	[p8l845t462r1165b542],
10	Cary	NNP	PERSON	Cary	appos	14	SENT_110	[p8l1201t461r1389b551],
11	,	,	O	,	_	0	SENT_110	[p8l1201t461r1389b551],
12	North	NNP	LOCATION	North	appos	14	SENT_110	[p8l1423t461r1642b528],
13	Carolina	NNP	LOCATION	Carolina	nn	14	SENT_110	[p8l1676t460r2007b542],
14	)	NN	O	)	dep	6	SENT_110	[p8l1676t460r2007b542],
15	for	IN	O	for	_	0	SENT_110	[p8l2042t461r2143b528],
16	all	DT	O	all	det	17	SENT_110	[p8l12t568r91b634],
17	analyses	NNS	O	analysis	prep_for	2	SENT_110	[p8l125t568r424b655],
18	.	.	O	.	_	0	SENT_110	[p8l125t568r424b655],

1	Voora	NNP	O	Voora	_	0	SENT_111	[p8l1484t670r1648b722],
2	et	FW	O	et	nn	3	SENT_111	[p8l1676t672r1733b722],
3	al.	FW	O	al.	dep	1	SENT_111	[p8l1754t670r1821b722],
4	1611	CD	DATE	1611	dep	1	SENT_111	[p8l1996t670r2138b722],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_112	[p8l668t759r1191b821],
2	of	IN	O	of	_	0	SENT_112	[p8l1216t758r1272b811],
3	Statin	NN	O	statin	nn	5	SENT_112	[p8l1294t758r1460b811],
4	Side	NN	O	side	nn	5	SENT_112	[p8l1486t758r1608b811],
5	Eﬂects	NNS	O	eﬂects	prep_of	1	SENT_112	[p8l1636t758r1822b811],

1	Results	NNS	O	result	_	0	SENT_113	[p8l13t981r334b1043],

1	At	IN	O	at	quantmod	2	SENT_114	[p8l8t1149r103b1216],
2	total	NN	O	total	num	5	SENT_114	[p8l162t1150r322b1216],
3	of	IN	O	of	quantmod	2	SENT_114	[p8l382t1150r462b1216],
4	452	CD	NUMBER	452	number	2	SENT_114	[p8l510t1150r639b1217],
5	subjects	NNS	O	subject	nsubj	19	SENT_114	[p8l703t1150r974b1239],
6	(	JJ	O	(	amod	5	SENT_114	[p8l1040t1148r1218b1230],
7	88	CD	PERCENT	88	num	8	SENT_114	[p8l1040t1148r1218b1230],
8	%	NN	PERCENT	%	dep	6	SENT_114	[p8l1040t1148r1218b1230],
9	of	IN	O	of	_	0	SENT_114	[p8l1280t1150r1360b1216],
10	total	JJ	O	total	amod	12	SENT_114	[p8l1408t1150r1568b1216],
11	STRENGTH	NN	O	strength	nn	12	SENT_114	[p8l1631t1148r2139b1216],
12	participants	NNS	O	participant	prep_of	8	SENT_114	[p8l9t1255r450b1346],
13	)	VBP	O	)	_	0	SENT_114	[p8l9t1255r450b1346],
14	received	VBN	O	receive	dep	13	SENT_114	[p8l505t1257r791b1323],
15	study	NN	O	study	nn	16	SENT_114	[p8l844t1257r1033b1346],
16	drug	NN	O	drug	dobj	14	SENT_114	[p8l1082t1257r1244b1346],
17	and	CC	O	and	_	0	SENT_114	[p8l1296t1257r1423b1323],
18	were	VBD	O	be	cop	19	SENT_114	[p8l1470t1283r1637b1323],
19	available	JJ	O	available	conj_and	13	SENT_114	[p8l1691t1257r1989b1323],
20	for	IN	O	for	prep	19	SENT_114	[p8l2042t1257r2142b1323],
21	follow	VB	O	follow	dep	20	SENT_114	[p8l10t1364r374b1453],
22	—	RB	O	—	advmod	21	SENT_114	[p8l10t1364r374b1453],
23	up	RB	O	up	advmod	21	SENT_114	[p8l10t1364r374b1453],
24	.	.	O	.	_	0	SENT_114	[p8l10t1364r374b1453],

1	During	IN	O	during	_	0	SENT_115	[p8l408t1365r667b1453],
2	the	DT	O	the	det	3	SENT_115	[p8l695t1364r805b1430],
3	course	NN	O	course	prep_during	13	SENT_115	[p8l836t1390r1056b1430],
4	of	IN	O	of	_	0	SENT_115	[p8l1086t1364r1166b1430],
5	the	DT	O	the	det	6	SENT_115	[p8l1182t1364r1292b1430],
6	study	NN	O	study	prep_of	3	SENT_115	[p8l1324t1364r1528b1453],
7	,	,	O	,	_	0	SENT_115	[p8l1324t1364r1528b1453],
8	99	CD	PERCENT	99	number	9	SENT_115	[p8l1562t1367r1643b1430],
9	(	CD	PERCENT	(	nsubj	13	SENT_115	[p8l1677t1362r1881b1444],
10	22	CD	PERCENT	22	num	11	SENT_115	[p8l1677t1362r1881b1444],
11	%	NN	PERCENT	%	dep	9	SENT_115	[p8l1677t1362r1881b1444],
12	)	CD	NUMBER	)	dep	9	SENT_115	[p8l1677t1362r1881b1444],
13	met	VBD	O	meet	_	0	SENT_115	[p8l1915t1381r2050b1430],
14	at	IN	O	at	quantmod	16	SENT_115	[p8l2079t1381r2142b1430],
15	least	JJS	O	least	mwe	14	SENT_115	[p8l9t1470r167b1536],
16	1	CD	NUMBER	1	num	17	SENT_115	[p8l206t1473r237b1535],
17	criterion	NN	O	criterion	dobj	13	SENT_115	[p8l280t1473r578b1536],
18	for	IN	O	for	_	0	SENT_115	[p8l614t1470r714b1536],
19	the	DT	O	the	det	20	SENT_115	[p8l748t1470r858b1536],
20	CAE	NNP	ORGANIZATION	CAE	prep_for	17	SENT_115	[p8l897t1468r1105b1551],
21	,	,	O	,	_	0	SENT_115	[p8l897t1468r1105b1551],
22	with	IN	O	with	_	0	SENT_115	[p8l1140t1470r1301b1536],
23	54	CD	NUMBER	54	prep_with	13	SENT_115	[p8l1337t1470r1423b1536],
24	discontinuing	VBG	O	discontinue	partmod	23	SENT_115	[p8l1460t1470r1945b1559],
25	drug	NN	O	drug	dobj	24	SENT_115	[p8l1980t1470r2142b1559],
26	for	IN	O	for	_	0	SENT_115	[p8l10t1577r111b1643],
27	any	DT	O	any	det	29	SENT_115	[p8l146t1603r269b1666],
28	side	JJ	O	side	amod	29	SENT_115	[p8l301t1577r435b1643],
29	effect	NN	O	effect	prep_for	25	SENT_115	[p8l472t1577r675b1658],
30	,	,	O	,	_	0	SENT_115	[p8l472t1577r675b1658],
31	61	CD	NUMBER	61	num	33	SENT_115	[p8l714t1580r793b1643],
32	developing	VBG	O	develop	amod	33	SENT_115	[p8l834t1577r1219b1666],
33	myalgias	NNS	O	myalgia	conj_and	25	SENT_115	[p8l1253t1577r1589b1666],
34	/	:	O	/	punct	36	SENT_115	[p8l1253t1577r1589b1666],
35	muscle	NN	O	muscle	nn	36	SENT_115	[p8l1592t1577r1832b1643],
36	cramps	NNS	O	cramp	dep	33	SENT_115	[p8l1869t1603r2137b1666],
37	,	,	O	,	_	0	SENT_115	[p8l1869t1603r2137b1666],
38	and	CC	O	and	_	0	SENT_115	[p8l12t1683r139b1749],
39	9	CD	NUMBER	9	num	42	SENT_115	[p8l181t1686r218b1749],
40	developing	VBG	O	develop	amod	42	SENT_115	[p8l263t1683r647b1772],
41	CK	NN	O	ck	nn	42	SENT_115	[p8l688t1683r815b1749],
42	elevations	NNS	O	elevation	conj_and	25	SENT_115	[p8l855t1683r1199b1749],
43	>	JJR	O	>	amod	42	SENT_115	[p8l1246t1686r1421b1749],
44	3	CD	NUMBER	3	dep	45	SENT_115	[p8l1246t1686r1421b1749],
45	>	JJR	O	>	npadvmod	46	SENT_115	[p8l1246t1686r1421b1749],
46	<	JJR	O	<	dep	43	SENT_115	[p8l1246t1686r1421b1749],
47	the	DT	O	the	det	49	SENT_115	[p8l1471t1683r1581b1749],
48	upper	JJ	O	upper	amod	49	SENT_115	[p8l1622t1709r1826b1772],
49	limit	NN	O	limit	dep	43	SENT_115	[p8l1864t1683r2033b1749],
50	of	IN	O	of	_	0	SENT_115	[p8l2073t1683r2153b1749],
51	normal	JJ	O	normal	prep_of	42	SENT_115	[p8l12t1789r279b1854],
52	.	.	O	.	_	0	SENT_115	[p8l12t1789r279b1854],

1	The	DT	O	the	det	3	SENT_116	[p8l306t1787r452b1854],
2	baseline	NN	O	baseline	nn	3	SENT_116	[p8l476t1789r758b1854],
3	characteristics	NNS	O	characteristic	nsubjpass	16	SENT_116	[p8l784t1789r1277b1854],
4	of	IN	O	of	_	0	SENT_116	[p8l1305t1789r1384b1854],
5	the	DT	O	the	det	7	SENT_116	[p8l1397t1789r1507b1854],
6	entire	JJ	O	entire	amod	7	SENT_116	[p8l1533t1792r1734b1854],
7	cohort	NN	O	cohort	prep_of	3	SENT_116	[p8l1760t1789r1989b1854],
8	and	CC	O	and	_	0	SENT_116	[p8l2014t1789r2141b1854],
9	those	DT	O	those	prep_of	3	SENT_116	[p8l10t1894r196b1959],
10	with	IN	O	with	_	0	SENT_116	[p8l225t1894r386b1959],
11	and	CC	O	and	_	0	SENT_116	[p8l419t1894r546b1959],
12	without	IN	O	without	_	0	SENT_116	[p8l573t1894r853b1960],
13	the	DT	O	the	det	14	SENT_116	[p8l883t1894r993b1959],
14	CAE	NNP	ORGANIZATION	CAE	prep_without	9	SENT_116	[p8l1027t1892r1215b1960],
15	are	VBP	O	be	auxpass	16	SENT_116	[p8l1248t1919r1349b1959],
16	described	VBN	O	describe	_	0	SENT_116	[p8l1382t1894r1714b1959],
17	in	IN	O	in	_	0	SENT_116	[p8l1744t1897r1812b1959],
18	Table	NNP	O	Table	prep_in	16	SENT_116	[p8l1840t1892r2045b1959],
19	1	CD	NUMBER	1	num	18	SENT_116	[p8l2081t1897r2136b1959],
20	.	.	O	.	_	0	SENT_116	[p8l2081t1897r2136b1959],

1	Of	IN	O	of	_	0	SENT_117	[p8l12t1999r120b2065],
2	these	DT	O	these	det	3	SENT_117	[p8l140t1999r320b2065],
3	characteristics	NNS	O	characteristic	prep_of	9	SENT_117	[p8l355t1999r869b2080],
4	,	,	O	,	_	0	SENT_117	[p8l355t1999r869b2080],
5	only	RB	O	only	advmod	6	SENT_117	[p8l906t1999r1059b2088],
6	sex	NN	O	sex	nsubj	9	SENT_117	[p8l1089t2025r1194b2065],
7	was	VBD	O	be	cop	9	SENT_117	[p8l1223t2025r1351b2065],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_117	[p8l1388t1999r1816b2088],
9	different	JJ	O	different	conj_or	9	SENT_117	[p8l1847t1999r2143b2065],
10	between	IN	O	between	_	0	SENT_117	[p8l9t2105r302b2171],
11	groups	NNS	O	group	prep_between	9	SENT_117	[p8l339t2131r575b2194],
12	with	IN	O	with	_	0	SENT_117	[p8l611t2105r772b2171],
13	or	CC	O	or	_	0	SENT_117	[p8l810t2131r883b2171],
14	without	IN	O	without	_	0	SENT_117	[p8l915t2105r1195b2171],
15	the	DT	O	the	det	16	SENT_117	[p8l1231t2105r1342b2171],
16	CAB	NN	O	cab	prep_without	9	SENT_117	[p8l1382t2103r1590b2186],
17	,	,	O	,	_	0	SENT_117	[p8l1382t2103r1590b2186],
18	with	IN	O	with	_	0	SENT_117	[p8l1627t2105r1788b2171],
19	a	DT	O	a	det	21	SENT_117	[p8l1828t2131r1862b2171],
20	greater	JJR	O	greater	amod	21	SENT_117	[p8l1897t2122r2143b2194],
21	percentage	NN	O	percentage	prep_with	9	SENT_117	[p8l9t2228r389b2300],
22	of	IN	O	of	_	0	SENT_117	[p8l418t2211r498b2277],
23	female	JJ	O	female	amod	24	SENT_117	[p8l513t2211r744b2277],
24	subjects	NNS	O	subject	prep_of	21	SENT_117	[p8l774t2211r1045b2300],
25	in	IN	O	in	_	0	SENT_117	[p8l1074t2214r1142b2276],
26	the	DT	O	the	det	28	SENT_117	[p8l1169t2211r1280b2277],
27	CAE	NNP	ORGANIZATION	CAE	nn	28	SENT_117	[p8l1309t2209r1497b2277],
28	group	NN	O	group	prep_in	24	SENT_117	[p8l1524t2237r1729b2300],
29	(	CD	NUMBER	(	num	30	SENT_117	[p8l1760t2209r1950b2291],
30	odds	NNS	O	odds	dep	24	SENT_117	[p8l1760t2209r1950b2291],
31	ratio	NN	O	ratio	nn	34	SENT_117	[p8l1979t2214r2139b2277],
32	[	CD	NUMBER	[	num	34	SENT_117	[p8l16t2315r223b2398],
33	OR	NN	O	or	nn	34	SENT_117	[p8l16t2315r223b2398],
34	]	NN	O	]	dep	30	SENT_117	[p8l16t2315r223b2398],
35	:	:	O	:	_	0	SENT_117	[p8l16t2315r223b2398],
36	2.0	CD	NUMBER	2.0	dep	30	SENT_117	[p8l264t2320r393b2398],
37	,	,	O	,	_	0	SENT_117	[p8l264t2320r393b2398],
38	95	CD	PERCENT	95	number	39	SENT_117	[p8l437t2317r587b2383],
39	%	NN	PERCENT	%	num	44	SENT_117	[p8l437t2317r587b2383],
40	confidence	NN	O	confidence	nn	44	SENT_117	[p8l627t2317r1004b2383],
41	interval	NN	O	interval	nn	44	SENT_117	[p8l1044t2317r1308b2383],
42	[	CD	NUMBER	[	num	44	SENT_117	[p8l1351t2315r1523b2398],
43	CI	NN	O	ci	nn	44	SENT_117	[p8l1351t2315r1523b2398],
44	]	NN	O	]	appos	36	SENT_117	[p8l1351t2315r1523b2398],
45	:	:	O	:	_	0	SENT_117	[p8l1351t2315r1523b2398],
46	1.2	CD	NUMBER	1.2	number	48	SENT_117	[p8l1569t2320r1671b2384],
47	to	TO	O	to	dep	48	SENT_117	[p8l1711t2334r1780b2383],
48	3.1	CD	NUMBER	3.1	dep	44	SENT_117	[p8l1820t2320r1947b2398],
49	,	,	O	,	_	0	SENT_117	[p8l1820t2320r1947b2398],
50	p	NN	O	p	appos	24	SENT_117	[p8l1987t2343r2029b2406],
51	=	JJ	O	=	amod	53	SENT_117	[p8l2078t2343r2132b2363],
52	0.004	CD	NUMBER	0.004	tmod	51	SENT_117	[p8l11t2421r255b2503],
53	)	NN	O	)	dep	50	SENT_117	[p8l11t2421r255b2503],
54	.	.	O	.	_	0	SENT_117	[p8l11t2421r255b2503],

1	Importantly	RB	O	importantly	advmod	8	SENT_118	[p8l287t2423r732b2512],
2	,	,	O	,	_	0	SENT_118	[p8l287t2423r732b2512],
3	assigned	VBN	O	assign	amod	5	SENT_118	[p8l765t2423r1061b2512],
4	statin	NN	O	statin	nn	5	SENT_118	[p8l1090t2426r1283b2489],
5	type	NN	O	type	nsubjpass	8	SENT_118	[p8l1311t2440r1458b2512],
6	was	VBD	O	be	auxpass	8	SENT_118	[p8l1483t2449r1612b2489],
7	not	RB	O	not	neg	8	SENT_118	[p8l1644t2440r1761b2489],
8	associated	VBN	O	associate	_	0	SENT_118	[p8l1789t2423r2141b2489],
9	with	IN	O	with	_	0	SENT_118	[p8l7t2529r168b2595],
10	the	DT	O	the	det	13	SENT_118	[p8l206t2529r316b2595],
11	CAE	NNP	O	CAE	nn	13	SENT_118	[p8l357t2527r544b2595],
12	(	NN	O	(	nn	13	SENT_118	[p8l586t2527r654b2618],
13	p	NN	O	p	prep_with	8	SENT_118	[p8l586t2527r654b2618],
14	=	JJ	O	=	amod	13	SENT_118	[p8l701t2555r755b2575],
15	0.9	CD	NUMBER	0.9	num	16	SENT_118	[p8l802t2527r958b2609],
16	)	NN	O	)	dep	14	SENT_118	[p8l802t2527r958b2609],
17	.	.	O	.	_	0	SENT_118	[p8l802t2527r958b2609],

1	Seven	CD	NUMBER	seven	num	3	SENT_119	[p8l1004t2529r1207b2595],
2	genetic	JJ	O	genetic	amod	3	SENT_119	[p8l1244t2532r1497b2618],
3	variants	NNS	O	variant	nsubj	9	SENT_119	[p8l1531t2532r1805b2595],
4	in	IN	O	in	_	0	SENT_119	[p8l1845t2532r1913b2594],
5	the	DT	O	the	det	8	SENT_119	[p8l1951t2529r2061b2595],
6	5	CD	NUMBER	5	num	8	SENT_119	[p8l2100t2529r2137b2595],
7	candidate	NN	O	candidate	nn	8	SENT_119	[p8l11t2635r349b2701],
8	genes	NNS	O	gene	prep_in	3	SENT_119	[p8l374t2661r568b2724],
9	(	VBP	O	(	_	0	SENT_119	[p8l599t2633r826b2715],
10	Table	NNP	O	Table	dobj	9	SENT_119	[p8l599t2633r826b2715],
11	2	CD	NUMBER	2	number	12	SENT_119	[p8l851t2633r919b2715],
12	)	CD	NUMBER	)	nsubj	13	SENT_119	[p8l851t2633r919b2715],
13	met	VBD	O	meet	rcmod	10	SENT_119	[p8l950t2652r1085b2701],
14	the	DT	O	the	det	16	SENT_119	[p8l1109t2635r1220b2701],
15	analysis	NN	O	analysis	nn	16	SENT_119	[p8l1247t2635r1512b2724],
16	criteria	NNS	O	criterion	dobj	13	SENT_119	[p8l1541t2638r1786b2701],
17	of	IN	O	of	_	0	SENT_119	[p8l1812t2635r1892b2701],
18	having	VBG	O	have	prepc_of	16	SENT_119	[p8l1905t2635r2142b2724],
19	a	DT	O	a	det	22	SENT_119	[p8l12t2767r47b2807],
20	minor	JJ	O	minor	amod	22	SENT_119	[p8l89t2744r304b2807],
21	allele	NN	O	allele	nn	22	SENT_119	[p8l347t2741r523b2807],
22	frequency	NN	O	frequency	dep	23	SENT_119	[p8l567t2741r914b2830],
23	>	JJR	O	>	dobj	18	SENT_119	[p8l958t2744r1178b2807],
24	0.10	CD	NUMBER	0.10	tmod	18	SENT_119	[p8l958t2744r1178b2807],
25	that	WDT	O	that	nsubjpass	28	SENT_119	[p8l1223t2741r1363b2807],
26	were	VBD	O	be	auxpass	28	SENT_119	[p8l1401t2767r1568b2807],
27	also	RB	O	also	advmod	28	SENT_119	[p8l1613t2741r1744b2807],
28	known	VBN	O	know	dep	18	SENT_119	[p8l1788t2741r2028b2807],
29	to	TO	O	to	aux	30	SENT_119	[p8l2072t2758r2139b2807],
30	reduce	VB	O	reduce	xcomp	28	SENT_119	[p8l10t2847r240b2913],
31	enzymatic	JJ	O	enzymatic	amod	32	SENT_119	[p8l283t2850r640b2936],
32	function	NN	O	function	dobj	30	SENT_119	[p8l679t2847r994b2913],
33	.	.	O	.	_	0	SENT_119	[p8l679t2847r994b2913],

1	One	CD	NUMBER	one	num	2	SENT_120	[p8l1041t2847r1193b2913],
2	SNP	NN	O	snp	nsubj	8	SENT_120	[p8l1238t2847r1404b2913],
3	(	CD	NUMBER	(	num	4	SENT_120	[p8l1448t2845r1911b2927],
4	CYP3ﬂ4	NN	O	cyp3ﬂ4	dep	2	SENT_120	[p8l1448t2845r1911b2927],
5	”‘	CD	NUMBER	”‘	num	7	SENT_120	[p8l1448t2845r1911b2927],
6	Jé	NN	O	jé	nn	7	SENT_120	[p8l1448t2845r1911b2927],
7	)	NN	O	)	dep	2	SENT_120	[p8l1448t2845r1911b2927],
8	deviated	VBD	O	deviate	_	0	SENT_120	[p8l1956t2847r2138b2913, p8l12t2953r164b3019],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_120	[p8l208t2953r656b3042],
10	from	IN	O	from	_	0	SENT_120	[p8l695t2953r870b3019],
11	Hardy	NNP	PERSON	Hardy	prep_from	8	SENT_120	[p8l915t2953r1559b3042],
12	.	.	O	.	_	0	SENT_120	[p8l915t2953r1559b3042],

1	—	NN	O	—	_	0	SENT_121	[p8l915t2953r1559b3042],
2	.	.	O	.	_	0	SENT_121	[p8l915t2953r1559b3042],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_122	[p8l915t2953r1559b3042],
2	equilibrium	NN	O	equilibrium	nsubj	6	SENT_122	[p8l1601t2953r2027b3042],
3	in	IN	O	in	_	0	SENT_122	[p8l2072t2956r2140b3018],
4	Caucasian	JJ	LOCATION	caucasian	amod	5	SENT_122	[p8l12t3059r386b3125],
5	controls	NNS	O	control	prep_in	2	SENT_122	[p8l418t3059r710b3125],
6	(	VBP	O	(	_	0	SENT_122	[p8l746t3057r815b3148],
7	p	NN	O	p	dobj	6	SENT_122	[p8l746t3057r815b3148],
8	=	JJ	O	=	advmod	6	SENT_122	[p8l857t3085r910b3105],
9	0.002	CD	NUMBER	0.002	num	10	SENT_122	[p8l951t3057r1207b3140],
10	)	NN	O	)	dep	8	SENT_122	[p8l951t3057r1207b3140],
11	;	:	O	;	_	0	SENT_122	[p8l951t3057r1207b3140],
12	however	RB	O	however	advmod	20	SENT_122	[p8l1242t3059r1568b3140],
13	,	,	O	,	_	0	SENT_122	[p8l1242t3059r1568b3140],
14	the	DT	O	the	det	15	SENT_122	[p8l1602t3059r1716b3125],
15	magnitude	NN	O	magnitude	nsubj	20	SENT_122	[p8l1750t3059r2140b3148],
16	of	IN	O	of	_	0	SENT_122	[p8l11t3165r93b3230],
17	the	DT	O	the	det	18	SENT_122	[p8l123t3165r236b3230],
18	deviation	NN	O	deviation	prep_of	15	SENT_122	[p8l280t3165r618b3230],
19	was	VBD	O	be	cop	20	SENT_122	[p8l656t3191r789b3231],
20	small	JJ	O	small	parataxis	6	SENT_122	[p8l834t3165r1045b3245],
21	,	,	O	,	_	0	SENT_122	[p8l834t3165r1045b3245],
22	and	CC	O	and	_	0	SENT_122	[p8l1091t3165r1222b3230],
23	therefore	RB	O	therefore	advmod	27	SENT_122	[p8l1263t3165r1595b3230],
24	the	DT	O	the	det	25	SENT_122	[p8l1638t3165r1752b3230],
25	SNP	NN	ORGANIZATION	snp	nsubjpass	27	SENT_122	[p8l1799t3165r1968b3231],
26	was	VBD	O	be	auxpass	27	SENT_122	[p8l2007t3191r2139b3231],
27	retained	VBN	O	retain	conj_and	20	SENT_122	[p8l10t3271r310b3337],
28	for	IN	O	for	_	0	SENT_122	[p8l340t3271r444b3337],
29	statistical	JJ	O	statistical	amod	30	SENT_122	[p8l475t3271r820b3337],
30	analysis	NN	O	analysis	prep_for	27	SENT_122	[p8l851t3271r1150b3360],
31	.	.	O	.	_	0	SENT_122	[p8l851t3271r1150b3360],

1	When	WRB	O	when	advmod	6	SENT_123	[p8l1181t3271r1413b3338],
2	these	DT	O	these	det	4	SENT_123	[p8l1444t3271r1631b3337],
3	7	CD	NUMBER	7	num	4	SENT_123	[p8l1664t3272r1703b3337],
4	SNPS	NNS	O	snp	nsubjpass	6	SENT_123	[p8l1738t3271r1939b3337],
5	were	VBD	O	be	auxpass	6	SENT_123	[p8l1968t3297r2140b3337],
6	tested	VBN	O	test	advcl	16	SENT_123	[p8l10t3377r227b3442],
7	in	IN	O	in	_	0	SENT_123	[p8l292t3380r361b3442],
8	dominant	JJ	O	dominant	amod	9	SENT_123	[p8l428t3377r785b3442],
9	models	NNS	O	model	prep_in	6	SENT_123	[p8l849t3377r1129b3457],
10	,	,	O	,	_	0	SENT_123	[p8l849t3377r1129b3457],
11	one	CD	NUMBER	one	num	12	SENT_123	[p8l1199t3403r1327b3442],
12	SNP	NN	O	snp	nsubj	16	SENT_123	[p8l1397t3377r1567b3443],
13	in	IN	O	in	_	0	SENT_123	[p8l1632t3380r1701b3442],
14	SLCOJBI	NNP	O	SLCOJBI	prep_in	12	SENT_123	[p8l1770t3380r2137b3443],
15	(	CD	NUMBER	(	num	14	SENT_123	[p8l13t3480r512b3562],
16	SLCOZBJ	NNP	O	SLCOZBJ	_	0	SENT_123	[p8l13t3480r512b3562],
17	*	CD	NUMBER	*	number	18	SENT_123	[p8l13t3480r512b3562],
18	5	CD	NUMBER	5	dep	16	SENT_123	[p8l13t3480r512b3562],
19	,	,	O	,	_	0	SENT_123	[p8l13t3480r512b3562],
20	rs4149056	NN	O	rs4149056	nn	23	SENT_123	[p8l566t3482r971b3562],
21	,	,	O	,	_	0	SENT_123	[p8l566t3482r971b3562],
22	V174A	NN	O	v174a	dep	23	SENT_123	[p8l1026t3480r1319b3562],
23	)	NN	O	)	nsubjpass	25	SENT_123	[p8l1026t3480r1319b3562],
24	was	VBD	O	be	auxpass	25	SENT_123	[p8l1371t3508r1504b3548],
25	associated	VBN	O	associate	dep	16	SENT_123	[p8l1559t3482r1927b3547],
26	with	IN	O	with	_	0	SENT_123	[p8l1975t3482r2141b3548],
27	the	DT	O	the	det	28	SENT_123	[p9l10t21r124b87],
28	CAE	NNP	O	CAE	prep_with	25	SENT_123	[p9l171t19r361b87],
29	during	IN	O	during	_	0	SENT_123	[p9l408t21r650b110],
30	the	DT	O	the	det	36	SENT_123	[p9l692t21r806b87],
31	STRENGTH	NN	O	strength	nn	36	SENT_123	[p9l854t19r1374b87],
32	trial	NN	O	trial	nn	36	SENT_123	[p9l1419t21r1568b87],
33	(	CD	NUMBER	(	num	36	SENT_123	[p9l1613t19r2025b110],
34	chi	NN	O	chus	nn	36	SENT_123	[p9l1613t19r2025b110],
35	—	NN	O	—	nn	36	SENT_123	[p9l1613t19r2025b110],
36	square	NN	O	square	prep_during	25	SENT_123	[p9l1613t19r2025b110],
37	=	JJ	O	=	amod	36	SENT_123	[p9l2078t47r2132b67],
38	4.2	CD	NUMBER	4.2	tmod	37	SENT_123	[p9l10t130r144b208],
39	,	,	O	,	_	0	SENT_123	[p9l10t130r144b208],
40	p	NN	O	p	dep	16	SENT_123	[p9l191t153r233b216],
41	=	JJ	O	=	amod	40	SENT_123	[p9l289t153r342b173],
42	0.03	CD	NUMBER	0.03	tmod	41	SENT_123	[p9l397t130r576b208],
43	,	,	O	,	_	0	SENT_123	[p9l397t130r576b208],
44	FDR	NNP	O	FDR	nn	47	SENT_123	[p9l625t128r815b192],
45	=	JJ	O	=	amod	47	SENT_123	[p9l866t153r919b173],
46	0.24	CD	NUMBER	0.24	tmod	45	SENT_123	[p9l975t125r1184b207],
47	)	NN	O	)	dobj	16	SENT_123	[p9l975t125r1184b207],
48	.	.	O	.	_	0	SENT_123	[p9l975t125r1184b207],

1	In	IN	O	in	_	0	SENT_124	[p9l1233t128r1312b192],
2	multivariate	JJ	O	multivariate	amod	3	SENT_124	[p9l1359t127r1799b193],
3	analyses	NNS	O	analysis	pobj	1	SENT_124	[p9l1848t127r2139b216],
4	adjusted	VBN	O	adjust	partmod	3	SENT_124	[p9l12t233r315b322],
5	for	IN	O	for	_	0	SENT_124	[p9l357t233r461b299],
6	race	NN	O	race	prep_for	4	SENT_124	[p9l501t259r666b314],
7	,	,	O	,	_	0	SENT_124	[p9l501t259r666b314],
8	female	JJ	O	female	amod	9	SENT_124	[p9l712t233r952b299],
9	sex	NN	O	sex	appos	6	SENT_124	[p9l996t259r1105b299],
10	and	CC	O	and	_	0	SENT_124	[p9l1147t233r1278b299],
11	SLCOZBZ	NN	O	slcozbz	appos	6	SENT_124	[p9l1321t236r1771b300],
12	*	CD	NUMBER	*	number	13	SENT_124	[p9l1321t236r1771b300],
13	5	CD	NUMBER	5	num	14	SENT_124	[p9l1321t236r1771b300],
14	genotype	NN	O	genotype	nsubjpass	17	SENT_124	[p9l1807t250r2140b322],
15	were	VBD	O	be	auxpass	17	SENT_124	[p9l7t365r179b405],
16	independently	RB	O	independently	advmod	17	SENT_124	[p9l218t339r747b428],
17	associated	VBN	O	associate	rcmod	9	SENT_124	[p9l784t339r1152b405],
18	with	IN	O	with	_	0	SENT_124	[p9l1186t339r1353b405],
19	the	DT	O	the	det	22	SENT_124	[p9l1391t339r1505b405],
20	CAE	NNP	O	CAE	nn	22	SENT_124	[p9l1547t337r1737b405],
21	(	CD	NUMBER	(	num	22	SENT_124	[p9l1781t337r1962b419],
22	OR	NN	O	or	prep_with	17	SENT_124	[p9l1781t337r1962b419],
23	:	:	O	:	_	0	SENT_124	[p9l1781t337r1962b419],
24	2.2	CD	NUMBER	2.2	dep	22	SENT_124	[p9l2003t342r2138b420],
25	,	,	O	,	_	0	SENT_124	[p9l2003t342r2138b420],

1	Baseline	NN	O	baseline	nn	2	SENT_125	[p9l411t613r678b664],
2	Characteristics	NNS	O	characteristic	_	0	SENT_125	[p9l705t613r1189b664],
3	of	IN	O	of	prep	2	SENT_125	[p9l1217t613r1276b664],

1	Ta	NN	O	ta	_	0	SENT_126	[p9l63t654r232b704],
2	'	''	O	'	_	0	SENT_126	[p9l63t654r232b704],
3	°	NN	O	°	nn	5	SENT_126	[p9l63t654r232b704],
4	'	''	O	'	_	0	SENT_126	[p9l63t654r232b704],
5	°	NN	O	°	dep	1	SENT_126	[p9l63t654r232b704],
6	1	CD	NUMBER	1	num	8	SENT_126	[p9l260t654r300b703],
7	STRENGTH	NN	O	strength	nn	8	SENT_126	[p9l407t693r751b744],
8	Cohort	NN	O	cohort	dep	1	SENT_126	[p9l781t693r991b744],
9	Stratified	VBN	O	stratify	partmod	1	SENT_126	[p9l1016t693r1307b744],
10	by	IN	O	by	_	0	SENT_126	[p9l1338t694r1406b756],
11	the	DT	O	the	det	12	SENT_126	[p9l1430t694r1532b744],
12	CAE	NNP	O	CAE	agent	9	SENT_126	[p9l1560t693r1690b744],

1	Entire	JJ	O	entire	amod	5	SENT_127	[p9l1042t862r1189b903],
2	Cohort	NNP	O	Cohort	nn	5	SENT_127	[p9l1212t862r1382b903],
3	CAE	NNP	O	CAE	nn	5	SENT_127	[p9l1548t862r1654b903],
4	No	NNP	O	No	nn	5	SENT_127	[p9l1856t862r1921b903],
5	CAE	NNP	O	CAE	_	0	SENT_127	[p9l1943t862r2049b903],
6	Characteristic	JJ	O	characteristic	amod	8	SENT_127	[p9l328t933r692b974],
7	(	NN	O	(	nn	8	SENT_127	[p9l1080t933r1128b983],
8	n	NN	O	n	nsubj	9	SENT_127	[p9l1080t933r1128b983],
9	=	JJ	O	=	rcmod	5	SENT_127	[p9l1157t946r1192b964],
10	452	CD	NUMBER	452	number	11	SENT_127	[p9l1219t933r1339b983],
11	)	CD	NUMBER	)	num	22	SENT_127	[p9l1219t933r1339b983],
12	(	NN	O	(	nn	22	SENT_127	[p9l1487t933r1536b983],
13	n	NN	O	n	nn	22	SENT_127	[p9l1487t933r1536b983],
14	=	JJ	O	=	amod	22	SENT_127	[p9l1564t946r1600b964],
15	99	CD	NUMBER	99	number	16	SENT_127	[p9l1627t933r1712b983],
16	)	CD	NUMBER	)	num	22	SENT_127	[p9l1627t933r1712b983],
17	(	NN	O	(	nn	22	SENT_127	[p9l1820t933r1869b983],
18	n	NN	O	n	nn	22	SENT_127	[p9l1820t933r1869b983],
19	=	JJ	O	=	amod	22	SENT_127	[p9l1897t946r1933b964],
20	353	CD	NUMBER	353	tmod	19	SENT_127	[p9l1960t933r2080b983],
21	)	JJ	O	)	amod	22	SENT_127	[p9l1960t933r2080b983],
22	Age	NN	O	age	dobj	9	SENT_127	[p9l62t1031r168b1080],
23	,	,	O	,	_	0	SENT_127	[p9l62t1031r168b1080],
24	yrs	VBZ	DURATION	yr	rcmod	22	SENT_127	[p9l189t1040r258b1080],
25	(	CD	NUMBER	(	num	26	SENT_127	[p9l278t1030r380b1079],
26	SD	NN	O	sd	dobj	24	SENT_127	[p9l278t1030r380b1079],
27	)	CD	NUMBER	)	num	29	SENT_127	[p9l278t1030r380b1079],
28	56	CD	NUMBER	56	num	29	SENT_127	[p9l1137t1030r1201b1070],
29	(	NN	O	(	dep	37	SENT_127	[p9l1219t1030r1319b1079],
30	10	CD	NUMBER	10	number	31	SENT_127	[p9l1219t1030r1319b1079],
31	)	CD	NUMBER	)	dep	29	SENT_127	[p9l1219t1030r1319b1079],
32	58	CD	NUMBER	58	dep	31	SENT_127	[p9l1518t1030r1583b1071],
33	(	NN	O	(	dep	37	SENT_127	[p9l1601t1030r1700b1079],
34	10	CD	NUMBER	10	num	33	SENT_127	[p9l1601t1030r1700b1079],
35	)	CD	NUMBER	)	num	37	SENT_127	[p9l1601t1030r1700b1079],
36	56	CD	NUMBER	56	num	37	SENT_127	[p9l1877t1030r1942b1071],
37	(	NN	O	(	dep	44	SENT_127	[p9l1960t1030r2059b1079],
38	11	CD	NUMBER	11	number	39	SENT_127	[p9l1960t1030r2059b1079],
39	)	CD	NUMBER	)	num	40	SENT_127	[p9l1960t1030r2059b1079],
40	Sex	NN	O	sex	dep	37	SENT_127	[p9l62t1110r162b1158],
41	,	,	O	,	_	0	SENT_127	[p9l62t1110r162b1158],
42	n	NN	O	n	appos	40	SENT_127	[p9l185t1120r210b1150],
43	(	CD	PERCENT	(	num	44	SENT_127	[p9l232t1110r308b1159],
44	%	NN	PERCENT	%	dep	45	SENT_127	[p9l232t1110r308b1159],
45	)	CD	NUMBER	)	dep	24	SENT_127	[p9l232t1110r308b1159],

1	Male	JJ	O	male	amod	2	SENT_128	[p9l123t1190r240b1230],
2	209	CD	NUMBER	209	dep	9	SENT_128	[p9l1103t1190r1201b1230],
3	(	CD	NUMBER	(	num	4	SENT_128	[p9l1219t1189r1319b1239],
4	46	CD	NUMBER	46	dep	2	SENT_128	[p9l1219t1189r1319b1239],
5	)	NN	O	)	dep	9	SENT_128	[p9l1219t1189r1319b1239],
6	33	CD	NUMBER	33	num	5	SENT_128	[p9l1518t1190r1582b1230],
7	(	CD	NUMBER	(	num	9	SENT_128	[p9l1601t1190r1700b1239],
8	33	CD	NUMBER	33	num	9	SENT_128	[p9l1601t1190r1700b1239],
9	)	NN	O	)	dep	18	SENT_128	[p9l1601t1190r1700b1239],
10	176	CD	NUMBER	176	num	11	SENT_128	[p9l1845t1189r1942b1230],
11	(	NN	O	(	dep	9	SENT_128	[p9l1960t1190r2059b1239],
12	50	CD	NUMBER	50	number	13	SENT_128	[p9l1960t1190r2059b1239],
13	)	CD	NUMBER	)	num	14	SENT_128	[p9l1960t1190r2059b1239],
14	Female	JJ	O	female	dep	11	SENT_128	[p9l123t1271r304b1311],
15	243	CD	NUMBER	243	number	16	SENT_128	[p9l1103t1270r1201b1311],
16	(	CD	NUMBER	(	num	14	SENT_128	[p9l1219t1270r1319b1319],
17	54	CD	NUMBER	54	num	18	SENT_128	[p9l1219t1270r1319b1319],
18	)	NN	O	)	dep	19	SENT_128	[p9l1219t1270r1319b1319],
19	66	CD	NUMBER	66	dep	38	SENT_128	[p9l1519t1270r1583b1311],
20	(	CD	NUMBER	(	number	21	SENT_128	[p9l1601t1270r1730b1319],
21	67	CD	NUMBER	67	num	30	SENT_128	[p9l1601t1270r1730b1319],
22	)	NN	O	)	nn	30	SENT_128	[p9l1601t1270r1730b1319],
23	*	NN	O	*	nn	30	SENT_128	[p9l1601t1270r1730b1319],
24	177	CD	NUMBER	177	num	30	SENT_128	[p9l1845t1270r1941b1310],
25	(	NN	O	(	amod	30	SENT_128	[p9l1960t1270r2059b1319],
26	50	CD	NUMBER	50	num	25	SENT_128	[p9l1960t1270r2059b1319],
27	)	CD	NUMBER	)	num	29	SENT_128	[p9l1960t1270r2059b1319],
28	Body	NN	O	body	nn	29	SENT_128	[p9l66t1350r184b1400],
29	mass	NN	O	mass	dep	25	SENT_128	[p9l204t1360r334b1390],
30	index	NN	O	index	dep	19	SENT_128	[p9l355t1350r495b1398],
31	,	,	O	,	_	0	SENT_128	[p9l355t1350r495b1398],
32	kg/m2	NN	O	kg/m2	nn	34	SENT_128	[p9l519t1337r677b1399],
33	(	CD	NUMBER	(	num	34	SENT_128	[p9l698t1350r801b1399],
34	SD	NN	O	sd	appos	30	SENT_128	[p9l698t1350r801b1399],
35	)	CD	NUMBER	)	number	36	SENT_128	[p9l698t1350r801b1399],
36	29.1	CD	NUMBER	29.1	num	37	SENT_128	[p9l1089t1350r1202b1390],
37	(	NN	O	(	dep	34	SENT_128	[p9l1219t1350r1333b1399],
38	5.2	CD	NUMBER	5.2	dep	51	SENT_128	[p9l1219t1350r1333b1399],
39	)	CD	NUMBER	)	number	40	SENT_128	[p9l1219t1350r1333b1399],
40	29.1	CD	NUMBER	29.1	dep	38	SENT_128	[p9l1470t1350r1584b1390],
41	(	NN	O	(	dep	40	SENT_128	[p9l1601t1350r1714b1399],
42	4.7	CD	NUMBER	4.7	num	41	SENT_128	[p9l1601t1350r1714b1399],
43	)	CD	NUMBER	)	number	44	SENT_128	[p9l1601t1350r1714b1399],
44	29.1	CD	NUMBER	29.1	num	45	SENT_128	[p9l1829t1350r1942b1390],
45	(	NN	O	(	dep	40	SENT_128	[p9l1960t1350r2073b1399],
46	5.4	CD	NUMBER	5.4	number	47	SENT_128	[p9l1960t1350r2073b1399],
47	)	CD	NUMBER	)	num	51	SENT_128	[p9l1960t1350r2073b1399],
48	Smoking	NN	MISC	smoking	nn	51	SENT_128	[p9l62t1430r282b1479],
49	status	NN	O	status	nn	51	SENT_128	[p9l299t1432r462b1477],
50	,	,	O	,	_	0	SENT_128	[p9l299t1432r462b1477],
51	n	NN	O	n	dep	54	SENT_128	[p9l485t1439r509b1469],
52	(	CD	PERCENT	(	num	53	SENT_128	[p9l532t1430r608b1479],
53	%	NN	PERCENT	%	dep	51	SENT_128	[p9l532t1430r608b1479],
54	)	CD	NUMBER	)	_	0	SENT_128	[p9l532t1430r608b1479],

1	Smoker	NNP	O	Smoker	dep	9	SENT_129	[p9l120t1510r313b1551],
2	84	CD	NUMBER	84	number	3	SENT_129	[p9l1136t1510r1201b1551],
3	(	CD	NUMBER	(	dep	1	SENT_129	[p9l1219t1510r1318b1559],
4	19	CD	NUMBER	19	num	5	SENT_129	[p9l1219t1510r1318b1559],
5	)	NN	O	)	dep	3	SENT_129	[p9l1219t1510r1318b1559],
6	18	CD	NUMBER	18	num	7	SENT_129	[p9l1519t1510r1583b1551],
7	(	NN	O	(	dep	9	SENT_129	[p9l1601t1510r1700b1559],
8	18	CD	NUMBER	18	num	9	SENT_129	[p9l1601t1510r1700b1559],
9	)	CD	NUMBER	)	dep	16	SENT_129	[p9l1601t1510r1700b1559],
10	66	CD	NUMBER	66	num	11	SENT_129	[p9l1878t1510r1942b1551],
11	(	NN	O	(	dep	9	SENT_129	[p9l1960t1510r2059b1559],
12	19	CD	NUMBER	19	number	13	SENT_129	[p9l1960t1510r2059b1559],
13	)	CD	NUMBER	)	num	14	SENT_129	[p9l1960t1510r2059b1559],
14	Nonsmoker	NN	O	nonsmoker	dep	11	SENT_129	[p9l123t1590r406b1630],
15	368	CD	NUMBER	368	num	16	SENT_129	[p9l1102t1590r1202b1630],
16	(	NN	O	(	dep	22	SENT_129	[p9l1219t1590r1318b1639],
17	81	CD	NUMBER	81	number	18	SENT_129	[p9l1219t1590r1318b1639],
18	)	CD	NUMBER	)	dep	16	SENT_129	[p9l1219t1590r1318b1639],
19	81	CD	NUMBER	81	num	20	SENT_129	[p9l1518t1590r1584b1630],
20	(	NN	O	(	dep	18	SENT_129	[p9l1600t1590r1700b1639],
21	82	CD	NUMBER	82	num	22	SENT_129	[p9l1600t1590r1700b1639],
22	)	NN	O	)	dep	24	SENT_129	[p9l1600t1590r1700b1639],
23	287	CD	NUMBER	287	num	24	SENT_129	[p9l1843t1590r1941b1630],
24	(	NN	O	(	dep	26	SENT_129	[p9l1960t1590r2059b1639],
25	81	CD	NUMBER	81	num	26	SENT_129	[p9l1960t1590r2059b1639],
26	)	NN	O	)	_	0	SENT_129	[p9l1960t1590r2059b1639],

1	Race	NN	O	race	_	0	SENT_130	[p9l66t1670r198b1717],
2	,	,	O	,	_	0	SENT_130	[p9l66t1670r198b1717],
3	n	NN	O	n	appos	1	SENT_130	[p9l222t1679r246b1709],
4	(	CD	PERCENT	(	num	5	SENT_130	[p9l268t1670r344b1719],
5	%	NN	PERCENT	%	dep	1	SENT_130	[p9l268t1670r344b1719],
6	)	CD	NUMBER	)	dep	5	SENT_130	[p9l268t1670r344b1719],

1	Caucasian	JJ	MISC	caucasian	dep	140	SENT_131	[p9l122t1750r373b1790],
2	389	CD	NUMBER	389	dep	140	SENT_131	[p9l1103t1750r1201b1790],
3	(	CD	NUMBER	(	dep	140	SENT_131	[p9l1219t1750r1318b1799],
4	86	CD	NUMBER	86	dep	140	SENT_131	[p9l1219t1750r1318b1799],
5	)	NN	O	)	dep	140	SENT_131	[p9l1219t1750r1318b1799],
6	87	CD	NUMBER	87	dep	140	SENT_131	[p9l1518t1750r1582b1790],
7	(	CD	NUMBER	(	dep	140	SENT_131	[p9l1601t1750r1700b1799],
8	89	CD	NUMBER	89	dep	140	SENT_131	[p9l1601t1750r1700b1799],
9	)	NN	O	)	dep	140	SENT_131	[p9l1601t1750r1700b1799],
10	300	CD	NUMBER	300	dep	140	SENT_131	[p9l1843t1750r1942b1790],
11	(	NN	O	(	dep	140	SENT_131	[p9l1960t1750r2059b1799],
12	85	CD	NUMBER	85	dep	140	SENT_131	[p9l1960t1750r2059b1799],
13	)	CD	NUMBER	)	dep	140	SENT_131	[p9l1960t1750r2059b1799],
14	African	JJ	MISC	african	dep	140	SENT_131	[p9l120t1830r292b1870],
15	American	JJ	MISC	american	dep	140	SENT_131	[p9l312t1830r547b1870],
16	22	CD	NUMBER	22	dep	140	SENT_131	[p9l1137t1830r1200b1870],
17	(	CD	NUMBER	(	dep	140	SENT_131	[p9l1219t1830r1285b1879],
18	5	CD	NUMBER	5	dep	140	SENT_131	[p9l1219t1830r1285b1879],
19	)	NN	O	)	dep	140	SENT_131	[p9l1219t1830r1285b1879],
20	3	CD	NUMBER	3	dep	140	SENT_131	[p9l1552t1830r1582b1870],
21	(	NN	O	(	dep	140	SENT_131	[p9l1600t1830r1666b1879],
22	3	CD	NUMBER	3	dep	140	SENT_131	[p9l1600t1830r1666b1879],
23	)	NN	O	)	dep	140	SENT_131	[p9l1600t1830r1666b1879],
24	19	CD	NUMBER	19	dep	140	SENT_131	[p9l1879t1830r1941b1870],
25	(	NN	O	(	dep	140	SENT_131	[p9l1960t1830r2025b1879],
26	5	CD	NUMBER	5	dep	140	SENT_131	[p9l1960t1830r2025b1879],
27	)	CD	NUMBER	)	dep	140	SENT_131	[p9l1960t1830r2025b1879],
28	Other	JJ	O	other	dep	140	SENT_131	[p9l122t1910r256b1950],
29	43	CD	NUMBER	43	dep	140	SENT_131	[p9l1137t1909r1200b1950],
30	(	CD	NUMBER	(	dep	140	SENT_131	[p9l1219t1910r1285b1959],
31	9	CD	NUMBER	9	dep	140	SENT_131	[p9l1219t1910r1285b1959],
32	)	NN	O	)	dep	140	SENT_131	[p9l1219t1910r1285b1959],
33	9	CD	NUMBER	9	dep	140	SENT_131	[p9l1552t1910r1582b1950],
34	(	NN	O	(	dep	140	SENT_131	[p9l1600t1910r1666b1959],
35	8	CD	NUMBER	8	dep	140	SENT_131	[p9l1600t1910r1666b1959],
36	)	NN	O	)	dep	140	SENT_131	[p9l1600t1910r1666b1959],
37	44	CD	NUMBER	44	dep	140	SENT_131	[p9l1877t1909r1942b1949],
38	(	NN	O	(	dep	140	SENT_131	[p9l1960t1909r2058b1959],
39	10	CD	NUMBER	10	dep	140	SENT_131	[p9l1960t1909r2058b1959],
40	)	CD	NUMBER	)	dep	140	SENT_131	[p9l1960t1909r2058b1959],
41	Total	JJ	O	total	dep	140	SENT_131	[p9l61t1991r181b2030],
42	cholesterol	NN	O	cholesterol	dep	140	SENT_131	[p9l203t1991r484b2038],
43	,	,	O	,	_	0	SENT_131	[p9l203t1991r484b2038],
44	mg/dl	NN	O	mg/dl	dep	140	SENT_131	[p9l507t1991r654b2040],
45	(	CD	NUMBER	(	dep	140	SENT_131	[p9l676t1990r778b2039],
46	SD	NN	O	sd	dep	140	SENT_131	[p9l676t1990r778b2039],
47	)	NN	O	)	dep	140	SENT_131	[p9l676t1990r778b2039],
48	258	CD	NUMBER	258	dep	140	SENT_131	[p9l1103t1990r1202b2030],
49	(	NN	O	(	dep	140	SENT_131	[p9l1219t1990r1318b2039],
50	32	CD	NUMBER	32	dep	140	SENT_131	[p9l1219t1990r1318b2039],
51	)	NN	O	)	dep	140	SENT_131	[p9l1219t1990r1318b2039],
52	263	CD	NUMBER	263	dep	140	SENT_131	[p9l1484t1990r1582b2030],
53	(	NN	O	(	dep	140	SENT_131	[p9l1601t1990r1700b2039],
54	32	CD	NUMBER	32	dep	140	SENT_131	[p9l1601t1990r1700b2039],
55	)	NN	O	)	dep	140	SENT_131	[p9l1601t1990r1700b2039],
56	256	CD	NUMBER	256	dep	140	SENT_131	[p9l1843t1990r1942b2030],
57	(	CD	NUMBER	(	dep	140	SENT_131	[p9l1960t1990r2059b2039],
58	32	CD	NUMBER	32	dep	140	SENT_131	[p9l1960t1990r2059b2039],
59	)	NN	O	)	dep	140	SENT_131	[p9l1960t1990r2059b2039],
60	LDL	NN	ORGANIZATION	ldl	dep	140	SENT_131	[p9l66t2070r168b2117],
61	,	,	O	,	_	0	SENT_131	[p9l66t2070r168b2117],
62	mg/dl	NN	O	mg/dl	dep	140	SENT_131	[p9l191t2070r338b2119],
63	(	CD	NUMBER	(	dep	140	SENT_131	[p9l360t2070r462b2119],
64	SD	NN	O	sd	dep	140	SENT_131	[p9l360t2070r462b2119],
65	)	NN	O	)	dep	140	SENT_131	[p9l360t2070r462b2119],
66	173	CD	NUMBER	173	dep	140	SENT_131	[p9l1104t2070r1201b2110],
67	(	NN	O	(	dep	140	SENT_131	[p9l1219t2070r1318b2119],
68	25	CD	NUMBER	25	dep	140	SENT_131	[p9l1219t2070r1318b2119],
69	)	NN	O	)	dep	140	SENT_131	[p9l1219t2070r1318b2119],
70	176	CD	NUMBER	176	dep	140	SENT_131	[p9l1486t2070r1583b2110],
71	(	NN	O	(	dep	140	SENT_131	[p9l1601t2070r1700b2119],
72	24	CD	NUMBER	24	dep	140	SENT_131	[p9l1601t2070r1700b2119],
73	)	NN	O	)	dep	140	SENT_131	[p9l1601t2070r1700b2119],
74	173	CD	NUMBER	173	dep	140	SENT_131	[p9l1845t2070r1941b2110],
75	(	NN	O	(	dep	140	SENT_131	[p9l1960t2070r2059b2119],
76	26	CD	NUMBER	26	dep	140	SENT_131	[p9l1960t2070r2059b2119],
77	)	CD	NUMBER	)	dep	140	SENT_131	[p9l1960t2070r2059b2119],
78	HDL	NN	O	hdl	dep	140	SENT_131	[p9l66t2150r177b2197],
79	,	,	O	,	_	0	SENT_131	[p9l66t2150r177b2197],
80	mg/dl	NN	O	mg/dl	dep	140	SENT_131	[p9l200t2150r346b2199],
81	(	CD	NUMBER	(	dep	140	SENT_131	[p9l368t2150r470b2199],
82	SD	NN	O	sd	dep	140	SENT_131	[p9l368t2150r470b2199],
83	)	NN	O	)	dep	140	SENT_131	[p9l368t2150r470b2199],
84	49	CD	NUMBER	49	dep	140	SENT_131	[p9l1137t2149r1201b2190],
85	(	CD	NUMBER	(	dep	140	SENT_131	[p9l1219t2149r1318b2199],
86	13	CD	NUMBER	13	dep	140	SENT_131	[p9l1219t2149r1318b2199],
87	)	NN	O	)	dep	140	SENT_131	[p9l1219t2149r1318b2199],
88	51	CD	NUMBER	51	dep	140	SENT_131	[p9l1518t2149r1584b2190],
89	(	CD	NUMBER	(	dep	140	SENT_131	[p9l1601t2149r1700b2199],
90	13	CD	NUMBER	13	dep	140	SENT_131	[p9l1601t2149r1700b2199],
91	)	NN	O	)	dep	140	SENT_131	[p9l1601t2149r1700b2199],
92	48	CD	NUMBER	48	dep	140	SENT_131	[p9l1877t2149r1942b2190],
93	(	CD	NUMBER	(	dep	140	SENT_131	[p9l1960t2149r2059b2199],
94	12	CD	NUMBER	12	dep	140	SENT_131	[p9l1960t2149r2059b2199],
95	)	CD	NUMBER	)	dep	140	SENT_131	[p9l1960t2149r2059b2199],
96	Triglycerides	NNS	O	triglyceride	dep	140	SENT_131	[p9l61t2231r382b2280],
97	,	,	O	,	_	0	SENT_131	[p9l61t2231r382b2280],
98	mg/dl	NN	O	mg/dl	dep	140	SENT_131	[p9l405t2231r551b2280],
99	(	CD	NUMBER	(	dep	140	SENT_131	[p9l573t2230r676b2279],
100	SD	NN	O	sd	dep	140	SENT_131	[p9l573t2230r676b2279],
101	)	NN	O	)	dep	140	SENT_131	[p9l573t2230r676b2279],
102	177	CD	NUMBER	177	dep	140	SENT_131	[p9l1104t2230r1201b2270],
103	(	NN	O	(	dep	140	SENT_131	[p9l1219t2230r1318b2279],
104	68	CD	NUMBER	68	dep	140	SENT_131	[p9l1219t2230r1318b2279],
105	)	NN	O	)	dep	140	SENT_131	[p9l1219t2230r1318b2279],
106	182	CD	NUMBER	182	dep	140	SENT_131	[p9l1486t2230r1581b2270],
107	(	NN	O	(	dep	140	SENT_131	[p9l1601t2230r1700b2279],
108	73	CD	NUMBER	73	dep	140	SENT_131	[p9l1601t2230r1700b2279],
109	)	NN	O	)	dep	140	SENT_131	[p9l1601t2230r1700b2279],
110	176	CD	NUMBER	176	dep	140	SENT_131	[p9l1845t2230r1942b2270],
111	(	NN	O	(	dep	140	SENT_131	[p9l1960t2230r2059b2279],
112	66	CD	NUMBER	66	dep	140	SENT_131	[p9l1960t2230r2059b2279],
113	)	CD	NUMBER	)	dep	140	SENT_131	[p9l1960t2230r2059b2279],
114	Baseline	NN	O	baseline	dep	140	SENT_131	[p9l66t2310r273b2350],
115	creatinine	NN	O	creatinine	dep	140	SENT_131	[p9l293t2310r536b2350],
116	kinase	NN	O	kinase	dep	140	SENT_131	[p9l559t2310r730b2358],
117	,	,	O	,	_	0	SENT_131	[p9l559t2310r730b2358],
118	U/I	NN	O	u/i	dep	140	SENT_131	[p9l753t2310r823b2359],
119	(	CD	NUMBER	(	dep	140	SENT_131	[p9l845t2310r947b2359],
120	SD	NN	O	sd	dep	140	SENT_131	[p9l845t2310r947b2359],
121	)	NN	O	)	dep	140	SENT_131	[p9l845t2310r947b2359],
122	121	CD	NUMBER	121	dep	140	SENT_131	[p9l1104t2310r1202b2349],
123	(	NN	O	(	dep	140	SENT_131	[p9l1219t2310r1319b2359],
124	81	CD	NUMBER	81	dep	140	SENT_131	[p9l1219t2310r1319b2359],
125	)	NN	O	)	dep	140	SENT_131	[p9l1219t2310r1319b2359],
126	123	CD	NUMBER	123	dep	140	SENT_131	[p9l1486t2310r1582b2350],
127	(	NN	O	(	dep	140	SENT_131	[p9l1601t2310r1700b2359],
128	94	CD	NUMBER	94	dep	140	SENT_131	[p9l1601t2310r1700b2359],
129	)	NN	O	)	dep	140	SENT_131	[p9l1601t2310r1700b2359],
130	121	CD	NUMBER	121	dep	140	SENT_131	[p9l1859t2310r2059b2359],
131	(	NN	O	(	dep	140	SENT_131	[p9l1859t2310r2059b2359],
132	71	CD	NUMBER	71	dep	140	SENT_131	[p9l1859t2310r2059b2359],
133	)	CD	NUMBER	)	dep	140	SENT_131	[p9l1859t2310r2059b2359],
134	Assigned	VBN	O	assign	dep	140	SENT_131	[p9l62t2391r282b2440],
135	statin	NN	O	statin	dep	140	SENT_131	[p9l303t2391r453b2438],
136	,	,	O	,	_	0	SENT_131	[p9l303t2391r453b2438],
137	n	NN	O	n	dep	140	SENT_131	[p9l477t2400r501b2430],
138	(	CD	PERCENT	(	dep	140	SENT_131	[p9l524t2391r599b2439],
139	%	NN	PERCENT	%	dep	140	SENT_131	[p9l524t2391r599b2439],
140	)	CD	NUMBER	)	_	0	SENT_131	[p9l524t2391r599b2439],

1	Atorvastatin	NN	O	atorvastatin	nn	3	SENT_132	[p9l120t2471r416b2510],
2	147	CD	NUMBER	147	num	3	SENT_132	[p9l1104t2470r1201b2510],
3	(	NN	O	(	dep	11	SENT_132	[p9l1219t2470r1318b2519],
4	32	CD	NUMBER	32	number	5	SENT_132	[p9l1219t2470r1318b2519],
5	)	CD	NUMBER	)	dep	3	SENT_132	[p9l1219t2470r1318b2519],
6	31	CD	NUMBER	31	num	7	SENT_132	[p9l1518t2470r1584b2510],
7	(	NN	O	(	dep	5	SENT_132	[p9l1601t2470r1700b2519],
8	31	CD	NUMBER	31	num	9	SENT_132	[p9l1601t2470r1700b2519],
9	)	NN	O	)	dep	11	SENT_132	[p9l1601t2470r1700b2519],
10	116	CD	NUMBER	116	num	11	SENT_132	[p9l1845t2470r1942b2510],
11	(	NN	O	(	dep	17	SENT_132	[p9l1960t2470r2059b2519],
12	33	CD	NUMBER	33	number	13	SENT_132	[p9l1960t2470r2059b2519],
13	)	CD	NUMBER	)	num	14	SENT_132	[p9l1960t2470r2059b2519],
14	Simvastatin	NN	O	simvastatin	dep	11	SENT_132	[p9l120t2550r410b2590],
15	162	CD	NUMBER	162	num	16	SENT_132	[p9l1104t2550r1200b2590],
16	(	CD	NUMBER	(	dep	14	SENT_132	[p9l1220t2550r1319b2599],
17	36	CD	NUMBER	36	dep	18	SENT_132	[p9l1220t2550r1319b2599],
18	)	NN	O	)	dep	20	SENT_132	[p9l1220t2550r1319b2599],
19	37	CD	NUMBER	37	num	18	SENT_132	[p9l1518t2550r1582b2590],
20	(	NN	O	(	dep	22	SENT_132	[p9l1601t2550r1700b2599],
21	37	CD	NUMBER	37	num	20	SENT_132	[p9l1601t2550r1700b2599],
22	)	NN	O	)	dep	24	SENT_132	[p9l1601t2550r1700b2599],
23	125	CD	NUMBER	125	num	22	SENT_132	[p9l1845t2550r1942b2590],
24	(	NN	O	(	dep	27	SENT_132	[p9l1960t2550r2059b2599],
25	35	CD	NUMBER	35	num	24	SENT_132	[p9l1960t2550r2059b2599],
26	)	CD	NUMBER	)	num	27	SENT_132	[p9l1960t2550r2059b2599],
27	Pravastatin	NN	O	pravastatin	dep	29	SENT_132	[p9l123t2631r398b2671],
28	143	CD	NUMBER	143	num	29	SENT_132	[p9l1104t2630r1201b2671],
29	(	NN	O	(	dep	35	SENT_132	[p9l1219t2630r1319b2679],
30	32	CD	NUMBER	32	number	31	SENT_132	[p9l1219t2630r1319b2679],
31	)	CD	NUMBER	)	dep	29	SENT_132	[p9l1219t2630r1319b2679],
32	31	CD	NUMBER	31	num	33	SENT_132	[p9l1518t2630r1584b2671],
33	(	NN	O	(	dep	31	SENT_132	[p9l1601t2630r1700b2679],
34	31	CD	NUMBER	31	num	35	SENT_132	[p9l1601t2630r1700b2679],
35	)	NN	O	)	dep	37	SENT_132	[p9l1601t2630r1700b2679],
36	112	CD	NUMBER	112	num	37	SENT_132	[p9l1845t2630r1941b2670],
37	(	NN	O	(	dep	39	SENT_132	[p9l1960t2630r2059b2679],
38	32	CD	NUMBER	32	num	39	SENT_132	[p9l1960t2630r2059b2679],
39	)	NN	O	)	_	0	SENT_132	[p9l1960t2630r2059b2679],

1	All	DT	O	all	det	2	SENT_133	[p9l9t2759r61b2794],
2	comparisons	NNS	O	comparison	nsubj	3	SENT_133	[p9l81t2759r359b2802],
3	are	VBP	O	be	conj_and	3	SENT_133	[p9l377t2767r444b2795],
4	between	IN	O	between	_	0	SENT_133	[p9l464t2759r645b2795],
5	those	DT	O	those	prep_between	3	SENT_133	[p9l664t2759r783b2795],
6	with	IN	O	with	_	0	SENT_133	[p9l800t2759r888b2794],
7	and	CC	O	and	_	0	SENT_133	[p9l908t2759r986b2795],
8	without	IN	O	without	_	0	SENT_133	[p9l1005t2759r1167b2795],
9	the	DT	O	the	det	10	SENT_133	[p9l1183t2759r1252b2795],
10	CAE	NNP	O	CAE	prep_with	3	SENT_133	[p9l1270t2759r1366b2795],
11	.	.	O	.	_	0	SENT_133	[p9l1270t2759r1366b2795],

1	*	NN	O	*	nn	2	SENT_134	[p9l1386t2759r1437b2802],
2	p	NN	O	p	_	0	SENT_134	[p9l1386t2759r1437b2802],
3	=	JJ	O	=	quantmod	4	SENT_134	[p9l1459t2771r1490b2783],
4	0.004	CD	NUMBER	0.004	num	2	SENT_134	[p9l1512t2758r1653b2795],
5	.	.	O	.	_	0	SENT_134	[p9l1512t2758r1653b2795],

1	CAE	NN	O	ca	nn	5	SENT_135	[p9l61t2816r146b2852],
2	=	JJ	O	=	amod	5	SENT_135	[p9l166t2829r197b2841],
3	composite	JJ	O	composite	amod	5	SENT_135	[p9l217t2817r443b2860],
4	adverse	JJ	O	adverse	amod	5	SENT_135	[p9l459t2817r628b2852],
5	event	NN	O	event	_	0	SENT_135	[p9l644t2819r772b2859],
6	;	:	O	;	_	0	SENT_135	[p9l644t2819r772b2859],
7	HDL	NN	O	hdl	dep	10	SENT_135	[p9l792t2817r879b2852],
8	=	JJ	O	=	amod	10	SENT_135	[p9l898t2829r930b2841],
9	high-density	JJ	O	high-density	amod	10	SENT_135	[p9l951t2817r1211b2860],
10	lipoprotein	NN	O	lipoprotein	dep	5	SENT_135	[p9l1228t2817r1469b2860],
11	;	:	O	;	_	0	SENT_135	[p9l1228t2817r1469b2860],
12	LDL	NN	O	ldl	dep	10	SENT_135	[p9l1488t2817r1569b2852],
13	=	JJ	O	=	amod	15	SENT_135	[p9l1588t2829r1619b2841],
14	low-density	JJ	O	low-density	amod	15	SENT_135	[p9l1641t2817r1882b2860],
15	lipoprotein	NN	O	lipoprotein	dep	12	SENT_135	[p9l1898t2817r2139b2860],
16	;	:	O	;	_	0	SENT_135	[p9l1898t2817r2139b2860],

1	STRENGTH	NN	O	strength	nsubj	5	SENT_136	[p9l9t2887r243b2923],
2	=	JJ	O	=	amod	4	SENT_136	[p9l267t2899r297b2911],
3	Statin	NN	O	statin	nn	4	SENT_136	[p9l318t2887r445b2923],
4	Response	NN	O	response	dep	1	SENT_136	[p9l466t2887r676b2931],
5	Examined	VBN	O	examine	_	0	SENT_136	[p9l696t2887r906b2923],
6	by	IN	O	by	_	0	SENT_136	[p9l927t2887r974b2931],
7	Genetic	JJ	O	genetic	amod	9	SENT_136	[p9l991t2887r1155b2923],
8	Haplotype	NN	O	haplotype	nn	9	SENT_136	[p9l1174t2887r1390b2931],
9	Markers	NNS	O	marker	prep_by	5	SENT_136	[p9l1409t2887r1595b2923],
10	.	.	O	.	_	0	SENT_136	[p9l1409t2887r1595b2923],

1	1612	CD	DATE	1612	num	2	SENT_137	[p9l45t3006r113b3031],
2	Voora	NNP	O	Voora	_	0	SENT_137	[p9l192t3006r268b3031],
3	et	FW	O	et	nn	4	SENT_137	[p9l279t3007r306b3031],
4	al.	FW	O	al.	dep	2	SENT_137	[p9l313t3006r344b3031],
5	.	.	O	.	_	0	SENT_137	[p9l313t3006r344b3031],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_138	[p9l194t3047r439b3077],
2	of	IN	O	of	_	0	SENT_138	[p9l448t3047r474b3072],
3	Statin	NN	O	statin	nn	5	SENT_138	[p9l481t3047r560b3072],
4	Side	NN	O	side	nn	5	SENT_138	[p9l569t3047r626b3072],
5	Elfects	NNS	O	elfect	prep_of	1	SENT_138	[p9l636t3047r724b3072],

1	JACC	NNP	O	JACC	nn	2	SENT_139	[p9l1808t3007r1862b3031],
2	Vol	NNP	O	Vol	_	0	SENT_139	[p9l1871t3007r1910b3031],
3	.	.	O	.	_	0	SENT_139	[p9l1871t3007r1910b3031],

1	54	CD	NUMBER	54	_	0	SENT_140	[p9l1921t3007r1956b3035],
2	,	,	O	,	_	0	SENT_140	[p9l1921t3007r1956b3035],
3	No.	NN	O	no.	appos	1	SENT_140	[p9l1968t3007r2002b3031],
4	17	CD	NUMBER	17	num	3	SENT_140	[p9l2014t3007r2048b3035],
5	,	,	O	,	_	0	SENT_140	[p9l2014t3007r2048b3035],
6	2009	CD	DATE	2009	num	7	SENT_140	[p9l2059t3007r2117b3031],
7	October	NNP	DATE	October	appos	1	SENT_140	[p9l1807t3048r1891b3072],
8	20	CD	DATE	20	num	7	SENT_140	[p9l1900t3048r1935b3076],
9	,	,	O	,	_	0	SENT_140	[p9l1900t3048r1935b3076],
10	2009:1609	CD	NUMBER	2009:1609	number	11	SENT_140	[p9l1946t3048r2117b3072],
11	—	CD	NUMBER	—	appos	1	SENT_140	[p9l1946t3048r2117b3072],
12	16	CD	NUMBER	16	dep	11	SENT_140	[p9l1946t3048r2117b3072],

1	Table	NNP	O	Table	nsubj	3	SENT_141	[p9l68t3180r147b3203],
2	2	CD	NUMBER	2	num	1	SENT_141	[p9l160t3179r178b3203],
3	Reduced	VBN	O	reduce	_	0	SENT_141	[p9l231t3179r358b3203],
4	Function	NN	O	function	nn	5	SENT_141	[p9l372t3179r498b3203],
5	Alleles	NNS	O	allele	dobj	3	SENT_141	[p9l511t3179r610b3203],
6	of	IN	O	of	_	0	SENT_141	[p9l622t3179r651b3203],
7	Statin	NNP	O	Statin	nn	9	SENT_141	[p9l661t3179r749b3203],
8	Pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_141	[p9l764t3179r1013b3203],
9	Genes	NNS	O	gene	prep_of	5	SENT_141	[p9l1026t3179r1117b3203],
10	and	CC	O	and	_	0	SENT_141	[p9l1130t3179r1182b3203],
11	Frequency	NN	O	frequency	prep_of	5	SENT_141	[p9l1196t3179r1347b3209],
12	in	IN	O	in	_	0	SENT_141	[p9l1360t3179r1384b3203],
13	the	DT	O	the	det	15	SENT_141	[p9l1396t3179r1444b3203],
14	STRENGTH	NN	O	strength	nn	15	SENT_141	[p9l1456t3179r1617b3203],
15	Study	NN	O	study	prep_in	3	SENT_141	[p9l1631t3179r1715b3209],

1	Entire	JJ	O	entire	dep	155	SENT_142	[p9l1452t3241r1521b3260],
2	cohort	NN	O	cohort	dep	155	SENT_142	[p9l1531t3241r1612b3260],
3	CAE	NNP	O	CAE	dep	155	SENT_142	[p9l1767t3241r1817b3260],
4	No	NNP	O	No	dep	155	SENT_142	[p9l1984t3241r2014b3260],
5	CAE	NNP	O	CAE	dep	155	SENT_142	[p9l2024t3241r2074b3260],
6	SNP	NN	O	snp	dep	155	SENT_142	[p9l114t3273r165b3293],
7	rsID	NN	O	rsid	dep	155	SENT_142	[p9l382t3273r428b3293],
8	Protein	NN	O	protein	dep	155	SENT_142	[p9l619t3273r704b3293],
9	Effect	NN	O	effect	dep	155	SENT_142	[p9l715t3273r785b3293],
10	Enzyme/Transporter	NN	O	enzyme/transporter	dep	155	SENT_142	[p9l954t3273r1200b3297],
11	Effect	NN	O	effect	dep	155	SENT_142	[p9l1210t3273r1294b3293],
12	*	CD	NUMBER	*	dep	155	SENT_142	[p9l1210t3273r1294b3293],
13	(	NN	O	(	dep	155	SENT_142	[p9l1470t3273r1493b3297],
14	n	NN	O	n	dep	155	SENT_142	[p9l1470t3273r1493b3297],
15	=	JJ	O	=	dep	155	SENT_142	[p9l1506t3279r1523b3288],
16	452	CD	NUMBER	452	dep	155	SENT_142	[p9l1535t3273r1591b3297],
17	)	CD	NUMBER	)	dep	155	SENT_142	[p9l1535t3273r1591b3297],
18	(	NN	O	(	dep	155	SENT_142	[p9l1738t3273r1761b3297],
19	n	NN	O	n	dep	155	SENT_142	[p9l1738t3273r1761b3297],
20	=	JJ	O	=	dep	155	SENT_142	[p9l1774t3279r1791b3288],
21	99	CD	NUMBER	99	dep	155	SENT_142	[p9l1804t3273r1844b3297],
22	)	CD	NUMBER	)	dep	155	SENT_142	[p9l1804t3273r1844b3297],
23	(	NN	O	(	dep	155	SENT_142	[p9l1967t3273r1990b3297],
24	n	NN	O	n	dep	155	SENT_142	[p9l1967t3273r1990b3297],
25	=	JJ	O	=	dep	155	SENT_142	[p9l2003t3279r2020b3288],
26	353	CD	NUMBER	353	dep	155	SENT_142	[p9l2032t3273r2089b3297],
27	)	CD	NUMBER	)	dep	155	SENT_142	[p9l2032t3273r2089b3297],
28	CYP2D6	NN	O	cyp2d6	dep	155	SENT_142	[p9l68t3323r193b3343],
29	*	CD	NUMBER	*	dep	155	SENT_142	[p9l68t3323r193b3343],
30	4	CD	NUMBER	4	dep	155	SENT_142	[p9l68t3323r193b3343],
31	rs3892097	NN	O	rs3892097	dep	155	SENT_142	[p9l330t3323r460b3342],
32	Spicing	NN	O	spicing	dep	155	SENT_142	[p9l597t3323r682b3347],
33	defect	NN	O	defect	dep	155	SENT_142	[p9l690t3323r762b3342],
34	Reduced	VBN	O	reduce	dep	155	SENT_142	[p9l923t3324r1022b3342],
35	due	JJ	O	due	dep	155	SENT_142	[p9l1033t3324r1074b3342],
36	to	TO	O	to	dep	155	SENT_142	[p9l1083t3325r1105b3342],
37	haploinsufficiency	NN	O	haploinsufficiency	dep	155	SENT_142	[p9l1116t3323r1323b3347],
38	142	CD	NUMBER	142	dep	155	SENT_142	[p9l1481t3323r1526b3342],
39	(	NN	O	(	dep	155	SENT_142	[p9l1535t3323r1582b3347],
40	32	CD	NUMBER	32	dep	155	SENT_142	[p9l1535t3323r1582b3347],
41	)	CD	NUMBER	)	dep	155	SENT_142	[p9l1535t3323r1582b3347],
42	34	CD	NUMBER	34	dep	155	SENT_142	[p9l1749t3323r1779b3342],
43	(	NN	O	(	dep	155	SENT_142	[p9l1788t3323r1834b3347],
44	34	CD	NUMBER	34	dep	155	SENT_142	[p9l1788t3323r1834b3347],
45	)	NN	O	)	dep	155	SENT_142	[p9l1788t3323r1834b3347],
46	108	CD	NUMBER	108	dep	155	SENT_142	[p9l1970t3323r2016b3342],
47	(	NN	O	(	dep	155	SENT_142	[p9l2024t3323r2071b3347],
48	31	CD	NUMBER	31	dep	155	SENT_142	[p9l2024t3323r2071b3347],
49	)	CD	NUMBER	)	dep	155	SENT_142	[p9l2024t3323r2071b3347],
50	CYP2D6	NN	O	cyp2d6	dep	155	SENT_142	[p9l68t3362r209b3382],
51	*	CD	NUMBER	*	dep	155	SENT_142	[p9l68t3362r209b3382],
52	10	CD	NUMBER	10	dep	155	SENT_142	[p9l68t3362r209b3382],
53	rs1065852	NN	O	rs1065852	dep	155	SENT_142	[p9l330t3362r460b3382],
54	Missense	NN	O	missense	dep	155	SENT_142	[p9l599t3363r711b3385],
55	,	,	O	,	_	0	SENT_142	[p9l599t3363r711b3385],
56	S34P	NN	O	s34p	dep	155	SENT_142	[p9l720t3362r783b3382],
57	Decreased	VBD	MISC	decrease	dep	155	SENT_142	[p9l923t3363r1044b3382],
58	161	CD	NUMBER	161	dep	155	SENT_142	[p9l1481t3362r1527b3382],
59	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1535t3362r1582b3386],
60	36	CD	NUMBER	36	dep	155	SENT_142	[p9l1535t3362r1582b3386],
61	)	CD	NUMBER	)	dep	155	SENT_142	[p9l1535t3362r1582b3386],
62	40	CD	NUMBER	40	dep	155	SENT_142	[p9l1749t3362r1779b3382],
63	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1788t3362r1834b3386],
64	40	CD	NUMBER	40	dep	155	SENT_142	[p9l1788t3362r1834b3386],
65	)	NN	O	)	dep	155	SENT_142	[p9l1788t3362r1834b3386],
66	121	CD	NUMBER	121	dep	155	SENT_142	[p9l1970t3362r2071b3386],
67	(	NN	O	(	dep	155	SENT_142	[p9l1970t3362r2071b3386],
68	35	CD	NUMBER	35	dep	155	SENT_142	[p9l1970t3362r2071b3386],
69	)	CD	NUMBER	)	dep	155	SENT_142	[p9l1970t3362r2071b3386],
70	CYP2C8	NN	O	cyp2c8	dep	155	SENT_142	[p9l68t3401r191b3420],
71	*	CD	NUMBER	*	dep	155	SENT_142	[p9l68t3401r191b3420],
72	3	CD	NUMBER	3	dep	155	SENT_142	[p9l68t3401r191b3420],
73	rs10509681	NN	O	rs10509681	dep	155	SENT_142	[p9l330t3401r477b3420],
74	Missense	NN	O	missense	dep	155	SENT_142	[p9l599t3401r711b3424],
75	,	,	O	,	_	0	SENT_142	[p9l599t3401r711b3424],
76	R399K	NN	O	r399k	dep	155	SENT_142	[p9l722t3401r801b3420],
77	Decreased	VBD	O	decrease	dep	155	SENT_142	[p9l923t3401r1044b3420],
78	94	CD	NUMBER	94	dep	155	SENT_142	[p9l1497t3401r1527b3420],
79	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1535t3401r1582b3424],
80	21	CD	NUMBER	21	dep	155	SENT_142	[p9l1535t3401r1582b3424],
81	)	NN	O	)	dep	155	SENT_142	[p9l1535t3401r1582b3424],
82	15	CD	NUMBER	15	dep	155	SENT_142	[p9l1750t3401r1779b3420],
83	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1788t3401r1834b3424],
84	15	CD	NUMBER	15	dep	155	SENT_142	[p9l1788t3401r1834b3424],
85	)	NN	O	)	dep	155	SENT_142	[p9l1788t3401r1834b3424],
86	79	CD	NUMBER	79	dep	155	SENT_142	[p9l1986t3401r2016b3420],
87	(	CD	NUMBER	(	dep	155	SENT_142	[p9l2024t3401r2071b3424],
88	23	CD	NUMBER	23	dep	155	SENT_142	[p9l2024t3401r2071b3424],
89	)	NN	O	)	dep	155	SENT_142	[p9l2024t3401r2071b3424],
90	CYP2C8	NN	O	cyp2c8	dep	155	SENT_142	[p9l69t3439r191b3459],
91	*	CD	NUMBER	*	dep	155	SENT_142	[p9l69t3439r191b3459],
92	4	CD	NUMBER	4	dep	155	SENT_142	[p9l69t3439r191b3459],
93	rs1058930	NN	O	rs1058930	dep	155	SENT_142	[p9l330t3439r460b3459],
94	Missense	NN	O	missense	dep	155	SENT_142	[p9l599t3440r711b3463],
95	,	,	O	,	_	0	SENT_142	[p9l599t3440r711b3463],
96	M264I	NNP	O	M264I	dep	155	SENT_142	[p9l722t3439r795b3459],
97	Decreased	VBD	O	decrease	dep	155	SENT_142	[p9l923t3440r1044b3459],
98	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1054t3439r1101b3463],
99	29	CD	NUMBER	29	dep	155	SENT_142	[p9l1054t3439r1101b3463],
100	)	NN	O	)	dep	155	SENT_142	[p9l1054t3439r1101b3463],
101	46	CD	NUMBER	46	dep	155	SENT_142	[p9l1496t3439r1527b3459],
102	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1535t3439r1582b3463],
103	10	CD	NUMBER	10	dep	155	SENT_142	[p9l1535t3439r1582b3463],
104	)	NN	O	)	dep	155	SENT_142	[p9l1535t3439r1582b3463],
105	8	CD	NUMBER	8	dep	155	SENT_142	[p9l1765t3439r1779b3459],
106	(	NN	O	(	dep	155	SENT_142	[p9l1788t3439r1818b3463],
107	8	CD	NUMBER	8	dep	155	SENT_142	[p9l1788t3439r1818b3463],
108	)	NN	O	)	dep	155	SENT_142	[p9l1788t3439r1818b3463],
109	38	CD	NUMBER	38	dep	155	SENT_142	[p9l1986t3439r2016b3459],
110	(	CD	NUMBER	(	dep	155	SENT_142	[p9l2024t3439r2071b3463],
111	11	CD	NUMBER	11	dep	155	SENT_142	[p9l2024t3439r2071b3463],
112	)	NN	O	)	dep	155	SENT_142	[p9l2024t3439r2071b3463],
113	CYP2c9	NN	O	cyp2c9	dep	155	SENT_142	[p9l68t3478r191b3498],
114	*	CD	NUMBER	*	dep	155	SENT_142	[p9l68t3478r191b3498],
115	3	CD	NUMBER	3	dep	155	SENT_142	[p9l68t3478r191b3498],
116	rs1057910	NN	O	rs1057910	dep	155	SENT_142	[p9l330t3478r460b3498],
117	Missense	NN	O	missense	dep	155	SENT_142	[p9l599t3478r711b3501],
118	,	,	O	,	_	0	SENT_142	[p9l599t3478r711b3501],
119	L395l	NN	O	l395l	dep	155	SENT_142	[p9l722t3478r787b3498],
120	Decreased	VBD	O	decrease	dep	155	SENT_142	[p9l923t3478r1044b3498],
121	47	CD	NUMBER	47	dep	155	SENT_142	[p9l1496t3478r1526b3497],
122	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1535t3478r1582b3502],
123	11	CD	NUMBER	11	dep	155	SENT_142	[p9l1535t3478r1582b3502],
124	)	NN	O	)	dep	155	SENT_142	[p9l1535t3478r1582b3502],
125	14	CD	NUMBER	14	dep	155	SENT_142	[p9l1750t3478r1779b3498],
126	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1788t3478r1834b3502],
127	14	CD	NUMBER	14	dep	155	SENT_142	[p9l1788t3478r1834b3502],
128	)	NN	O	)	dep	155	SENT_142	[p9l1788t3478r1834b3502],
129	33	CD	NUMBER	33	dep	155	SENT_142	[p9l1986t3478r2055b3502],
130	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1986t3478r2055b3502],
131	9	CD	NUMBER	9	dep	155	SENT_142	[p9l1986t3478r2055b3502],
132	)	NN	O	)	dep	155	SENT_142	[p9l1986t3478r2055b3502],
133	CYP3A4	NN	O	cyp3a4	dep	155	SENT_142	[p9l68t3517r206b3536],
134	*	CD	NUMBER	*	dep	155	SENT_142	[p9l68t3517r206b3536],
135	1b	NN	O	1b	dep	155	SENT_142	[p9l68t3517r206b3536],
136	rs2740574	NN	O	rs2740574	dep	155	SENT_142	[p9l330t3517r460b3536],
137	-392	CD	NUMBER	-392	dep	155	SENT_142	[p9l600t3517r666b3536],
138	A	DT	O	a	dep	155	SENT_142	[p9l675t3517r730b3536],
139	>	JJR	O	>	dep	155	SENT_142	[p9l675t3517r730b3536],
140	G	NN	O	g	dep	155	SENT_142	[p9l675t3517r730b3536],
141	Decreased	VBN	O	decrease	dep	155	SENT_142	[p9l923t3517r1044b3536],
142	60	CD	NUMBER	60	dep	155	SENT_142	[p9l1497t3517r1527b3536],
143	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1535t3517r1582b3540],
144	13	CD	NUMBER	13	dep	155	SENT_142	[p9l1535t3517r1582b3540],
145	)	NN	O	)	dep	155	SENT_142	[p9l1535t3517r1582b3540],
146	14	CD	NUMBER	14	dep	155	SENT_142	[p9l1750t3517r1779b3536],
147	(	CD	NUMBER	(	dep	155	SENT_142	[p9l1788t3517r1834b3540],
148	14	CD	NUMBER	14	dep	155	SENT_142	[p9l1788t3517r1834b3540],
149	)	NN	O	)	dep	155	SENT_142	[p9l1788t3517r1834b3540],
150	46	CD	NUMBER	46	dep	155	SENT_142	[p9l1986t3517r2016b3536],
151	(	CD	NUMBER	(	dep	155	SENT_142	[p9l2024t3517r2071b3540],
152	13	CD	NUMBER	13	dep	155	SENT_142	[p9l2024t3517r2071b3540],
153	)	CD	NUMBER	)	dep	155	SENT_142	[p9l2024t3517r2071b3540],
154	$	$	MONEY	$	dep	155	SENT_142	[p9l67t3555r207b3575],
155	LCO	CD	MONEY	lco	_	0	SENT_142	[p9l67t3555r207b3575],
156	.	.	O	.	_	0	SENT_142	[p9l67t3555r207b3575],

1	‘	NN	O	‘	nn	3	SENT_143	[p9l67t3555r207b3575],
2	l.	NN	O	l.	nn	3	SENT_143	[p9l67t3555r207b3575],
3	B1	NN	O	b1	ccomp	10	SENT_143	[p9l67t3555r207b3575],
4	*	CD	NUMBER	*	number	5	SENT_143	[p9l67t3555r207b3575],
5	5	CD	NUMBER	5	dep	3	SENT_143	[p9l67t3555r207b3575],
6	rs4149056	NN	O	rs4149056	nn	7	SENT_143	[p9l330t3555r460b3575],
7	Missense	NN	O	missense	dep	3	SENT_143	[p9l599t3556r711b3579],
8	,	,	O	,	_	0	SENT_143	[p9l599t3556r711b3579],
9	V174A	NNP	O	V174A	nsubj	10	SENT_143	[p9l720t3555r798b3575],
10	Decreased	VBD	O	decrease	dep	30	SENT_143	[p9l923t3556r1044b3575],
11	(	CD	NUMBER	(	number	12	SENT_143	[p9l1054t3555r1101b3579],
12	10	CD	NUMBER	10	num	13	SENT_143	[p9l1054t3555r1101b3579],
13	)	NN	O	)	dobj	10	SENT_143	[p9l1054t3555r1101b3579],
14	123	CD	NUMBER	123	number	15	SENT_143	[p9l1481t3555r1527b3575],
15	(	CD	NUMBER	(	num	13	SENT_143	[p9l1535t3555r1582b3579],
16	28	CD	NUMBER	28	num	17	SENT_143	[p9l1535t3555r1582b3579],
17	)	NN	O	)	dep	25	SENT_143	[p9l1535t3555r1582b3579],
18	35	CD	NUMBER	35	number	19	SENT_143	[p9l1749t3555r1779b3575],
19	(	CD	NUMBER	(	dep	17	SENT_143	[p9l1788t3555r1834b3579],
20	35	CD	NUMBER	35	dep	19	SENT_143	[p9l1788t3555r1834b3579],
21	)	NN	O	)	dep	25	SENT_143	[p9l1788t3555r1834b3579],
22	88	CD	NUMBER	88	num	21	SENT_143	[p9l1986t3555r2016b3575],
23	(	CD	NUMBER	(	number	24	SENT_143	[p9l2024t3555r2086b3579],
24	25	CD	NUMBER	25	num	25	SENT_143	[p9l2024t3555r2086b3579],
25	)	NN	O	)	dep	13	SENT_143	[p9l2024t3555r2086b3579],
26	1	CD	NUMBER	1	dep	25	SENT_143	[p9l2024t3555r2086b3579],
27	'	''	O	'	_	0	SENT_143	[p9l2024t3555r2086b3579],
28	Values	NNS	O	value	nsubj	30	SENT_143	[p9l42t3616r110b3633],
29	are	VBP	O	be	cop	30	SENT_143	[p9l118t3620r150b3633],
30	n	NN	O	n	_	0	SENT_143	[p9l159t3620r169b3633],
31	(	CD	PERCENT	(	num	32	SENT_143	[p9l178t3616r215b3637],
32	%	NN	PERCENT	%	dep	30	SENT_143	[p9l178t3616r215b3637],
33	)	CD	NUMBER	)	dep	32	SENT_143	[p9l178t3616r215b3637],
34	.	.	O	.	_	0	SENT_143	[p9l178t3616r215b3637],

1	*	NN	O	*	dep	4	SENT_144	[p9l225t3616r304b3633],
2	Unless	IN	O	unless	mark	4	SENT_144	[p9l225t3616r304b3633],
3	otherwise	RB	O	otherwise	advmod	4	SENT_144	[p9l311t3616r410b3633],
4	by	IN	O	by	_	0	SENT_144	[p9l419t3616r441b3637],
5	(	CD	NUMBER	(	num	7	SENT_144	[p9l449t3616r553b3637],
6	reference	NN	O	reference	nn	7	SENT_144	[p9l449t3616r553b3637],
7	number	NN	O	number	pobj	4	SENT_144	[p9l562t3616r652b3637],
8	)	CD	NUMBER	)	dep	7	SENT_144	[p9l562t3616r652b3637],
9	,	,	O	,	_	0	SENT_144	[p9l562t3616r652b3637],
10	enzymatic	JJ	O	enzymatic	amod	11	SENT_144	[p9l661t3616r765b3637],
11	effects	NNS	O	effect	appos	7	SENT_144	[p9l773t3616r842b3633],
12	taken	VBN	O	take	partmod	11	SENT_144	[p9l849t3616r907b3633],
13	from	IN	O	from	_	0	SENT_144	[p9l915t3616r963b3633],
14	http://www	JJ	O	http://www	prep_from	12	SENT_144	[p9l972t3616r1096b3637],
15	.	.	O	.	_	0	SENT_144	[p9l972t3616r1096b3637],

1	alleles	NNS	O	allele	_	0	SENT_145	[p9l1133t3616r1257b3633],
2	.	.	O	.	_	0	SENT_145	[p9l1133t3616r1257b3633],

1	ki	NN	O	kus	_	0	SENT_146	[p9l1133t3616r1257b3633],
2	.	.	O	.	_	0	SENT_146	[p9l1133t3616r1257b3633],

1	se	FW	O	se	_	0	SENT_147	[p9l1133t3616r1257b3633],
2	.	.	O	.	_	0	SENT_147	[p9l1133t3616r1257b3633],

1	1p	NN	O	1p	nsubj	2	SENT_148	[p9l1267t3616r1292b3637],
2	=	JJ	O	=	_	0	SENT_148	[p9l1302t3622r1317b3628],
3	0.03	CD	NUMBER	0.03	dobj	2	SENT_148	[p9l1327t3616r1379b3633],
4	.	.	O	.	_	0	SENT_148	[p9l1327t3616r1379b3633],

1	rslD	NN	O	rsld	_	0	SENT_149	[p9l67t3643r106b3660],
2	=	JJ	O	=	amod	6	SENT_149	[p9l117t3649r131b3655],
3	reference	NN	O	reference	nn	6	SENT_149	[p9l142t3643r238b3660],
4	sequence	NN	O	sequence	nn	6	SENT_149	[p9l246t3647r344b3664],
5	identiﬁcation	NN	O	identiﬁcation	nn	6	SENT_149	[p9l352t3643r484b3660],
6	number	NN	O	number	dep	1	SENT_149	[p9l494t3643r577b3663],
7	;	:	O	;	_	0	SENT_149	[p9l494t3643r577b3663],
8	SNP	NN	O	snp	dep	1	SENT_149	[p9l585t3643r628b3660],
9	=	JJ	O	=	amod	12	SENT_149	[p9l638t3649r653b3655],
10	single	JJ	O	single	amod	12	SENT_149	[p9l663t3643r723b3664],
11	nucleotide	NN	O	nucleotide	nn	12	SENT_149	[p9l732t3643r837b3660],
12	polymorphism	NN	O	polymorphism	dep	8	SENT_149	[p9l846t3643r996b3664],
13	;	:	O	;	_	0	SENT_149	[p9l846t3643r996b3664],
14	other	JJ	O	other	amod	16	SENT_149	[p9l1005t3643r1058b3660],
15	ab	NN	O	ab	nn	16	SENT_149	[p9l1066t3643r1090b3660],
16	viations	NNS	O	viation	dep	1	SENT_149	[p9l1124t3643r1203b3660],
17	as	IN	O	as	prep	16	SENT_149	[p9l1211t3647r1234b3660],
18	in	IN	O	in	pcomp	17	SENT_149	[p9l1243t3643r1259b3660],
19	Table	NNP	O	Table	pobj	18	SENT_149	[p9l1267t3643r1323b3660],
20	1	CD	NUMBER	1	num	19	SENT_149	[p9l1331t3643r1349b3660],
21	.	.	O	.	_	0	SENT_149	[p9l1331t3643r1349b3660],

1	95	CD	PERCENT	95	number	2	SENT_150	[p10l12t63r166b129],
2	%	NN	PERCENT	%	amod	3	SENT_150	[p10l12t63r166b129],
3	CI	NN	O	ci	_	0	SENT_150	[p10l211t63r327b129],
4	:	:	O	:	_	0	SENT_150	[p10l211t63r327b129],
5	1.4	CD	NUMBER	1.4	number	7	SENT_150	[p10l378t66r485b129],
6	to	TO	O	to	dep	7	SENT_150	[p10l528t80r598b129],
7	3.6	CD	NUMBER	3.6	dep	3	SENT_150	[p10l643t66r775b144],
8	,	,	O	,	_	0	SENT_150	[p10l643t66r775b144],
9	p	NN	O	p	conj_and	3	SENT_150	[p10l820t89r862b152],
10	=	JJ	O	=	amod	9	SENT_150	[p10l914t89r967b109],
11	0.001	CD	NUMBER	0.001	tmod	10	SENT_150	[p10l1020t66r1218b129],
12	and	CC	O	and	_	0	SENT_150	[p10l1268t63r1398b129],
13	OR	NN	O	or	conj_and	3	SENT_150	[p10l1443t63r1594b129],
14	:	:	O	:	_	0	SENT_150	[p10l1443t63r1594b129],
15	1.7	CD	NUMBER	1.7	dep	3	SENT_150	[p10l1645t64r1774b144],
16	,	,	O	,	_	0	SENT_150	[p10l1645t64r1774b144],
17	95	CD	PERCENT	95	number	18	SENT_150	[p10l1822t63r1976b129],
18	%	NN	PERCENT	%	amod	19	SENT_150	[p10l1822t63r1976b129],
19	CI	NN	O	ci	appos	15	SENT_150	[p10l2021t63r2136b129],
20	:	:	O	:	_	0	SENT_150	[p10l2021t63r2136b129],
21	1.04	CD	NUMBER	1.04	dep	3	SENT_150	[p10l15t172r190b250],
22	,	,	O	,	_	0	SENT_150	[p10l15t172r190b250],
23	2.8	CD	NUMBER	2.8	appos	21	SENT_150	[p10l222t172r357b250],
24	,	,	O	,	_	0	SENT_150	[p10l222t172r357b250],
25	p	NN	O	p	appos	21	SENT_150	[p10l390t195r432b258],
26	=	JJ	O	=	amod	25	SENT_150	[p10l473t195r526b215],
27	0.03	CD	NUMBER	0.03	tmod	26	SENT_150	[p10l567t172r745b250],
28	,	,	O	,	_	0	SENT_150	[p10l567t172r745b250],
29	respectively	RB	O	respectively	advmod	30	SENT_150	[p10l779t167r1256b258],
30	)	CD	NUMBER	)	appos	21	SENT_150	[p10l779t167r1256b258],
31	.	.	O	.	_	0	SENT_150	[p10l779t167r1256b258],

1	When	WRB	O	when	advmod	3	SENT_151	[p10l1288t169r1520b236],
2	we	PRP	O	we	nsubj	3	SENT_151	[p10l1547t195r1647b235],
3	analyzed	VBD	O	analyze	advcl	12	SENT_151	[p10l1681t169r1996b258],
4	the	DT	O	the	det	6	SENT_151	[p10l2027t169r2140b235],
5	individual	JJ	O	individual	amod	6	SENT_151	[p10l10t276r379b342],
6	components	NNS	O	component	dobj	3	SENT_151	[p10l429t293r874b365],
7	of	IN	O	of	_	0	SENT_151	[p10l926t276r1008b342],
8	the	DT	O	the	det	9	SENT_151	[p10l1046t276r1159b342],
9	CAE	NNP	ORGANIZATION	CAE	prep_of	6	SENT_151	[p10l1212t275r1426b357],
10	,	,	O	,	_	0	SENT_151	[p10l1212t275r1426b357],
11	we	PRP	O	we	nsubj	12	SENT_151	[p10l1475t302r1575b342],
12	observed	VBD	O	observe	_	0	SENT_151	[p10l1627t276r1947b342],
13	that	IN	O	that	complm	21	SENT_151	[p10l1996t276r2142b342],
14	drug	NN	O	drug	nn	15	SENT_151	[p10l11t381r179b470],
15	discontinuation	NN	O	discontinuation	nsubj	21	SENT_151	[p10l213t381r789b447],
16	attributable	JJ	O	attributable	amod	15	SENT_151	[p10l825t381r1248b447],
17	to	TO	O	to	_	0	SENT_151	[p10l1284t398r1353b447],
18	a	DT	O	a	det	20	SENT_151	[p10l1390t407r1425b447],
19	side	JJ	O	side	amod	20	SENT_151	[p10l1459t381r1599b447],
20	effect	NN	O	effect	prep_to	16	SENT_151	[p10l1635t381r1829b447],
21	was	VBD	O	be	ccomp	12	SENT_151	[p10l1858t407r1990b447],
22	the	DT	O	the	det	24	SENT_151	[p10l2026t381r2140b447],
23	primary	JJ	O	primary	amod	24	SENT_151	[p10l9t491r300b577],
24	determinant	NN	O	determinant	npadvmod	28	SENT_151	[p10l334t488r786b554],
25	of	IN	O	of	_	0	SENT_151	[p10l823t488r904b554],
26	the	DT	O	the	det	27	SENT_151	[p10l929t488r1043b554],
27	associations	NNS	O	association	prep_of	24	SENT_151	[p10l1082t491r1514b554],
28	for	IN	O	for	dep	21	SENT_151	[p10l1552t488r1656b554],
29	SLCO1BZ	NN	O	slco1bz	pobj	28	SENT_151	[p10l1695t491r2145b555],
30	*	CD	NUMBER	*	number	31	SENT_151	[p10l1695t491r2145b555],
31	5	CD	NUMBER	5	amod	29	SENT_151	[p10l1695t491r2145b555],
32	and	CC	O	and	_	0	SENT_151	[p10l12t594r143b660],
33	female	JJ	O	female	amod	34	SENT_151	[p10l179t594r419b660],
34	sex	NN	O	sex	npadvmod	40	SENT_151	[p10l458t620r566b660],
35	with	IN	O	with	_	0	SENT_151	[p10l598t594r764b660],
36	the	DT	O	the	det	39	SENT_151	[p10l801t594r914b660],
37	CAE	NNP	O	CAE	nn	39	SENT_151	[p10l954t592r1144b660],
38	(	NN	O	(	nn	39	SENT_151	[p10l1185t592r1254b683],
39	p	NN	O	p	prep_with	34	SENT_151	[p10l1185t592r1254b683],
40	<	JJR	O	<	amod	29	SENT_151	[p10l1297t604r1356b655],
41	0.05	CD	NUMBER	0.05	npadvmod	42	SENT_151	[p10l1400t594r1554b660],
42	for	IN	O	for	dep	28	SENT_151	[p10l1593t594r1697b660],
43	both	CC	O	both	dep	28	SENT_151	[p10l1730t592r1950b674],
44	)	RB	O	)	conj	28	SENT_151	[p10l1730t592r1950b674],
45	.	.	O	.	_	0	SENT_151	[p10l1730t592r1950b674],

1	A	DT	O	a	det	3	SENT_152	[p10l97t697r164b764],
2	previous	JJ	O	previous	amod	3	SENT_152	[p10l200t702r492b788],
3	study	NN	O	study	nsubj	8	SENT_152	[p10l535t699r724b788],
4	(	CD	NUMBER	(	num	6	SENT_152	[p10l762t697r900b779],
5	12	CD	NUMBER	12	num	6	SENT_152	[p10l762t697r900b779],
6	)	NN	O	)	dep	3	SENT_152	[p10l762t697r900b779],
7	has	VBZ	O	have	aux	8	SENT_152	[p10l942t699r1055b765],
8	demonstrated	VBN	O	demonstrate	_	0	SENT_152	[p10l1096t699r1580b765],
9	that	IN	O	that	complm	11	SENT_152	[p10l1619t699r1760b765],
10	there	EX	O	there	expl	11	SENT_152	[p10l1797t699r1975b765],
11	is	VBZ	O	be	ccomp	8	SENT_152	[p10l2015t702r2065b765],
12	a	DT	O	a	det	15	SENT_152	[p10l2107t725r2141b765],
13	gene	NN	O	gene	nn	15	SENT_152	[p10l9t831r172b894],
14	dose	NN	O	dose	nn	15	SENT_152	[p10l207t805r361b871],
15	effect	NN	O	effect	nsubj	11	SENT_152	[p10l396t805r581b871],
16	with	IN	O	with	_	0	SENT_152	[p10l608t805r769b871],
17	the	DT	O	the	det	21	SENT_152	[p10l801t805r912b871],
18	SLCOJBZ	NNP	O	SLCOJBZ	nn	21	SENT_152	[p10l948t808r1304b872],
19	*	CD	NUMBER	*	num	21	SENT_152	[p10l1317t808r1383b871],
20	5	CD	NUMBER	5	amod	21	SENT_152	[p10l1317t808r1383b871],
21	allele	NN	O	allele	prep_with	15	SENT_152	[p10l1413t805r1589b871],
22	in	IN	O	in	_	0	SENT_152	[p10l1623t808r1690b870],
23	relationship	NN	O	relationship	prep_in	21	SENT_152	[p10l1722t805r2139b894],
24	to	TO	O	to	_	0	SENT_152	[p10l10t928r78b977],
25	statin	NN	O	statin	nn	27	SENT_152	[p10l112t914r305b977],
26	drug	NN	O	drug	nn	27	SENT_152	[p10l337t911r499b1000],
27	concentrations	NNS	O	concentration	prep_to	23	SENT_152	[p10l529t914r1064b977],
28	.	.	O	.	_	0	SENT_152	[p10l529t914r1064b977],

1	Therefore	RB	O	therefore	advmod	4	SENT_153	[p10l1097t909r1473b992],
2	,	,	O	,	_	0	SENT_153	[p10l1097t909r1473b992],
3	We	PRP	O	we	nsubj	4	SENT_153	[p10l1503t937r1602b977],
4	sought	VBD	O	seek	_	0	SENT_153	[p10l1635t911r1872b1000],
5	to	TO	O	to	aux	6	SENT_153	[p10l1901t928r1969b977],
6	ﬁnd	VB	O	ﬁnd	xcomp	4	SENT_153	[p10l2001t911r2141b977],
7	a	DT	O	a	det	9	SENT_153	[p10l12t1043r46b1083],
8	similar	JJ	O	similar	amod	9	SENT_153	[p10l78t1017r317b1083],
9	relationship	NN	O	relationship	dobj	6	SENT_153	[p10l347t1017r764b1106],
10	with	IN	O	with	_	0	SENT_153	[p10l794t1017r955b1083],
11	the	DT	O	the	det	12	SENT_153	[p10l988t1017r1098b1083],
12	CAE	NNP	O	CAE	prep_with	6	SENT_153	[p10l1133t1015r1339b1083],
13	.	.	O	.	_	0	SENT_153	[p10l1133t1015r1339b1083],

1	In	IN	O	in	_	0	SENT_154	[p10l1375t1018r1452b1082],
2	the	DT	O	the	det	4	SENT_154	[p10l1485t1017r1595b1083],
3	STRENGTH	NN	O	strength	nn	4	SENT_154	[p10l1631t1015r2138b1083],
4	study	NN	O	study	prep_in	7	SENT_154	[p10l12t1123r216b1212],
5	,	,	O	,	_	0	SENT_154	[p10l12t1123r216b1212],
6	we	PRP	O	we	nsubj	7	SENT_154	[p10l271t1149r370b1189],
7	found	VBD	O	find	_	0	SENT_154	[p10l426t1123r634b1189],
8	that	IN	O	that	complm	11	SENT_154	[p10l689t1123r830b1189],
9	there	EX	O	there	expl	11	SENT_154	[p10l884t1123r1062b1189],
10	indeed	RB	O	indeed	advmod	11	SENT_154	[p10l1119t1123r1355b1189],
11	was	VBD	O	be	ccomp	7	SENT_154	[p10l1407t1149r1536b1189],
12	evidence	NN	O	evidence	nsubj	11	SENT_154	[p10l1595t1123r1895b1189],
13	for	IN	O	for	_	0	SENT_154	[p10l1951t1123r2052b1189],
14	a	DT	O	a	det	18	SENT_154	[p10l2108t1149r2142b1189],
15	gene	NN	O	gene	nn	18	SENT_154	[p10l9t1229r368b1318],
16	—	NN	O	—	nn	18	SENT_154	[p10l9t1229r368b1318],
17	dose	NN	O	dose	nn	18	SENT_154	[p10l9t1229r368b1318],
18	effect	NN	O	effect	prep_for	12	SENT_154	[p10l421t1229r622b1295],
19	:	:	O	:	_	0	SENT_154	[p10l421t1229r622b1295],
20	the	DT	O	the	det	21	SENT_154	[p10l677t1229r787b1295],
21	proportion	NN	O	proportion	nsubj	27	SENT_154	[p10l837t1232r1219b1318],
22	of	IN	O	of	_	0	SENT_154	[p10l1270t1229r1350b1295],
23	individuals	NNS	O	individual	prep_of	21	SENT_154	[p10l1388t1229r1770b1295],
24	with	IN	O	with	_	0	SENT_154	[p10l1818t1229r1979b1295],
25	the	DT	O	the	det	26	SENT_154	[p10l2030t1229r2140b1295],
26	CAE	NNP	ORGANIZATION	CAE	prep_with	23	SENT_154	[p10l12t1333r199b1401],
27	increased	VBD	O	increase	parataxis	7	SENT_154	[p10l227t1335r553b1401],
28	with	IN	O	with	_	0	SENT_154	[p10l575t1335r737b1401],
29	increasing	VBG	O	increase	amod	30	SENT_154	[p10l762t1338r1120b1424],
30	numbers	NNS	O	number	prep_with	27	SENT_154	[p10l1145t1335r1448b1401],
31	of	IN	O	of	_	0	SENT_154	[p10l1476t1335r1556b1401],
32	the	DT	O	the	det	34	SENT_154	[p10l1569t1335r1680b1401],
33	SL	NNP	O	SL	nn	34	SENT_154	[p10l1709t1338r1803b1401],
34	COJBZ	NNP	O	COJBZ	prep_of	30	SENT_154	[p10l1814t1338r2067b1402],
35	*	CD	NUMBER	*	number	36	SENT_154	[p10l2078t1338r2145b1401],
36	5	CD	NUMBER	5	num	38	SENT_154	[p10l2078t1338r2145b1401],
37	risk	NN	O	risk	nn	38	SENT_154	[p10l10t1440r141b1505],
38	allele	NN	O	allele	dobj	27	SENT_154	[p10l180t1440r375b1505],
39	.	.	O	.	_	0	SENT_154	[p10l180t1440r375b1505],

1	For	IN	O	for	_	0	SENT_155	[p10l422t1441r547b1505],
2	noncarriers	NNS	O	noncarrier	prep_for	73	SENT_155	[p10l588t1443r979b1505],
3	(	CD	NUMBER	(	num	4	SENT_155	[p10l1025t1438r1096b1520],
4	n	NN	O	n	dep	2	SENT_155	[p10l1025t1438r1096b1520],
5	=	JJ	O	=	quantmod	6	SENT_155	[p10l1145t1465r1199b1486],
6	325	CD	NUMBER	325	num	7	SENT_155	[p10l1250t1438r1428b1520],
7	)	NN	O	)	dep	4	SENT_155	[p10l1250t1438r1428b1520],
8	,	,	O	,	_	0	SENT_155	[p10l1250t1438r1428b1520],
9	carriers	NNS	O	carrier	nsubj	73	SENT_155	[p10l1473t1443r1726b1505],
10	of	IN	O	of	_	0	SENT_155	[p10l1770t1440r1850b1505],
11	1	CD	NUMBER	1	num	14	SENT_155	[p10l1884t1443r1915b1505],
12	allele	NN	O	allele	nn	14	SENT_155	[p10l1964t1440r2140b1505],
13	(	NN	O	(	nn	14	SENT_155	[p10l13t1544r84b1626],
14	n	NN	O	n	prep_of	9	SENT_155	[p10l13t1544r84b1626],
15	=	JJ	O	=	amod	14	SENT_155	[p10l122t1572r176b1592],
16	115	CD	NUMBER	115	num	17	SENT_155	[p10l219t1544r394b1627],
17	)	NN	O	)	tmod	15	SENT_155	[p10l219t1544r394b1627],
18	,	,	O	,	_	0	SENT_155	[p10l219t1544r394b1627],
19	and	CC	O	and	_	0	SENT_155	[p10l429t1546r556b1612],
20	carriers	NNS	O	carrier	conj_and	17	SENT_155	[p10l587t1549r839b1612],
21	of	IN	O	of	_	0	SENT_155	[p10l872t1546r952b1612],
22	2	CD	NUMBER	2	num	23	SENT_155	[p10l968t1549r1009b1613],
23	alleles	NNS	O	allele	prep_of	14	SENT_155	[p10l1043t1546r1250b1612],
24	(	CD	NUMBER	(	num	25	SENT_155	[p10l1285t1544r1355b1626],
25	n	NN	O	n	npadvmod	26	SENT_155	[p10l1285t1544r1355b1626],
26	=	JJ	O	=	amod	23	SENT_155	[p10l1394t1572r1447b1592],
27	8	CD	NUMBER	8	number	28	SENT_155	[p10l1489t1544r1553b1626],
28	)	CD	NUMBER	)	num	30	SENT_155	[p10l1489t1544r1553b1626],
29	the	DT	O	the	det	30	SENT_155	[p10l1587t1546r1697b1612],
30	proportions	NNS	O	proportion	nsubj	36	SENT_155	[p10l1727t1549r2139b1635],
31	with	IN	O	with	_	0	SENT_155	[p10l7t1651r168b1717],
32	the	DT	O	the	det	33	SENT_155	[p10l215t1651r325b1716],
33	CAE	NNP	ORGANIZATION	CAE	prep_with	30	SENT_155	[p10l376t1649r563b1717],
34	were	VBD	O	be	cop	36	SENT_155	[p10l608t1676r774b1717],
35	0.19	CD	PERCENT	0.19	num	36	SENT_155	[p10l824t1654r973b1717],
36	(	CD	PERCENT	(	rcmod	14	SENT_155	[p10l1026t1649r1205b1731],
37	95	CD	PERCENT	95	number	38	SENT_155	[p10l1026t1649r1205b1731],
38	%	NN	PERCENT	%	amod	39	SENT_155	[p10l1026t1649r1205b1731],
39	CI	NN	O	ci	dep	36	SENT_155	[p10l1255t1651r1366b1717],
40	:	:	O	:	_	0	SENT_155	[p10l1255t1651r1366b1717],
41	0.15	CD	NUMBER	0.15	conj_and	36	SENT_155	[p10l1419t1651r1568b1717],
42	to	TO	O	to	_	0	SENT_155	[p10l1618t1668r1686b1716],
43	0.24	CD	NUMBER	0.24	num	44	SENT_155	[p10l1736t1649r1937b1731],
44	)	CD	NUMBER	)	prep_to	41	SENT_155	[p10l1736t1649r1937b1731],
45	,	,	O	,	_	0	SENT_155	[p10l1736t1649r1937b1731],
46	0.27	CD	PERCENT	0.27	num	47	SENT_155	[p10l1988t1652r2140b1717],
47	(	CD	PERCENT	(	conj_and	36	SENT_155	[p10l13t1755r192b1837],
48	95	CD	PERCENT	95	number	49	SENT_155	[p10l13t1755r192b1837],
49	%	NN	PERCENT	%	amod	50	SENT_155	[p10l13t1755r192b1837],
50	CI	NN	O	ci	dep	47	SENT_155	[p10l230t1757r342b1823],
51	:	:	O	:	_	0	SENT_155	[p10l230t1757r342b1823],
52	0.19	CD	NUMBER	0.19	conj_and	36	SENT_155	[p10l383t1760r533b1823],
53	to	TO	O	to	_	0	SENT_155	[p10l571t1774r639b1822],
54	0.36	CD	NUMBER	0.36	num	55	SENT_155	[p10l677t1755r878b1837],
55	)	CD	NUMBER	)	prep_to	52	SENT_155	[p10l677t1755r878b1837],
56	,	,	O	,	_	0	SENT_155	[p10l677t1755r878b1837],
57	and	CC	O	and	_	0	SENT_155	[p10l919t1757r1046b1822],
58	0.50	CD	PERCENT	0.50	num	62	SENT_155	[p10l1082t1757r1233b1823],
59	(	CD	PERCENT	(	number	60	SENT_155	[p10l1273t1755r1451b1837],
60	95	CD	PERCENT	95	dep	61	SENT_155	[p10l1273t1755r1451b1837],
61	%	NN	PERCENT	%	dep	62	SENT_155	[p10l1273t1755r1451b1837],
62	CI	NN	O	ci	conj_and	36	SENT_155	[p10l1489t1757r1602b1823],
63	:	:	O	:	_	0	SENT_155	[p10l1489t1757r1602b1823],
64	0.16	CD	NUMBER	0.16	dep	62	SENT_155	[p10l1642t1760r1792b1823],
65	to	TO	O	to	_	0	SENT_155	[p10l1831t1774r1898b1822],
66	0.84	CD	NUMBER	0.84	num	67	SENT_155	[p10l1936t1755r2137b1837],
67	)	CD	NUMBER	)	prep_to	64	SENT_155	[p10l1936t1755r2137b1837],
68	,	,	O	,	_	0	SENT_155	[p10l1936t1755r2137b1837],
69	respectively	RB	O	respectively	advmod	72	SENT_155	[p10l10t1863r421b1952],
70	(	CD	NUMBER	(	number	71	SENT_155	[p10l453t1861r742b1943],
71	1	CD	NUMBER	1	num	72	SENT_155	[p10l453t1861r742b1943],
72	—	NN	O	—	rcmod	64	SENT_155	[p10l453t1861r742b1943],
73	sided	VBD	O	side	_	0	SENT_155	[p10l453t1861r742b1943],
74	trend	NN	O	trend	nn	75	SENT_155	[p10l775t1863r962b1929],
75	p	NN	O	p	dobj	73	SENT_155	[p10l993t1889r1035b1952],
76	=	JJ	O	=	advmod	73	SENT_155	[p10l1078t1889r1131b1909],
77	0.01	CD	NUMBER	0.01	num	78	SENT_155	[p10l1174t1861r1373b1943],
78	)	NN	O	)	dep	76	SENT_155	[p10l1174t1861r1373b1943],
79	.	.	O	.	_	0	SENT_155	[p10l1174t1861r1373b1943],

1	Sequencing	NN	O	sequencing	nn	2	SENT_156	[p10l103t1969r510b2058],
2	SLCOZBJ	NN	O	slcozbj	nsubj	7	SENT_156	[p10l545t1972r902b2036],
3	in	IN	O	in	_	0	SENT_156	[p10l939t1972r1007b2034],
4	the	DT	O	the	det	6	SENT_156	[p10l1040t1969r1151b2035],
5	STRENGTH	NN	O	strength	nn	6	SENT_156	[p10l1190t1967r1697b2035],
6	study	NN	O	study	prep_in	2	SENT_156	[p10l1734t1969r1923b2058],
7	identiﬁed	VBD	O	identiﬁed	_	0	SENT_156	[p10l1953t1969r2137b2035, p10l10t2075r193b2141],
8	8	CD	NUMBER	8	num	10	SENT_156	[p10l251t2078r286b2141],
9	additional	JJ	O	additional	amod	10	SENT_156	[p10l347t2075r703b2141],
10	polymorphisms	NNS	O	polymorphism	dobj	7	SENT_156	[p10l757t2075r1302b2164],
11	with	IN	O	with	_	0	SENT_156	[p10l1357t2075r1519b2141],
12	MAF	NN	O	maf	prep_with	7	SENT_156	[p10l1574t2073r1781b2140],
13	>	JJR	O	>	amod	12	SENT_156	[p10l1840t2078r2016b2141],
14	1	CD	PERCENT	1	num	15	SENT_156	[p10l1840t2078r2016b2141],
15	%	NN	PERCENT	%	dep	13	SENT_156	[p10l1840t2078r2016b2141],
16	in	IN	O	in	_	0	SENT_156	[p10l2073t2078r2140b2140],
17	STRENGTH	NN	O	strength	nn	18	SENT_156	[p10l14t2180r521b2248],
18	Caucasians	NNS	MISC	caucasian	prep_in	7	SENT_156	[p10l573t2182r982b2248],
19	.	.	O	.	_	0	SENT_156	[p10l573t2182r982b2248],

1	When	WRB	O	when	_	0	SENT_157	[p10l1031t2182r1258b2248],
2	these	DT	O	these	det	4	SENT_157	[p10l1306t2182r1485b2247],
3	additional	JJ	O	additional	amod	4	SENT_157	[p10l1536t2182r1892b2247],
4	SNPS	NNS	O	snp	dep	1	SENT_157	[p10l1943t2182r2138b2248],

1	were	VBD	O	be	auxpass	2	SENT_158	[p10l7t2314r173b2354],
2	tested	VBN	O	test	ccomp	20	SENT_158	[p10l201t2288r409b2354],
3	individually	RB	O	individually	advmod	2	SENT_158	[p10l436t2288r853b2377],
4	for	IN	O	for	_	0	SENT_158	[p10l876t2288r977b2354],
5	their	PRP$	O	they	poss	6	SENT_158	[p10l1002t2288r1169b2354],
6	association	NN	O	association	prep_for	2	SENT_158	[p10l1195t2291r1578b2354],
7	with	IN	O	with	_	0	SENT_158	[p10l1601t2288r1763b2354],
8	the	DT	O	the	det	9	SENT_158	[p10l1790t2288r1900b2354],
9	CAE	NNP	ORGANIZATION	CAE	prep_with	2	SENT_158	[p10l1930t2286r2138b2369],
10	,	,	O	,	_	0	SENT_158	[p10l1930t2286r2138b2369],
11	1	CD	NUMBER	1	num	12	SENT_158	[p10l14t2397r46b2459],
12	SNP	NN	ORGANIZATION	snp	nsubj	20	SENT_158	[p10l90t2394r256b2460],
13	in	IN	O	in	_	0	SENT_158	[p10l291t2397r358b2459],
14	the	DT	O	the	det	16	SENT_158	[p10l393t2394r503b2460],
15	13th	JJ	ORDINAL	13th	amod	16	SENT_158	[p10l543t2394r701b2460],
16	intron	NN	O	intron	prep_in	12	SENT_158	[p10l735t2397r972b2475],
17	,	,	O	,	_	0	SENT_158	[p10l735t2397r972b2475],
18	rs4149080	NN	O	rs4149080	appos	16	SENT_158	[p10l1010t2397r1400b2475],
19	,	,	O	,	_	0	SENT_158	[p10l1010t2397r1400b2475],
20	provided	VBD	O	provide	_	0	SENT_158	[p10l1436t2394r1748b2483],
21	a	DT	O	a	det	23	SENT_158	[p10l1783t2420r1817b2460],
22	stronger	JJR	O	stronger	amod	23	SENT_158	[p10l1852t2411r2143b2483],
23	association	NN	O	association	nn	37	SENT_158	[p10l12t2503r394b2566],
24	with	IN	O	with	_	0	SENT_158	[p10l429t2500r591b2566],
25	the	DT	O	the	det	30	SENT_158	[p10l629t2500r739b2566],
26	CAE	NNP	O	CAE	nn	30	SENT_158	[p10l781t2498r968b2566],
27	(	CD	NUMBER	(	num	30	SENT_158	[p10l1011t2498r1405b2589],
28	chi	NN	O	chus	nn	30	SENT_158	[p10l1011t2498r1405b2589],
29	—	NN	O	—	nn	30	SENT_158	[p10l1011t2498r1405b2589],
30	square	NN	O	square	prep_with	23	SENT_158	[p10l1011t2498r1405b2589],
31	=	JJ	O	=	amod	23	SENT_158	[p10l1453t2526r1507b2546],
32	7.5	CD	NUMBER	7.5	tmod	31	SENT_158	[p10l1556t2500r1682b2581],
33	,	,	O	,	_	0	SENT_158	[p10l1556t2500r1682b2581],
34	p	NN	O	p	appos	23	SENT_158	[p10l1723t2526r1764b2589],
35	=	JJ	O	=	amod	37	SENT_158	[p10l1813t2526r1866b2546],
36	0.006	CD	NUMBER	0.006	tmod	35	SENT_158	[p10l1915t2498r2137b2580],
37	)	NN	O	)	dobj	20	SENT_158	[p10l1915t2498r2137b2580],
38	compared	VBN	O	compare	_	0	SENT_158	[p10l11t2606r358b2695],
39	with	IN	O	with	prepc_compared_with	20	SENT_158	[p10l384t2606r545b2672],
40	SLCO1BZ	NN	O	slco1bz	pobj	20	SENT_158	[p10l578t2609r1029b2687],
41	*	CD	NUMBER	*	number	42	SENT_158	[p10l578t2609r1029b2687],
42	5	CD	NUMBER	5	num	40	SENT_158	[p10l578t2609r1029b2687],
43	;	:	O	;	_	0	SENT_158	[p10l578t2609r1029b2687],
44	however	RB	O	however	advmod	47	SENT_158	[p10l1062t2606r1376b2687],
45	,	,	O	,	_	0	SENT_158	[p10l1062t2606r1376b2687],
46	there	EX	O	there	expl	47	SENT_158	[p10l1409t2606r1587b2672],
47	was	VBD	O	be	parataxis	20	SENT_158	[p10l1615t2632r1744b2672],
48	signiﬁcant	JJ	O	signiﬁcant	amod	50	SENT_158	[p10l1777t2606r2142b2695],
49	linkage	NN	O	linkage	nn	50	SENT_158	[p10l9t2712r263b2801],
50	disequilibrium	NN	O	disequilibrium	nn	62	SENT_158	[p10l293t2712r803b2801],
51	between	IN	O	between	_	0	SENT_158	[p10l830t2712r1124b2778],
52	rs4149080	NN	O	rs4149080	prep_between	50	SENT_158	[p10l1152t2715r1521b2778],
53	and	CC	O	and	_	0	SENT_158	[p10l1551t2712r1679b2778],
54	SLCOZB	NN	O	slcozb	nn	56	SENT_158	[p10l1709t2715r2066b2779],
55	]	CD	NUMBER	]	num	56	SENT_158	[p10l1709t2715r2066b2779],
56	*	NN	O	*	conj_and	50	SENT_158	[p10l2078t2715r2145b2778],
57	5	CD	NUMBER	5	number	58	SENT_158	[p10l2078t2715r2145b2778],
58	(	CD	NUMBER	(	num	59	SENT_158	[p10l13t2806r99b2898],
59	r2	NN	O	r2	dep	56	SENT_158	[p10l13t2806r99b2898],
60	=	JJ	O	=	amod	62	SENT_158	[p10l141t2844r195b2865],
61	0.85	CD	NUMBER	0.85	number	60	SENT_158	[p10l237t2816r415b2898],
62	)	NN	O	)	nsubj	47	SENT_158	[p10l237t2816r415b2898],
63	in	IN	O	in	_	0	SENT_158	[p10l452t2822r519b2883],
64	STRENGTH	NN	O	strength	nn	66	SENT_158	[p10l556t2816r1063b2884],
65	Caucasian	JJ	MISC	caucasian	amod	66	SENT_158	[p10l1100t2819r1459b2885],
66	subjects	NNS	O	subject	prep_in	47	SENT_158	[p10l1493t2819r1784b2907],
67	.	.	O	.	_	0	SENT_158	[p10l1493t2819r1784b2907],

1	Because	IN	O	because	_	0	SENT_159	[p10l100t2926r381b2991],
2	of	IN	O	of	prepc_because_of	10	SENT_159	[p10l411t2925r491b2991],
3	the	DT	O	the	det	6	SENT_159	[p10l507t2925r617b2991],
4	2-stage	JJ	O	2-stage	amod	6	SENT_159	[p10l645t2928r902b3014],
5	trial	NN	O	trial	nn	6	SENT_159	[p10l931t2925r1072b2991],
6	design	NN	O	design	pobj	10	SENT_159	[p10l1100t2925r1346b3014],
7	,	,	O	,	_	0	SENT_159	[p10l1100t2925r1346b3014],
8	we	PRP	O	we	nsubj	10	SENT_159	[p10l1373t2951r1472b2991],
9	also	RB	O	also	advmod	10	SENT_159	[p10l1503t2925r1633b2991],
10	examined	VBD	O	examine	_	0	SENT_159	[p10l1664t2925r2002b2991],
11	the	DT	O	the	det	12	SENT_159	[p10l2030t2925r2140b2991],
12	timing	NN	O	timing	dobj	10	SENT_159	[p10l10t3034r247b3120],
13	of	IN	O	of	_	0	SENT_159	[p10l283t3031r363b3097],
14	the	DT	O	the	det	15	SENT_159	[p10l388t3031r498b3097],
15	occurrence	NN	O	occurrence	prep_of	12	SENT_159	[p10l537t3057r914b3097],
16	of	IN	O	of	_	0	SENT_159	[p10l953t3031r1033b3097],
17	CAE	NN	ORGANIZATION	ca	prep_of	15	SENT_159	[p10l1060t3029r1247b3097],
18	with	IN	O	with	_	0	SENT_159	[p10l1282t3031r1444b3097],
19	respect	NN	O	respect	prep_with	10	SENT_159	[p10l1481t3048r1728b3120],
20	to	TO	O	to	_	0	SENT_159	[p10l1763t3048r1831b3097],
21	sex	NN	O	sex	nn	24	SENT_159	[p10l1871t3057r1976b3097],
22	and	CC	O	and	_	0	SENT_159	[p10l2014t3031r2141b3097],
23	SLCOZBJ	NN	O	slcozbj	nn	24	SENT_159	[p10l13t3140r370b3204],
24	genotype	NN	O	genotype	prep_to	10	SENT_159	[p10l423t3154r762b3226],
25	.	.	O	.	_	0	SENT_159	[p10l423t3154r762b3226],

1	Of	IN	O	of	_	0	SENT_160	[p10l819t3137r926b3203],
2	the	DT	O	the	det	4	SENT_160	[p10l964t3137r1075b3203],
3	99	CD	NUMBER	99	num	4	SENT_160	[p10l1128t3140r1209b3203],
4	subjects	NNS	O	subject	prep_of	18	SENT_160	[p10l1263t3137r1534b3226],
5	who	WP	O	who	nsubj	6	SENT_160	[p10l1583t3137r1735b3203],
6	developed	VBD	O	develop	rcmod	4	SENT_160	[p10l1788t3137r2141b3226],
7	CAE	NNP	ORGANIZATION	CAE	dobj	6	SENT_160	[p10l12t3241r220b3324],
8	,	,	O	,	_	0	SENT_160	[p10l12t3241r220b3324],
9	many	JJ	O	many	amod	11	SENT_160	[p10l252t3269r448b3332],
10	(	NN	O	(	nn	11	SENT_160	[p10l474t3241r545b3323],
11	n	NN	O	n	appos	7	SENT_160	[p10l474t3241r545b3323],
12	=	JJ	O	=	amod	11	SENT_160	[p10l581t3269r634b3289],
13	61	CD	NUMBER	61	tmod	12	SENT_160	[p10l672t3246r776b3324],
14	,	,	O	,	_	0	SENT_160	[p10l672t3246r776b3324],
15	62	CD	PERCENT	62	num	16	SENT_160	[p10l809t3241r985b3323],
16	%	NN	PERCENT	%	nsubj	18	SENT_160	[p10l809t3241r985b3323],
17	)	CD	NUMBER	)	dep	16	SENT_160	[p10l809t3241r985b3323],
18	developed	VBD	O	develop	_	0	SENT_160	[p10l1018t3243r1371b3332],
19	these	DT	O	these	dobj	18	SENT_160	[p10l1398t3243r1578b3309],
20	during	IN	O	during	_	0	SENT_160	[p10l1608t3243r1841b3332],
21	the	DT	O	the	det	22	SENT_160	[p10l1867t3243r1977b3309],
22	ﬁrst	NN	O	ﬁrst	prep_during	18	SENT_160	[p10l2006t3243r2143b3309],
23	8	CD	DURATION	8	num	24	SENT_160	[p10l13t3352r49b3415],
24	weeks	NNS	NUMBER	week	tmod	22	SENT_160	[p10l98t3349r309b3415],
25	of	IN	O	of	_	0	SENT_160	[p10l362t3349r442b3415],
26	the	DT	O	the	det	27	SENT_160	[p10l480t3349r591b3415],
27	trial	NN	O	trial	prep_of	22	SENT_160	[p10l641t3349r783b3415],
28	during	IN	O	during	_	0	SENT_160	[p10l833t3349r1066b3438],
29	the	DT	O	the	det	31	SENT_160	[p10l1115t3349r1225b3415],
30	low-dose	JJ	O	low-dose	amod	31	SENT_160	[p10l1275t3349r1596b3415],
31	phase	NN	O	phase	prep_during	18	SENT_160	[p10l1646t3349r1863b3438],
32	.	.	O	.	_	0	SENT_160	[p10l1646t3349r1863b3438],

1	When	WRB	O	when	advmod	23	SENT_161	[p10l1914t3349r2140b3416],
2	restricting	VBG	O	restrict	partmod	23	SENT_161	[p10l10t3458r370b3544],
3	the	DT	O	the	det	4	SENT_161	[p10l394t3455r504b3521],
4	analysis	NN	O	analysis	dobj	2	SENT_161	[p10l532t3455r797b3544],
5	of	IN	O	of	_	0	SENT_161	[p10l825t3455r905b3521],
6	the	DT	O	the	det	7	SENT_161	[p10l919t3455r1029b3521],
7	CAE	NNP	ORGANIZATION	CAE	prep_of	4	SENT_161	[p10l1057t3453r1244b3521],
8	to	TO	O	to	_	0	SENT_161	[p10l1271t3472r1339b3521],
9	the	DT	O	the	det	11	SENT_161	[p10l1366t3455r1476b3521],
10	low-dose	JJ	O	low-dose	amod	11	SENT_161	[p10l1501t3455r1822b3521],
11	phase	NN	O	phase	prep_to	2	SENT_161	[p10l1848t3455r2046b3544],
12	of	IN	O	of	_	0	SENT_161	[p10l2073t3455r2153b3521],
13	the	DT	O	the	det	14	SENT_161	[p10l10t3561r120b3627],
14	trial	NN	O	trial	prep_of	11	SENT_161	[p10l148t3561r307b3642],
15	,	,	O	,	_	0	SENT_161	[p10l148t3561r307b3642],
16	female	JJ	O	female	amod	17	SENT_161	[p10l337t3561r569b3627],
17	sex	NN	O	sex	nsubj	23	SENT_161	[p10l598t3587r703b3627],
18	and	CC	O	and	_	0	SENT_161	[p10l730t3561r857b3627],
19	SLCOZBZ	NN	O	slcozbz	conj_and	17	SENT_161	[p10l887t3564r1243b3628],
20	*	CD	NUMBER	*	number	21	SENT_161	[p10l1256t3564r1322b3627],
21	5	CD	NUMBER	5	num	22	SENT_161	[p10l1256t3564r1322b3627],
22	genotype	NN	O	genotype	dep	19	SENT_161	[p10l1344t3578r1664b3650],
23	continued	VBD	O	continue	_	0	SENT_161	[p10l1692t3561r2045b3627],
24	to	TO	O	to	aux	26	SENT_161	[p10l2072t3578r2139b3627],
25	be	VB	O	be	auxpass	26	SENT_161	[p10l9t3667r89b3733],
26	associated	VBN	O	associate	xcomp	23	SENT_161	[p10l135t3667r487b3733],
27	with	IN	O	with	_	0	SENT_161	[p10l527t3667r689b3733],
28	the	DT	O	the	det	31	SENT_161	[p10l732t3667r842b3733],
29	CAE	NNP	O	CAE	nn	31	SENT_161	[p10l889t3665r1076b3733],
30	(	NN	O	(	nn	31	SENT_161	[p10l1125t3665r1191b3756],
31	p	NN	O	p	prep_with	26	SENT_161	[p10l1125t3665r1191b3756],
32	=	JJ	O	=	amod	31	SENT_161	[p10l1245t3693r1299b3713],
33	0.009	CD	NUMBER	0.009	tmod	32	SENT_161	[p10l1352t3670r1546b3733],
34	and	CC	O	and	_	0	SENT_161	[p10l1594t3667r1721b3733],
35	p	NN	O	p	conj_and	31	SENT_161	[p10l1763t3693r1805b3756],
36	=	JJ	O	=	amod	35	SENT_161	[p10l1859t3693r1912b3713],
37	0.03	CD	NUMBER	0.03	tmod	36	SENT_161	[p10l1966t3670r2138b3748],
38	,	,	O	,	_	0	SENT_161	[p10l1966t3670r2138b3748],

1	respectively	RB	O	respectively	dep	2	SENT_162	[p11l10t15r465b106],
2	)	CD	NUMBER	)	_	0	SENT_162	[p11l10t15r465b106],
3	.	.	O	.	_	0	SENT_162	[p11l10t15r465b106],

1	Because	IN	O	because	mark	4	SENT_163	[p11l100t124r381b189],
2	of	IN	O	of	amod	3	SENT_163	[p11l440t123r520b189],
3	the	DT	O	the	nsubj	4	SENT_163	[p11l565t123r675b189],
4	randomized	VBN	O	randomize	advcl	10	SENT_163	[p11l734t123r1156b189],
5	drug	NN	O	drug	nn	6	SENT_163	[p11l1213t123r1376b212],
6	allocation	NN	O	allocation	dobj	4	SENT_163	[p11l1433t123r1794b204],
7	,	,	O	,	_	0	SENT_163	[p11l1433t123r1794b204],
8	we	PRP	O	we	nsubj	10	SENT_163	[p11l1851t149r1949b189],
9	also	RB	O	also	advmod	10	SENT_163	[p11l2009t123r2139b189],
10	observed	VBD	O	observe	_	0	SENT_163	[p11l11t229r320b295],
11	the	DT	O	the	det	12	SENT_163	[p11l365t229r475b295],
12	proportions	NNS	O	proportion	dobj	10	SENT_163	[p11l521t232r932b318],
13	with	IN	O	with	_	0	SENT_163	[p11l976t229r1138b295],
14	the	DT	O	the	det	15	SENT_163	[p11l1183t229r1294b295],
15	CAE	NN	ORGANIZATION	ca	prep_with	12	SENT_163	[p11l1342t227r1529b295],
16	with	IN	O	with	_	0	SENT_163	[p11l1574t229r1735b295],
17	respect	NN	O	respect	prep_with	15	SENT_163	[p11l1780t246r2027b318],
18	to	TO	O	to	_	0	SENT_163	[p11l2071t246r2139b295],
19	SL	NNP	ORGANIZATION	SL	nn	20	SENT_163	[p11l13t338r107b401],
20	Co	NNP	ORGANIZATION	Co	prep_to	10	SENT_163	[p11l118t338r271b402],
21	]	CD	NUMBER	]	num	22	SENT_163	[p11l118t338r271b402],
22	B1	NN	O	b1	tmod	10	SENT_163	[p11l277t339r371b400],
23	*	CD	NUMBER	*	number	24	SENT_163	[p11l382t338r449b401],
24	5	CD	NUMBER	5	num	26	SENT_163	[p11l382t338r449b401],
25	carrier	NN	O	carrier	nn	26	SENT_163	[p11l470t338r694b401],
26	status	NN	O	status	dep	22	SENT_163	[p11l718t352r914b401],
27	and	CC	O	and	_	0	SENT_163	[p11l941t335r1069b401],
28	sex	NN	O	sex	tmod	10	SENT_163	[p11l1094t361r1199b401],
29	stratiﬁed	JJ	O	stratiﬁed	amod	28	SENT_163	[p11l1223t335r1532b401],
30	by	IN	O	by	_	0	SENT_163	[p11l1553t335r1639b424],
31	assigned	VBN	O	assign	amod	33	SENT_163	[p11l1661t335r1956b424],
32	drug	NN	O	drug	nn	33	SENT_163	[p11l1980t335r2142b424],
33	treatment	NN	O	treatment	prep_by	29	SENT_163	[p11l11t458r357b507],
34	(	CD	NUMBER	(	num	35	SENT_163	[p11l392t439r553b530],
35	Fig	NN	O	fig	dep	22	SENT_163	[p11l392t439r553b530],
36	.	.	O	.	_	0	SENT_163	[p11l392t439r553b530],

1	1	CD	NUMBER	1	_	0	SENT_164	[p11l596t439r680b521],
2	)	NN	O	)	dep	1	SENT_164	[p11l596t439r680b521],
3	.	.	O	.	_	0	SENT_164	[p11l596t439r680b521],

1	Subjects	NNS	O	subject	nsubj	18	SENT_165	[p11l721t441r1008b530],
2	who	WP	O	who	nsubjpass	15	SENT_165	[p11l1039t441r1191b507],
3	carried	VBD	O	carry	rcmod	1	SENT_165	[p11l1227t441r1466b507],
4	at	IN	O	at	quantmod	6	SENT_165	[p11l1501t458r1564b507],
5	least	JJS	O	least	mwe	4	SENT_165	[p11l1595t441r1753b507],
6	1	CD	NUMBER	1	num	7	SENT_165	[p11l1789t444r1821b506],
7	allele	NN	O	allele	dobj	3	SENT_165	[p11l1862t441r2038b507],
8	of	IN	O	of	_	0	SENT_165	[p11l2073t441r2153b507],
9	SLCOJ	NNP	O	SLCOJ	nn	10	SENT_165	[p11l13t550r271b614],
10	B1	NN	O	b1	prep_of	7	SENT_165	[p11l277t551r371b612],
11	*	CD	NUMBER	*	number	12	SENT_165	[p11l382t550r449b613],
12	5	CD	NUMBER	5	num	10	SENT_165	[p11l382t550r449b613],
13	and	CC	O	and	_	0	SENT_165	[p11l476t547r603b613],
14	were	VBD	O	be	auxpass	15	SENT_165	[p11l629t573r795b613],
15	assigned	VBN	O	assign	rcmod	1	SENT_165	[p11l827t547r1122b636],
16	to	TO	O	to	_	0	SENT_165	[p11l1150t564r1218b613],
17	simvastatin	NN	O	simvastatin	prep_to	15	SENT_165	[p11l1251t550r1647b613],
18	had	VBD	O	have	_	0	SENT_165	[p11l1676t547r1806b613],
19	a	DT	O	a	det	21	SENT_165	[p11l1836t573r1870b613],
20	greater	JJR	O	greater	amod	21	SENT_165	[p11l1897t564r2142b636],
21	incidence	NN	O	incidence	dobj	18	SENT_165	[p11l11t653r344b719],
22	of	IN	O	of	_	0	SENT_165	[p11l384t653r464b719],
23	the	DT	O	the	det	24	SENT_165	[p11l491t653r601b719],
24	CAE	NNP	ORGANIZATION	CAE	prep_of	21	SENT_165	[p11l643t651r851b734],
25	,	,	O	,	_	0	SENT_165	[p11l643t651r851b734],
26	and	CC	O	and	_	0	SENT_165	[p11l894t653r1022b719],
27	those	DT	O	those	nsubj	31	SENT_165	[p11l1060t653r1246b719],
28	assigned	VBN	O	assign	partmod	27	SENT_165	[p11l1288t653r1583b742],
29	to	TO	O	to	_	0	SENT_165	[p11l1621t670r1689b719],
30	atorvastatin	NN	O	atorvastatin	prep_to	28	SENT_165	[p11l1731t656r2141b719],
31	showed	VBD	O	show	conj_and	18	SENT_165	[p11l12t759r277b825],
32	a	DT	O	a	det	34	SENT_165	[p11l309t785r343b825],
33	similar	JJ	O	similar	amod	34	SENT_165	[p11l374t759r612b825],
34	trend	NN	O	trend	dobj	31	SENT_165	[p11l641t759r829b825],
35	when	WRB	O	when	advmod	36	SENT_165	[p11l855t759r1049b825],
36	compared	VBN	O	compare	advcl	31	SENT_165	[p11l1081t759r1428b848],
37	with	IN	O	with	_	0	SENT_165	[p11l1455t759r1616b825],
38	those	DT	O	those	prep_with	36	SENT_165	[p11l1646t759r1832b825],
39	with	IN	O	with	_	0	SENT_165	[p11l1861t759r2022b825],
40	no	DT	O	no	det	41	SENT_165	[p11l2054t785r2139b825],
41	alleles	NNS	O	allele	prep_with	38	SENT_165	[p11l12t865r239b931],
42	.	.	O	.	_	0	SENT_165	[p11l12t865r239b931],

1	Interestingly	RB	O	interestingly	advmod	9	SENT_166	[p11l278t865r744b954],
2	,	,	O	,	_	0	SENT_166	[p11l278t865r744b954],
3	carriers	NNS	O	carrier	nsubj	9	SENT_166	[p11l783t868r1035b931],
4	of	IN	O	of	_	0	SENT_166	[p11l1073t865r1153b931],
5	SLCOJB	NNP	O	SLCOJB	prep_of	3	SENT_166	[p11l1178t868r1613b932],
6	]	CD	NUMBER	]	num	5	SENT_166	[p11l1178t868r1613b932],
7	*	CD	NUMBER	*	number	8	SENT_166	[p11l1178t868r1613b932],
8	5	CD	NUMBER	5	num	5	SENT_166	[p11l1178t868r1613b932],
9	had	VBD	O	have	_	0	SENT_166	[p11l1644t865r1773b931],
10	no	DT	O	no	det	12	SENT_166	[p11l1808t891r1894b931],
11	excess	JJ	O	excess	amod	12	SENT_166	[p11l1931t891r2139b931],
12	occurrence	NN	O	occurrence	dobj	9	SENT_166	[p11l11t997r389b1037],
13	of	IN	O	of	_	0	SENT_166	[p11l421t971r500b1037],
14	the	DT	O	the	det	15	SENT_166	[p11l518t971r629b1037],
15	CAE	NNP	ORGANIZATION	CAE	prep_of	12	SENT_166	[p11l662t969r849b1037],
16	if	IN	O	if	mark	19	SENT_166	[p11l880t971r940b1036],
17	they	PRP	O	they	nsubjpass	19	SENT_166	[p11l958t971r1111b1060],
18	were	VBD	O	be	auxpass	19	SENT_166	[p11l1134t997r1300b1037],
19	assigned	VBN	O	assign	advcl	9	SENT_166	[p11l1333t971r1628b1060],
20	to	TO	O	to	_	0	SENT_166	[p11l1657t988r1725b1037],
21	pravastatin	NN	O	pravastatin	prep_to	19	SENT_166	[p11l1756t974r2141b1060],
22	compared	VBN	O	compare	_	0	SENT_166	[p11l12t1077r358b1166],
23	with	IN	O	with	prepc_compared_with	19	SENT_166	[p11l395t1077r557b1143],
24	noncarriers	NNS	O	noncarrier	pobj	19	SENT_166	[p11l599t1080r1010b1143],
25	.	.	O	.	_	0	SENT_166	[p11l599t1080r1010b1143],

1	These	DT	O	these	det	2	SENT_167	[p11l1052t1075r1269b1143],
2	trends	NNS	O	trend	nsubj	3	SENT_167	[p11l1310t1077r1527b1143],
3	were	VBD	O	be	_	0	SENT_167	[p11l1566t1103r1733b1143],
4	not	RB	O	not	neg	3	SENT_167	[p11l1776t1094r1911b1158],
5	,	,	O	,	_	0	SENT_167	[p11l1776t1094r1911b1158],
6	however	RB	O	however	advmod	3	SENT_167	[p11l1955t1077r2138b1143, p11l12t1210r171b1265],
7	,	,	O	,	_	0	SENT_167	[p11l1955t1077r2138b1143, p11l12t1210r171b1265],
8	statistically	RB	O	statistically	advmod	9	SENT_167	[p11l209t1184r601b1273],
9	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_167	[p11l632t1184r997b1273],
10	(	NN	O	(	nn	11	SENT_167	[p11l1031t1182r1220b1273],
11	gene	NN	O	gene	dep	15	SENT_167	[p11l1031t1182r1220b1273],
12	>	JJR	O	>	npadvmod	13	SENT_167	[p11l1262t1194r1315b1246],
13	<	JJR	O	<	amod	11	SENT_167	[p11l1262t1194r1315b1246],
14	treatment	NN	O	treatment	nn	15	SENT_167	[p11l1358t1201r1704b1250],
15	interaction	NN	O	interaction	ccomp	3	SENT_167	[p11l1736t1187r2138b1265],
16	,	,	O	,	_	0	SENT_167	[p11l1736t1187r2138b1265],
17	p	NN	O	p	dep	20	SENT_167	[p11l10t1316r51b1379],
18	=	JJ	O	=	amod	20	SENT_167	[p11l93t1316r147b1336],
19	0.4	CD	NUMBER	0.4	num	20	SENT_167	[p11l188t1288r343b1370],
20	)	NN	O	)	ccomp	3	SENT_167	[p11l188t1288r343b1370],
21	.	.	O	.	_	0	SENT_167	[p11l188t1288r343b1370],

1	In	IN	O	in	_	0	SENT_168	[p11l380t1291r457b1355],
2	contrast	NN	O	contrast	prep_in	13	SENT_168	[p11l490t1307r790b1371],
3	,	,	O	,	_	0	SENT_168	[p11l490t1307r790b1371],
4	the	DT	O	the	det	5	SENT_168	[p11l825t1290r935b1356],
5	effect	NN	O	effect	nsubj	13	SENT_168	[p11l969t1290r1154b1356],
6	of	IN	O	of	_	0	SENT_168	[p11l1185t1290r1265b1356],
7	female	JJ	O	female	amod	8	SENT_168	[p11l1285t1290r1517b1356],
8	sex	NN	O	sex	prep_of	5	SENT_168	[p11l1551t1316r1656b1356],
9	on	IN	O	on	_	0	SENT_168	[p11l1688t1316r1775b1356],
10	the	DT	O	the	det	11	SENT_168	[p11l1807t1290r1917b1356],
11	CAE	NNP	O	CAE	prep_on	8	SENT_168	[p11l1952t1288r2139b1356],
12	appeared	VBD	O	appear	cop	13	SENT_168	[p11l12t1397r327b1486],
13	consistent	JJ	O	consistent	_	0	SENT_168	[p11l361t1400r715b1463],
14	across	IN	O	across	_	0	SENT_168	[p11l748t1423r953b1463],
15	all	DT	O	all	det	17	SENT_168	[p11l990t1397r1070b1463],
16	3	CD	NUMBER	3	num	17	SENT_168	[p11l1102t1400r1138b1463],
17	statins	NNS	O	statin	prep_across	13	SENT_168	[p11l1177t1400r1419b1463],
18	.	.	O	.	_	0	SENT_168	[p11l1177t1400r1419b1463],

1	Changes	NNS	O	change	nsubjpass	27	SENT_169	[p11l102t1503r406b1592],
2	in	IN	O	in	_	0	SENT_169	[p11l455t1506r522b1568],
3	low	JJ	O	low	amod	8	SENT_169	[p11l568t1503r987b1592],
4	—	NN	O	—	nn	8	SENT_169	[p11l568t1503r987b1592],
5	density	NN	O	density	nn	8	SENT_169	[p11l568t1503r987b1592],
6	lipoprotein	NN	O	lipoprotein	nn	8	SENT_169	[p11l1030t1503r1421b1592],
7	(	NN	O	(	nn	8	SENT_169	[p11l1471t1501r1709b1583],
8	LDL	NN	O	ldl	prep_in	1	SENT_169	[p11l1471t1501r1709b1583],
9	)	CD	NUMBER	)	num	10	SENT_169	[p11l1471t1501r1709b1583],
10	cholesterol	NN	O	cholesterol	dep	8	SENT_169	[p11l1761t1503r2142b1569],
11	and	CC	O	and	_	0	SENT_169	[p11l12t1609r139b1675],
12	CK	NN	O	ck	nn	13	SENT_169	[p11l170t1609r297b1675],
13	levels	NNS	O	level	dep	8	SENT_169	[p11l322t1609r510b1675],
14	during	IN	O	during	_	0	SENT_169	[p11l542t1609r775b1698],
15	the	DT	O	the	det	17	SENT_169	[p11l802t1609r912b1675],
16	low	JJ	O	low	amod	17	SENT_169	[p11l941t1609r1100b1675],
17	—	NN	O	—	prep_during	10	SENT_169	[p11l941t1609r1100b1675],
18	and	CC	O	and	_	0	SENT_169	[p11l1134t1609r1261b1675],
19	high	JJ	O	high	amod	22	SENT_169	[p11l1290t1609r1644b1698],
20	—	NN	O	—	nn	22	SENT_169	[p11l1290t1609r1644b1698],
21	dose	NN	O	dose	nn	22	SENT_169	[p11l1290t1609r1644b1698],
22	phases	NNS	O	phase	conj_and	8	SENT_169	[p11l1673t1609r1902b1698],
23	of	IN	O	of	_	0	SENT_169	[p11l1933t1609r2013b1675],
24	the	DT	O	the	det	25	SENT_169	[p11l2030t1609r2140b1675],
25	trial	NN	O	trial	prep_of	22	SENT_169	[p11l10t1715r152b1781],
26	were	VBD	O	be	auxpass	27	SENT_169	[p11l171t1741r338b1781],
27	measured	VBN	O	measure	_	0	SENT_169	[p11l364t1715r716b1781],
28	.	.	O	.	_	0	SENT_169	[p11l364t1715r716b1781],

1	We	PRP	O	we	nsubj	2	SENT_170	[p11l741t1716r872b1782],
2	found	VBD	O	find	_	0	SENT_170	[p11l897t1715r1105b1781],
3	that	IN	O	that	complm	11	SENT_170	[p11l1128t1715r1269b1781],
4	the	DT	O	the	det	6	SENT_170	[p11l1292t1715r1402b1781],
5	percent	NN	O	percent	nn	6	SENT_170	[p11l1426t1732r1689b1804],
6	reduction	NN	O	reduction	nsubj	11	SENT_170	[p11l1712t1715r2048b1781],
7	in	IN	O	in	_	0	SENT_170	[p11l2073t1718r2140b1780],
8	LDL	NN	O	ldl	nn	9	SENT_170	[p11l12t1821r197b1885],
9	cholesterol	NN	O	cholesterol	prep_in	6	SENT_170	[p11l230t1820r611b1885],
10	was	VBD	O	be	cop	11	SENT_170	[p11l638t1846r767b1886],
11	similar	JJ	O	similar	ccomp	2	SENT_170	[p11l802t1820r1040b1885],
12	for	IN	O	for	_	0	SENT_170	[p11l1070t1820r1171b1885],
13	carriers	NNS	O	carrier	prep_for	11	SENT_170	[p11l1201t1823r1454b1885],
14	and	CC	O	and	_	0	SENT_170	[p11l1489t1820r1616b1885],
15	noncarriers	NNS	O	noncarrier	conj_and	13	SENT_170	[p11l1648t1823r2039b1885],
16	of	IN	O	of	prep	11	SENT_170	[p11l2074t1820r2153b1885],

1	SLCOJB1	NN	O	slcojb1	_	0	SENT_171	[p11l13t1929r449b1993],
2	*	CD	NUMBER	*	number	3	SENT_171	[p11l13t1929r449b1993],
3	5	CD	NUMBER	5	dep	1	SENT_171	[p11l13t1929r449b1993],
4	at	IN	O	at	_	0	SENT_171	[p11l478t1943r542b1992],
5	both	CC	O	both	preconj	7	SENT_171	[p11l570t1926r734b1992],
6	low	JJ	O	low	amod	7	SENT_171	[p11l764t1926r923b1992],
7	—	NN	O	—	prep_at	3	SENT_171	[p11l764t1926r923b1992],
8	and	CC	O	and	_	0	SENT_171	[p11l959t1926r1087b1992],
9	high	JJ	O	high	amod	12	SENT_171	[p11l1118t1926r1473b2015],
10	—	NN	O	—	nn	12	SENT_171	[p11l1118t1926r1473b2015],
11	dose	NN	O	dose	nn	12	SENT_171	[p11l1118t1926r1473b2015],
12	treatment	NN	O	treatment	conj_and	7	SENT_171	[p11l1505t1943r1851b1992],
13	(	CD	NUMBER	(	num	15	SENT_171	[p11l1885t1924r2138b2006, p11l12t2032r303b2121],
14	statinadjusted	JJ	O	statinadjusted	amod	15	SENT_171	[p11l1885t1924r2138b2006, p11l12t2032r303b2121],
15	percent	NN	O	percent	dep	1	SENT_171	[p11l360t2049r623b2121],
16	LDL	NN	O	ldl	nn	17	SENT_171	[p11l680t2033r866b2097],
17	reduction	NN	O	reduction	dep	15	SENT_171	[p11l924t2032r1260b2098],
18	:	:	O	:	_	0	SENT_171	[p11l1327t2041r1380b2094],
19	SE	NN	O	se	dep	15	SENT_171	[p11l1451t2032r1553b2098],
20	in	IN	O	in	_	0	SENT_171	[p11l1612t2035r1680b2097],
21	carriers	NNS	O	carrier	prep_in	19	SENT_171	[p11l1739t2035r1991b2098],
22	vs.	CC	O	vs.	prep	21	SENT_171	[p11l2048t2058r2136b2098],
23	noncarriers	NNS	O	noncarrier	dep	22	SENT_171	[p11l12t2141r403b2204],
24	at	IN	O	at	_	0	SENT_171	[p11l431t2155r494b2204],
25	low	JJ	O	low	amod	28	SENT_171	[p11l516t2138r645b2204],
26	and	CC	O	and	_	0	SENT_171	[p11l668t2138r795b2204],
27	high	JJ	O	high	conj_and	25	SENT_171	[p11l819t2138r979b2227],
28	dose	NN	O	dose	prep_at	23	SENT_171	[p11l1004t2138r1178b2204],
29	:	:	O	:	_	0	SENT_171	[p11l1004t2138r1178b2204],
30	-31	CD	NUMBER	-31	dep	15	SENT_171	[p11l1216t2141r1362b2204],
31	i	FW	O	i	dep	30	SENT_171	[p11l1400t2147r1453b2200],
32	1	CD	NUMBER	1	dep	1	SENT_171	[p11l1491t2141r1523b2203],
33	vs.	CC	O	vs.	prep	32	SENT_171	[p11l1549t2164r1638b2204],
34	-32	CD	NUMBER	-32	dep	33	SENT_171	[p11l1675t2141r1825b2205],
35	:	:	O	:	_	0	SENT_171	[p11l1859t2147r1913b2200],
36	1	CD	NUMBER	1	dep	32	SENT_171	[p11l1951t2141r1983b2203],
37	and	CC	O	and	_	0	SENT_171	[p11l2014t2138r2141b2204],
38	-41	CD	NUMBER	-41	dep	32	SENT_171	[p11l19t2247r165b2309],
39	i	FW	O	i	dep	36	SENT_171	[p11l220t2253r273b2306],
40	1	CD	NUMBER	1	dep	1	SENT_171	[p11l328t2247r360b2309],
41	vs.	CC	O	vs.	prep	40	SENT_171	[p11l404t2270r491b2310],
42	-41	CD	NUMBER	-41	num	44	SENT_171	[p11l546t2247r692b2309],
43	:	:	O	:	_	0	SENT_171	[p11l747t2253r801b2306],
44	1	CD	NUMBER	1	dep	41	SENT_171	[p11l856t2247r912b2325],
45	,	,	O	,	_	0	SENT_171	[p11l856t2247r912b2325],
46	p	NN	O	p	appos	44	SENT_171	[p11l956t2270r997b2333],
47	>	JJR	O	>	amod	48	SENT_171	[p11l1046t2254r1106b2305],
48	0.5	CD	NUMBER	0.5	dep	1	SENT_171	[p11l1154t2244r1258b2310],
49	for	IN	O	for	prep	48	SENT_171	[p11l1303t2244r1403b2310],
50	both	CC	O	both	dep	48	SENT_171	[p11l1441t2244r1606b2310],
51	comparisons	NNS	O	comparison	conj	48	SENT_171	[p11l1648t2242r2136b2333],
52	)	CD	NUMBER	)	num	51	SENT_171	[p11l1648t2242r2136b2333],
53	.	.	O	.	_	0	SENT_171	[p11l1648t2242r2136b2333],

1	Analysis	NN	O	analysis	nsubj	5	SENT_172	[p11l8t2348r305b2439],
2	of	IN	O	of	_	0	SENT_172	[p11l336t2350r416b2416],
3	CK	NN	O	ck	nn	4	SENT_172	[p11l434t2350r561b2416],
4	levels	NNS	O	level	prep_of	1	SENT_172	[p11l585t2350r773b2416],
5	revealed	VBD	O	reveal	_	0	SENT_172	[p11l802t2350r1089b2416],
6	that	IN	O	that	complm	8	SENT_172	[p11l1117t2350r1257b2416],
7	there	EX	O	there	expl	8	SENT_172	[p11l1284t2350r1462b2416],
8	was	VBD	O	be	ccomp	5	SENT_172	[p11l1488t2376r1617b2416],
9	an	DT	O	a	det	10	SENT_172	[p11l1648t2376r1729b2416],
10	association	NN	O	association	nsubj	8	SENT_172	[p11l1758t2353r2141b2416],
11	between	IN	O	between	_	0	SENT_172	[p11l8t2456r302b2522],
12	statin	NN	O	statin	nn	13	SENT_172	[p11l362t2459r554b2522],
13	dose	NN	O	dose	prep_between	10	SENT_172	[p11l614t2456r768b2522],
14	and	CC	O	and	_	0	SENT_172	[p11l829t2456r956b2522],
15	marginally	RB	O	marginally	advmod	16	SENT_172	[p11l1015t2456r1391b2545],
16	greater	JJR	O	greater	amod	18	SENT_172	[p11l1444t2473r1689b2545],
17	CK	NN	O	ck	nn	18	SENT_172	[p11l1747t2456r1874b2522],
18	levels	NNS	O	level	prep_between	10	SENT_172	[p11l1929t2456r2136b2522],
19	:	:	O	:	_	0	SENT_172	[p11l1929t2456r2136b2522],
20	average	JJ	O	average	amod	21	SENT_172	[p11l12t2588r270b2651],
21	CK	NN	O	ck	dep	10	SENT_172	[p11l330t2562r457b2628],
22	(	CD	NUMBER	(	num	24	SENT_172	[p11l515t2560r778b2651],
23	mg/dl	NN	O	mg/dl	nn	24	SENT_172	[p11l515t2560r778b2651],
24	)	NN	O	)	dep	21	SENT_172	[p11l515t2560r778b2651],
25	at	IN	O	at	_	0	SENT_172	[p11l842t2579r904b2628],
26	baseline	NN	O	baseline	prep_at	24	SENT_172	[p11l958t2562r1261b2643],
27	,	,	O	,	_	0	SENT_172	[p11l958t2562r1261b2643],
28	during	IN	O	during	_	0	SENT_172	[p11l1322t2562r1556b2651],
29	low-dose	JJ	O	low-dose	prep_during	24	SENT_172	[p11l1610t2562r1952b2643],
30	,	,	O	,	_	0	SENT_172	[p11l1610t2562r1952b2643],
31	and	CC	O	and	_	0	SENT_172	[p11l2014t2562r2141b2628],
32	during	IN	O	during	_	0	SENT_172	[p11l11t2668r244b2757],
33	high	JJ	O	high	amod	35	SENT_172	[p11l275t2668r434b2757],
34	dose	NN	O	dose	nn	35	SENT_172	[p11l467t2668r622b2734],
35	phases	NNS	O	phase	prep_during	24	SENT_172	[p11l653t2668r902b2757],
36	:	:	O	:	_	0	SENT_172	[p11l653t2668r902b2757],
37	121	CD	NUMBER	121	num	39	SENT_172	[p11l943t2671r1063b2735],
38	:	:	O	:	_	0	SENT_172	[p11l1109t2677r1162b2730],
39	81	CD	NUMBER	81	dep	10	SENT_172	[p11l1206t2671r1308b2749],
40	,	,	O	,	_	0	SENT_172	[p11l1206t2671r1308b2749],
41	123	CD	NUMBER	123	num	43	SENT_172	[p11l1347t2671r1469b2735],
42	:	:	O	:	_	0	SENT_172	[p11l1513t2677r1567b2730],
43	90	CD	NUMBER	90	dep	10	SENT_172	[p11l1609t2671r1713b2749],
44	,	,	O	,	_	0	SENT_172	[p11l1609t2671r1713b2749],
45	and	CC	NUMBER	and	_	0	SENT_172	[p11l1750t2668r1877b2734],
46	126	CD	NUMBER	126	num	48	SENT_172	[p11l1912t2671r2036b2735],
47	:	:	O	:	_	0	SENT_172	[p11l2078t2677r2131b2730],
48	82	CD	NUMBER	82	dep	10	SENT_172	[p11l13t2777r116b2855],
49	,	,	O	,	_	0	SENT_172	[p11l13t2777r116b2855],
50	repeated	VBN	O	repeat	partmod	10	SENT_172	[p11l154t2774r453b2863],
51	measures	NNS	O	measure	nn	52	SENT_172	[p11l489t2800r807b2840],
52	analysis	NN	O	analysis	dobj	50	SENT_172	[p11l845t2774r1110b2863],
53	of	IN	O	of	_	0	SENT_172	[p11l1148t2774r1228b2840],
54	variance	NN	O	variance	prep_of	52	SENT_172	[p11l1248t2777r1558b2855],
55	,	,	O	,	_	0	SENT_172	[p11l1248t2777r1558b2855],
56	p	NN	O	p	appos	54	SENT_172	[p11l1595t2800r1637b2863],
57	=	JJ	O	=	amod	59	SENT_172	[p11l1682t2800r1735b2820],
58	0.004	CD	NUMBER	0.004	tmod	57	SENT_172	[p11l1780t2772r2024b2854],
59	)	NN	O	)	dep	56	SENT_172	[p11l1780t2772r2024b2854],
60	.	.	O	.	_	0	SENT_172	[p11l1780t2772r2024b2854],

1	In	IN	O	in	dep	11	SENT_173	[p11l2063t2775r2141b2839],
2	the	DT	O	the	det	5	SENT_173	[p11l10t2879r120b2944],
3	entire	JJ	O	entire	amod	5	SENT_173	[p11l183t2882r383b2944],
4	STRENGTH	NN	O	strength	nn	5	SENT_173	[p11l448t2877r955b2945],
5	cohort	NN	O	cohort	pobj	1	SENT_173	[p11l1018t2879r1265b2959],
6	,	,	O	,	_	0	SENT_173	[p11l1018t2879r1265b2959],
7	however	RB	O	however	advmod	5	SENT_173	[p11l1328t2879r1642b2959],
8	,	,	O	,	_	0	SENT_173	[p11l1328t2879r1642b2959],
9	SLCO1B1	NN	O	slco1b1	appos	5	SENT_173	[p11l1709t2882r2145b2945],
10	*	CD	NUMBER	*	num	11	SENT_173	[p11l1709t2882r2145b2945],
11	5	CD	NUMBER	5	_	0	SENT_173	[p11l1709t2882r2145b2945],

1	genotype	NN	O	genotype	nsubjpass	4	SENT_174	[p11l9t3002r329b3074],
2	was	VBD	O	be	auxpass	4	SENT_174	[p11l362t3011r491b3051],
3	not	RB	O	not	neg	4	SENT_174	[p11l529t3002r646b3051],
4	associated	VBN	O	associate	dep	20	SENT_174	[p11l682t2985r1033b3051],
5	with	IN	O	with	_	0	SENT_174	[p11l1065t2985r1226b3051],
6	CK	NN	O	ck	nn	7	SENT_174	[p11l1263t2985r1390b3051],
7	levels	NNS	O	level	prep_with	4	SENT_174	[p11l1421t2985r1609b3051],
8	alone	RB	O	alone	advmod	4	SENT_174	[p11l1648t2985r1852b3066],
9	,	,	O	,	_	0	SENT_174	[p11l1648t2985r1852b3066],
10	neither	CC	O	neither	dep	4	SENT_174	[p11l1892t2985r2143b3051],
11	during	IN	O	during	conj	4	SENT_174	[p11l11t3091r244b3180],
12	the	DT	O	the	det	14	SENT_174	[p11l276t3091r386b3157],
13	low	JJ	O	low	amod	14	SENT_174	[p11l418t3091r577b3157],
14	—	NN	O	—	pobj	11	SENT_174	[p11l418t3091r577b3157],
15	nor	CC	O	nor	_	0	SENT_174	[p11l614t3117r733b3157],
16	high	JJ	O	high	amod	19	SENT_174	[p11l764t3091r1119b3180],
17	—	NN	O	—	nn	19	SENT_174	[p11l764t3091r1119b3180],
18	dose	NN	O	dose	nn	19	SENT_174	[p11l764t3091r1119b3180],
19	phases	NNS	O	phase	conj_nor	14	SENT_174	[p11l1151t3091r1380b3180],
20	(	VBP	O	(	_	0	SENT_174	[p11l1418t3089r1485b3180],
21	p	NN	O	p	dep	22	SENT_174	[p11l1418t3089r1485b3180],
22	>	JJR	O	>	dobj	20	SENT_174	[p11l1525t3101r1585b3152],
23	0.5	CD	NUMBER	0.5	num	24	SENT_174	[p11l1624t3089r1779b3171],
24	)	NN	O	)	nsubj	20	SENT_174	[p11l1624t3089r1779b3171],
25	.	.	O	.	_	0	SENT_174	[p11l1624t3089r1779b3171],

1	In	IN	O	in	_	0	SENT_175	[p11l99t3198r176b3262],
2	exploratory	NN	O	exploratory	nn	3	SENT_175	[p11l214t3197r613b3286],
3	analyses	NNS	O	analysis	prep_in	22	SENT_175	[p11l647t3197r927b3286],
4	to	TO	O	to	aux	5	SENT_175	[p11l965t3214r1033b3263],
5	understand	VB	O	understand	infmod	3	SENT_175	[p11l1070t3197r1467b3263],
6	the	DT	O	the	det	10	SENT_175	[p11l1503t3197r1613b3263],
7	statin	NN	O	statin	nn	10	SENT_175	[p11l1652t3197r2142b3286],
8	—	NN	O	—	nn	10	SENT_175	[p11l1652t3197r2142b3286],
9	speciﬁc	NN	O	speciﬁc	nn	10	SENT_175	[p11l1652t3197r2142b3286],
10	associations	NNS	O	association	dep	16	SENT_175	[p11l12t3305r424b3367],
11	of	IN	O	of	_	0	SENT_175	[p11l470t3302r549b3367],
12	SLCO	NNP	O	SLCO	prep_of	10	SENT_175	[p11l583t3305r1018b3368],
13	]	CD	NUMBER	]	num	12	SENT_175	[p11l583t3305r1018b3368],
14	BJ	NNP	O	BJ	dep	16	SENT_175	[p11l583t3305r1018b3368],
15	*	CD	NUMBER	*	number	16	SENT_175	[p11l583t3305r1018b3368],
16	5	CD	NUMBER	5	dep	5	SENT_175	[p11l583t3305r1018b3368],
17	with	IN	O	with	_	0	SENT_175	[p11l1054t3302r1215b3368],
18	the	DT	O	the	det	19	SENT_175	[p11l1258t3302r1367b3367],
19	CAB	NN	O	cab	prep_with	16	SENT_175	[p11l1414t3300r1621b3382],
20	,	,	O	,	_	0	SENT_175	[p11l1414t3300r1621b3382],
21	we	PRP	O	we	nsubj	22	SENT_175	[p11l1663t3328r1762b3368],
22	measured	VBD	O	measure	dep	34	SENT_175	[p11l1806t3302r2141b3367],
23	simvastatin	NN	O	simvastatin	nn	26	SENT_175	[p12l12t23r408b86],
24	and	CC	O	and	_	0	SENT_175	[p12l440t20r567b86],
25	pravastatin	NN	O	pravastatin	nn	26	SENT_175	[p12l595t23r981b109],
26	acid	NN	O	acid	dobj	22	SENT_175	[p12l1013t20r1153b86],
27	and	CC	O	and	_	0	SENT_175	[p12l1184t20r1311b86],
28	lactone	NN	O	lactone	nn	29	SENT_175	[p12l1339t20r1592b86],
29	concentrations	NNS	O	concentration	dobj	22	SENT_175	[p12l1624t23r2139b86],
30	from	IN	O	from	_	0	SENT_175	[p12l10t126r180b192],
31	stored	VBN	O	store	amod	33	SENT_175	[p12l217t126r432b192],
32	plasma	NN	O	plasma	nn	33	SENT_175	[p12l464t126r711b215],
33	samples	NNS	O	sample	prep_from	22	SENT_175	[p12l746t126r1018b215],
34	(	VBP	O	(	_	0	SENT_175	[p12l1057t124r1286b206],
35	Table	NNP	O	Table	dobj	34	SENT_175	[p12l1057t124r1286b206],
36	3	CD	NUMBER	3	num	37	SENT_175	[p12l1322t124r1409b206],
37	)	NN	O	)	nsubj	34	SENT_175	[p12l1322t124r1409b206],
38	.	.	O	.	_	0	SENT_175	[p12l1322t124r1409b206],

1	Statin	NN	O	statin	nn	3	SENT_176	[p12l1452t126r1659b192],
2	lactone	NN	O	lactone	nn	3	SENT_176	[p12l1693t126r1945b192],
3	concentrations	NNS	O	concentration	nsubj	8	SENT_176	[p12l1981t152r2138b192, p12l11t235r399b298],
4	in	IN	O	in	_	0	SENT_176	[p12l449t235r516b297],
5	the	DT	O	the	det	7	SENT_176	[p12l565t232r675b298],
6	STRENGTH	NN	O	strength	nn	7	SENT_176	[p12l728t230r1235b298],
7	study	NN	O	study	prep_in	3	SENT_176	[p12l1286t232r1475b321],
8	demonstrated	VBD	O	demonstrate	_	0	SENT_176	[p12l1520t232r2005b298],
9	no	DT	O	no	det	11	SENT_176	[p12l2054t258r2139b298],
10	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_176	[p12l12t338r377b427],
11	differences	NNS	O	difference	nsubj	28	SENT_176	[p12l415t338r786b404],
12	by	IN	O	by	_	0	SENT_176	[p12l825t338r911b427],
13	SLCO	NN	ORGANIZATION	slco	nn	15	SENT_176	[p12l950t341r1385b405],
14	]	CD	NUMBER	]	num	15	SENT_176	[p12l950t341r1385b405],
15	B1	NN	O	b1	prep_by	11	SENT_176	[p12l950t341r1385b405],
16	*	CD	NUMBER	*	num	15	SENT_176	[p12l950t341r1385b405],
17	5	CD	NUMBER	5	num	18	SENT_176	[p12l950t341r1385b405],
18	genotype	NN	O	genotype	npadvmod	11	SENT_176	[p12l1419t355r1739b427],
19	for	IN	O	for	_	0	SENT_176	[p12l1779t338r1880b404],
20	pravastatin	NN	O	pravastatin	prep_for	18	SENT_176	[p12l1917t364r2138b427, p12l12t447r204b510],
21	or	CC	O	or	_	0	SENT_176	[p12l241t470r313b510],
22	simvastatin	NN	O	simvastatin	conj_or	20	SENT_176	[p12l349t447r745b510],
23	at	IN	O	at	_	0	SENT_176	[p12l782t461r846b510],
24	low	JJ	O	low	amod	27	SENT_176	[p12l878t444r1008b510],
25	or	CC	O	or	_	0	SENT_176	[p12l1041t470r1113b510],
26	high	JJ	O	high	amod	27	SENT_176	[p12l1148t444r1307b533],
27	doses	NNS	O	dose	prep_at	11	SENT_176	[p12l1344t444r1529b510],
28	(	VBP	O	(	ccomp	8	SENT_176	[p12l1570t442r1637b533],
29	p	NN	O	p	npadvmod	30	SENT_176	[p12l1570t442r1637b533],
30	>	JJR	O	>	acomp	28	SENT_176	[p12l1680t454r1740b505],
31	0.3	CD	NUMBER	0.3	tmod	30	SENT_176	[p12l1782t447r1886b510],
32	for	IN	O	for	mark	35	SENT_176	[p12l1926t444r2026b510],
33	all	DT	O	all	det	34	SENT_176	[p12l2062t444r2142b510],
34	comparisons	NNS	O	comparison	nsubj	35	SENT_176	[p12l11t548r500b639],
35	)	VBP	O	)	ccomp	30	SENT_176	[p12l11t548r500b639],
36	.	.	O	.	_	0	SENT_176	[p12l11t548r500b639],

1	In	IN	O	in	_	0	SENT_177	[p12l536t551r613b615],
2	contrast	NN	O	contrast	prep_in	11	SENT_177	[p12l646t567r946b631],
3	,	,	O	,	_	0	SENT_177	[p12l646t567r946b631],
4	the	DT	O	the	det	5	SENT_177	[p12l981t550r1091b616],
5	concentration	NN	O	concentration	nsubjpass	11	SENT_177	[p12l1125t553r1611b616],
6	of	IN	O	of	_	0	SENT_177	[p12l1644t550r1723b616],
7	simvastatin	NN	O	simvastatin	nn	8	SENT_177	[p12l1745t553r2141b616],
8	acid	NN	O	acid	prep_of	5	SENT_177	[p12l12t656r152b722],
9	was	VBD	O	be	auxpass	11	SENT_177	[p12l183t682r312b722],
10	positively	RB	O	positively	advmod	11	SENT_177	[p12l347t656r684b745],
11	correlated	VBN	O	correlate	_	0	SENT_177	[p12l716t656r1065b722],
12	with	IN	O	with	_	0	SENT_177	[p12l1096t656r1257b722],
13	SLCO1B	NN	O	slco1b	prep_with	11	SENT_177	[p12l1294t659r1730b723],
14	]	CD	NUMBER	]	num	13	SENT_177	[p12l1294t659r1730b723],
15	*	CD	NUMBER	*	number	16	SENT_177	[p12l1294t659r1730b723],
16	5	CD	NUMBER	5	dep	13	SENT_177	[p12l1294t659r1730b723],
17	both	DT	O	both	dep	16	SENT_177	[p12l1758t656r1923b722],
18	at	IN	O	at	dep	22	SENT_177	[p12l1959t673r2022b722],
19	20	CD	NUMBER	20	number	20	SENT_177	[p12l2053t659r2139b723],
20	(	CD	NUMBER	(	num	21	SENT_177	[p12l13t760r81b851],
21	p	NN	O	p	pobj	22	SENT_177	[p12l13t760r81b851],
22	=	JJ	O	=	advmod	16	SENT_177	[p12l121t788r174b808],
23	0.006	CD	NUMBER	0.006	num	24	SENT_177	[p12l214t760r436b842],
24	)	NN	O	)	dep	22	SENT_177	[p12l214t760r436b842],
25	and	CC	O	and	_	0	SENT_177	[p12l472t762r599b828],
26	80	CD	NUMBER	80	num	29	SENT_177	[p12l632t765r713b828],
27	mg	NN	O	mg	nn	29	SENT_177	[p12l746t788r858b851],
28	(	NN	O	(	nn	29	SENT_177	[p12l890t760r957b851],
29	p	NN	O	p	conj_and	13	SENT_177	[p12l890t760r957b851],
30	=	JJ	O	=	amod	32	SENT_177	[p12l998t788r1051b808],
31	0.03	CD	NUMBER	0.03	tmod	30	SENT_177	[p12l1091t760r1290b842],
32	)	NN	O	)	dep	29	SENT_177	[p12l1091t760r1290b842],
33	.	.	O	.	_	0	SENT_177	[p12l1091t760r1290b842],

1	This	DT	O	this	det	2	SENT_178	[p12l1323t760r1486b828],
2	pattern	NN	O	pattern	nsubj	8	SENT_178	[p12l1517t779r1790b851],
3	,	,	O	,	_	0	SENT_178	[p12l1517t779r1790b851],
4	however	RB	O	however	advmod	8	SENT_178	[p12l1823t762r2137b843],
5	,	,	O	,	_	0	SENT_178	[p12l1823t762r2137b843],
6	was	VBD	O	be	cop	8	SENT_178	[p12l7t894r135b934],
7	not	RB	O	not	neg	8	SENT_178	[p12l177t885r294b934],
8	evident	JJ	O	evident	_	0	SENT_178	[p12l332t868r589b934],
9	for	IN	O	for	_	0	SENT_178	[p12l626t868r726b934],
10	pravastatin	NN	O	pravastatin	nn	13	SENT_178	[p12l762t871r1147b957],
11	acid	NN	O	acid	nn	13	SENT_178	[p12l1188t868r1328b934],
12	(	NN	O	(	nn	13	SENT_178	[p12l1369t866r1435b957],
13	p	NN	O	p	prep_for	8	SENT_178	[p12l1369t866r1435b957],
14	>	JJR	O	>	dep	13	SENT_178	[p12l1481t878r1541b929],
15	0.5	CD	NUMBER	0.5	num	16	SENT_178	[p12l1586t866r1741b948],
16	)	NN	O	)	dep	14	SENT_178	[p12l1586t866r1741b948],
17	.	.	O	.	_	0	SENT_178	[p12l1586t866r1741b948],

1	When	WRB	O	when	advmod	3	SENT_179	[p12l1780t868r2006b935],
2	we	PRP	O	we	nsubj	3	SENT_179	[p12l2041t894r2139b934],
3	tested	VBD	O	test	advcl	13	SENT_179	[p12l10t975r218b1041],
4	for	IN	O	for	_	0	SENT_179	[p12l241t975r342b1041],
5	a	DT	O	a	det	6	SENT_179	[p12l366t1001r401b1041],
6	gene	NN	O	gene	nn	10	SENT_179	[p12l423t1001r586b1064],
7	>	JJR	O	>	npadvmod	8	SENT_179	[p12l620t984r672b1037],
8	<	JJR	O	<	amod	10	SENT_179	[p12l620t984r672b1037],
9	statin	NN	O	statin	nn	10	SENT_179	[p12l708t978r900b1041],
10	interaction	NN	O	interaction	prep_for	3	SENT_179	[p12l924t978r1327b1056],
11	,	,	O	,	_	0	SENT_179	[p12l924t978r1327b1056],
12	there	EX	O	there	expl	13	SENT_179	[p12l1354t975r1532b1041],
13	was	VBD	O	be	_	0	SENT_179	[p12l1553t1001r1683b1041],
14	a	DT	O	a	det	15	SENT_179	[p12l1710t1001r1745b1041],
15	suggestion	NN	O	suggestion	nsubj	13	SENT_179	[p12l1769t978r2140b1064],
16	for	IN	O	for	_	0	SENT_179	[p12l10t1080r111b1145],
17	statistical	JJ	O	statistical	amod	18	SENT_179	[p12l141t1080r469b1145],
18	evidence	NN	O	evidence	prep_for	15	SENT_179	[p12l500t1080r801b1146],
19	with	IN	O	with	_	0	SENT_179	[p12l829t1080r990b1146],
20	low	JJ	O	low	amod	24	SENT_179	[p12l1019t1080r1149b1146],
21	dose	NN	O	dose	nn	24	SENT_179	[p12l1178t1080r1332b1145],
22	statin	NN	O	statin	nn	24	SENT_179	[p12l1366t1083r1558b1145],
23	acid	NN	O	acid	nn	24	SENT_179	[p12l1591t1080r1731b1145],
24	concentrations	NNS	O	concentration	prep_with	18	SENT_179	[p12l1762t1097r2137b1145, p12l10t1189r180b1252],

1	(	NN	O	(	nn	2	SENT_180	[p12l219t1184r407b1275],
2	gene	NN	O	gene	nsubj	9	SENT_180	[p12l219t1184r407b1275],
3	>	JJR	O	>	dep	2	SENT_180	[p12l450t1196r503b1248],
4	<	JJR	O	<	amod	6	SENT_180	[p12l450t1196r503b1248],
5	treatment	NN	O	treatment	nn	6	SENT_180	[p12l546t1203r893b1252],
6	interaction	NN	O	interaction	dep	2	SENT_180	[p12l925t1189r1307b1252],
7	p	NN	O	p	nn	8	SENT_180	[p12l1340t1212r1382b1275],
8	value	NN	O	value	dep	6	SENT_180	[p12l1414t1186r1595b1252],
9	=	JJ	O	=	_	0	SENT_180	[p12l1638t1212r1691b1232],
10	0.21	CD	NUMBER	0.21	number	11	SENT_180	[p12l1735t1184r1912b1266],
11	)	CD	NUMBER	)	dobj	9	SENT_180	[p12l1735t1184r1912b1266],
12	when	WRB	O	when	advmod	13	SENT_180	[p12l1946t1186r2140b1252],
13	using	VBG	O	use	dep	11	SENT_180	[p12l9t1295r199b1381],
14	the	DT	O	the	det	18	SENT_180	[p12l225t1292r335b1358],
15	more	RBR	O	more	advmod	18	SENT_180	[p12l364t1318r543b1358],
16	liberal	JJ	O	liberal	dep	17	SENT_180	[p12l569t1292r789b1358],
17	alpha	NN	O	alpha	amod	18	SENT_180	[p12l816t1292r1005b1381],
18	threshold	NN	O	threshold	dobj	13	SENT_180	[p12l1031t1292r1365b1358],
19	as	IN	O	as	mark	22	SENT_180	[p12l1393t1318r1457b1358],
20	has	VBZ	O	have	aux	22	SENT_180	[p12l1485t1292r1598b1358],
21	been	VBN	O	be	auxpass	22	SENT_180	[p12l1625t1292r1791b1358],
22	proposed	VBN	O	propose	advcl	13	SENT_180	[p12l1817t1292r2142b1381],
23	for	IN	O	for	_	0	SENT_180	[p12l10t1398r111b1464],
24	evaluating	VBG	O	evaluate	prepc_for	22	SENT_180	[p12l160t1398r520b1487],
25	interactions	NNS	O	interaction	dobj	24	SENT_180	[p12l568t1401r980b1464],
26	(	CD	NUMBER	(	dep	13	SENT_180	[p12l1035t1396r1305b1479],
27	23,24	CD	NUMBER	23,24	num	28	SENT_180	[p12l1035t1396r1305b1479],
28	)	NN	O	)	dep	26	SENT_180	[p12l1035t1396r1305b1479],
29	.	.	O	.	_	0	SENT_180	[p12l1035t1396r1305b1479],

1	With	IN	O	with	_	0	SENT_181	[p12l1356t1398r1549b1465],
2	respect	NN	O	respect	_	0	SENT_181	[p12l1599t1415r1846b1487],
3	to	TO	O	to	_	0	SENT_181	[p12l1894t1415r1962b1464],
4	sex	NN	O	sex	prep_with_respect_to	7	SENT_181	[p12l2014t1424r2137b1479],
5	,	,	O	,	_	0	SENT_181	[p12l2014t1424r2137b1479],
6	there	EX	O	there	expl	7	SENT_181	[p12l10t1504r188b1570],
7	were	VBD	O	be	_	0	SENT_181	[p12l212t1530r378b1570],
8	no	DT	O	no	det	10	SENT_181	[p12l407t1530r492b1570],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_181	[p12l521t1504r886b1593],
10	differences	NNS	O	difference	npadvmod	29	SENT_181	[p12l912t1504r1282b1570],
11	in	IN	O	in	_	0	SENT_181	[p12l1310t1507r1378b1569],
12	statin	JJ	O	statin	amod	13	SENT_181	[p12l1405t1507r1598b1570],
13	acid	NN	O	acid	prep_in	10	SENT_181	[p12l1626t1504r1766b1570],
14	or	CC	O	or	_	0	SENT_181	[p12l1792t1530r1864b1570],
15	lactone	NN	O	lactone	nn	16	SENT_181	[p12l1888t1504r2140b1570],
16	concentrations	NNS	O	concentration	conj_or	13	SENT_181	[p12l11t1613r527b1676],
17	at	IN	O	at	_	0	SENT_181	[p12l565t1627r628b1676],
18	low	JJ	O	low	amod	19	SENT_181	[p12l660t1610r789b1676],
19	dose	NN	O	dose	prep_at	13	SENT_181	[p12l821t1610r976b1676],
20	or	CC	O	or	_	0	SENT_181	[p12l1012t1636r1084b1676],
21	high	JJ	O	high	amod	22	SENT_181	[p12l1117t1610r1277b1699],
22	doses	NNS	O	dose	prep_in	10	SENT_181	[p12l1312t1610r1498b1676],
23	of	IN	O	of	_	0	SENT_181	[p12l1535t1610r1615b1676],
24	simvastatin	NN	O	simvastatin	nn	28	SENT_181	[p12l1639t1613r2035b1676],
25	or	CC	O	or	_	0	SENT_181	[p12l2070t1636r2142b1676],
26	pravastatin	NN	O	pravastatin	nn	28	SENT_181	[p12l9t1719r394b1805],
27	(	NN	O	(	nn	28	SENT_181	[p12l430t1714r498b1805],
28	p	NN	O	p	prep_of	22	SENT_181	[p12l430t1714r498b1805],
29	>	JJR	O	>	acomp	7	SENT_181	[p12l537t1726r597b1777],
30	0.5	CD	NUMBER	0.5	tmod	29	SENT_181	[p12l636t1716r741b1782],
31	for	IN	O	for	mark	34	SENT_181	[p12l777t1716r877b1782],
32	all	DT	O	all	det	33	SENT_181	[p12l910t1716r990b1782],
33	comparisons	NNS	O	comparison	nsubj	34	SENT_181	[p12l1022t1714r1511b1805],
34	)	VBP	O	)	ccomp	29	SENT_181	[p12l1022t1714r1511b1805],
35	.	.	O	.	_	0	SENT_181	[p12l1022t1714r1511b1805],

1	To	TO	O	to	aux	2	SENT_182	[p12l96t1819r201b1886],
2	assess	VB	O	assess	purpcl	21	SENT_182	[p12l235t1847r431b1886],
3	Whether	NNP	O	Whether	nn	4	SENT_182	[p12l460t1821r754b1887],
4	SLCO	NNP	O	SLCO	nsubj	5	SENT_182	[p12l786t1824r1221b1887],
5	]	VBD	O	]	ccomp	2	SENT_182	[p12l786t1824r1221b1887],
6	B1	NN	O	b1	dobj	5	SENT_182	[p12l786t1824r1221b1887],
7	*	CD	NUMBER	*	num	8	SENT_182	[p12l786t1824r1221b1887],
8	5	CD	NUMBER	5	nsubjpass	10	SENT_182	[p12l786t1824r1221b1887],
9	was	VBD	O	be	auxpass	10	SENT_182	[p12l1245t1847r1374b1887],
10	associated	VBN	O	associate	rcmod	6	SENT_182	[p12l1408t1821r1760b1886],
11	with	IN	O	with	_	0	SENT_182	[p12l1787t1821r1948b1887],
12	mild	JJ	O	mild	amod	14	SENT_182	[p12l1980t1821r2141b1886],
13	side	JJ	O	side	amod	14	SENT_182	[p12l12t1927r146b1993],
14	effects	NNS	O	effect	prep_with	10	SENT_182	[p12l170t1927r384b1993],
15	without	IN	O	without	_	0	SENT_182	[p12l405t1927r686b1993],
16	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_182	[p12l708t1927r1074b2016],
17	CK	NN	O	ck	nn	18	SENT_182	[p12l1097t1927r1224b1993],
18	elevations	NNS	O	elevation	prep_without	10	SENT_182	[p12l1245t1927r1610b2008],
19	,	,	O	,	_	0	SENT_182	[p12l1245t1927r1610b2008],
20	we	PRP	O	we	nsubj	21	SENT_182	[p12l1633t1953r1731b1993],
21	limited	VBD	O	limit	_	0	SENT_182	[p12l1754t1927r2007b1993],
22	the	DT	O	the	dobj	21	SENT_182	[p12l2029t1927r2139b1993],

1	JACC	NNP	O	JACC	nn	2	SENT_183	[p12l42t2092r96b2116],
2	Vol	NNP	O	Vol	_	0	SENT_183	[p12l108t2092r147b2116],
3	.	.	O	.	_	0	SENT_183	[p12l108t2092r147b2116],

1	54	CD	NUMBER	54	dep	9	SENT_184	[p12l162t2092r196b2120],
2	,	,	O	,	_	0	SENT_184	[p12l162t2092r196b2120],
3	No.	NN	O	no.	appos	1	SENT_184	[p12l211t2092r244b2116],
4	17	CD	NUMBER	17	num	3	SENT_184	[p12l259t2092r293b2120],
5	,	,	O	,	_	0	SENT_184	[p12l259t2092r293b2120],
6	2009	CD	DATE	2009	appos	1	SENT_184	[p12l307t2092r365b2116],
7	Voora	NNP	O	Voora	dep	9	SENT_184	[p12l1809t2091r1886b2116],
8	et	FW	O	et	nn	9	SENT_184	[p12l1899t2092r1926b2116],
9	al.	FW	O	al.	dep	17	SENT_184	[p12l1936t2091r1967b2116],
10	1613	CD	DATE	1613	dep	9	SENT_184	[p12l2049t2091r2117b2116],
11	October	NNP	DATE	October	tmod	10	SENT_184	[p12l43t2133r127b2157],
12	20	CD	DATE	20	num	11	SENT_184	[p12l140t2133r174b2161],
13	,	,	O	,	_	0	SENT_184	[p12l140t2133r174b2161],
14	2009:1609	CD	NUMBER	2009:1609	num	11	SENT_184	[p12l188t2133r359b2157],
15	—	CD	NUMBER	—	number	16	SENT_184	[p12l188t2133r359b2157],
16	16	CD	NUMBER	16	num	17	SENT_184	[p12l188t2133r359b2157],
17	Phannacogenetics	NNS	O	phannacogenetic	_	0	SENT_184	[p12l1427t2132r1672b2162],
18	of	IN	O	of	_	0	SENT_184	[p12l1684t2132r1710b2157],
19	statin	NN	O	statin	nn	21	SENT_184	[p12l1720t2132r1798b2157],
20	Side	NN	O	side	nn	21	SENT_184	[p12l1810t2132r1868b2157],
21	Effects	NNS	O	effect	prep_of	17	SENT_184	[p12l1880t2132r1968b2157],

1	Simvastatin	NNP	O	Simvastatin	nn	3	SENT_185	[p13l690t102r856b127],
2	Atorvastatin	NNP	O	Atorvastatin	nn	3	SENT_185	[p13l992t102r1165b127],
3	Pravastatin	NNP	O	Pravastatin	_	0	SENT_185	[p13l1308t102r1467b127],

1	P	NN	O	p	_	0	SENT_186	[p13l725t190r744b215],
2	=	JJ	O	=	amod	7	SENT_186	[p13l755t197r772b208],
3	0.01	CD	NUMBER	0.01	num	4	SENT_186	[p13l785t190r843b215],
4	P	NN	O	p	dep	2	SENT_186	[p13l1026t190r1045b215],
5	=	JJ	O	=	amod	7	SENT_186	[p13l1057t197r1074b208],
6	0.3	CD	NUMBER	0.3	tmod	5	SENT_186	[p13l1086t190r1131b215],
7	P	NN	O	p	dep	1	SENT_186	[p13l1315t190r1335b215],
8	=	JJ	O	=	amod	7	SENT_186	[p13l1346t197r1363b208],
9	0.97	CD	NUMBER	0.97	tmod	8	SENT_186	[p13l1375t190r1438b215],

1	25	CD	NUMBER	25	num	4	SENT_187	[p13l558t339r595b365],
2	D	NN	O	d	nn	4	SENT_187	[p13l1555t354r1575b375],
3	o	NN	O	o	nn	4	SENT_187	[p13l1584t351r1599b375],
4	alleles	NNS	O	allele	_	0	SENT_187	[p13l1609t351r1694b375],
5	I	PRP	O	I	dep	4	SENT_187	[p13l1555t423r1575b443],
6	>	JJR	O	>	dep	7	SENT_187	[p13l1584t424r1600b439],
7	=	JJ	O	=	amod	5	SENT_187	[p13l1608t420r1641b443],
8	1	CD	NUMBER	1	num	9	SENT_187	[p13l1608t420r1641b443],
9	allele	NN	O	allele	dep	4	SENT_187	[p13l1652t420r1722b443],

1	Force	NNP	O	Force	_	0	SENT_188	[p13l470t482r500b578],
2	ntaga	NN	O	ntaga	dep	1	SENT_188	[p13l471t387r508b477],
3	with	IN	O	with	_	0	SENT_188	[p13l470t306r500b375],
4	CAE	NN	ORGANIZATION	ca	prep_with	2	SENT_188	[p13l470t218r500b293],
5	8	CD	NUMBER	8	number	4	SENT_188	[p13l558t405r593b429],
6	81	CD	NUMBER	81	number	4	SENT_188	[p13l558t215r595b241],
7	8	CD	NUMBER	8	number	4	SENT_188	[p13l558t153r593b178],

1	N	NN	O	n	nn	3	SENT_189	[p13l434t705r452b728],
2	with/without	NN	O	with/without	nn	3	SENT_189	[p13l461t705r616b728],
3	CAE	NN	O	ca	_	0	SENT_189	[p13l626t705r685b728],
4	17/108	CD	NUMBER	17/108	num	5	SENT_189	[p13l707t705r796b728],
5	17/50	CD	NUMBER	17/50	dep	3	SENT_189	[p13l815t705r887b728],
6	21/109	CD	NUMBER	21/109	number	7	SENT_189	[p13l994t705r1084b728],
7	10/37	CD	NUMBER	10/37	num	9	SENT_189	[p13l1096t705r1167b728],
8	23/106	CD	NUMBER	23/106	number	9	SENT_189	[p13l1302t705r1392b728],
9	8/36	CD	NUMBER	8/36	dep	5	SENT_189	[p13l1401t705r1458b728],

1	Sirnvastatin	NNP	O	Sirnvastatin	nn	3	SENT_190	[p13l696t800r881b825],
2	Atonrastatin	NNP	O	Atonrastatin	nn	3	SENT_190	[p13l990t800r1176b825],
3	Pravastatin	NNP	O	Pravastatin	_	0	SENT_190	[p13l1289t800r1464b825],

1	P	NN	O	p	_	0	SENT_191	[p13l779t892r826b917],
2	=	JJ	O	=	amod	4	SENT_191	[p13l779t892r826b917],
3	0.2	CD	NUMBER	0.2	tmod	2	SENT_191	[p13l839t892r883b917],
4	P	NN	O	p	dep	1	SENT_191	[p13l1048t892r1095b917],
5	=	JJ	O	=	dep	1	SENT_191	[p13l1048t892r1095b917],
6	0.06	CD	NUMBER	0.06	num	7	SENT_191	[p13l1108t892r1170b917],
7	P	NN	O	p	dep	5	SENT_191	[p13l1327t892r1374b917],
8	=	JJ	O	=	prep	7	SENT_191	[p13l1327t892r1374b917],
9	0.04	CD	NUMBER	0.04	dep	8	SENT_191	[p13l1387t892r1449b917],
10	'	''	O	'	_	0	SENT_191	[p13l480t928r508b977],

1	-	:	O	-	_	0	SENT_192	[p13l480t928r508b977],
2	‘	NN	O	‘	_	0	SENT_192	[p13l480t928r508b977],
3	z	SYM	O	z	dep	4	SENT_192	[p13l480t928r508b977],
4	’	FW	O	’	rcmod	2	SENT_192	[p13l480t928r508b977],
5	o	NN	O	o	dep	2	SENT_192	[p13l480t975r508b1000],
6	5	CD	NUMBER	5	num	5	SENT_192	[p13l480t1011r508b1041],
7	E	NN	O	e	nn	12	SENT_192	[p13l480t1042r508b1077],
8	3	CD	NUMBER	3	num	12	SENT_192	[p13l480t1087r515b1155],
9	=	JJ	O	=	amod	12	SENT_192	[p13l487t1156r508b1174],
10	O	NN	O	o	nn	12	SENT_192	[p13l487t1177r508b1194],
11	2	CD	NUMBER	2	num	12	SENT_192	[p13l487t1196r508b1225],
12	O	NN	O	o	npadvmod	13	SENT_192	[p13l487t1229r508b1246],
13	n.	IN	O	n.	dep	2	SENT_192	[p13l480t1247r508b1267],

1	N	NN	O	n	nn	2	SENT_193	[p13l434t1352r452b1374],
2	withlwithout	NN	O	withlwithout	_	0	SENT_193	[p13l461t1352r616b1374],
3	CAE	NNP	O	CAE	dep	2	SENT_193	[p13l626t1352r685b1374],
4	16186	CD	NUMBER	16186	num	3	SENT_193	[p13l704t1352r776b1374],
5	21/76	CD	NUMBER	21/76	number	6	SENT_193	[p13l794t1352r868b1374],
6	3160 23/37	CD	NUMBER	3160 23/37	num	8	SENT_193	[p13l1095t1352r1168b1374],[p13l1002t1352r1059b1374],
7	9/63	CD	NUMBER	9/63	number	8	SENT_193	[p13l1312t1352r1367b1374],
8	22/80	CD	NUMBER	22/80	dep	3	SENT_193	[p13l1393t1352r1467b1374],

1	Statin	NNP	O	Statin	nn	3	SENT_194	[p13l241t1445r330b1469],
2	Stratified	NNP	O	Stratified	nn	3	SENT_194	[p13l342t1445r479b1469],
3	Analyses	NNS	O	analysis	nsubjpass	40	SENT_194	[p13l491t1445r624b1474],
4	of	IN	O	of	_	0	SENT_194	[p13l636t1445r665b1468],
5	Adverse	JJ	O	adverse	amod	7	SENT_194	[p13l675t1445r793b1469],
6	Events	NNS	O	event	nn	7	SENT_194	[p13l807t1445r905b1469],
7	Percentage	NN	O	percentage	prep_of	3	SENT_194	[p13l69t1528r198b1553],
8	and	CC	O	and	_	0	SENT_194	[p13l210t1528r251b1548],
9	number	NN	O	number	prep_of	3	SENT_194	[p13l263t1528r351b1548],
10	of	IN	O	of	_	0	SENT_194	[p13l361t1528r383b1548],
11	those	DT	O	those	prep_of	3	SENT_194	[p13l391t1528r457b1548],
12	with	IN	O	with	_	0	SENT_194	[p13l467t1528r513b1548],
13	the	DT	O	the	det	15	SENT_194	[p13l524t1528r561b1548],
14	CAE	NNP	ORGANIZATION	CAE	nn	15	SENT_194	[p13l572t1528r617b1548],
15	outcome	NN	O	outcome	prep_with	11	SENT_194	[p13l628t1530r728b1548],
16	in	IN	O	in	_	0	SENT_194	[p13l740t1528r758b1547],
17	the	DT	O	the	det	19	SENT_194	[p13l768t1528r805b1548],
18	STRENGTH	NN	O	strength	nn	19	SENT_194	[p13l817t1528r943b1548],
19	study	NN	O	study	prep_in	15	SENT_194	[p13l955t1528r1017b1552],
20	stratified	VBN	O	stratify	partmod	19	SENT_194	[p13l1028t1528r1129b1548],
21	by	IN	O	by	_	0	SENT_194	[p13l1141t1528r1165b1552],
22	SLCO1B1	NN	O	slco1b1	agent	20	SENT_194	[p13l1176t1528r1322b1548],
23	*	CD	NUMBER	*	number	24	SENT_194	[p13l1176t1528r1322b1548],
24	5	CD	NUMBER	5	num	25	SENT_194	[p13l1176t1528r1322b1548],
25	genotype	NN	O	genotype	dep	19	SENT_194	[p13l1330t1530r1436b1553],
26	(	CD	NUMBER	(	num	28	SENT_194	[p13l1447t1528r1504b1552],
27	top	JJ	O	top	quantmod	26	SENT_194	[p13l1447t1528r1504b1552],
28	)	NN	O	)	dep	19	SENT_194	[p13l1447t1528r1504b1552],
29	and	CC	O	and	_	0	SENT_194	[p13l1516t1528r1557b1548],
30	sex	NN	O	sex	nn	33	SENT_194	[p13l1569t1533r1608b1548],
31	(	JJ	O	(	amod	33	SENT_194	[p13l1619t1528r1723b1552],
32	bottom	JJ	O	bottom	amod	33	SENT_194	[p13l1619t1528r1723b1552],
33	)	NN	O	)	prep_in	15	SENT_194	[p13l1619t1528r1723b1552],
34	for	IN	O	for	_	0	SENT_194	[p13l1734t1528r1766b1548],
35	each	DT	O	each	det	38	SENT_194	[p13l1775t1528r1830b1548],
36	assigned	VBN	O	assign	amod	38	SENT_194	[p13l1842t1528r1946b1553],
37	statin	NN	O	statin	nn	38	SENT_194	[p13l1957t1528r2022b1548],
38	type	NN	O	type	prep_for	33	SENT_194	[p13l2032t1530r2080b1552],
39	is	VBZ	O	be	auxpass	40	SENT_194	[p13l69t1566r87b1585],
40	displayed	VBN	O	display	_	0	SENT_194	[p13l98t1566r214b1590],
41	.	.	O	.	_	0	SENT_194	[p13l98t1566r214b1590],

1	Carriers	NNS	O	carrier	nsubj	6	SENT_195	[p13l227t1566r317b1585],
2	of	IN	O	of	_	0	SENT_195	[p13l328t1566r351b1585],
3	SLCO1B1	NN	O	slco1b1	prep_of	1	SENT_195	[p13l361t1566r507b1585],
4	*	CD	NUMBER	*	number	5	SENT_195	[p13l361t1566r507b1585],
5	5	CD	NUMBER	5	num	3	SENT_195	[p13l361t1566r507b1585],
6	appear	VBP	O	appear	_	0	SENT_195	[p13l516t1570r597b1589],
7	to	TO	O	to	aux	8	SENT_195	[p13l605t1567r628b1585],
8	have	VB	O	have	xcomp	6	SENT_195	[p13l640t1566r693b1585],
9	no	DT	O	no	det	11	SENT_195	[p13l704t1570r731b1585],
10	excess	JJ	O	excess	amod	11	SENT_195	[p13l742t1570r822b1585],
11	risk	NN	O	risk	dobj	8	SENT_195	[p13l834t1566r875b1585],
12	of	IN	O	of	_	0	SENT_195	[p13l885t1566r908b1585],
13	CAE	NNP	ORGANIZATION	CAE	prep_of	11	SENT_195	[p13l917t1566r963b1585],
14	when	WRB	O	when	advmod	15	SENT_195	[p13l972t1566r1032b1585],
15	assigned	VBN	O	assign	advcl	8	SENT_195	[p13l1044t1566r1148b1590],
16	to	TO	O	to	_	0	SENT_195	[p13l1159t1567r1181b1585],
17	pravastatin	NN	O	pravastatin	prep_to	15	SENT_195	[p13l1193t1566r1329b1589],
18	,	,	O	,	_	0	SENT_195	[p13l1193t1566r1329b1589],
19	whereas	IN	O	whereas	mark	22	SENT_195	[p13l1340t1566r1438b1585],
20	female	JJ	O	female	amod	21	SENT_195	[p13l1448t1566r1528b1585],
21	patients	NNS	O	patient	nsubj	22	SENT_195	[p13l1540t1566r1633b1589],
22	appear	VBP	O	appear	advcl	6	SENT_195	[p13l1645t1570r1725b1589],
23	to	TO	O	to	aux	24	SENT_195	[p13l1734t1567r1756b1585],
24	have	VB	O	have	xcomp	22	SENT_195	[p13l1768t1566r1821b1585],
25	an	DT	O	a	det	27	SENT_195	[p13l1833t1570r1859b1585],
26	increased	VBN	O	increase	amod	27	SENT_195	[p13l1871t1566r1983b1585],
27	risk	NN	O	risk	dobj	24	SENT_195	[p13l1996t1566r2036b1585],
28	with	IN	O	with	_	0	SENT_195	[p13l2046t1566r2092b1585],
29	all	DT	O	all	det	31	SENT_195	[p13l69t1603r93b1623],
30	3	CD	NUMBER	3	num	31	SENT_195	[p13l105t1603r119b1623],
31	statins	NNS	O	statin	prep_with	27	SENT_195	[p13l130t1603r216b1623],
32	.	.	O	.	_	0	SENT_195	[p13l130t1603r216b1623],

1	CAE	NN	O	ca	nn	5	SENT_196	[p13l229t1603r274b1623],
2	=	JJ	O	=	amod	5	SENT_196	[p13l287t1610r303b1617],
3	composite	JJ	O	composite	amod	5	SENT_196	[p13l316t1603r437b1627],
4	adverse	JJ	O	adverse	amod	5	SENT_196	[p13l449t1603r539b1623],
5	event	NN	O	event	_	0	SENT_196	[p13l550t1605r620b1626],
6	;	:	O	;	_	0	SENT_196	[p13l550t1605r620b1626],
7	STRENGTH	NN	O	strength	dep	5	SENT_196	[p13l632t1603r758b1623],
8	=	JJ	O	=	amod	10	SENT_196	[p13l773t1610r789b1617],
9	Statin	NN	O	statin	nn	10	SENT_196	[p13l802t1603r869b1623],
10	Response	NN	O	response	dep	7	SENT_196	[p13l882t1603r997b1627],
11	Examined	VBN	O	examine	partmod	7	SENT_196	[p13l1009t1603r1120b1623],
12	by	IN	O	by	_	0	SENT_196	[p13l1132t1603r1157b1627],
13	Genetic	JJ	O	genetic	amod	15	SENT_196	[p13l1167t1603r1255b1623],
14	Haplotype	NN	O	haplotype	nn	15	SENT_196	[p13l1266t1603r1381b1627],
15	Markers	NNS	O	marker	agent	11	SENT_196	[p13l1393t1603r1493b1623],
16	.	.	O	.	_	0	SENT_196	[p13l1393t1603r1493b1623],

1	population	NN	O	population	nsubj	58	SENT_197	[p13l43t1712r222b1754],
2	to	TO	O	to	_	0	SENT_197	[p13l238t1720r270b1743],
3	either	CC	O	either	dep	6	SENT_197	[p13l286t1712r382b1743],
4	the	DT	O	the	det	6	SENT_197	[p13l397t1712r448b1743],
5	90	CD	NUMBER	90	num	6	SENT_197	[p13l465t1714r504b1743],
6	cases	NNS	O	case	prep_to	1	SENT_197	[p13l521t1724r600b1743],
7	with	IN	O	with	_	0	SENT_197	[p13l615t1712r691b1743],
8	CK	NN	O	ck	nn	9	SENT_197	[p13l707t1712r767b1743],
9	levels	NNS	O	level	prep_with	58	SENT_197	[p13l781t1712r869b1743],
10	<	JJR	O	<	npadvmod	13	SENT_197	[p13l888t1714r970b1743],
11	3	CD	NUMBER	3	number	12	SENT_197	[p13l888t1714r970b1743],
12	>	JJR	O	>	amod	10	SENT_197	[p13l888t1714r970b1743],
13	<	JJR	O	<	amod	9	SENT_197	[p13l888t1714r970b1743],
14	the	DT	O	the	det	15	SENT_197	[p13l990t1712r1041b1743],
15	carriers	NNS	O	carrier	nsubj	58	SENT_197	[p13l1119t1714r1243b1743],
16	of	IN	O	of	_	0	SENT_197	[p13l1260t1712r1298b1743],
17	the	DT	O	the	det	20	SENT_197	[p13l1308t1712r1362b1743],
18	reduced	VBN	O	reduce	amod	20	SENT_197	[p13l1378t1712r1513b1743],
19	function	NN	O	function	nn	20	SENT_197	[p13l1529t1712r1674b1743],
20	allele	NN	O	allele	prep_of	15	SENT_197	[p13l1690t1712r1777b1743],
21	(	CD	NUMBER	(	number	22	SENT_197	[p13l1795t1711r1855b1750],
22	*	CD	NUMBER	*	dep	37	SENT_197	[p13l1795t1711r1855b1750],
23	5	CD	NUMBER	5	num	24	SENT_197	[p13l1795t1711r1855b1750],
24	)	NN	O	)	npadvmod	37	SENT_197	[p13l1795t1711r1855b1750],
25	of	IN	O	of	_	0	SENT_197	[p13l1873t1712r1911b1743],
26	the	DT	O	the	det	29	SENT_197	[p13l1921t1712r1974b1743],
27	organic	JJ	O	organic	amod	29	SENT_197	[p13l1991t1714r2118b1754],
28	upper	JJ	O	upper	amod	29	SENT_197	[p13l9t1797r213b1861],
29	limit	NN	O	limit	prep_of	24	SENT_197	[p13l252t1772r423b1838],
30	of	IN	O	of	_	0	SENT_197	[p13l464t1771r543b1838],
31	normal	JJ	O	normal	amod	34	SENT_197	[p13l574t1772r826b1838],
32	(	CD	NUMBER	(	num	34	SENT_197	[p13l870t1769r935b1852],
33	9	CD	NUMBER	9	num	34	SENT_197	[p13l870t1769r935b1852],
34	cases	NNS	O	case	prep_of	29	SENT_197	[p13l980t1798r1151b1838],
35	with	IN	O	with	_	0	SENT_197	[p13l1190t1772r1352b1838],
36	CK	NN	O	ck	prep_with	34	SENT_197	[p13l1396t1771r1524b1838],
37	>	JJR	O	>	amod	20	SENT_197	[p13l1569t1775r1744b1838],
38	3	CD	NUMBER	3	dep	39	SENT_197	[p13l1569t1775r1744b1838],
39	>	JJR	O	>	npadvmod	40	SENT_197	[p13l1569t1775r1744b1838],
40	<	JJR	O	<	dep	37	SENT_197	[p13l1569t1775r1744b1838],
41	the	DT	O	the	det	43	SENT_197	[p13l1795t1772r1905b1838],
42	upper	JJ	O	upper	amod	43	SENT_197	[p13l1947t1797r2152b1861],
43	limit	NN	O	limit	dep	40	SENT_197	[p13l8t1877r179b1944],
44	of	IN	O	of	_	0	SENT_197	[p13l205t1877r285b1944],
45	normal	JJ	O	normal	amod	47	SENT_197	[p13l302t1878r554b1944],
46	excluded	VBN	O	exclude	amod	47	SENT_197	[p13l580t1876r915b1958],
47	)	NN	O	)	prep_of	20	SENT_197	[p13l580t1876r915b1958],
48	or	CC	O	or	_	0	SENT_197	[p13l947t1903r1019b1944],
49	the	DT	O	the	det	51	SENT_197	[p13l1044t1878r1155b1944],
50	71	CD	NUMBER	71	num	51	SENT_197	[p13l1185t1879r1264b1944],
51	cases	NNS	O	case	prep_of	20	SENT_197	[p13l1297t1904r1467b1944],
52	with	IN	O	with	_	0	SENT_197	[p13l1493t1878r1655b1944],
53	musculoskel	NN	O	musculoskel	prep_with	51	SENT_197	[p13l1682t1877r2147b1944],
54	—	CD	NUMBER	—	num	57	SENT_197	[p13l1682t1877r2147b1944],
55	etal	JJ	O	etal	amod	57	SENT_197	[p13l10t1984r135b2051],
56	side	JJ	O	side	amod	57	SENT_197	[p13l185t1985r319b2051],
57	effects	NNS	O	effect	dep	51	SENT_197	[p13l370t1984r585b2051],
58	(	VBP	O	(	_	0	SENT_197	[p13l639t1983r1029b2074],
59	remaining	VBG	O	remain	xcomp	58	SENT_197	[p13l639t1983r1029b2074],
60	18	CD	NUMBER	18	dobj	59	SENT_197	[p13l1081t1988r1159b2051],
61	with	IN	O	with	_	0	SENT_197	[p13l1208t1985r1370b2051],
62	gastrointestinal	JJ	O	gastrointestinal	amod	64	SENT_197	[p13l1419t1985r1965b2074],
63	side	JJ	O	side	amod	64	SENT_197	[p13l2015t1984r2149b2051],
64	effects	NNS	O	effect	prep_with	59	SENT_197	[p13l10t2090r225b2157],
65	coded	VBN	O	code	partmod	64	SENT_197	[p13l259t2090r467b2157],
66	as	IN	O	as	_	0	SENT_197	[p13l500t2117r563b2157],
67	controls	NNS	O	control	prep_as	65	SENT_197	[p13l597t2088r927b2171],
68	)	RB	O	)	advmod	65	SENT_197	[p13l597t2088r927b2171],
69	.	.	O	.	_	0	SENT_197	[p13l597t2088r927b2171],

1	In	IN	O	in	_	0	SENT_198	[p13l962t2091r1040b2156],
2	these	DT	O	these	det	3	SENT_198	[p13l1071t2091r1252b2157],
3	analyses	NNS	O	analysis	prep_in	18	SENT_198	[p13l1286t2090r1587b2180],
4	,	,	O	,	_	0	SENT_198	[p13l1286t2090r1587b2180],
5	the	DT	O	the	det	6	SENT_198	[p13l1622t2091r1732b2157],
6	association	NN	O	association	nsubjpass	21	SENT_198	[p13l1766t2093r2150b2157],
7	of	IN	O	of	_	0	SENT_198	[p13l10t2196r91b2263],
8	SLCO1BZ	NN	O	slco1bz	prep_of	6	SENT_198	[p13l128t2200r566b2264],
9	*	CD	NUMBER	*	number	10	SENT_198	[p13l128t2200r566b2264],
10	5	CD	NUMBER	5	dep	8	SENT_198	[p13l128t2200r566b2264],
11	and	CC	O	and	_	0	SENT_198	[p13l610t2197r738b2263],
12	sex	NN	O	sex	prep_of	6	SENT_198	[p13l785t2223r891b2263],
13	with	IN	O	with	_	0	SENT_198	[p13l933t2196r1095b2263],
14	mild	JJ	O	mild	amod	16	SENT_198	[p13l1143t2197r1304b2263],
15	side	JJ	O	side	amod	16	SENT_198	[p13l1352t2196r1486b2263],
16	effects	NNS	O	effect	prep_with	12	SENT_198	[p13l1535t2196r1749b2263],
17	either	CC	O	either	preconj	18	SENT_198	[p13l1799t2197r2003b2263],
18	remained	VBD	O	remain	_	0	SENT_198	[p13l2049t2222r2147b2263, p13l10t2304r273b2370],
19	or	CC	O	or	_	0	SENT_198	[p13l310t2329r382b2370],
20	were	VBD	O	be	auxpass	21	SENT_198	[p13l414t2329r582b2370],
21	strengthened	VBN	O	strengthen	conj_or	18	SENT_198	[p13l622t2303r1084b2393],
22	(	RB	O	(	advmod	21	SENT_198	[p13l1124t2302r1352b2384],
23	Table	NNP	O	Table	prep	21	SENT_198	[p13l1124t2302r1352b2384],
24	4	CD	NUMBER	4	num	25	SENT_198	[p13l1390t2301r1480b2384],
25	)	CD	NUMBER	)	dep	23	SENT_198	[p13l1390t2301r1480b2384],
26	.	.	O	.	_	0	SENT_198	[p13l1390t2301r1480b2384],

1	Finally	RB	O	finally	advmod	32	SENT_199	[p13l1522t2303r1785b2393],
2	,	,	O	,	_	0	SENT_199	[p13l1522t2303r1785b2393],
3	when	WRB	O	when	advmod	5	SENT_199	[p13l1822t2303r2017b2370],
4	we	PRP	O	we	nsubj	5	SENT_199	[p13l2051t2330r2150b2370],
5	included	VBD	O	include	advcl	32	SENT_199	[p13l9t2409r314b2476],
6	those	DT	O	those	det	7	SENT_199	[p13l351t2409r538b2476],
7	subjects	NNS	O	subject	dobj	5	SENT_199	[p13l579t2409r851b2499],
8	who	WP	O	who	nsubjpass	15	SENT_199	[p13l888t2409r1041b2476],
9	received	VBD	O	receive	rcmod	7	SENT_199	[p13l1080t2409r1368b2476],
10	study	NN	O	study	nn	11	SENT_199	[p13l1407t2409r1597b2499],
11	drug	NN	O	drug	dobj	9	SENT_199	[p13l1633t2409r1795b2499],
12	but	CC	O	but	_	0	SENT_199	[p13l1830t2409r1949b2476],
13	were	VBD	O	be	auxpass	15	SENT_199	[p13l1982t2435r2149b2476],
14	originally	RB	O	originally	advmod	15	SENT_199	[p13l10t2515r346b2605],
15	excluded	VBN	O	exclude	conj_but	9	SENT_199	[p13l392t2515r702b2582],
16	(	NN	O	(	nn	17	SENT_199	[p13l752t2513r823b2596],
17	n	NN	O	n	dobj	15	SENT_199	[p13l752t2513r823b2596],
18	=	JJ	O	=	amod	17	SENT_199	[p13l880t2541r933b2562],
19	57	CD	NUMBER	57	tmod	18	SENT_199	[p13l992t2516r1097b2596],
20	,	,	O	,	_	0	SENT_199	[p13l992t2516r1097b2596],
21	coded	VBN	O	code	partmod	17	SENT_199	[p13l1150t2516r1359b2582],
22	as	IN	O	as	_	0	SENT_199	[p13l1408t2542r1471b2582],
23	control	JJ	O	control	amod	24	SENT_199	[p13l1523t2515r1775b2582],
24	subjects	NNS	O	subject	prep_as	21	SENT_199	[p13l1824t2513r2147b2605],
25	)	JJ	O	)	amod	28	SENT_199	[p13l1824t2513r2147b2605],
26	,	,	O	,	_	0	SENT_199	[p13l1824t2513r2147b2605],
27	female	JJ	O	female	amod	28	SENT_199	[p13l9t2620r242b2686],
28	sex	NN	O	sex	nsubj	32	SENT_199	[p13l270t2646r375b2686],
29	and	CC	O	and	_	0	SENT_199	[p13l401t2620r529b2686],
30	carrier	NN	O	carrier	nn	31	SENT_199	[p13l555t2623r780b2686],
31	status	NN	O	status	conj_and	28	SENT_199	[p13l806t2637r1003b2686],
32	continued	VBD	O	continue	_	0	SENT_199	[p13l1032t2620r1386b2686],
33	to	TO	O	to	aux	35	SENT_199	[p13l1411t2638r1479b2686],
34	be	VB	O	be	auxpass	35	SENT_199	[p13l1504t2621r1585b2686],
35	associated	VBN	O	associate	xcomp	32	SENT_199	[p13l1613t2620r1967b2686],
36	with	IN	O	with	_	0	SENT_199	[p13l1988t2620r2150b2686],
37	the	DT	O	the	det	40	SENT_199	[p13l9t2726r120b2793],
38	CAE	NNP	O	CAE	nn	40	SENT_199	[p13l156t2725r344b2793],
39	(	NN	O	(	nn	40	SENT_199	[p13l381t2724r449b2816],
40	p	NN	O	p	prep_with	35	SENT_199	[p13l381t2724r449b2816],
41	=	JJ	O	=	amod	40	SENT_199	[p13l492t2752r545b2773],
42	0.003	CD	NUMBER	0.003	tmod	41	SENT_199	[p13l588t2730r781b2793],
43	and	CC	O	and	_	0	SENT_199	[p13l820t2727r948b2793],
44	p	NN	O	p	prep_with	35	SENT_199	[p13l979t2753r1021b2816],
45	=	JJ	O	=	amod	44	SENT_199	[p13l1065t2752r1118b2773],
46	0.04	CD	NUMBER	0.04	tmod	45	SENT_199	[p13l1161t2730r1333b2807],
47	,	,	O	,	_	0	SENT_199	[p13l1161t2730r1333b2807],
48	respectively	RB	O	respectively	advmod	49	SENT_199	[p13l1369t2724r1825b2816],
49	)	CD	NUMBER	)	rcmod	44	SENT_199	[p13l1369t2724r1825b2816],
50	.	.	O	.	_	0	SENT_199	[p13l1369t2724r1825b2816],

1	Discussion	NN	O	discussion	_	0	SENT_200	[p13l12t2943r470b3006],

1	In	IN	O	in	_	0	SENT_201	[p13l9t3115r88b3179],
2	this	DT	O	this	det	3	SENT_201	[p13l124t3114r257b3180],
3	study	NN	O	study	prep_in	6	SENT_201	[p13l296t3114r510b3203],
4	,	,	O	,	_	0	SENT_201	[p13l296t3114r510b3203],
5	we	PRP	O	we	nsubj	6	SENT_201	[p13l545t3140r646b3180],
6	sought	VBD	O	seek	_	0	SENT_201	[p13l684t3114r931b3203],
7	to	TO	O	to	aux	8	SENT_201	[p13l965t3131r1035b3180],
8	identify	VB	O	identify	xcomp	6	SENT_201	[p13l1072t3114r1360b3203],
9	common	JJ	O	common	amod	11	SENT_201	[p13l1394t3140r1736b3195],
10	,	,	O	,	_	0	SENT_201	[p13l1394t3140r1736b3195],
11	functional	JJ	O	functional	amod	13	SENT_201	[p13l1775t3114r2152b3180],
12	genetic	JJ	O	genetic	amod	13	SENT_201	[p13l8t3223r273b3309],
13	variants	NNS	O	variant	dobj	8	SENT_201	[p13l310t3223r598b3286],
14	in	IN	O	in	_	0	SENT_201	[p13l640t3223r710b3285],
15	drug	NN	O	drug	prep_in	8	SENT_201	[p13l752t3220r1446b3309],
16	—	CD	NUMBER	—	num	15	SENT_201	[p13l752t3220r1446b3309],
17	metabolizing	VBG	O	metabolize	xcomp	8	SENT_201	[p13l752t3220r1446b3309],
18	enzymes	NNS	O	enzyme	nsubj	34	SENT_201	[p13l1486t3246r1795b3309],
19	or	CC	O	or	_	0	SENT_201	[p13l1839t3246r1913b3286],
20	a	DT	O	a	det	22	SENT_201	[p13l1954t3246r1988b3286],
21	hepatic	JJ	O	hepatic	amod	22	SENT_201	[p13l2028t3220r2147b3286, p13l8t3329r186b3415],
22	transporter	NN	O	transporter	nsubj	34	SENT_201	[p13l228t3343r639b3415],
23	that	WDT	O	that	nsubjpass	25	SENT_201	[p13l679t3326r826b3392],
24	were	VBD	O	be	auxpass	25	SENT_201	[p13l862t3352r1035b3392],
25	associated	VBN	O	associate	rcmod	22	SENT_201	[p13l1080t3326r1449b3392],
26	with	IN	O	with	_	0	SENT_201	[p13l1487t3326r1655b3392],
27	a	DT	O	a	det	29	SENT_201	[p13l1698t3352r1733b3392],
28	composite	JJ	O	composite	amod	29	SENT_201	[p13l1774t3329r2149b3415],
29	measure	NN	O	measure	prep_with	25	SENT_201	[p13l10t3458r309b3498],
30	of	IN	O	of	_	0	SENT_201	[p13l360t3432r441b3498],
31	mild	JJ	O	mild	amod	33	SENT_201	[p13l479t3432r646b3498],
32	statin	NN	O	statin	nn	33	SENT_201	[p13l695t3432r1233b3498],
33	—	NN	O	—	prep_of	29	SENT_201	[p13l695t3432r1233b3498],
34	induced	VBD	O	induce	ccomp	17	SENT_201	[p13l695t3432r1233b3498],
35	side	JJ	O	side	amod	36	SENT_201	[p13l1282t3432r1422b3498],
36	effects	NNS	O	effect	dobj	34	SENT_201	[p13l1472t3432r1697b3498],
37	in	IN	O	in	_	0	SENT_201	[p13l1748t3435r1817b3497],
38	a	DT	O	a	det	45	SENT_201	[p13l1867t3458r1901b3498],
39	large	JJ	O	large	amod	45	SENT_201	[p13l1947t3432r2147b3521],
40	,	,	O	,	_	0	SENT_201	[p13l1947t3432r2147b3521],
41	prospective	JJ	O	prospective	amod	45	SENT_201	[p13l8t3541r425b3627],
42	pharmacogenetics	NNS	O	pharmacogenetic	nn	45	SENT_201	[p13l474t3538r1138b3627],
43	statin	NN	O	statin	nn	45	SENT_201	[p13l1190t3541r1393b3604],
44	challenge	NN	O	challenge	nn	45	SENT_201	[p13l1442t3538r1787b3627],
45	study	NN	O	study	prep_in	36	SENT_201	[p13l1839t3538r2035b3627],
46	in	IN	O	in	_	0	SENT_201	[p13l2080t3541r2150b3603],
47	which	WDT	O	which	rel	54	SENT_201	[p13l6t3644r231b3711],
48	one	CD	NUMBER	one	nsubj	54	SENT_201	[p13l274t3670r403b3710],
49	of	IN	O	of	_	0	SENT_201	[p13l446t3644r528b3710],
50	the	DT	O	the	det	52	SENT_201	[p13l557t3644r671b3710],
51	primary	JJ	O	primary	amod	52	SENT_201	[p13l713t3647r1005b3733],
52	objectives	NNS	O	objective	prep_of	48	SENT_201	[p13l1044t3644r1401b3733],
53	was	VBD	O	be	aux	54	SENT_201	[p13l1441t3670r1574b3710],
54	understanding	VBG	O	understand	rcmod	36	SENT_201	[p13l1617t3644r2152b3733],
55	statin	NN	O	statin	nn	56	SENT_201	[p14l11t19r213b82],
56	safety	NN	O	safety	dobj	54	SENT_201	[p14l255t16r482b105],
57	.	.	O	.	_	0	SENT_201	[p14l255t16r482b105],

1	We	PRP	O	we	nsubj	2	SENT_202	[p14l523t17r656b83],
2	deﬁned	VBD	O	deﬁned	_	0	SENT_202	[p14l698t16r969b82],
3	a	DT	O	a	det	4	SENT_202	[p14l1010t42r1044b82],
4	CAB	NN	O	cab	dobj	2	SENT_202	[p14l1085t14r1276b83],
5	as	IN	O	as	_	0	SENT_202	[p14l1320t42r1385b82],
6	discontinuation	NN	O	discontinuation	prep_as	4	SENT_202	[p14l1428t16r2007b82],
7	for	IN	O	for	_	0	SENT_202	[p14l2047t16r2152b82],
8	any	DT	O	any	det	10	SENT_202	[p14l11t148r138b211],
9	side	JJ	O	side	amod	10	SENT_202	[p14l189t122r329b188],
10	effect	NN	O	effect	prep_for	6	SENT_202	[p14l383t122r598b203],
11	,	,	O	,	_	0	SENT_202	[p14l383t122r598b203],
12	the	DT	O	the	det	13	SENT_202	[p14l654t122r768b188],
13	development	NN	O	development	dobj	2	SENT_202	[p14l823t122r1299b211],
14	of	IN	O	of	_	0	SENT_202	[p14l1351t122r1433b188],
15	myalgia	NN	O	myalgium	prep_of	13	SENT_202	[p14l1475t122r1780b211],
16	,	,	O	,	_	0	SENT_202	[p14l1475t122r1780b211],
17	and	CC	O	and	_	0	SENT_202	[p14l1838t122r1969b188],
18	CK	NN	O	ck	nn	19	SENT_202	[p14l2024t122r2153b188],
19	elevation	NN	O	elevation	dep	20	SENT_202	[p14l10t228r340b294],
20	>	JJR	O	>	dobj	2	SENT_202	[p14l394t231r573b294],
21	3	CD	NUMBER	3	number	22	SENT_202	[p14l394t231r573b294],
22	>	JJR	O	>	amod	20	SENT_202	[p14l394t231r573b294],
23	<	JJR	O	<	amod	25	SENT_202	[p14l394t231r573b294],
24	upper	JJ	O	upper	amod	25	SENT_202	[p14l630t254r841b317],
25	limit	NN	O	limit	tmod	2	SENT_202	[p14l887t228r1064b294],
26	of	IN	O	of	_	0	SENT_202	[p14l1112t228r1194b294],
27	normal	JJ	O	normal	prep_of	25	SENT_202	[p14l1231t228r1511b294],
28	.	.	O	.	_	0	SENT_202	[p14l1231t228r1511b294],

1	We	PRP	O	we	nsubj	2	SENT_203	[p14l1559t229r1692b295],
2	found	VBD	O	find	_	0	SENT_203	[p14l1741t228r1957b294],
3	that	IN	O	that	complm	11	SENT_203	[p14l2005t228r2152b294],
4	acid	NN	O	acid	nn	7	SENT_203	[p14l12t337r158b404],
5	transporter	NN	O	transporter	nn	7	SENT_203	[p14l201t355r609b427],
6	SLCOJB	NN	O	slcojb	nn	7	SENT_203	[p14l655t341r1023b404],
7	]	NN	O	]	nsubj	11	SENT_203	[p14l655t341r1023b404],
8	and	CC	O	and	_	0	SENT_203	[p14l1072t337r1203b404],
9	female	JJ	O	female	amod	10	SENT_203	[p14l1246t337r1486b404],
10	subjects	NNS	O	subject	nsubj	11	SENT_203	[p14l1533t338r1816b427],
11	were	VBD	O	be	ccomp	2	SENT_203	[p14l1859t363r2030b404],
12	at	IN	O	at	_	0	SENT_203	[p14l2077t355r2142b404],
13	greater	JJR	O	greater	amod	14	SENT_203	[p14l9t464r265b536],
14	risk	NN	O	risk	prep_at	11	SENT_203	[p14l310t447r446b513],
15	of	IN	O	of	_	0	SENT_203	[p14l489t446r571b513],
16	developing	VBG	O	develop	prepc_of	14	SENT_203	[p14l606t447r1007b536],
17	this	DT	O	this	det	18	SENT_203	[p14l1052t446r1184b513],
18	CAE	NN	O	ca	dobj	16	SENT_203	[p14l1234t445r1446b513],
19	.	.	O	.	_	0	SENT_203	[p14l1234t445r1446b513],

1	This	DT	O	this	det	2	SENT_204	[p14l1494t445r1663b513],
2	ﬁnding	NN	O	ﬁnding	nsubj	5	SENT_204	[p14l1711t446r1975b536],
3	not	RB	O	not	neg	4	SENT_204	[p14l2022t464r2142b513],
4	only	RB	O	only	preconj	5	SENT_204	[p14l11t555r169b645],
5	conﬁrms	VBZ	O	conﬁrms	_	0	SENT_204	[p14l212t555r527b622],
6	the	DT	O	the	det	7	SENT_204	[p14l575t555r688b622],
7	association	NN	O	association	nsubj	11	SENT_204	[p14l737t558r1137b622],
8	with	IN	O	with	_	0	SENT_204	[p14l1179t556r1346b622],
9	simvastatin	NN	O	simvastatin	nn	10	SENT_204	[p14l1394t555r2141b622],
10	—	NN	O	—	prep_with	7	SENT_204	[p14l1394t555r2141b622],
11	induced	VBD	O	induce	ccomp	5	SENT_204	[p14l1394t555r2141b622],
12	myopathy	NN	O	myopathy	dobj	11	SENT_204	[p14l11t664r376b754],
13	with	IN	O	with	_	0	SENT_204	[p14l422t665r588b731],
14	CK	NN	O	ck	nn	15	SENT_204	[p14l644t664r772b731],
15	elevations	NNS	O	elevation	prep_with	11	SENT_204	[p14l824t664r1184b731],
16	identiﬁed	VBN	O	identiﬁed	partmod	15	SENT_204	[p14l1239t664r1590b731],
17	in	IN	O	in	_	0	SENT_204	[p14l1643t667r1712b730],
18	a	DT	O	a	det	22	SENT_204	[p14l1767t691r1801b731],
19	genome	NN	O	genome	nn	22	SENT_204	[p14l1852t691r2139b754],
20	wide	JJ	O	wide	amod	22	SENT_204	[p14l7t773r180b840],
21	association	NN	O	association	nn	22	SENT_204	[p14l218t777r618b840],
22	study	NN	O	study	prep_in	16	SENT_204	[p14l655t774r851b863],
23	(	CD	NUMBER	(	number	24	SENT_204	[p14l885t771r1028b854],
24	14	CD	NUMBER	14	num	25	SENT_204	[p14l885t771r1028b854],
25	)	NN	O	)	dep	16	SENT_204	[p14l885t771r1028b854],
26	but	CC	O	but	_	0	SENT_204	[p14l1065t773r1187b840],
27	also	RB	O	also	advmod	28	SENT_204	[p14l1222t773r1358b840],
28	expands	VBZ	O	expand	conj_but	5	SENT_204	[p14l1395t773r1686b863],
29	this	DT	O	this	det	30	SENT_204	[p14l1722t773r1854b840],
30	association	NN	O	association	dobj	28	SENT_204	[p14l1893t776r2137b840, p14l12t885r195b948],
31	to	TO	O	to	_	0	SENT_204	[p14l246t899r316b948],
32	the	DT	O	the	det	36	SENT_204	[p14l368t882r482b948],
33	most	RBS	O	most	advmod	34	SENT_204	[p14l535t899r713b948],
34	common	JJ	O	common	amod	36	SENT_204	[p14l764t908r1084b948],
35	statin	NN	O	statin	nn	36	SENT_204	[p14l1136t882r1671b948],
36	—	NN	O	—	prep_to	28	SENT_204	[p14l1136t882r1671b948],
37	induced	VBD	O	induce	rcmod	36	SENT_204	[p14l1136t882r1671b948],
38	side	JJ	O	side	amod	39	SENT_204	[p14l1723t882r1862b948],
39	effects	NNS	O	effect	nsubj	40	SENT_204	[p14l1915t882r2139b948],
40	(	VBP	O	(	ccomp	37	SENT_204	[p14l13t991r191b1082],
41	e.g.	FW	O	e.g.	dobj	40	SENT_204	[p14l13t991r191b1082],
42	,	,	O	,	_	0	SENT_204	[p14l13t991r191b1082],
43	myalgia	NN	O	myalgium	conj_or	41	SENT_204	[p14l249t993r533b1082],
44	or	CC	O	or	_	0	SENT_204	[p14l587t1018r661b1059],
45	muscle	NN	O	muscle	nn	46	SENT_204	[p14l715t992r964b1059],
46	ache	NN	O	ache	conj_or	41	SENT_204	[p14l1021t992r1181b1059],
47	without	IN	O	without	_	0	SENT_204	[p14l1233t992r1524b1059],
48	signiﬁcant	JJ	O	signiﬁcant	amod	49	SENT_204	[p14l1579t992r1960b1082],
49	CK	NN	O	ck	prep_without	40	SENT_204	[p14l2015t992r2143b1059],

1	elevations	NNS	O	elevation	nsubj	6	SENT_205	[p14l11t1136r400b1219],
2	)	CD	NUMBER	)	num	1	SENT_205	[p14l11t1136r400b1219],
3	in	IN	O	in	_	0	SENT_205	[p14l447t1141r516b1204],
4	a	DT	O	a	det	5	SENT_205	[p14l560t1165r595b1205],
5	population	NN	O	population	prep_in	1	SENT_205	[p14l635t1138r1033b1228],
6	treated	VBN	O	treat	_	0	SENT_205	[p14l1076t1138r1331b1205],
7	with	IN	O	with	_	0	SENT_205	[p14l1369t1139r1536b1205],
8	various	JJ	O	various	amod	9	SENT_205	[p14l1575t1141r1835b1205],
9	statins	NNS	O	statin	prep_with	6	SENT_205	[p14l1881t1141r2136b1205],
10	.	.	O	.	_	0	SENT_205	[p14l1881t1141r2136b1205],

1	Further	RB	O	further	advmod	4	SENT_206	[p14l11t1247r312b1328],
2	,	,	O	,	_	0	SENT_206	[p14l11t1247r312b1328],
3	we	PRP	O	we	nsubj	4	SENT_206	[p14l344t1274r444b1314],
4	found	VBD	O	find	_	0	SENT_206	[p14l478t1247r693b1314],
5	that	IN	O	that	complm	12	SENT_206	[p14l725t1248r871b1314],
6	the	DT	O	the	det	7	SENT_206	[p14l903t1248r1016b1314],
7	risk	NN	O	risk	nsubj	12	SENT_206	[p14l1050t1248r1186b1314],
8	of	IN	O	of	_	0	SENT_206	[p14l1215t1247r1297b1314],
9	the	DT	O	the	det	10	SENT_206	[p14l1318t1248r1431b1314],
10	CAB	NN	O	cab	prep_of	7	SENT_206	[p14l1467t1246r1658b1314],
11	was	VBD	O	be	cop	12	SENT_206	[p14l1689t1274r1821b1314],
12	greatest	JJS	O	greatest	ccomp	4	SENT_206	[p14l1855t1264r2142b1337],
13	in	IN	O	in	_	0	SENT_206	[p14l10t1359r80b1422],
14	those	DT	O	those	det	16	SENT_206	[p14l111t1356r305b1422],
15	SLCOJB1	NN	O	slcojb1	nn	16	SENT_206	[p14l341t1359r790b1423],
16	*	NN	O	*	prep_in	12	SENT_206	[p14l341t1359r790b1423],
17	5	CD	NUMBER	5	num	18	SENT_206	[p14l341t1359r790b1423],
18	carriers	NNS	O	carrier	dep	16	SENT_206	[p14l819t1359r1084b1423],
19	assigned	VBN	O	assign	partmod	16	SENT_206	[p14l1119t1356r1427b1445],
20	to	TO	O	to	_	0	SENT_206	[p14l1458t1373r1528b1422],
21	simvastatin	NN	O	simvastatin	nn	49	SENT_206	[p14l1563t1359r1976b1423],
22	and	CC	O	and	_	0	SENT_206	[p14l2010t1356r2141b1423],
23	negligible	JJ	O	negligible	nn	49	SENT_206	[p14l11t1466r369b1555],
24	in	IN	O	in	_	0	SENT_206	[p14l405t1469r474b1532],
25	those	DT	O	those	prep_in	23	SENT_206	[p14l509t1466r703b1532],
26	assigned	VBN	O	assign	dep	25	SENT_206	[p14l740t1466r1048b1555],
27	to	TO	O	to	_	0	SENT_206	[p14l1082t1483r1152b1532],
28	pravastatin	NN	O	pravastatin	prep_to	26	SENT_206	[p14l1188t1469r1591b1556],
29	and	CC	O	and	_	0	SENT_206	[p14l1627t1466r1759b1532],
30	is	VBZ	O	be	cop	31	SENT_206	[p14l1793t1469r1845b1532],
31	consistent	JJ	O	consistent	conj_and	26	SENT_206	[p14l1883t1469r2137b1532, p14l10t1592r155b1641],
32	with	IN	O	with	_	0	SENT_206	[p14l190t1575r357b1641],
33	our	PRP$	O	we	poss	34	SENT_206	[p14l397t1600r518b1641],
34	observation	NN	O	observation	prep_with	31	SENT_206	[p14l557t1575r979b1641],
35	that	IN	O	that	complm	44	SENT_206	[p14l1019t1575r1166b1641],
36	the	DT	O	the	det	39	SENT_206	[p14l1204t1575r1317b1641],
37	acid	NN	O	acid	nn	39	SENT_206	[p14l1359t1575r1505b1641],
38	metabolite	NN	O	metabolite	nn	39	SENT_206	[p14l1545t1575r1933b1641],
39	concentration	NN	O	concentration	nsubj	44	SENT_206	[p14l1975t1601r2137b1641, p14l11t1687r385b1750],
40	of	IN	O	of	_	0	SENT_206	[p14l420t1684r502b1750],
41	the	DT	O	the	det	42	SENT_206	[p14l524t1684r638b1750],
42	drug	NN	O	drug	prep_of	39	SENT_206	[p14l674t1684r831b1773],
43	was	VBD	O	be	cop	44	SENT_206	[p14l857t1710r982b1750],
44	elevated	JJ	O	elevated	ccomp	31	SENT_206	[p14l1016t1684r1288b1750],
45	in	IN	O	in	_	0	SENT_206	[p14l1318t1687r1384b1750],
46	carriers	NNS	O	carrier	prep_in	44	SENT_206	[p14l1416t1687r1656b1750],
47	who	WP	O	who	nsubj	48	SENT_206	[p14l1686t1684r1834b1751],
48	received	VBD	O	receive	rcmod	46	SENT_206	[p14l1867t1684r2141b1751],
49	simvastatin	NN	O	simvastatin	prep_to	19	SENT_206	[p14l12t1797r390b1860],
50	but	CC	O	but	_	0	SENT_206	[p14l417t1794r533b1860],
51	not	RB	O	not	_	0	SENT_206	[p14l561t1811r675b1860],
52	in	IN	O	in	_	0	SENT_206	[p14l703t1797r769b1859],
53	subjects	NNS	O	subject	prep_in	19	SENT_206	[p14l799t1794r1059b1883],
54	receiving	VBG	O	receive	partmod	53	SENT_206	[p14l1089t1797r1393b1883],
55	pravastatin	NN	O	pravastatin	dobj	54	SENT_206	[p14l1420t1797r1804b1883],
56	.	.	O	.	_	0	SENT_206	[p14l1420t1797r1804b1883],

1	Although	IN	O	although	mark	8	SENT_207	[p14l96t1901r441b1992],
2	the	DT	O	the	det	4	SENT_207	[p14l469t1903r579b1969],
3	precise	JJ	O	precise	amod	4	SENT_207	[p14l606t1906r847b1992],
4	mechanisms	NNS	O	mechanism	nsubj	8	SENT_207	[p14l876t1903r1308b1969],
5	for	IN	O	for	_	0	SENT_207	[p14l1337t1903r1438b1969],
6	statin	NN	O	statin	nn	7	SENT_207	[p14l1465t1903r1977b1969],
7	—	NN	O	—	prep_for	4	SENT_207	[p14l1465t1903r1977b1969],
8	induced	VBD	O	induce	advcl	17	SENT_207	[p14l1465t1903r1977b1969],
9	side	JJ	O	side	amod	10	SENT_207	[p14l2006t1903r2140b1969],
10	effects	NNS	O	effect	nsubj	12	SENT_207	[p14l11t2012r224b2078],
11	are	VBP	O	be	cop	12	SENT_207	[p14l252t2038r353b2078],
12	unknown	JJ	O	unknown	ccomp	8	SENT_207	[p14l378t2012r731b2093],
13	,	,	O	,	_	0	SENT_207	[p14l378t2012r731b2093],
14	they	PRP	O	they	nsubjpass	17	SENT_207	[p14l759t2012r912b2101],
15	likely	RB	O	likely	advmod	17	SENT_207	[p14l932t2012r1124b2101],
16	are	VBP	O	be	auxpass	17	SENT_207	[p14l1146t2038r1247b2078],
17	caused	VBN	O	cause	_	0	SENT_207	[p14l1273t2012r1505b2078],
18	by	IN	O	by	_	0	SENT_207	[p14l1527t2012r1613b2101],
19	a	DT	O	a	det	20	SENT_207	[p14l1636t2038r1670b2078],
20	combination	NN	O	combination	agent	17	SENT_207	[p14l1694t2012r2140b2078],
21	of	IN	O	of	_	0	SENT_207	[p14l11t2122r91b2188],
22	patient	NN	O	patient	nn	25	SENT_207	[p14l108t2125r356b2211],
23	and	CC	O	and	_	0	SENT_207	[p14l387t2122r514b2188],
24	statin	NN	O	statin	nn	25	SENT_207	[p14l545t2125r738b2188],
25	characteristics	NNS	O	characteristic	prep_of	20	SENT_207	[p14l769t2122r1282b2188],
26	.	.	O	.	_	0	SENT_207	[p14l769t2122r1282b2188],

1	Several	JJ	O	several	amod	2	SENT_208	[p14l1321t2122r1569b2188],
2	patient	NN	O	patient	nsubj	28	SENT_208	[p14l1597t2122r2141b2211],
3	—	CD	NUMBER	—	num	6	SENT_208	[p14l1597t2122r2141b2211],
4	speciﬁc	NN	O	speciﬁc	nn	6	SENT_208	[p14l1597t2122r2141b2211],
5	risk	NN	O	risk	nn	6	SENT_208	[p14l10t2231r141b2297],
6	characteristics	NNS	O	characteristic	nsubjpass	9	SENT_208	[p14l176t2231r669b2297],
7	have	VBP	O	have	aux	9	SENT_208	[p14l709t2231r867b2297],
8	been	VBN	O	be	auxpass	9	SENT_208	[p14l905t2231r1071b2297],
9	identiﬁed	VBN	O	identiﬁed	rcmod	2	SENT_208	[p14l1110t2231r1447b2297],
10	such	JJ	O	such	_	0	SENT_208	[p14l1486t2231r1642b2297],
11	as	IN	O	as	_	0	SENT_208	[p14l1683t2257r1746b2297],
12	older	JJR	O	older	amod	13	SENT_208	[p14l1787t2231r1966b2297],
13	age	NN	O	age	prep_such_as	9	SENT_208	[p14l2004t2257r2137b2320],
14	,	,	O	,	_	0	SENT_208	[p14l2004t2257r2137b2320],
15	reduced	VBD	O	reduce	partmod	13	SENT_208	[p14l10t2340r288b2406],
16	body	NN	O	body	nn	17	SENT_208	[p14l331t2340r507b2429],
17	mass	NN	O	mass	dobj	15	SENT_208	[p14l550t2366r738b2421],
18	,	,	O	,	_	0	SENT_208	[p14l550t2366r738b2421],
19	hypothyroidism	NN	O	hypothyroidism	conj_and	17	SENT_208	[p14l787t2340r1367b2429],
20	,	,	O	,	_	0	SENT_208	[p14l787t2340r1367b2429],
21	and	CC	O	and	_	0	SENT_208	[p14l1417t2340r1544b2406],
22	female	JJ	O	female	amod	23	SENT_208	[p14l1589t2340r1821b2406],
23	sex	NN	O	sex	dobj	15	SENT_208	[p14l1869t2366r1974b2406],
24	+	CC	O	+	_	0	SENT_208	[p14l2021t2338r2136b2420],
25	Our	PRP$	O	we	poss	26	SENT_208	[p14l12t2448r157b2515],
26	ﬁndings	NNS	O	ﬁndings	conj_+	23	SENT_208	[p14l193t2448r476b2538],
27	are	VBP	O	be	cop	28	SENT_208	[p14l518t2474r618b2515],
28	consistent	JJ	O	consistent	dep	39	SENT_208	[p14l658t2451r1013b2515],
29	with	IN	O	with	_	0	SENT_208	[p14l1046t2448r1207b2515],
30	a	DT	O	a	det	32	SENT_208	[p14l1246t2475r1281b2515],
31	previous	JJ	O	previous	amod	32	SENT_208	[p14l1317t2451r1610b2538],
32	association	NN	O	association	prep_with	28	SENT_208	[p14l1651t2451r2034b2515],
33	of	IN	O	of	_	0	SENT_208	[p14l2073t2448r2153b2515],
34	female	JJ	O	female	amod	35	SENT_208	[p14l10t2557r242b2624],
35	sex	NN	O	sex	prep_of	32	SENT_208	[p14l292t2584r397b2624],
36	and	CC	O	and	_	0	SENT_208	[p14l445t2557r572b2624],
37	simvastatin	NN	O	simvastatin	nn	38	SENT_208	[p14l620t2557r1336b2624],
38	—	NN	O	—	prep_of	32	SENT_208	[p14l620t2557r1336b2624],
39	induced	VBD	O	induce	_	0	SENT_208	[p14l620t2557r1336b2624],
40	myopathy	JJ	O	myopathy	amod	41	SENT_208	[p14l1384t2558r1737b2647],
41	(	NN	O	(	dobj	39	SENT_208	[p14l1784t2555r1943b2638],
42	14	CD	NUMBER	14	num	43	SENT_208	[p14l1784t2555r1943b2638],
43	)	NN	O	)	nsubj	39	SENT_208	[p14l1784t2555r1943b2638],
44	.	.	O	.	_	0	SENT_208	[p14l1784t2555r1943b2638],

1	The	DT	O	the	_	0	SENT_209	[p14l1993t2556r2139b2624],

1	1614	CD	DATE	1614	num	2	SENT_210	[p14l45t2722r113b2747],
2	Voora	NNP	O	Voora	_	0	SENT_210	[p14l192t2722r268b2747],
3	et	FW	O	et	nn	4	SENT_210	[p14l279t2723r306b2747],
4	al.	FW	O	al.	dep	2	SENT_210	[p14l313t2722r344b2747],
5	.	.	O	.	_	0	SENT_210	[p14l313t2722r344b2747],

1	JACC	NNP	O	JACC	nn	2	SENT_211	[p14l1808t2723r1862b2747],
2	Vol	NNP	O	Vol	_	0	SENT_211	[p14l1871t2723r1910b2747],
3	.	.	O	.	_	0	SENT_211	[p14l1871t2723r1910b2747],

1	54	CD	NUMBER	54	_	0	SENT_212	[p14l1922t2723r1956b2751],
2	,	,	O	,	_	0	SENT_212	[p14l1922t2723r1956b2751],
3	No.	NN	O	no.	appos	1	SENT_212	[p14l1968t2723r2002b2747],
4	17	CD	NUMBER	17	num	3	SENT_212	[p14l2014t2723r2048b2751],
5	,	,	O	,	_	0	SENT_212	[p14l2014t2723r2048b2751],
6	2009	CD	DATE	2009	num	7	SENT_212	[p14l2059t2723r2117b2747],
7	Phannacogenetics	NNS	O	phannacogenetic	appos	1	SENT_212	[p14l194t2759r439b2789],
8	of	IN	O	of	_	0	SENT_212	[p14l448t2759r474b2784],
9	Statin	NNP	O	Statin	nn	11	SENT_212	[p14l482t2759r560b2784],
10	Side	NNP	O	Side	nn	11	SENT_212	[p14l569t2759r626b2784],
11	Elfects	NNP	O	Elfects	prep_of	7	SENT_212	[p14l636t2759r724b2784],
12	October	NNP	DATE	October	tmod	11	SENT_212	[p14l1807t2760r1891b2784],
13	20	CD	DATE	20	num	12	SENT_212	[p14l1900t2760r1935b2788],
14	,	,	O	,	_	0	SENT_212	[p14l1900t2760r1935b2788],
15	2009:1609	CD	NUMBER	2009:1609	num	12	SENT_212	[p14l1946t2760r2117b2784],
16	—	CD	NUMBER	—	num	17	SENT_212	[p14l1946t2760r2117b2784],
17	16	CD	NUMBER	16	dep	1	SENT_212	[p14l1946t2760r2117b2784],

1	Table	NNP	O	Table	_	0	SENT_213	[p14l68t2882r147b2905],
2	3	CD	NUMBER	3	num	1	SENT_213	[p14l160t2881r177b2905],
3	Simvastatin	NNP	O	Simvastatin	dep	1	SENT_213	[p14l229t2881r404b2905],
4	and	CC	O	and	_	0	SENT_213	[p14l418t2881r469b2905],
5	Pravastatin	NNP	O	Pravastatin	nn	7	SENT_213	[p14l484t2881r651b2905],
6	Metabolite	NNP	O	Metabolite	nn	7	SENT_213	[p14l666t2881r825b2905],
7	Concentrations	NNPS	O	Concentrations	conj_and	3	SENT_213	[p14l838t2881r1064b2905],
8	in	IN	O	in	_	0	SENT_213	[p14l1078t2881r1101b2905],
9	the	DT	O	the	det	11	SENT_213	[p14l1114t2881r1162b2905],
10	STRENGTH	NN	O	strength	nn	11	SENT_213	[p14l1174t2881r1335b2905],
11	Study	NN	O	study	prep_in	7	SENT_213	[p14l1348t2881r1432b2911],

1	Sex	NN	O	sex	_	0	SENT_214	[p14l1525t2988r1615b3027],

1	Metabolite	NN	O	metabolite	nn	2	SENT_215	[p14l269t3113r532b3152],
2	Male	NN	O	male	_	0	SENT_215	[p14l1167t3113r1285b3152],
3	Female	JJ	O	female	dep	2	SENT_215	[p14l1830t3113r2003b3152],

1	Simvastatin	NNP	O	Simvastatin	nn	2	SENT_216	[p14l58t3206r334b3245],
2	acid	NN	O	acid	_	0	SENT_216	[p14l355t3207r448b3245],
3	(	RB	O	(	advmod	6	SENT_216	[p14l470t3206r547b3253],
4	20	CD	NUMBER	20	num	6	SENT_216	[p14l470t3206r547b3253],
5	mg	NN	O	mg	nn	6	SENT_216	[p14l568t3207r656b3254],
6	)	NN	O	)	dep	2	SENT_216	[p14l568t3207r656b3254],
7	28	CD	NUMBER	28	number	8	SENT_216	[p14l1195t3206r1256b3245],
8	30	CD	NUMBER	30	amod	6	SENT_216	[p14l1885t3206r1946b3245],

1	1.7	CD	NUMBER	1.7	num	2	SENT_217	[p14l1058t3279r1130b3317],
2	[	CD	NUMBER	[	dep	9	SENT_217	[p14l1150t3279r1360b3326],
3	O.	NNP	O	O.	dep	2	SENT_217	[p14l1150t3279r1360b3326],
4	8	CD	NUMBER	8	number	5	SENT_217	[p14l1150t3279r1360b3326],
5	—	CD	NUMBER	—	dep	3	SENT_217	[p14l1150t3279r1360b3326],
6	2.9	CD	NUMBER	2.9	num	7	SENT_217	[p14l1150t3279r1360b3326],
7	]	NN	O	]	dep	9	SENT_217	[p14l1150t3279r1360b3326],
8	1.1	CD	NUMBER	1.1	num	9	SENT_217	[p14l1748t3279r1823b3317],
9	[	NN	O	[	dep	13	SENT_217	[p14l1841t3279r2050b3326],
10	0.4	CD	NUMBER	0.4	num	11	SENT_217	[p14l1841t3279r2050b3326],
11	—	NN	O	—	dep	9	SENT_217	[p14l1841t3279r2050b3326],
12	2.1	CD	NUMBER	2.1	num	13	SENT_217	[p14l1841t3279r2050b3326],
13	]	NN	O	]	_	0	SENT_217	[p14l1841t3279r2050b3326],

1	Simvastatin	NNP	PERSON	Simvastatin	nn	2	SENT_218	[p14l58t3448r334b3486],
2	Iactone	NNP	PERSON	Iactone	_	0	SENT_218	[p14l357t3448r526b3486],
3	(	CD	NUMBER	(	number	4	SENT_218	[p14l545t3448r623b3495],
4	20	CD	NUMBER	20	num	6	SENT_218	[p14l545t3448r623b3495],
5	mg	NN	O	mg	nn	6	SENT_218	[p14l644t3448r732b3495],
6	)	NN	O	)	dep	2	SENT_218	[p14l644t3448r732b3495],
7	28	CD	NUMBER	28	number	8	SENT_218	[p14l1195t3448r1256b3486],
8	30	CD	NUMBER	30	amod	6	SENT_218	[p14l1885t3448r1946b3486],

1	0.5	CD	NUMBER	0.5	number	2	SENT_219	[p14l1057t3525r1131b3564],
2	[	CD	NUMBER	[	_	0	SENT_219	[p14l1150t3525r1360b3572],
3	0.2-1	CD	NUMBER	0.2-1	num	5	SENT_219	[p14l1150t3525r1360b3572],
4	.0	CD	NUMBER	.0	num	5	SENT_219	[p14l1150t3525r1360b3572],
5	]	NN	O	]	dep	2	SENT_219	[p14l1150t3525r1360b3572],
6	0.4	CD	NUMBER	0.4	num	8	SENT_219	[p14l1747t3525r1822b3564],
7	[	CD	NUMBER	[	num	8	SENT_219	[p14l1841t3525r2050b3572],
8	O.3-0	NN	O	o.3-0	dep	2	SENT_219	[p14l1841t3525r2050b3572],
9	.8	CD	NUMBER	.8	num	10	SENT_219	[p14l1841t3525r2050b3572],
10	]	NN	O	]	dep	8	SENT_219	[p14l1841t3525r2050b3572],

1	Simvastatin	NNP	O	Simvastatin	nn	2	SENT_220	[p14l58t3602r334b3640],
2	acid	NN	O	acid	_	0	SENT_220	[p14l355t3602r448b3640],
3	(	CD	NUMBER	(	number	4	SENT_220	[p14l470t3602r547b3649],
4	80	CD	NUMBER	80	num	6	SENT_220	[p14l470t3602r547b3649],
5	mg	NN	O	mg	nn	6	SENT_220	[p14l568t3602r656b3650],
6	)	NN	O	)	dep	2	SENT_220	[p14l568t3602r656b3650],
7	27	CD	NUMBER	27	num	8	SENT_220	[p14l1195t3602r1255b3640],
8	26	CD	NUMBER	26	dep	6	SENT_220	[p14l1885t3602r1946b3640],

1	Simvastatin	NNP	O	Simvastatin	nn	2	SENT_221	[p14l58t3756r334b3795],
2	Iactone	NNP	O	Iactone	_	0	SENT_221	[p14l357t3757r526b3795],
3	(	CD	NUMBER	(	number	4	SENT_221	[p14l545t3756r623b3803],
4	80	CD	NUMBER	80	num	6	SENT_221	[p14l545t3756r623b3803],
5	mg	NN	O	mg	nn	6	SENT_221	[p14l644t3757r732b3804],
6	)	NN	O	)	dep	2	SENT_221	[p14l644t3757r732b3804],
7	27	CD	NUMBER	27	num	8	SENT_221	[p14l1195t3756r1255b3794],
8	26	CD	NUMBER	26	dep	6	SENT_221	[p14l1885t3756r1946b3795],

1	Pravastatin	NN	O	pravastatin	nn	2	SENT_222	[p15l62t98r322b136],
2	acid	NN	O	acid	_	0	SENT_222	[p15l343t98r437b136],
3	(	CD	NUMBER	(	number	4	SENT_222	[p15l458t97r535b145],
4	10	CD	NUMBER	10	dep	2	SENT_222	[p15l458t97r535b145],
5	mg	NN	O	mg	nn	6	SENT_222	[p15l556t98r644b145],
6	)	NN	O	)	dep	4	SENT_222	[p15l556t98r644b145],

1	Pravastatin	NN	O	pravastatin	nn	2	SENT_223	[p15l62t252r322b290],
2	lactone	NN	O	lactone	_	0	SENT_223	[p15l345t253r514b290],
3	(	CD	NUMBER	(	number	4	SENT_223	[p15l533t252r611b299],
4	10	CD	NUMBER	10	dep	2	SENT_223	[p15l533t252r611b299],
5	mg	NN	O	mg	nn	6	SENT_223	[p15l632t252r720b300],
6	)	NN	O	)	dep	4	SENT_223	[p15l632t252r720b300],

1	Pravastatin	NN	O	pravastatin	nn	2	SENT_224	[p15l62t407r322b445],
2	acid	NN	O	acid	_	0	SENT_224	[p15l343t407r437b445],
3	(	CD	NUMBER	(	number	4	SENT_224	[p15l458t406r535b453],
4	40	CD	NUMBER	40	dep	2	SENT_224	[p15l458t406r535b453],
5	mg	NN	O	mg	nn	6	SENT_224	[p15l556t407r644b454],
6	)	NN	O	)	dep	4	SENT_224	[p15l556t407r644b454],

1	Pravastatin	NN	O	pravastatin	nn	2	SENT_225	[p15l62t560r322b598],
2	lactone	NN	O	lactone	_	0	SENT_225	[p15l345t560r514b598],
3	(	CD	NUMBER	(	number	4	SENT_225	[p15l534t559r611b607],
4	40	CD	NUMBER	40	dep	2	SENT_225	[p15l534t559r611b607],
5	mg	NN	O	mg	nn	6	SENT_225	[p15l632t560r720b607],
6	)	NN	O	)	dep	4	SENT_225	[p15l632t560r720b607],

1	1.1	CD	NUMBER	1.1	number	2	SENT_226	[p15l304t1598r382b1638],
2	[	CD	NUMBER	[	_	0	SENT_226	[p15l401t1598r619b1647],
3	O.	NNP	O	O.	dep	2	SENT_226	[p15l401t1598r619b1647],
4	8	CD	NUMBER	8	number	5	SENT_226	[p15l401t1598r619b1647],
5	—	CD	NUMBER	—	dep	2	SENT_226	[p15l401t1598r619b1647],
6	3.5	CD	NUMBER	3.5	num	7	SENT_226	[p15l401t1598r619b1647],
7	]	NN	O	]	dep	5	SENT_226	[p15l401t1598r619b1647],

1	0.06	CD	NUMBER	0.06	_	0	SENT_227	[p15l1025t637r1132b676],
2	[	CD	NUMBER	[	num	3	SENT_227	[p15l1150t637r1425b684],
3	0.03	CD	NUMBER	0.03	dep	1	SENT_227	[p15l1150t637r1425b684],
4	.	.	O	.	_	0	SENT_227	[p15l1150t637r1425b684],

1	—	NN	O	—	_	0	SENT_228	[p15l1150t637r1425b684],
2	.	.	O	.	_	0	SENT_228	[p15l1150t637r1425b684],

1	O.	NNP	O	O.	_	0	SENT_229	[p15l1150t637r1425b684],
2	11	CD	NUMBER	11	number	3	SENT_229	[p15l1150t637r1425b684],
3	]	CD	NUMBER	]	dep	1	SENT_229	[p15l1150t637r1425b684],
4	SLCO1B1	NN	O	slco1b1	nn	5	SENT_229	[p15l931t718r1174b759],
5	Genotype	NN	O	genotype	dep	3	SENT_229	[p15l1194t718r1432b768],

1	1	CD	NUMBER	1	dep	5	SENT_230	[p15l1829t1515r1859b1554],
2	3.7	CD	NUMBER	3.7	dep	1	SENT_230	[p15l1827t1598r1904b1638],
3	1	CD	NUMBER	1	dep	5	SENT_230	[p15l1829t1679r1859b1719],
4	0.2	CD	NUMBER	0.2	num	5	SENT_230	[p15l1828t1763r1904b1803],
5	1	CD	NUMBER	1	dep	9	SENT_230	[p15l1829t1845r1859b1884],
6	0.002	CD	NUMBER	0.002	num	7	SENT_230	[p15l1828t1928r1971b1968],
7	N	NN	O	n	dep	5	SENT_230	[p15l1854t2012r1914b2060],
8	/	:	O	/	punct	9	SENT_230	[p15l1854t2012r1914b2060],
9	A	DT	O	a	_	0	SENT_230	[p15l1915t2012r1949b2051],

1	N/A	NN	O	n/a	_	0	SENT_231	[p15l1855t2177r1950b2226],

1	Each	DT	O	each	det	2	SENT_232	[p15l44t2368r91b2385],
2	cell	NN	O	cell	nsubj	3	SENT_232	[p15l97t2368r131b2385],
3	contains	VBZ	O	contain	_	0	SENT_232	[p15l137t2368r224b2385],
4	the	DT	O	the	det	5	SENT_232	[p15l229t2368r261b2385],
5	number	NN	O	number	dobj	3	SENT_232	[p15l268t2368r347b2385],
6	tested	VBN	O	test	partmod	5	SENT_232	[p15l351t2368r420b2389],
7	,	,	O	,	_	0	SENT_232	[p15l351t2368r420b2389],
8	median	JJ	O	median	amod	11	SENT_232	[p15l428t2368r503b2385],
9	(	NN	O	(	nn	11	SENT_232	[p15l510t2368r592b2389],
10	ng/ml	NN	O	ng/ml	nn	11	SENT_232	[p15l510t2368r592b2389],
11	)	NN	O	)	dobj	3	SENT_232	[p15l510t2368r592b2389],
12	,	,	O	,	_	0	SENT_232	[p15l510t2368r592b2389],
13	25th	JJ	ORDINAL	25th	amod	16	SENT_232	[p15l598t2368r645b2385],
14	and	CC	ORDINAL	and	_	0	SENT_232	[p15l652t2368r689b2385],
15	75th	JJ	ORDINAL	75th	amod	16	SENT_232	[p15l696t2368r742b2385],
16	percentiles	NNS	O	percentile	appos	11	SENT_232	[p15l749t2368r861b2389],
17	[	VBP	O	[	rcmod	16	SENT_232	[p15l867t2368r890b2389],
18	in	IN	O	in	_	0	SENT_232	[p15l867t2368r890b2389],
19	brackets	NNS	O	bracket	prep_in	17	SENT_232	[p15l898t2368r997b2389],
20	]	RB	O	]	advmod	17	SENT_232	[p15l898t2368r997b2389],
21	,	,	O	,	_	0	SENT_232	[p15l898t2368r997b2389],
22	and	CC	O	and	_	0	SENT_232	[p15l1004t2368r1040b2385],
23	p	NN	O	p	nn	24	SENT_232	[p15l1048t2372r1059b2389],
24	value	NN	O	value	dobj	3	SENT_232	[p15l1064t2368r1118b2385],
25	where	WRB	O	where	advmod	34	SENT_232	[p15l1124t2368r1186b2385],
26	appropriate	JJ	O	appropriate	amod	27	SENT_232	[p15l1192t2368r1310b2389],
27	(	NN	O	(	nsubj	34	SENT_232	[p15l1316t2368r1383b2389],
28	based	VBN	O	base	_	0	SENT_232	[p15l1316t2368r1383b2389],
29	on	IN	O	on	prepc_based_on	27	SENT_232	[p15l1390t2372r1413b2385],
30	linear	JJ	O	linear	amod	31	SENT_232	[p15l1421t2368r1477b2385],
31	regression	NN	O	regression	pobj	27	SENT_232	[p15l1483t2368r1587b2389],
32	on	IN	O	on	_	0	SENT_232	[p15l1594t2372r1618b2385],
33	log	NN	O	log	prep_on	31	SENT_232	[p15l1625t2368r1655b2389],
34	transformed	VBN	O	transform	rcmod	24	SENT_232	[p15l1659t2368r1785b2385],
35	values	NNS	O	value	dobj	34	SENT_232	[p15l1791t2368r1868b2389],
36	)	CD	NUMBER	)	tmod	34	SENT_232	[p15l1791t2368r1868b2389],
37	.	.	O	.	_	0	SENT_232	[p15l1791t2368r1868b2389],

1	*	NN	O	*	nn	3	SENT_233	[p15l1876t2368r1900b2389],
2	p	NN	O	p	nn	3	SENT_233	[p15l1876t2368r1900b2389],
3	value	NN	O	value	_	0	SENT_233	[p15l1905t2368r1959b2385],
4	for	IN	O	for	_	0	SENT_233	[p15l1965t2368r1992b2385],
5	comparison	NN	O	comparison	prep_for	3	SENT_233	[p15l1998t2368r2117b2389],
6	across	IN	O	across	_	0	SENT_233	[p15l10t2424r146b2451],
7	genotypes	NNS	O	genotype	prep_across	3	SENT_233	[p15l163t2418r391b2459],
8	.	.	O	.	_	0	SENT_233	[p15l163t2418r391b2459],

1	N/A	NN	O	n/a	_	0	SENT_234	[p15l62t2478r145b2520],
2	=	JJ	O	=	amod	5	SENT_234	[p15l166t2489r195b2501],
3	no	DT	O	no	det	5	SENT_234	[p15l219t2486r268b2513],
4	available	JJ	O	available	amod	5	SENT_234	[p15l286t2478r476b2513],
5	sample	NN	O	sample	dep	1	SENT_234	[p15l492t2478r660b2520],
6	;	:	O	;	_	0	SENT_234	[p15l492t2478r660b2520],
7	other	JJ	O	other	amod	8	SENT_234	[p15l679t2478r790b2513],
8	abbreviations	NNS	O	abbreviation	dep	1	SENT_234	[p15l806t2478r1094b2513],
9	as	IN	O	as	prep	8	SENT_234	[p15l1110t2486r1158b2513],
10	in	IN	O	in	pcomp	9	SENT_234	[p15l1176t2478r1210b2512],
11	Table	NNP	O	Table	pobj	10	SENT_234	[p15l1227t2478r1342b2513],
12	1	CD	NUMBER	1	num	11	SENT_234	[p15l1361t2477r1397b2512],
13	.	.	O	.	_	0	SENT_234	[p15l1361t2477r1397b2512],

1	reason	NN	O	reason	nsubj	8	SENT_235	[p15l10t2683r232b2722],
2	for	IN	O	for	_	0	SENT_235	[p15l289t2658r387b2722],
3	the	DT	O	the	det	4	SENT_235	[p15l442t2658r550b2722],
4	effect	NN	O	effect	prep_for	1	SENT_235	[p15l609t2658r790b2722],
5	of	IN	O	of	_	0	SENT_235	[p15l846t2658r924b2722],
6	sex	NN	O	sex	prep_of	4	SENT_235	[p15l970t2683r1073b2722],
7	is	VBZ	O	be	cop	8	SENT_235	[p15l1129t2661r1178b2722],
8	unclear	JJ	O	unclear	_	0	SENT_235	[p15l1235t2658r1504b2737],
9	,	,	O	,	_	0	SENT_235	[p15l1235t2658r1504b2737],
10	but	CC	O	but	_	0	SENT_235	[p15l1563t2658r1679b2722],
11	one	CD	NUMBER	one	num	12	SENT_235	[p15l1735t2683r1856b2722],
12	study	NN	O	study	nsubj	13	SENT_235	[p15l1916t2658r2101b2745],
13	identiﬁed	VBD	O	identiﬁed	conj_but	8	SENT_235	[p15l10t2763r341b2827],
14	greater	JJR	O	greater	amod	15	SENT_235	[p15l381t2780r620b2850],
15	concentrations	NNS	O	concentration	dobj	13	SENT_235	[p15l662t2766r1167b2827],
16	of	IN	O	of	_	0	SENT_235	[p15l1210t2763r1289b2827],
17	pravastatin	NN	O	pravastatin	prep_of	15	SENT_235	[p15l1317t2766r1695b2850],
18	in	IN	O	in	_	0	SENT_235	[p15l1736t2766r1802b2827],
19	women	NNS	O	woman	prep_in	13	SENT_235	[p15l1840t2788r2097b2827],
20	than	IN	O	than	advmod	23	SENT_235	[p15l10t2867r165b2931],
21	in	IN	O	in	_	0	SENT_235	[p15l198t2870r264b2930],
22	men	NNS	O	man	prep_in	20	SENT_235	[p15l299t2892r448b2931],
23	(	VBP	O	(	dep	19	SENT_235	[p15l485t2865r641b2945],
24	13	CD	NUMBER	13	number	25	SENT_235	[p15l485t2865r641b2945],
25	)	CD	NUMBER	)	dobj	23	SENT_235	[p15l485t2865r641b2945],
26	.	.	O	.	_	0	SENT_235	[p15l485t2865r641b2945],

1	In	IN	O	in	_	0	SENT_236	[p15l678t2868r753b2930],
2	STRENGTH	NN	O	strength	prep_in	5	SENT_236	[p15l790t2865r1308b2945],
3	,	,	O	,	_	0	SENT_236	[p15l790t2865r1308b2945],
4	we	PRP	O	we	nsubj	5	SENT_236	[p15l1341t2892r1437b2931],
5	found	VBD	O	find	_	0	SENT_236	[p15l1471t2867r1675b2931],
6	no	DT	O	no	det	7	SENT_236	[p15l1708t2892r1792b2931],
7	association	NN	O	association	nsubj	14	SENT_236	[p15l1828t2870r2095b2931, p15l10t2973r148b3034],
8	between	IN	O	between	_	0	SENT_236	[p15l178t2970r455b3034],
9	sex	NN	O	sex	nn	13	SENT_236	[p15l487t2995r587b3034],
10	and	CC	O	and	_	0	SENT_236	[p15l618t2970r739b3034],
11	statin	NN	O	statin	conj_and	9	SENT_236	[p15l770t2973r950b3034],
12	metabolite	NN	O	metabolite	nn	13	SENT_236	[p15l982t2970r1332b3034],
13	concentrations	NNS	O	concentration	prep_between	7	SENT_236	[p15l1364t2973r1847b3034],
14	(	VBP	O	(	ccomp	5	SENT_236	[p15l1882t2968r2097b3048],
15	Table	NNP	O	Table	nsubj	17	SENT_236	[p15l1882t2968r2097b3048],
16	3	CD	NUMBER	3	num	17	SENT_236	[p15l11t3071r94b3151],
17	)	NN	O	)	xcomp	14	SENT_236	[p15l11t3071r94b3151],
18	.	.	O	.	_	0	SENT_236	[p15l11t3071r94b3151],

1	Further	RB	O	further	advmod	15	SENT_237	[p15l122t3073r393b3151],
2	,	,	O	,	_	0	SENT_237	[p15l122t3073r393b3151],
3	the	DT	O	the	det	4	SENT_237	[p15l418t3073r523b3137],
4	association	NN	O	association	nsubj	15	SENT_237	[p15l548t3076r906b3137],
5	of	IN	O	of	_	0	SENT_237	[p15l929t3073r1006b3137],
6	female	JJ	O	female	amod	7	SENT_237	[p15l1017t3073r1236b3137],
7	sex	NN	O	sex	prep_of	4	SENT_237	[p15l1261t3098r1360b3137],
8	with	IN	O	with	_	0	SENT_237	[p15l1379t3073r1531b3137],
9	the	DT	O	the	det	10	SENT_237	[p15l1554t3073r1659b3137],
10	CAE	NNP	O	CAE	prep_with	7	SENT_237	[p15l1684t3071r1865b3137],
11	in	IN	O	in	_	0	SENT_237	[p15l1889t3076r1953b3136],
12	this	DT	O	this	det	13	SENT_237	[p15l1976t3073r2095b3137],
13	analysis	NN	O	analysis	prep_in	10	SENT_237	[p15l12t3177r260b3264],
14	appeared	VBD	O	appear	cop	15	SENT_237	[p15l295t3177r592b3264],
15	consistent	JJ	O	consistent	_	0	SENT_237	[p15l626t3180r957b3241],
16	across	IN	O	across	_	0	SENT_237	[p15l990t3202r1183b3241],
17	statin	NN	O	statin	nn	18	SENT_237	[p15l1219t3180r1399b3241],
18	types	NNS	O	type	prep_across	15	SENT_237	[p15l1432t3194r1616b3264],
19	.	.	O	.	_	0	SENT_237	[p15l1432t3194r1616b3264],

1	These	DT	O	these	det	2	SENT_238	[p15l1650t3175r1855b3241],
2	observations	NNS	O	observation	nsubj	3	SENT_238	[p15l1890t3177r2095b3241, p15l7t3284r242b3346],
3	suggest	VBP	O	suggest	_	0	SENT_238	[p15l279t3298r521b3368],
4	that	IN	O	that	complm	18	SENT_238	[p15l553t3281r686b3345],
5	the	DT	O	the	det	6	SENT_238	[p15l718t3281r822b3345],
6	mechanism	NN	O	mechanism	nsubj	18	SENT_238	[p15l858t3281r1238b3345],
7	for	IN	O	for	_	0	SENT_238	[p15l1272t3281r1368b3345],
8	the	DT	O	the	det	10	SENT_238	[p15l1400t3281r1504b3345],
9	increased	VBN	O	increase	amod	10	SENT_238	[p15l1539t3281r1845b3345],
10	risk	NN	O	risk	prep_for	6	SENT_238	[p15l1878t3281r2001b3345],
11	of	IN	O	of	_	0	SENT_238	[p15l2032t3281r2108b3345],
12	side	JJ	O	side	amod	13	SENT_238	[p15l12t3385r138b3449],
13	effects	NNS	O	effect	prep_of	10	SENT_238	[p15l166t3385r364b3449],
14	in	IN	O	in	_	0	SENT_238	[p15l392t3388r456b3449],
15	Women	NNS	O	woman	prep_in	13	SENT_238	[p15l479t3410r729b3450],
16	may	MD	O	may	aux	18	SENT_238	[p15l756t3410r897b3472],
17	not	RB	O	not	neg	18	SENT_238	[p15l921t3402r1032b3449],
18	relate	VB	O	relate	ccomp	3	SENT_238	[p15l1056t3385r1235b3449],
19	to	TO	O	to	_	0	SENT_238	[p15l1262t3402r1326b3449],
20	altered	JJ	O	altered	amod	22	SENT_238	[p15l1355t3385r1577b3449],
21	statin	NN	O	statin	nn	22	SENT_238	[p15l1604t3388r1784b3449],
22	pharmacokinetics	NNS	O	pharmacokinetic	prep_to	18	SENT_238	[p15l1809t3385r2095b3472, p15l11t3489r337b3553],
23	or	CC	O	or	_	0	SENT_238	[p15l368t3514r437b3553],
24	statin	NN	O	statin	nn	27	SENT_238	[p15l466t3489r923b3576],
25	—	NN	O	—	nn	27	SENT_238	[p15l466t3489r923b3576],
26	speciﬁc	NN	O	speciﬁc	nn	27	SENT_238	[p15l466t3489r923b3576],
27	characteristics	NNS	O	characteristic	conj_or	22	SENT_238	[p15l952t3489r1429b3553],
28	.	.	O	.	_	0	SENT_238	[p15l952t3489r1429b3553],

1	Whether	IN	O	whether	complm	7	SENT_239	[p15l94t3593r412b3658],
2	statin-induced	JJ	O	statin-induced	amod	4	SENT_239	[p15l450t3593r951b3657],
3	side	JJ	O	side	amod	4	SENT_239	[p15l989t3593r1120b3657],
4	effects	NNS	O	effect	nsubj	7	SENT_239	[p15l1159t3593r1368b3657],
5	are	VBP	O	be	cop	7	SENT_239	[p15l1409t3618r1507b3657],
6	class	NN	O	class	nn	7	SENT_239	[p15l1547t3593r1698b3657],
7	effects	NNS	O	effect	csubjpass	10	SENT_239	[p15l1738t3593r1946b3657],
8	has	VBZ	O	have	aux	10	SENT_239	[p15l1986t3593r2096b3657],
9	been	VBN	O	be	auxpass	10	SENT_239	[p16l8t26r171b90],
10	debated	VBN	O	debate	_	0	SENT_239	[p16l225t26r512b90],
11	.	.	O	.	_	0	SENT_239	[p16l225t26r512b90],

1	Cerivastatin	NNP	MISC	Cerivastatin	nsubj	7	SENT_240	[p16l571t26r1008b105],
2	,	,	O	,	_	0	SENT_240	[p16l571t26r1008b105],
3	according	VBG	O	accord	_	0	SENT_240	[p16l1065t26r1401b113],
4	to	TO	O	to	prepc_according_to	7	SENT_240	[p16l1451t43r1518b90],
5	some	DT	O	some	pobj	7	SENT_240	[p16l1573t51r1769b105],
6	,	,	O	,	_	0	SENT_240	[p16l1573t51r1769b105],
7	has	VBZ	O	have	_	0	SENT_240	[p16l1825t26r1935b90],
8	the	DT	O	the	det	10	SENT_240	[p16l1989t26r2096b90],
9	greatest	JJS	O	greatest	amod	10	SENT_240	[p16l9t146r279b217],
10	risk	NN	O	risk	dobj	7	SENT_240	[p16l306t130r434b194],
11	of	IN	O	of	_	0	SENT_240	[p16l459t130r538b194],
12	musculoskeletal	JJ	O	musculoskeletal	amod	14	SENT_240	[p16l555t130r1101b194],
13	side	JJ	O	side	amod	14	SENT_240	[p16l1130t130r1261b194],
14	effects	NNS	O	effect	prep_of	10	SENT_240	[p16l1292t130r1522b209],
15	,	,	O	,	_	0	SENT_240	[p16l1292t130r1522b209],
16	especially	RB	O	especially	advmod	17	SENT_240	[p16l1554t130r1883b217],
17	rhab	JJ	O	rhab	amod	19	SENT_240	[p16l1907t130r2095b194],
18	—	NN	O	—	nn	19	SENT_240	[p16l1907t130r2095b194],
19	domyolysis	NN	O	domyolysis	appos	14	SENT_240	[p16l11t234r412b321],
20	,	,	O	,	_	0	SENT_240	[p16l11t234r412b321],
21	when	WRB	O	when	advmod	26	SENT_240	[p16l443t234r633b298],
22	compared	VBN	O	compare	csubj	26	SENT_240	[p16l665t234r1005b321],
23	with	IN	O	with	_	0	SENT_240	[p16l1033t234r1191b299],
24	other	JJ	O	other	amod	25	SENT_240	[p16l1223t234r1405b298],
25	statins	NNS	O	statin	prep_with	22	SENT_240	[p16l1436t237r1654b298],
26	(	VBP	O	(	dep	14	SENT_240	[p16l1690t232r1846b313],
27	25	CD	NUMBER	25	num	28	SENT_240	[p16l1690t232r1846b313],
28	)	CD	NUMBER	)	dobj	26	SENT_240	[p16l1690t232r1846b313],
29	.	.	O	.	_	0	SENT_240	[p16l1690t232r1846b313],

1	In	IN	O	in	_	0	SENT_241	[p16l1881t235r1958b298],
2	the	DT	O	the	det	4	SENT_241	[p16l1989t234r2096b298],
3	present	JJ	DATE	present	amod	4	SENT_241	[p16l9t355r262b425],
4	study	NN	O	study	prep_in	7	SENT_241	[p16l291t338r492b425],
5	,	,	O	,	_	0	SENT_241	[p16l291t338r492b425],
6	we	PRP	O	we	nsubj	7	SENT_241	[p16l520t363r616b402],
7	observed	VBD	O	observe	_	0	SENT_241	[p16l647t338r949b402],
8	that	IN	O	that	complm	14	SENT_241	[p16l977t338r1115b402],
9	carriers	NNS	O	carrier	nsubj	14	SENT_241	[p16l1143t341r1390b402],
10	of	IN	O	of	_	0	SENT_241	[p16l1422t338r1500b402],
11	SLCOJB1	NN	O	slcojb1	prep_of	9	SENT_241	[p16l1520t341r1946b403],
12	*	CD	NUMBER	*	number	13	SENT_241	[p16l1520t341r1946b403],
13	5	CD	NUMBER	5	num	11	SENT_241	[p16l1520t341r1946b403],
14	had	VBD	O	have	ccomp	7	SENT_241	[p16l1971t338r2098b402],
15	no	DT	O	no	det	17	SENT_241	[p16l11t467r95b506],
16	excess	JJ	O	excess	amod	17	SENT_241	[p16l135t467r339b506],
17	risk	NN	O	risk	dobj	14	SENT_241	[p16l378t442r506b506],
18	of	IN	O	of	_	0	SENT_241	[p16l540t442r617b506],
19	adverse	JJ	O	adverse	amod	20	SENT_241	[p16l644t442r893b506],
20	events	NNS	O	event	prep_of	17	SENT_241	[p16l933t459r1144b507],
21	if	IN	O	if	mark	22	SENT_241	[p16l1182t442r1241b506],
22	assigned	VBN	O	assign	dep	14	SENT_241	[p16l1268t442r1557b529],
23	to	TO	O	to	_	0	SENT_241	[p16l1594t459r1660b506],
24	pravastatin	NN	O	pravastatin	prep_to	22	SENT_241	[p16l1697t445r2094b529],
25	,	,	O	,	_	0	SENT_241	[p16l1697t445r2094b529],
26	even	RB	O	even	advmod	22	SENT_241	[p16l11t571r165b610],
27	though	IN	O	though	mark	33	SENT_241	[p16l195t546r444b633],
28	the	DT	O	the	det	30	SENT_241	[p16l473t546r581b610],
29	CAE	NNP	ORGANIZATION	CAE	nn	30	SENT_241	[p16l614t544r797b611],
30	rates	NNS	O	rate	nsubj	33	SENT_241	[p16l828t563r986b610],
31	were	VBD	O	be	cop	33	SENT_241	[p16l1014t571r1177b611],
32	the	DT	O	the	det	33	SENT_241	[p16l1208t546r1315b610],
33	same	JJ	O	same	dep	22	SENT_241	[p16l1347t571r1517b610],
34	for	IN	O	for	_	0	SENT_241	[p16l1548t546r1647b610],
35	all	DT	O	all	det	37	SENT_241	[p16l1676t546r1755b610],
36	3	CD	NUMBER	3	num	37	SENT_241	[p16l1784t549r1819b611],
37	statins	NNS	O	statin	prep_for	33	SENT_241	[p16l1855t549r2093b610],
38	.	.	O	.	_	0	SENT_241	[p16l1855t549r2093b610],

1	There	EX	O	there	expl	2	SENT_242	[p16l8t648r218b714],
2	are	VBP	O	be	_	0	SENT_242	[p16l260t675r358b714],
3	2	CD	NUMBER	2	number	4	SENT_242	[p16l397t653r438b715],
4	likely	JJ	O	likely	amod	5	SENT_242	[p16l477t650r665b737],
5	reasons	NNS	O	reason	nsubj	2	SENT_242	[p16l701t675r952b714],
6	why	WRB	O	why	advmod	8	SENT_242	[p16l989t650r1138b737],
7	carriers	NNS	O	carrier	nsubj	8	SENT_242	[p16l1175t653r1422b714],
8	appear	VBP	O	appear	advcl	2	SENT_242	[p16l1465t675r1692b737],
9	to	TO	O	to	aux	10	SENT_242	[p16l1731t667r1797b714],
10	tolerate	VB	O	tolerate	xcomp	8	SENT_242	[p16l1838t650r2096b714],
11	pravastatin	NN	O	pravastatin	dep	12	SENT_242	[p16l9t757r387b841],
12	better	JJR	O	better	dobj	10	SENT_242	[p16l424t754r627b818],
13	than	IN	O	than	_	0	SENT_242	[p16l664t754r819b818],
14	simvastatin	NN	O	simvastatin	prep_than	10	SENT_242	[p16l859t757r1265b818],
15	.	.	O	.	_	0	SENT_242	[p16l859t757r1265b818],

1	First	RB	ORDINAL	first	advmod	4	SENT_243	[p16l1309t755r1488b833],
2	,	,	O	,	_	0	SENT_243	[p16l1309t755r1488b833],
3	we	PRP	O	we	nsubj	4	SENT_243	[p16l1526t779r1622b819],
4	showed	VBD	O	show	_	0	SENT_243	[p16l1663t754r1922b819],
5	that	IN	O	that	complm	14	SENT_243	[p16l1961t754r2099b818],
6	after	IN	O	after	_	0	SENT_243	[p16l12t859r167b923],
7	8	CD	DURATION	8	num	8	SENT_243	[p16l203t862r237b924],
8	weeks	NNS	NUMBER	week	prep_after	14	SENT_243	[p16l271t859r477b924],
9	of	IN	O	of	_	0	SENT_243	[p16l514t859r592b923],
10	statin	NN	O	statin	nn	11	SENT_243	[p16l616t862r804b923],
11	therapy	NN	O	therapy	prep_of	8	SENT_243	[p16l839t859r1116b946],
12	,	,	O	,	_	0	SENT_243	[p16l839t859r1116b946],
13	carriers	NNS	O	carrier	nsubj	14	SENT_243	[p16l1154t862r1402b923],
14	accumulate	VBP	O	accumulate	ccomp	4	SENT_243	[p16l1439t859r1825b923],
15	greater	JJR	O	greater	amod	16	SENT_243	[p16l1859t876r2099b946],
16	concentrations	NNS	O	concentration	dobj	14	SENT_243	[p16l11t966r516b1027],
17	of	IN	O	of	_	0	SENT_243	[p16l550t963r629b1027],
18	simvastatin	NN	O	simvastatin	nn	19	SENT_243	[p16l650t966r1037b1027],
19	acid	NN	O	acid	prep_of	16	SENT_243	[p16l1071t963r1208b1027],
20	but	CC	O	but	_	0	SENT_243	[p16l1237t963r1353b1027],
21	not	RB	O	not	_	0	SENT_243	[p16l1384t980r1499b1027],
22	pravastatin	NN	O	pravastatin	nn	23	SENT_243	[p16l1528t966r1905b1050],
23	acid	NN	O	acid	conj_negcc	16	SENT_243	[p16l1939t963r2093b1027],
24	.	.	O	.	_	0	SENT_243	[p16l1939t963r2093b1027],

1	Although	IN	O	although	mark	5	SENT_244	[p16l8t1065r346b1154],
2	both	DT	O	both	det	3	SENT_244	[p16l373t1067r534b1131],
3	statins	NNS	O	statin	nsubj	5	SENT_244	[p16l566t1070r783b1131],
4	are	VBP	O	be	cop	5	SENT_244	[p16l816t1092r914b1131],
5	substrates	NNS	O	substrate	advcl	17	SENT_244	[p16l947t1067r1281b1131],
6	for	IN	O	for	_	0	SENT_244	[p16l1312t1067r1411b1131],
7	SLCOJB1	NN	O	slcojb1	prep_for	5	SENT_244	[p16l1442t1070r1792b1132],
8	(	CD	NUMBER	(	num	7	SENT_244	[p16l1828t1065r2094b1146],
9	11,13	CD	NUMBER	11,13	num	10	SENT_244	[p16l1828t1065r2094b1146],
10	)	NN	O	)	dep	7	SENT_244	[p16l1828t1065r2094b1146],
11	,	,	O	,	_	0	SENT_244	[p16l1828t1065r2094b1146],
12	these	DT	O	these	det	13	SENT_244	[p16l10t1171r186b1235],
13	studies	NNS	O	study	nsubjpass	17	SENT_244	[p16l242t1171r474b1235],
14	have	VBP	O	have	aux	17	SENT_244	[p16l529t1171r684b1236],
15	all	DT	O	all	advmod	17	SENT_244	[p16l739t1171r818b1235],
16	been	VBN	O	be	auxpass	17	SENT_244	[p16l868t1171r1031b1235],
17	performed	VBN	O	perform	_	0	SENT_244	[p16l1083t1171r1446b1258],
18	after	IN	O	after	_	0	SENT_244	[p16l1499t1171r1655b1235],
19	single	JJ	O	single	amod	21	SENT_244	[p16l1708t1171r2097b1258],
20	—	NN	O	—	nn	21	SENT_244	[p16l1708t1171r2097b1258],
21	dose	NN	O	dose	prep_after	17	SENT_244	[p16l1708t1171r2097b1258],

1	Table	NNP	O	Table	_	0	SENT_245	[p16l62t1457r227b1505],
2	4	CD	NUMBER	4	num	4	SENT_245	[p16l254t1457r293b1505],
3	Sensitivity	NN	O	sensitivity	nn	4	SENT_245	[p16l399t1456r724b1518],
4	Analyses	NNS	O	analysis	dep	1	SENT_245	[p16l749t1457r1025b1518],
5	Using	VBG	O	use	partmod	1	SENT_245	[p16l1053t1456r1226b1518],
6	Various	JJ	O	various	amod	8	SENT_245	[p16l1249t1456r1478b1506],
7	End-Point	NN	O	end-point	nn	8	SENT_245	[p16l1507t1456r1797b1506],
8	Definitions	NNS	MISC	definition	nsubj	10	SENT_245	[p16l1825t1456r2152b1506],
9	challenge	NN	O	challenge	nn	10	SENT_245	[p16l11t1592r340b1681],
10	studies	NNS	O	study	xcomp	5	SENT_245	[p16l372t1592r630b1658],
11	.	.	O	.	_	0	SENT_245	[p16l372t1592r630b1658],

1	We	PRP	O	we	nsubj	2	SENT_246	[p16l660t1593r790b1659],
2	speculate	VBP	O	speculate	_	0	SENT_246	[p16l822t1592r1140b1681],
3	that	IN	O	that	complm	14	SENT_246	[p16l1169t1592r1311b1658],
4	during	IN	O	during	_	0	SENT_246	[p16l1339t1592r1572b1681],
5	extended	VBN	O	extend	amod	7	SENT_246	[p16l1601t1592r1918b1658],
6	statin	NN	O	statin	nn	7	SENT_246	[p16l1948t1595r2140b1658],
7	therapy	NN	O	therapy	prep_during	14	SENT_246	[p16l10t1699r278b1788],
8	there	EX	O	there	expl	14	SENT_246	[p16l317t1699r495b1765],
9	may	MD	O	may	aux	14	SENT_246	[p16l539t1725r688b1788],
10	be	VB	O	be	cop	14	SENT_246	[p16l725t1699r805b1765],
11	alternative	JJ	O	alternative	amod	13	SENT_246	[p16l850t1699r1236b1780],
12	,	,	O	,	_	0	SENT_246	[p16l850t1699r1236b1780],
13	compensatory	JJ	O	compensatory	amod	14	SENT_246	[p16l1282t1716r1777b1788],
14	routes	NNS	O	route	ccomp	2	SENT_246	[p16l1815t1716r2028b1765],
15	of	IN	O	of	_	0	SENT_246	[p16l2073t1699r2153b1765],
16	elimination	NN	O	elimination	prep_of	14	SENT_246	[p16l11t1805r416b1871],
17	for	IN	O	for	_	0	SENT_246	[p16l446t1805r547b1871],
18	pravastatin	NN	O	pravastatin	prep_for	16	SENT_246	[p16l574t1808r960b1894],
19	(	CD	NUMBER	(	num	18	SENT_246	[p16l993t1803r1162b1894],
20	e.g.	FW	O	e.g.	nsubjpass	33	SENT_246	[p16l993t1803r1162b1894],
21	,	,	O	,	_	0	SENT_246	[p16l993t1803r1162b1894],
22	renal	JJ	O	renal	amod	23	SENT_246	[p16l1195t1803r1394b1885],
23	)	NN	O	)	appos	20	SENT_246	[p16l1195t1803r1394b1885],
24	such	JJ	O	such	dep	23	SENT_246	[p16l1430t1805r1586b1871],
25	that	IN	O	that	_	0	SENT_246	[p16l1616t1805r1758b1871],
26	carriers	NNS	O	carrier	prep_that	23	SENT_246	[p16l1787t1808r2040b1871],
27	of	IN	O	of	_	0	SENT_246	[p16l2073t1805r2153b1871],
28	the	DT	O	the	det	31	SENT_246	[p16l10t1911r120b1977],
29	*	NN	O	*	nn	31	SENT_246	[p16l149t1911r216b1977],
30	5	CD	NUMBER	5	num	31	SENT_246	[p16l149t1911r216b1977],
31	allele	NN	O	allele	prep_of	26	SENT_246	[p16l250t1911r426b1977],
32	are	VBP	O	be	auxpass	33	SENT_246	[p16l457t1937r557b1977],
33	protected	VBN	O	protect	rcmod	14	SENT_246	[p16l585t1911r919b2000],
34	from	IN	O	from	_	0	SENT_246	[p16l947t1911r1117b1977],
35	drug	NN	O	drug	nn	36	SENT_246	[p16l1147t1911r1309b2000],
36	accumulation	NN	O	accumulation	prep_from	33	SENT_246	[p16l1337t1911r1828b1977],
37	.	.	O	.	_	0	SENT_246	[p16l1337t1911r1828b1977],

1	Second	RB	ORDINAL	second	advmod	7	SENT_247	[p16l1864t1911r2137b1992],
2	,	,	O	,	_	0	SENT_247	[p16l1864t1911r2137b1992],
3	the	DT	O	the	det	6	SENT_247	[p16l10t2017r120b2083],
4	2	CD	NUMBER	2	num	6	SENT_247	[p16l165t2020r206b2084],
5	statin	NN	O	statin	nn	6	SENT_247	[p16l254t2020r447b2083],
6	metabolites	NNS	O	metabolite	nsubj	7	SENT_247	[p16l493t2017r896b2083],
7	differ	VBP	O	differ	_	0	SENT_247	[p16l944t2017r1127b2083],
8	markedly	RB	O	markedly	advmod	7	SENT_247	[p16l1172t2017r1501b2106],
9	in	IN	O	in	_	0	SENT_247	[p16l1543t2020r1610b2082],
10	their	PRP$	O	they	prep_in	8	SENT_247	[p16l1655t2017r1822b2083],
11	in	FW	O	in	nn	12	SENT_247	[p16l1865t2020r1933b2082],
12	vitro	FW	O	vitro	advmod	13	SENT_247	[p16l1975t2020r2139b2083],
13	myotoxicity	NN	O	myotoxicity	rcmod	10	SENT_247	[p16l11t2126r428b2212],
14	such	JJ	O	such	prep	7	SENT_247	[p16l477t2123r633b2189],
15	that	IN	O	that	complm	22	SENT_247	[p16l683t2123r824b2189],
16	simvastatin	NN	O	simvastatin	nn	17	SENT_247	[p16l875t2126r1271b2189],
17	acid	NN	O	acid	nsubj	22	SENT_247	[p16l1323t2123r1463b2189],
18	is	VBZ	O	be	cop	22	SENT_247	[p16l1513t2126r1563b2189],
19	nearly	RB	O	nearly	advmod	22	SENT_247	[p16l1617t2123r1831b2212],
20	10-fold	RB	O	10-fold	advmod	22	SENT_247	[p16l1882t2123r2141b2189],
21	more	RBR	O	more	advmod	22	SENT_247	[p16l11t2255r191b2295],
22	myotoxic	JJ	O	myotoxic	ccomp	7	SENT_247	[p16l233t2232r556b2318],
23	than	IN	O	than	_	0	SENT_247	[p16l597t2229r755b2295],
24	pravastatin	NN	O	pravastatin	nn	25	SENT_247	[p16l795t2232r1181b2318],
25	acid	NN	O	acid	prep_than	22	SENT_247	[p16l1224t2229r1364b2295],
26	(	CD	NUMBER	(	num	28	SENT_247	[p16l1408t2227r1568b2309],
27	26	CD	NUMBER	26	num	28	SENT_247	[p16l1408t2227r1568b2309],
28	)	NN	O	)	dep	25	SENT_247	[p16l1408t2227r1568b2309],
29	.	.	O	.	_	0	SENT_247	[p16l1408t2227r1568b2309],

1	Therefore	RB	O	therefore	_	0	SENT_248	[p16l1610t2227r1986b2310],
2	,	,	O	,	_	0	SENT_248	[p16l1610t2227r1986b2310],
3	the	DT	O	the	det	5	SENT_248	[p16l2030t2229r2140b2295],
4	greater	JJR	O	greater	amod	5	SENT_248	[p16l9t2353r244b2425],
5	exposure	NN	O	exposure	dep	6	SENT_248	[p16l275t2362r569b2425],
6	to	TO	O	to	dep	1	SENT_248	[p16l600t2353r666b2402],
7	simvastatin	NN	O	simvastatin	nn	8	SENT_248	[p16l701t2339r1079b2402],
8	acid	NN	O	acid	pobj	6	SENT_248	[p16l1112t2336r1264b2417],
9	,	,	O	,	_	0	SENT_248	[p16l1112t2336r1264b2417],
10	a	DT	O	a	det	13	SENT_248	[p16l1300t2362r1334b2402],
11	potentially	RB	O	potentially	advmod	13	SENT_248	[p16l1363t2336r1725b2425],
12	more	RBR	O	more	advmod	13	SENT_248	[p16l1753t2362r1927b2402],
13	myotoxic	JJ	O	myotoxic	appos	8	SENT_248	[p16l1960t2362r2138b2425, p16l10t2480r173b2543],

1	metabolite	NN	O	metabolite	nsubj	8	SENT_249	[p16l197t2477r553b2543],
2	compared	VBN	O	compare	_	0	SENT_249	[p16l579t2477r914b2566],
3	with	IN	O	with	prepc_compared_with	1	SENT_249	[p16l934t2477r1090b2543],
4	pravastatin	NN	O	pravastatin	nn	5	SENT_249	[p16l1112t2480r1480b2566],
5	acid	NN	O	acid	pobj	1	SENT_249	[p16l1505t2477r1658b2558],
6	,	,	O	,	_	0	SENT_249	[p16l1505t2477r1658b2558],
7	may	MD	O	may	aux	8	SENT_249	[p16l1686t2503r1830b2566],
8	mediate	VB	O	mediate	_	0	SENT_249	[p16l1851t2477r2138b2558],
9	,	,	O	,	_	0	SENT_249	[p16l1851t2477r2138b2558],
10	in	IN	O	in	_	0	SENT_249	[p16l10t2586r76b2648],
11	part	NN	O	part	prep_in	8	SENT_249	[p16l132t2600r285b2672],
12	,	,	O	,	_	0	SENT_249	[p16l132t2600r285b2672],
13	the	DT	O	the	det	15	SENT_249	[p16l344t2583r451b2649],
14	side	JJ	O	side	amod	15	SENT_249	[p16l510t2583r638b2649],
15	effects	NNS	O	effect	appos	11	SENT_249	[p16l697t2583r900b2649],
16	observed	VBN	O	observe	partmod	15	SENT_249	[p16l959t2583r1254b2649],
17	in	IN	O	in	_	0	SENT_249	[p16l1310t2586r1377b2648],
18	carriers	NNS	O	carrier	prep_in	16	SENT_249	[p16l1434t2586r1674b2649],
19	assigned	VBN	O	assign	partmod	18	SENT_249	[p16l1735t2583r2018b2672],
20	to	TO	O	to	_	0	SENT_249	[p16l2073t2600r2139b2649],
21	simvastatin	NN	O	simvastatin	prep_to	19	SENT_249	[p16l12t2691r407b2754],
22	.	.	O	.	_	0	SENT_249	[p16l12t2691r407b2754],

1	These	DT	O	these	det	2	SENT_250	[p16l445t2686r655b2753],
2	results	NNS	O	result	nsubj	6	SENT_250	[p16l693t2688r924b2768],
3	,	,	O	,	_	0	SENT_250	[p16l693t2688r924b2768],
4	however	RB	O	however	advmod	6	SENT_250	[p16l964t2688r1266b2768],
5	,	,	O	,	_	0	SENT_250	[p16l964t2688r1266b2768],
6	need	VBP	O	need	_	0	SENT_250	[p16l1307t2688r1467b2753],
7	to	TO	O	to	aux	9	SENT_250	[p16l1503t2705r1570b2753],
8	be	VB	O	be	auxpass	9	SENT_250	[p16l1606t2688r1685b2753],
9	evaluated	VBN	O	evaluate	xcomp	6	SENT_250	[p16l1724t2688r2039b2754],
10	in	IN	O	in	_	0	SENT_250	[p16l2075t2691r2140b2753],
11	other	JJ	O	other	prep_in	9	SENT_250	[p16l11t2795r207b2876],
12	,	,	O	,	_	0	SENT_250	[p16l11t2795r207b2876],
13	larger	JJR	O	larger	amod	14	SENT_250	[p16l239t2795r433b2884],
14	populations	NNS	O	population	appos	11	SENT_250	[p16l460t2795r856b2884],
15	and	CC	O	and	cc	6	SENT_250	[p16l890t2795r1031b2876],
16	,	,	O	,	_	0	SENT_250	[p16l890t2795r1031b2876],
17	if	IN	O	if	mark	18	SENT_250	[p16l1065t2795r1123b2860],
18	replicated	VBN	O	replicate	advcl	27	SENT_250	[p16l1142t2795r1488b2884],
19	,	,	O	,	_	0	SENT_250	[p16l1142t2795r1488b2884],
20	prescribing	VBG	O	prescribe	amod	21	SENT_250	[p16l1520t2795r1898b2884],
21	pravastatin	NN	O	pravastatin	nsubj	27	SENT_250	[p16l1926t2821r2138b2884, p16l12t2904r196b2967],
22	would	MD	O	would	aux	27	SENT_250	[p16l218t2901r431b2967],
23	be	VB	O	be	cop	27	SENT_250	[p16l454t2901r532b2967],
24	a	DT	O	a	det	27	SENT_250	[p16l560t2927r594b2967],
25	reasonable	JJ	O	reasonable	amod	27	SENT_250	[p16l618t2901r971b2967],
26	first	JJ	ORDINAL	first	amod	27	SENT_250	[p16l998t2901r1129b2967],
27	choice	NN	O	choice	ccomp	6	SENT_250	[p16l1154t2901r1367b2967],
28	for	IN	O	for	_	0	SENT_250	[p16l1393t2901r1491b2967],
29	patients	NNS	O	patient	prep_for	27	SENT_250	[p16l1513t2904r1778b2990],
30	who	WP	O	who	nsubj	31	SENT_250	[p16l1802t2901r1950b2967],
31	carry	VBP	O	carry	rcmod	29	SENT_250	[p16l1978t2927r2144b2990],
32	SLCOJB1	NN	O	slcojb1	dobj	31	SENT_250	[p16l13t3009r435b3072],
33	*	CD	NUMBER	*	number	34	SENT_250	[p16l13t3009r435b3072],
34	5	CD	NUMBER	5	nsubj	39	SENT_250	[p16l13t3009r435b3072],
35	to	TO	O	to	aux	36	SENT_250	[p16l473t3023r539b3071],
36	avoid	VB	O	avoid	infmod	34	SENT_250	[p16l585t3006r764b3072],
37	statin	NN	O	statin	nn	38	SENT_250	[p16l808t3006r1297b3071],
38	—	NN	O	—	dobj	36	SENT_250	[p16l808t3006r1297b3071],
39	induced	VBD	O	induce	rcmod	32	SENT_250	[p16l808t3006r1297b3071],
40	side	JJ	O	side	amod	41	SENT_250	[p16l1341t3006r1469b3071],
41	effects	NNS	O	effect	dobj	39	SENT_250	[p16l1514t3006r1734b3071],
42	.	.	O	.	_	0	SENT_250	[p16l1514t3006r1734b3071],

1	The	DT	O	the	det	4	SENT_251	[p16l1778t3004r1922b3071],
2	more	JJR	O	more	dep	3	SENT_251	[p16l1966t3031r2140b3071],
3	potent	JJ	O	potent	amod	4	SENT_251	[p17l9t44r232b116],
4	statins	NNS	O	statin	nsubjpass	8	SENT_251	[p17l270t30r482b93],
5	could	MD	O	could	aux	8	SENT_251	[p17l523t27r708b93],
6	then	RB	O	then	advmod	8	SENT_251	[p17l745t27r899b93],
7	be	VB	O	be	auxpass	8	SENT_251	[p17l935t27r1014b93],
8	reserved	VBN	O	reserve	_	0	SENT_251	[p17l1053t27r1329b93],
9	for	IN	O	for	_	0	SENT_251	[p17l1367t27r1464b93],
10	those	DT	O	those	prep_for	8	SENT_251	[p17l1501t27r1680b93],
11	who	WP	O	who	nsubj	14	SENT_251	[p17l1715t27r1864b93],
12	do	VBP	O	do	aux	14	SENT_251	[p17l1905t27r1988b93],
13	not	RB	O	not	neg	14	SENT_251	[p17l2029t44r2143b93],
14	achieve	VB	O	achieve	rcmod	10	SENT_251	[p17l12t133r256b199],
15	their	PRP$	O	they	poss	17	SENT_251	[p17l286t133r446b199],
16	LDL	NN	O	ldl	nn	17	SENT_251	[p17l475t134r657b198],
17	goals	NNS	O	goal	dobj	14	SENT_251	[p17l685t133r872b222],
18	.	.	O	.	_	0	SENT_251	[p17l685t133r872b222],

1	Study	NNP	O	Study	_	0	SENT_252	[p17l13t238r228b328],
2	limitations	NNS	O	limitation	dep	1	SENT_252	[p17l257t238r686b305],
3	.	.	O	.	_	0	SENT_252	[p17l257t238r686b305],

1	Despite	IN	O	despite	_	0	SENT_253	[p17l738t240r1011b328],
2	the	DT	O	the	det	4	SENT_253	[p17l1048t239r1158b305],
3	interesting	JJ	O	interesting	amod	4	SENT_253	[p17l1194t242r1572b328],
4	ﬁndings	NNS	O	ﬁndings	prep_despite	11	SENT_253	[p17l1606t239r1889b328],
5	of	IN	O	of	_	0	SENT_253	[p17l1927t239r2007b305],
6	the	DT	O	the	det	8	SENT_253	[p17l2030t239r2140b305],
7	present	JJ	DATE	present	amod	8	SENT_253	[p17l9t362r268b434],
8	study	NN	O	study	prep_of	4	SENT_253	[p17l321t345r526b434],
9	,	,	O	,	_	0	SENT_253	[p17l321t345r526b434],
10	there	EX	O	there	expl	11	SENT_253	[p17l582t345r760b411],
11	are	VBP	O	be	_	0	SENT_253	[p17l816t371r916b411],
12	several	JJ	O	several	amod	13	SENT_253	[p17l972t345r1205b411],
13	limitations	NNS	O	limitation	nsubj	11	SENT_253	[p17l1256t345r1636b411],
14	that	WDT	O	that	nsubj	15	SENT_253	[p17l1691t345r1832b411],
15	deserve	VBP	O	deserve	rcmod	13	SENT_253	[p17l1885t345r2140b411],
16	mention	NN	O	mention	dobj	15	SENT_253	[p17l11t454r326b517],
17	.	.	O	.	_	0	SENT_253	[p17l11t454r326b517],

1	First	RB	ORDINAL	first	advmod	16	SENT_254	[p17l365t452r548b532],
2	,	,	O	,	_	0	SENT_254	[p17l365t452r548b532],
3	our	PRP$	O	we	poss	4	SENT_254	[p17l586t477r704b517],
4	ﬁnding	NN	O	ﬁnding	nsubj	16	SENT_254	[p17l736t451r991b540],
5	for	IN	O	for	_	0	SENT_254	[p17l1024t451r1124b517],
6	SLCO1B	NN	O	slco1b	nn	8	SENT_254	[p17l1160t454r1595b518],
7	]	CD	NUMBER	]	num	8	SENT_254	[p17l1160t454r1595b518],
8	”‘	NN	O	”‘	prep_for	4	SENT_254	[p17l1160t454r1595b518],
9	5	CD	NUMBER	5	num	8	SENT_254	[p17l1160t454r1595b518],
10	in	IN	O	in	_	0	SENT_254	[p17l1626t454r1694b516],
11	a	DT	O	a	det	13	SENT_254	[p17l1730t477r1764b517],
12	dominant	JJ	O	dominant	amod	13	SENT_254	[p17l1799t451r2143b517],
13	model	NN	O	model	prep_in	4	SENT_254	[p17l11t557r231b623],
14	does	VBZ	O	do	aux	16	SENT_254	[p17l260t557r414b623],
15	not	RB	O	not	neg	16	SENT_254	[p17l446t574r564b623],
16	survive	VB	O	survive	_	0	SENT_254	[p17l592t560r832b623],
17	correction	NN	O	correction	dobj	16	SENT_254	[p17l863t560r1218b623],
18	for	IN	O	for	_	0	SENT_254	[p17l1247t557r1348b623],
19	multiple	JJ	O	multiple	amod	20	SENT_254	[p17l1376t557r1669b646],
20	comparisons	NNS	O	comparison	prep_for	16	SENT_254	[p17l1700t560r2139b646],
21	using	VBG	O	use	partmod	20	SENT_254	[p17l9t666r200b752],
22	the	DT	O	the	det	23	SENT_254	[p17l223t663r334b729],
23	FDR	NNP	O	FDR	dobj	21	SENT_254	[p17l361t664r562b729],
24	.	.	O	.	_	0	SENT_254	[p17l361t664r562b729],

1	However	RB	O	however	advmod	6	SENT_255	[p17l593t664r934b744],
2	,	,	O	,	_	0	SENT_255	[p17l593t664r934b744],
3	our	PRP$	O	we	poss	4	SENT_255	[p17l964t689r1080b729],
4	analysis	NN	O	analysis	nsubj	6	SENT_255	[p17l1106t663r1371b752],
5	was	VBD	O	be	cop	6	SENT_255	[p17l1395t689r1524b729],
6	conservative	JJ	O	conservative	_	0	SENT_255	[p17l1552t666r1980b729],
7	in	IN	O	in	_	0	SENT_255	[p17l2007t666r2074b728],
8	3	CD	NUMBER	3	num	9	SENT_255	[p17l2101t666r2137b729],
9	ways	NNS	O	way	prep_in	6	SENT_255	[p17l7t795r195b858],
10	:	:	O	:	_	0	SENT_255	[p17l7t795r195b858],
11	SNPS	NNS	O	snp	nsubjpass	17	SENT_255	[p17l255t769r452b835],
12	that	WDT	O	that	nsubj	13	SENT_255	[p17l506t769r647b835],
13	belonged	VBD	O	belong	rcmod	11	SENT_255	[p17l696t769r1020b858],
14	to	TO	O	to	_	0	SENT_255	[p17l1072t786r1140b835],
15	CYP2D6	NN	O	cyp2d6	prep_to	13	SENT_255	[p17l1201t772r1509b836],
16	were	VBD	O	be	auxpass	17	SENT_255	[p17l1558t795r1724b835],
17	treated	VBN	O	treat	parataxis	6	SENT_255	[p17l1777t769r2022b835],
18	as	IN	O	as	prep	17	SENT_255	[p17l2076t795r2139b835],

1	Drug	NN	MISC	drug	nn	3	SENT_256	[p17l702t933r758b957],
2	Discontinuation	NNP	MISC	Discontinuation	nn	3	SENT_256	[p17l768t933r956b953],
3	Due	NNP	MISC	Due	dep	10	SENT_256	[p17l968t933r1013b953],
4	to	TO	MISC	to	_	0	SENT_256	[p17l1022t934r1047b953],
5	Any	DT	MISC	any	det	6	SENT_256	[p17l1056t933r1101b957],
6	Drug	NN	MISC	drug	prep_to	3	SENT_256	[p17l1290t933r1346b957],
7	Discontinuation	NNP	MISC	Discontinuation	nn	8	SENT_256	[p17l1356t933r1543b953],
8	Drug	NNP	MISC	Drug	dep	10	SENT_256	[p17l1732t933r1788b957],
9	Discontinuation	NNP	MISC	Discontinuation	nn	10	SENT_256	[p17l1798t933r1986b953],
10	Due	NNP	MISC	Due	dep	36	SENT_256	[p17l1997t933r2042b953],
11	to	TO	O	to	_	0	SENT_256	[p17l2052t934r2076b953],
12	Side	NNP	O	Side	prep_to	10	SENT_256	[p17l686t966r738b986],
13	Effect	NN	O	effect	nn	16	SENT_256	[p17l749t966r819b986],
14	+	CC	O	+	_	0	SENT_256	[p17l831t968r848b985],
15	Muscle	NN	O	muscle	conj_+	13	SENT_256	[p17l862t966r948b986],
16	Symptoms	NNS	O	symptom	dep	12	SENT_256	[p17l957t966r1083b990],
17	+	CC	O	+	_	0	SENT_256	[p17l1096t968r1113b985],
18	Due	JJ	O	due	_	0	SENT_256	[p17l1263t966r1309b986],
19	to	TO	O	to	_	0	SENT_256	[p17l1318t967r1343b986],
20	Any	DT	O	any	det	22	SENT_256	[p17l1352t966r1397b990],
21	Side	NN	O	side	nn	22	SENT_256	[p17l1406t966r1458b986],
22	Effect	NN	O	effect	prep_due_to	30	SENT_256	[p17l1469t966r1539b986],
23	+	CC	O	+	_	0	SENT_256	[p17l1551t968r1568b985],
24	Musculoskeletal	JJ	O	musculoskeletal	amod	26	SENT_256	[p17l1719t966r1916b986],
25	Side	NN	O	side	nn	26	SENT_256	[p17l1926t966r1978b986],
26	Effect	NN	O	effect	prep_due_to	30	SENT_256	[p17l1989t966r2059b986],
27	+	CC	O	+	_	0	SENT_256	[p17l2071t968r2088b985],
28	Factor	NN	O	factor	nn	29	SENT_256	[p17l98t999r175b1018],
29	CK	NN	O	ck	conj_+	22	SENT_256	[p17l762t999r796b1018],
30	>	JJR	O	>	conj_+	12	SENT_256	[p17l809t999r863b1018],
31	3	CD	NUMBER	3	dep	32	SENT_256	[p17l809t999r863b1018],
32	>	JJR	O	>	npadvmod	33	SENT_256	[p17l809t999r863b1018],
33	<	JJR	O	<	amod	12	SENT_256	[p17l809t999r863b1018],
34	ULN	CD	NUMBER	uln	num	36	SENT_256	[p17l877t999r924b1018],
35	(	NN	O	(	nn	36	SENT_256	[p17l935t999r958b1023],
36	n	NN	O	n	_	0	SENT_256	[p17l935t999r958b1023],
37	=	JJ	O	=	amod	41	SENT_256	[p17l970t1005r987b1014],
38	99	CD	NUMBER	99	number	39	SENT_256	[p17l999t999r1039b1023],
39	)	CD	NUMBER	)	dep	37	SENT_256	[p17l999t999r1039b1023],
40	Muscle	NN	O	muscle	nn	41	SENT_256	[p17l1248t999r1334b1018],
41	Symptoms	NNS	O	symptom	nsubj	42	SENT_256	[p17l1344t999r1470b1023],
42	(	VBP	O	(	rcmod	36	SENT_256	[p17l1481t999r1504b1023],
43	n	NN	O	n	nsubj	49	SENT_256	[p17l1481t999r1504b1023],
44	=	JJ	O	=	dep	49	SENT_256	[p17l1516t1005r1533b1014],
45	90	CD	NUMBER	90	number	46	SENT_256	[p17l1544t999r1584b1023],
46	)	CD	NUMBER	)	num	48	SENT_256	[p17l1544t999r1584b1023],
47	Muscle	NN	O	muscle	nn	48	SENT_256	[p17l1736t999r1822b1018],
48	Symptoms	NNS	O	symptom	nsubj	49	SENT_256	[p17l1831t999r1958b1023],
49	(	VBP	O	(	xcomp	42	SENT_256	[p17l1968t999r1991b1023],
50	n	NN	O	n	dobj	49	SENT_256	[p17l1968t999r1991b1023],
51	=	JJ	O	=	amod	50	SENT_256	[p17l2003t1005r2020b1014],
52	71	CD	NUMBER	71	tmod	51	SENT_256	[p17l2032t999r2072b1023],
53	)	CD	NUMBER	)	num	54	SENT_256	[p17l2032t999r2072b1023],
54	SLC01B1	NN	O	slc01b1	dep	61	SENT_256	[p17l67t1044r207b1064],
55	*	CD	NUMBER	*	number	56	SENT_256	[p17l67t1044r207b1064],
56	5	CD	NUMBER	5	dep	54	SENT_256	[p17l67t1044r207b1064],
57	p	NN	O	p	dep	56	SENT_256	[p17l333t1049r345b1068],
58	value	NN	O	value	dep	61	SENT_256	[p17l354t1045r415b1064],
59	0.03	CD	NUMBER	0.03	num	58	SENT_256	[p17l867t1044r919b1064],
60	0.01	CD	NUMBER	0.01	num	61	SENT_256	[p17l1382t1044r1435b1064],
61	0.03	CD	NUMBER	0.03	dep	66	SENT_256	[p17l1870t1044r1922b1064],
62	Chi	NNP	O	Chi	dep	61	SENT_256	[p17l332t1080r400b1104],
63	—	CD	NUMBER	—	num	62	SENT_256	[p17l332t1080r400b1104],
64	sq	NN	O	sq	nn	66	SENT_256	[p17l332t1080r400b1104],
65	uare	NN	O	uare	nn	66	SENT_256	[p17l404t1085r454b1100],
66	statistic	NN	O	statistic	dep	73	SENT_256	[p17l462t1080r553b1100],
67	4.8	CD	NUMBER	4.8	number	68	SENT_256	[p17l867t1080r904b1100],
68	8.9	CD	NUMBER	8.9	dep	66	SENT_256	[p17l1382t1080r1419b1100],
69	4.5	CD	NUMBER	4.5	num	72	SENT_256	[p17l1869t1080r1906b1100],
70	Female	JJ	O	female	amod	72	SENT_256	[p17l69t1116r153b1135],
71	sex	NN	O	sex	nn	72	SENT_256	[p17l162t1121r200b1135],
72	p	NN	O	p	dep	68	SENT_256	[p17l333t1121r345b1139],
73	value	NN	O	value	dep	75	SENT_256	[p17l354t1116r415b1135],
74	0.004	CD	NUMBER	0.004	num	73	SENT_256	[p17l867t1116r935b1135],
75	0.0002	CD	NUMBER	0.0002	dep	77	SENT_256	[p17l1382t1116r1466b1135],
76	0.0001	CD	NUMBER	0.0001	num	77	SENT_256	[p17l1870t1116r1955b1135],
77	Chi-square	NN	O	chi-square	dep	78	SENT_256	[p17l332t1151r454b1174],
78	statistic	NN	O	statistic	dep	81	SENT_256	[p17l462t1151r553b1170],
79	8.4	CD	NUMBER	8.4	num	78	SENT_256	[p17l867t1151r904b1170],
80	14.1	CD	NUMBER	14.1	num	81	SENT_256	[p17l1367t1151r1419b1170],
81	14.4	CD	NUMBER	14.4	dep	49	SENT_256	[p17l1854t1151r1907b1170],

1	ULN	NN	O	uln	_	0	SENT_257	[p17l44t1223r82b1240],
2	=	JJ	O	=	amod	4	SENT_257	[p17l94t1229r108b1235],
3	upper	JJ	O	upper	amod	4	SENT_257	[p17l119t1227r177b1244],
4	limit	NN	O	limit	dep	1	SENT_257	[p17l185t1223r230b1240],
5	of	IN	O	of	_	0	SENT_257	[p17l238t1223r257b1240],
6	normal	JJ	O	normal	prep_of	4	SENT_257	[p17l266t1223r342b1240],
7	.	.	O	.	_	0	SENT_257	[p17l266t1223r342b1240],

1	JACC	NNP	O	JACC	nn	2	SENT_258	[p17l9t1404r123b1455],
2	Vol	NNP	O	Vol	_	0	SENT_258	[p17l150t1405r232b1455],
3	.	.	O	.	_	0	SENT_258	[p17l150t1405r232b1455],

1	54	CD	NUMBER	54	_	0	SENT_259	[p17l263t1405r336b1464],
2	,	,	O	,	_	0	SENT_259	[p17l263t1405r336b1464],
3	No.	NN	O	no.	appos	1	SENT_259	[p17l368t1405r440b1455],
4	17	CD	NUMBER	17	num	3	SENT_259	[p17l472t1405r544b1464],
5	,	,	O	,	_	0	SENT_259	[p17l472t1405r544b1464],
6	2009	CD	DATE	2009	num	7	SENT_259	[p17l574t1404r697b1455],
7	October	NNP	DATE	October	appos	1	SENT_259	[p17l11t1493r190b1544],
8	20	CD	DATE	20	num	7	SENT_259	[p17l216t1493r289b1552],
9	,	,	O	,	_	0	SENT_259	[p17l216t1493r289b1552],
10	2009:1609	CD	NUMBER	2009:1609	number	11	SENT_259	[p17l320t1493r684b1544],
11	—	CD	NUMBER	—	appos	1	SENT_259	[p17l320t1493r684b1544],
12	16	CD	NUMBER	16	dep	11	SENT_259	[p17l320t1493r684b1544],

1	independent	JJ	O	independent	amod	2	SENT_260	[p17l10t1712r455b1801],
2	tests	NNS	O	test	_	0	SENT_260	[p17l504t1729r657b1778],
3	even	RB	O	even	prep	2	SENT_260	[p17l711t1738r868b1778],
4	though	RB	O	though	dep	3	SENT_260	[p17l919t1712r1191b1801],
5	,	,	O	,	_	0	SENT_260	[p17l919t1712r1191b1801],
6	as	IN	O	as	_	0	SENT_260	[p17l1247t1738r1310b1778],
7	the	DT	O	the	det	8	SENT_260	[p17l1362t1712r1473b1778],
8	result	NN	O	result	prep_as	20	SENT_260	[p17l1524t1712r1719b1778],
9	of	IN	O	of	_	0	SENT_260	[p17l1769t1712r1848b1778],
10	linkage	NN	O	linkage	nn	11	SENT_260	[p17l1886t1712r2140b1801],
11	disequalibrium	NN	O	disequalibrium	prep_of	8	SENT_260	[p17l11t1818r536b1907],
12	in	IN	O	in	_	0	SENT_260	[p17l585t1821r652b1883],
13	STRENGTH	NN	O	strength	nn	15	SENT_260	[p17l703t1816r1211b1884],
14	Caucasian	JJ	MISC	caucasian	amod	15	SENT_260	[p17l1262t1818r1621b1884],
15	subjects	NNS	O	subject	prep_in	11	SENT_260	[p17l1671t1818r1942b1907],
16	they	PRP	O	they	nsubj	20	SENT_260	[p17l1991t1818r2145b1907],
17	are	VBP	O	be	cop	20	SENT_260	[p17l12t1950r113b1990],
18	not	RB	O	not	neg	20	SENT_260	[p17l145t1941r262b1990],
19	truly	RB	O	truly	advmod	20	SENT_260	[p17l291t1924r457b2013],
20	independent	JJ	O	independent	dep	2	SENT_260	[p17l484t1924r946b2013],
21	;	:	O	;	_	0	SENT_260	[p17l484t1924r946b2013],
22	the	DT	O	the	det	23	SENT_260	[p17l980t1924r1090b1990],
23	tests	NNS	O	test	nsubj	36	SENT_260	[p17l1121t1941r1274b1990],
24	of	IN	O	of	_	0	SENT_260	[p17l1308t1924r1387b1990],
25	SLCOZBZ	NNP	O	SLCOZBZ	prep_of	23	SENT_260	[p17l1409t1927r1766b1991],
26	*	CD	NUMBER	*	number	27	SENT_260	[p17l1778t1927r1844b1990],
27	5	CD	NUMBER	5	dep	25	SENT_260	[p17l1778t1927r1844b1990],
28	and	CC	O	and	_	0	SENT_260	[p17l1873t1924r2000b1990],
29	the	DT	O	the	det	31	SENT_260	[p17l2030t1924r2140b1990],
30	other	JJ	O	other	amod	31	SENT_260	[p17l11t2030r197b2096],
31	variants	NNS	O	variant	prep_of	23	SENT_260	[p17l223t2033r498b2096],
32	might	MD	O	might	aux	36	SENT_260	[p17l531t2030r743b2119],
33	logically	RB	O	logically	advmod	36	SENT_260	[p17l772t2030r1066b2119],
34	have	VB	O	have	aux	36	SENT_260	[p17l1093t2030r1251b2096],
35	been	VBN	O	be	cop	36	SENT_260	[p17l1281t2030r1448b2096],
36	1-sided	JJ	O	1-sided	dep	2	SENT_260	[p17l1483t2030r1742b2096],
37	because	IN	O	because	_	0	SENT_260	[p17l1771t2030r2040b2096],
38	of	IN	O	of	_	0	SENT_260	[p17l2073t2030r2152b2096],
39	the	DT	O	the	det	41	SENT_260	[p17l10t2136r120b2202],
40	known	JJ	O	known	amod	41	SENT_260	[p17l147t2136r388b2202],
41	direction	NN	O	direction	prep_because_of	36	SENT_260	[p17l414t2136r728b2202],
42	of	IN	O	of	_	0	SENT_260	[p17l755t2136r835b2202],
43	their	PRP$	O	they	poss	44	SENT_260	[p17l848t2136r1015b2202],
44	function	NN	O	function	prep_of	41	SENT_260	[p17l1039t2136r1355b2217],
45	;	:	O	;	_	0	SENT_260	[p17l1039t2136r1355b2217],
46	and	CC	O	and	_	0	SENT_260	[p17l1385t2136r1512b2202],
47	the	DT	O	the	det	48	SENT_260	[p17l1537t2136r1648b2202],
48	test	NN	O	test	nsubj	54	SENT_260	[p17l1674t2153r1799b2202],
49	of	IN	O	of	_	0	SENT_260	[p17l1824t2136r1904b2202],
50	a	DT	O	a	det	53	SENT_260	[p17l1919t2162r1953b2202],
51	gene	NN	O	gene	nn	53	SENT_260	[p17l1977t2162r2139b2225],
52	dose	NN	O	dose	nn	53	SENT_260	[p17l11t2242r178b2308],
53	effect	NN	O	effect	prep_of	48	SENT_260	[p17l249t2242r452b2308],
54	increases	VBZ	O	increase	conj_and	20	SENT_260	[p17l520t2245r859b2308],
55	the	DT	O	the	det	57	SENT_260	[p17l930t2242r1047b2308],
56	statistical	JJ	O	statistical	amod	57	SENT_260	[p17l1119t2242r1483b2308],
57	signiﬁcance	NN	O	signiﬁcance	dobj	54	SENT_260	[p17l1553t2242r1998b2331],
58	of	IN	O	of	_	0	SENT_260	[p17l2070t2242r2153b2308],
59	SLCOZB	NNP	O	SLCOZB	prep_of	57	SENT_260	[p17l13t2351r489b2414],
60	]	CD	NUMBER	]	number	61	SENT_260	[p17l13t2351r489b2414],
61	*	CD	NUMBER	*	num	64	SENT_260	[p17l13t2351r489b2414],
62	5	CD	NUMBER	5	poss	64	SENT_260	[p17l13t2351r489b2414],
63	’s	POS	O	’s	_	0	SENT_260	[p17l13t2351r489b2414],
64	eﬁect	NN	O	eﬁect	dep	59	SENT_260	[p17l521t2348r722b2413],
65	.	.	O	.	_	0	SENT_260	[p17l521t2348r722b2413],

1	Moreover	RB	O	moreover	advmod	10	SENT_261	[p17l758t2349r1126b2428],
2	,	,	O	,	_	0	SENT_261	[p17l758t2349r1126b2428],
3	SLCO	NN	O	slco	nn	5	SENT_261	[p17l1164t2351r1600b2414],
4	]	NN	O	]	nn	5	SENT_261	[p17l1164t2351r1600b2414],
5	B	NN	O	b	nsubjpass	10	SENT_261	[p17l1164t2351r1600b2414],
6	]	CD	NUMBER	]	num	7	SENT_261	[p17l1164t2351r1600b2414],
7	*	NN	O	*	dep	5	SENT_261	[p17l1164t2351r1600b2414],
8	5	CD	NUMBER	5	dep	5	SENT_261	[p17l1164t2351r1600b2414],
9	was	VBD	O	be	auxpass	10	SENT_261	[p17l1625t2374r1753b2414],
10	associated	VBN	O	associate	_	0	SENT_261	[p17l1789t2348r2141b2413],
11	with	IN	O	with	_	0	SENT_261	[p17l7t2455r168b2521],
12	simvastatin	NN	O	simvastatin	nn	13	SENT_261	[p17l213t2458r608b2521],
13	myopathy	NN	O	myopathy	prep_with	10	SENT_261	[p17l651t2455r1004b2544],
14	in	IN	O	in	_	0	SENT_261	[p17l1043t2458r1111b2520],
15	a	DT	O	a	det	16	SENT_261	[p17l1155t2481r1189b2521],
16	genome	NN	O	genome	prep_in	13	SENT_261	[p17l1229t2455r1713b2544],
17	—	CD	NUMBER	—	num	20	SENT_261	[p17l1229t2455r1713b2544],
18	wide	JJ	O	wide	amod	20	SENT_261	[p17l1229t2455r1713b2544],
19	association	NN	O	association	nn	20	SENT_261	[p17l1758t2458r2140b2521],
20	study	NN	O	study	dep	35	SENT_261	[p17l12t2561r201b2650],
21	with	IN	O	with	_	0	SENT_261	[p17l230t2561r391b2627],
22	a	DT	O	a	det	25	SENT_261	[p17l429t2587r464b2627],
23	much	JJ	O	much	amod	25	SENT_261	[p17l500t2561r696b2627],
24	stronger	JJR	O	stronger	dep	23	SENT_261	[p17l734t2578r1024b2650],
25	level	NN	O	level	prep_with	20	SENT_261	[p17l1058t2561r1217b2627],
26	of	IN	O	of	_	0	SENT_261	[p17l1253t2561r1332b2627],
27	association	NN	O	association	nn	29	SENT_261	[p17l1358t2564r1740b2627],
28	(	CD	NUMBER	(	num	29	SENT_261	[p17l1780t2559r1847b2650],
29	p	NN	O	p	prep_of	25	SENT_261	[p17l1780t2559r1847b2650],
30	=	JJ	O	=	amod	25	SENT_261	[p17l1894t2587r1947b2607],
31	1	CD	NUMBER	1	tmod	30	SENT_261	[p17l1997t2565r2028b2626],
32	X	NN	O	x	dep	35	SENT_261	[p17l2078t2571r2131b2623],
33	10-9	CD	NUMBER	10-9	num	32	SENT_261	[p17l15t2653r211b2746],
34	)	CD	NUMBER	)	num	35	SENT_261	[p17l15t2653r211b2746],
35	(	NN	O	(	dep	13	SENT_261	[p17l258t2663r418b2746],
36	27	CD	NUMBER	27	num	37	SENT_261	[p17l258t2663r418b2746],
37	)	NN	O	)	dep	35	SENT_261	[p17l258t2663r418b2746],
38	;	:	O	;	_	0	SENT_261	[p17l258t2663r418b2746],
39	therefore	RB	O	therefore	advmod	44	SENT_261	[p17l462t2666r800b2746],
40	,	,	O	,	_	0	SENT_261	[p17l462t2666r800b2746],
41	our	PRP$	O	we	poss	42	SENT_261	[p17l844t2691r962b2731],
42	results	NNS	O	result	nsubj	44	SENT_261	[p17l1000t2666r1223b2731],
43	are	VBP	O	be	cop	44	SENT_261	[p17l1267t2691r1367b2731],
44	conﬁrmatory	NN	O	conﬁrmatory	parataxis	10	SENT_261	[p17l1409t2666r1867b2754],
45	of	IN	O	of	_	0	SENT_261	[p17l1904t2666r1984b2731],
46	this	DT	O	this	det	48	SENT_261	[p17l2012t2666r2139b2731],
47	initial	JJ	O	initial	amod	48	SENT_261	[p17l10t2772r216b2838],
48	report	NN	O	report	prep_of	44	SENT_261	[p17l253t2789r485b2862],
49	.	.	O	.	_	0	SENT_261	[p17l253t2789r485b2862],

1	Consistently	RB	O	consistently	advmod	20	SENT_262	[p17l530t2772r993b2861],
2	,	,	O	,	_	0	SENT_262	[p17l530t2772r993b2861],
3	in	IN	O	in	_	0	SENT_262	[p17l1035t2775r1102b2837],
4	STRENGTH	NN	O	strength	prep_in	20	SENT_262	[p17l1145t2770r1673b2853],
5	,	,	O	,	_	0	SENT_262	[p17l1145t2770r1673b2853],
6	the	DT	O	the	det	7	SENT_262	[p17l1715t2772r1825b2838],
7	association	NN	O	association	nsubj	20	SENT_262	[p17l1866t2775r2138b2838, p17l10t2881r151b2944],
8	of	IN	O	of	_	0	SENT_262	[p17l178t2878r258b2944],
9	SLCOZBZ	NNP	O	SLCOZBZ	prep_of	7	SENT_262	[p17l275t2881r632b2945],
10	*	CD	NUMBER	*	number	11	SENT_262	[p17l644t2881r711b2944],
11	5	CD	NUMBER	5	dep	9	SENT_262	[p17l644t2881r711b2944],
12	with	IN	O	with	_	0	SENT_262	[p17l730t2878r891b2944],
13	adverse	JJ	O	adverse	amod	14	SENT_262	[p17l919t2878r1174b2944],
14	events	NNS	O	event	prep_with	11	SENT_262	[p17l1202t2895r1417b2945],
15	in	IN	O	in	_	0	SENT_262	[p17l1446t2881r1514b2943],
16	patients	NNS	O	patient	prep_in	14	SENT_262	[p17l1539t2881r1816b2968],
17	assigned	VBN	O	assign	partmod	16	SENT_262	[p17l1846t2878r2141b2967],
18	to	TO	O	to	_	0	SENT_262	[p17l10t3002r78b3051],
19	simvastatin	NN	O	simvastatin	prep_to	17	SENT_262	[p17l114t2988r510b3051],
20	appeared	VBD	O	appear	_	0	SENT_262	[p17l544t2985r860b3075],
21	to	TO	O	to	aux	24	SENT_262	[p17l892t3002r960b3051],
22	be	VB	O	be	cop	24	SENT_262	[p17l992t2985r1073b3051],
23	the	DT	O	the	det	24	SENT_262	[p17l1107t2985r1217b3051],
24	strongest	JJS	O	strongest	xcomp	20	SENT_262	[p17l1252t3002r1588b3074],
25	.	.	O	.	_	0	SENT_262	[p17l1252t3002r1588b3074],

1	Second	RB	ORDINAL	second	advmod	4	SENT_263	[p17l103t3091r376b3172],
2	,	,	O	,	_	0	SENT_263	[p17l103t3091r376b3172],
3	we	PRP	O	we	nsubj	4	SENT_263	[p17l417t3117r515b3157],
4	had	VBD	O	have	_	0	SENT_263	[p17l557t3091r687b3157],
5	no	DT	O	no	det	8	SENT_263	[p17l728t3117r814b3157],
6	placebo	NN	O	placebo	nn	8	SENT_263	[p17l855t3091r1121b3181],
7	control	NN	O	control	nn	8	SENT_263	[p17l1165t3091r1415b3157],
8	arm	NN	O	arm	dobj	4	SENT_263	[p17l1457t3117r1591b3157],
9	as	IN	O	as	_	0	SENT_263	[p17l1634t3117r1697b3157],
10	part	NN	O	part	prep_as	8	SENT_263	[p17l1739t3108r1881b3180],
11	of	IN	O	of	_	0	SENT_263	[p17l1921t3091r2001b3157],
12	the	DT	O	the	det	13	SENT_263	[p17l2029t3091r2139b3157],
13	study	NN	O	study	prep_of	10	SENT_263	[p17l12t3197r215b3286],
14	.	.	O	.	_	0	SENT_263	[p17l12t3197r215b3286],

1	Several	JJ	O	several	amod	3	SENT_264	[p17l267t3197r515b3263],
2	placebo	NN	O	placebo	nn	3	SENT_264	[p17l556t3197r1221b3286],
3	—	NN	O	—	nsubj	8	SENT_264	[p17l556t3197r1221b3286],
4	controlled	VBN	O	control	partmod	3	SENT_264	[p17l556t3197r1221b3286],
5	trials	NNS	O	trial	dobj	4	SENT_264	[p17l1264t3197r1434b3263],
6	of	IN	O	of	_	0	SENT_264	[p17l1480t3197r1560b3263],
7	statins	NNS	O	statin	prep_of	5	SENT_264	[p17l1593t3200r1815b3263],
8	demonstrate	VBP	O	demonstrate	_	0	SENT_264	[p17l1862t3197r2137b3263, p17l12t3321r201b3370],
9	that	IN	O	that	complm	15	SENT_264	[p17l240t3304r381b3370],
10	a	DT	O	a	det	12	SENT_264	[p17l419t3330r454b3370],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_264	[p17l492t3304r857b3393],
12	proportion	NN	O	proportion	nsubj	15	SENT_264	[p17l893t3307r1275b3394],
13	of	IN	O	of	_	0	SENT_264	[p17l1314t3304r1394b3370],
14	patients	NNS	O	patient	prep_of	12	SENT_264	[p17l1419t3307r1696b3393],
15	assigned	VBN	O	assign	ccomp	8	SENT_264	[p17l1738t3304r2033b3393],
16	to	TO	O	to	_	0	SENT_264	[p17l2071t3321r2139b3370],
17	placebo	NN	O	placebo	nn	20	SENT_264	[p18l9t32r275b121],
18	experience	NN	O	experience	nn	20	SENT_264	[p18l311t35r679b121],
19	adverse	JJ	O	adverse	amod	20	SENT_264	[p18l714t32r969b98],
20	events	NNS	O	event	prep_to	15	SENT_264	[p18l1003t49r1219b98],
21	at	IN	O	at	_	0	SENT_264	[p18l1255t49r1318b98],
22	rates	NNS	O	rate	prep_at	15	SENT_264	[p18l1349t49r1510b98],
23	comparable	JJ	O	comparable	amod	22	SENT_264	[p18l1545t32r1950b121],
24	with	IN	O	with	_	0	SENT_264	[p18l1979t32r2141b98],
25	those	DT	O	those	prep_with	23	SENT_264	[p18l10t138r196b204],
26	assigned	VBN	O	assign	partmod	25	SENT_264	[p18l236t138r531b227],
27	to	TO	O	to	aux	28	SENT_264	[p18l568t155r635b204],
28	statin	VB	O	statin	xcomp	26	SENT_264	[p18l675t141r868b204],
29	(	CD	NUMBER	(	number	30	SENT_264	[p18l908t136r1178b219],
30	28,29	CD	NUMBER	28,29	num	31	SENT_264	[p18l908t136r1178b219],
31	)	NN	O	)	dobj	28	SENT_264	[p18l908t136r1178b219],
32	.	.	O	.	_	0	SENT_264	[p18l908t136r1178b219],

1	Therefore	RB	O	therefore	advmod	11	SENT_265	[p18l1217t136r1592b219],
2	,	,	O	,	_	0	SENT_265	[p18l1217t136r1592b219],
3	in	IN	O	in	_	0	SENT_265	[p18l1632t141r1700b203],
4	the	DT	O	the	det	6	SENT_265	[p18l1737t138r1847b204],
5	present	JJ	DATE	present	amod	6	SENT_265	[p18l1884t155r2143b227],
6	study	NN	O	study	prep_in	11	SENT_265	[p18l12t244r217b333],
7	,	,	O	,	_	0	SENT_265	[p18l12t244r217b333],
8	we	PRP	O	we	nsubj	11	SENT_265	[p18l256t270r354b310],
9	can	MD	O	can	aux	11	SENT_265	[p18l396t261r635b310],
10	not	RB	O	not	neg	11	SENT_265	[p18l396t261r635b310],
11	quantify	VB	O	quantify	_	0	SENT_265	[p18l675t244r968b334],
12	the	DT	O	the	det	14	SENT_265	[p18l1004t244r1114b310],
13	attributable	JJ	O	attributable	amod	14	SENT_265	[p18l1157t244r1561b310],
14	risk	NN	O	risk	dobj	11	SENT_265	[p18l1602t244r1733b310],
15	of	IN	O	of	_	0	SENT_265	[p18l1769t244r1849b310],
16	AES	NN	ORGANIZATION	ae	prep_of	14	SENT_265	[p18l1874t243r2031b310],
17	in	IN	O	in	_	0	SENT_265	[p18l2073t247r2140b309],
18	carriers	NNS	O	carrier	prep_in	11	SENT_265	[p18l11t353r264b416],
19	of	IN	O	of	_	0	SENT_265	[p18l320t350r400b416],
20	SLCO	NN	O	slco	nn	22	SENT_265	[p18l445t353r895b416],
21	]	NN	O	]	nn	22	SENT_265	[p18l445t353r895b416],
22	B	NN	O	b	prep_of	18	SENT_265	[p18l445t353r895b416],
23	]	CD	NUMBER	]	num	24	SENT_265	[p18l445t353r895b416],
24	*	NN	O	*	dep	22	SENT_265	[p18l445t353r895b416],
25	5	CD	NUMBER	5	dep	24	SENT_265	[p18l445t353r895b416],
26	.	.	O	.	_	0	SENT_265	[p18l445t353r895b416],

1	However	RB	O	however	advmod	5	SENT_266	[p18l954t351r1295b430],
2	,	,	O	,	_	0	SENT_266	[p18l954t351r1295b430],
3	we	PRP	O	we	nsubj	5	SENT_266	[p18l1348t376r1446b416],
4	can	MD	O	can	aux	5	SENT_266	[p18l1502t376r1620b416],
5	calculate	VB	O	calculate	_	0	SENT_266	[p18l1675t350r1975b416],
6	the	DT	O	the	det	8	SENT_266	[p18l2030t350r2140b416],
7	relative	JJ	O	relative	amod	8	SENT_266	[p18l10t455r264b521],
8	risk	NN	O	risk	dobj	5	SENT_266	[p18l303t455r434b521],
9	of	IN	O	of	_	0	SENT_266	[p18l470t455r550b521],
10	AES	NN	ORGANIZATION	ae	prep_of	8	SENT_266	[p18l574t454r731b521],
11	in	IN	O	in	_	0	SENT_266	[p18l772t458r839b520],
12	carriers	NNS	O	carrier	prep_in	5	SENT_266	[p18l879t458r1132b521],
13	versus	CC	O	versus	_	0	SENT_266	[p18l1169t480r1383b521],
14	noncarriers	NNS	O	noncarrier	prep_in	5	SENT_266	[p18l1425t458r1816b521],
15	and	CC	O	and	_	0	SENT_266	[p18l1858t455r1986b521],
16	our	PRP$	O	we	poss	17	SENT_266	[p18l2025t480r2142b521],
17	estimates	NNS	O	estimate	nsubj	19	SENT_266	[p18l11t564r335b627],
18	are	VBP	O	be	cop	19	SENT_266	[p18l373t587r474b627],
19	similar	JJ	O	similar	conj_and	5	SENT_266	[p18l511t561r750b627],
20	in	IN	O	in	_	0	SENT_266	[p18l784t564r852b627],
21	magnitude	NN	O	magnitude	prep_in	19	SENT_266	[p18l888t561r1264b650],
22	to	TO	O	to	_	0	SENT_266	[p18l1300t578r1368b627],
23	those	DT	O	those	prep_to	19	SENT_266	[p18l1405t561r1591b627],
24	obtained	VBN	O	obtain	partmod	23	SENT_266	[p18l1628t561r1936b627],
25	from	IN	O	from	_	0	SENT_266	[p18l1970t561r2140b627],
26	the	DT	O	the	det	29	SENT_266	[p18l10t667r120b733],
27	recently	RB	DATE	recently	advmod	28	SENT_266	[p18l175t667r455b756],
28	reported	VBN	O	report	amod	29	SENT_266	[p18l505t667r804b756],
29	genome	NN	O	genome	prep_from	24	SENT_266	[p18l856t667r1339b756],
30	—	CD	NUMBER	—	num	33	SENT_266	[p18l856t667r1339b756],
31	wide	JJ	O	wide	amod	33	SENT_266	[p18l856t667r1339b756],
32	association	NN	O	association	nn	33	SENT_266	[p18l1396t670r1778b733],
33	study	NN	O	study	nsubj	37	SENT_266	[p18l1833t667r2022b756],
34	of	IN	O	of	_	0	SENT_266	[p18l2073t667r2153b733],
35	simvastatin	NN	O	simvastatin	nn	36	SENT_266	[p18l12t773r727b839],
36	—	NN	O	—	prep_of	33	SENT_266	[p18l12t773r727b839],
37	induced	VBD	O	induce	rcmod	29	SENT_266	[p18l12t773r727b839],
38	myopathy	JJ	O	myopathy	amod	39	SENT_266	[p18l761t773r1113b862],
39	(	NN	O	(	dobj	37	SENT_266	[p18l1146t771r1305b853],
40	27	CD	NUMBER	27	num	41	SENT_266	[p18l1146t771r1305b853],
41	)	NN	O	)	dep	39	SENT_266	[p18l1146t771r1305b853],
42	.	.	O	.	_	0	SENT_266	[p18l1146t771r1305b853],

1	Finally	RB	O	finally	advmod	4	SENT_267	[p18l100t879r362b968],
2	,	,	O	,	_	0	SENT_267	[p18l100t879r362b968],
3	we	PRP	O	we	nsubj	4	SENT_267	[p18l391t905r489b945],
4	used	VBD	O	use	_	0	SENT_267	[p18l519t879r678b945],
5	a	DT	O	a	det	8	SENT_267	[p18l708t905r742b945],
6	composite	JJ	O	composite	amod	8	SENT_267	[p18l771t882r1130b968],
7	end	NN	O	end	nn	8	SENT_267	[p18l1161t879r1289b945],
8	point	NN	O	point	dobj	4	SENT_267	[p18l1317t882r1506b969],
9	that	WDT	O	that	nsubj	10	SENT_267	[p18l1533t879r1674b945],
10	reﬂects	VBZ	O	reﬂects	rcmod	8	SENT_267	[p18l1702t879r1948b945],
11	mild	JJ	O	mild	amod	13	SENT_267	[p18l1980t879r2141b945],
12	statin	NN	O	statin	nn	13	SENT_267	[p18l12t985r524b1051],
13	—	NN	O	—	nsubj	14	SENT_267	[p18l12t985r524b1051],
14	induced	VBD	O	induce	ccomp	10	SENT_267	[p18l12t985r524b1051],
15	side	JJ	O	side	amod	16	SENT_267	[p18l563t985r697b1051],
16	effects	NNS	O	effect	dobj	14	SENT_267	[p18l737t985r950b1051],
17	that	WDT	O	that	nsubj	18	SENT_267	[p18l990t985r1131b1051],
18	developed	VBD	O	develop	rcmod	16	SENT_267	[p18l1168t985r1522b1075],
19	during	IN	O	during	_	0	SENT_267	[p18l1561t985r1794b1074],
20	the	DT	O	the	det	21	SENT_267	[p18l1830t985r1940b1051],
21	trial	NN	O	trial	prep_during	18	SENT_267	[p18l1979t985r2136b1051],
22	.	.	O	.	_	0	SENT_267	[p18l1979t985r2136b1051],

1	However	RB	O	however	advmod	30	SENT_268	[p18l11t1092r352b1172],
2	,	,	O	,	_	0	SENT_268	[p18l11t1092r352b1172],
3	when	WRB	O	when	advmod	5	SENT_268	[p18l394t1091r588b1158],
4	we	PRP	O	we	nsubj	5	SENT_268	[p18l627t1117r725b1158],
5	limited	VBD	O	limit	advcl	30	SENT_268	[p18l767t1091r1020b1157],
6	the	DT	O	the	det	7	SENT_268	[p18l1061t1091r1171b1157],
7	analysis	NN	O	analysis	dobj	5	SENT_268	[p18l1216t1091r1481b1180],
8	to	TO	O	to	_	0	SENT_268	[p18l1525t1108r1592b1157],
9	those	DT	O	those	prep_to	5	SENT_268	[p18l1636t1091r1822b1157],
10	without	IN	O	without	_	0	SENT_268	[p18l1862t1091r2142b1158],
11	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_268	[p18l12t1197r377b1286],
12	CK	NN	O	ck	nn	13	SENT_268	[p18l406t1197r533b1264],
13	elevation	NN	O	elevation	prep_without	9	SENT_268	[p18l560t1197r874b1263],
14	or	CC	O	or	_	0	SENT_268	[p18l904t1223r976b1263],
15	those	DT	O	those	conj_or	9	SENT_268	[p18l1003t1197r1189b1263],
16	with	IN	O	with	_	0	SENT_268	[p18l1215t1197r1377b1263],
17	only	RB	O	only	advmod	19	SENT_268	[p18l1406t1197r1559b1286],
18	musculoskeletal	JJ	O	musculoskeletal	amod	19	SENT_268	[p18l1585t1197r2142b1263],
19	symptoms	NNS	O	symptom	prep_with	15	SENT_268	[p18l12t1320r369b1393],
20	without	IN	O	without	_	0	SENT_268	[p18l425t1303r705b1369],
21	CK	NN	O	ck	nn	22	SENT_268	[p18l763t1303r890b1369],
22	elevations	NNS	O	elevation	prep_without	5	SENT_268	[p18l946t1303r1312b1384],
23	,	,	O	,	_	0	SENT_268	[p18l946t1303r1312b1384],
24	the	DT	O	the	det	25	SENT_268	[p18l1372t1303r1482b1369],
25	association	NN	O	association	nsubj	30	SENT_268	[p18l1543t1306r1925b1369],
26	with	IN	O	with	_	0	SENT_268	[p18l1979t1303r2140b1369],
27	SLCOJBJ	NN	O	slcojbj	prep_with	25	SENT_268	[p18l13t1411r449b1474],
28	*	CD	NUMBER	*	number	29	SENT_268	[p18l13t1411r449b1474],
29	5	CD	NUMBER	5	num	27	SENT_268	[p18l13t1411r449b1474],
30	holds	VBZ	O	hold	_	0	SENT_268	[p18l477t1408r665b1474],
31	(	RB	O	(	amod	34	SENT_268	[p18l703t1406r931b1488],
32	Table	NNP	O	Table	tmod	31	SENT_268	[p18l703t1406r931b1488],
33	3	CD	NUMBER	3	num	32	SENT_268	[p18l966t1406r1053b1488],
34	)	NN	O	)	dobj	30	SENT_268	[p18l966t1406r1053b1488],
35	.	.	O	.	_	0	SENT_268	[p18l966t1406r1053b1488],

1	There	EX	O	there	expl	2	SENT_269	[p18l96t1512r311b1580],
2	were	VBD	O	be	_	0	SENT_269	[p18l346t1540r512b1581],
3	several	JJ	O	several	amod	5	SENT_269	[p18l551t1514r785b1580],
4	methodological	JJ	O	methodological	amod	5	SENT_269	[p18l821t1514r1370b1603],
5	strengths	NNS	O	strength	nsubj	2	SENT_269	[p18l1407t1514r1727b1603],
6	to	TO	O	to	_	0	SENT_269	[p18l1765t1531r1833b1580],
7	our	PRP$	O	we	poss	8	SENT_269	[p18l1872t1540r1989b1580],
8	approach	NN	O	approach	prep_to	5	SENT_269	[p18l2026t1540r2138b1603, p18l9t1620r268b1709],
9	.	.	O	.	_	0	SENT_269	[p18l2026t1540r2138b1603, p18l9t1620r268b1709],

1	First	RB	ORDINAL	first	advmod	4	SENT_270	[p18l298t1621r481b1701],
2	,	,	O	,	_	0	SENT_270	[p18l298t1621r481b1701],
3	we	PRP	O	we	nsubj	4	SENT_270	[p18l505t1646r603b1686],
4	provided	VBD	O	provide	_	0	SENT_270	[p18l628t1620r939b1710],
5	a	DT	O	a	det	8	SENT_270	[p18l965t1646r999b1686],
6	clear	JJ	O	clear	amod	8	SENT_270	[p18l1023t1620r1186b1686],
7	biological	JJ	O	biological	amod	8	SENT_270	[p18l1207t1620r1551b1709],
8	rationale	NN	O	rationale	dobj	4	SENT_270	[p18l1574t1620r1881b1686],
9	for	IN	O	for	_	0	SENT_270	[p18l1906t1620r2007b1686],
10	the	DT	O	the	det	12	SENT_270	[p18l2030t1620r2140b1686],
11	candidate	NN	O	candidate	nn	12	SENT_270	[p18l11t1726r349b1792],
12	genes	NNS	O	gene	prep_for	4	SENT_270	[p18l373t1752r566b1815],
13	and	CC	O	and	_	0	SENT_270	[p18l594t1726r721b1792],
14	SNPS	NNS	O	snp	prep_for	4	SENT_270	[p18l748t1726r945b1793],
15	of	IN	O	of	_	0	SENT_270	[p18l971t1726r1051b1792],
16	interest	NN	O	interest	prep_of	12	SENT_270	[p18l1063t1729r1327b1792],
17	based	VBN	O	base	_	0	SENT_270	[p18l1348t1726r1545b1792],
18	on	IN	O	on	prepc_based_on	4	SENT_270	[p18l1570t1752r1657b1792],
19	known	JJ	O	known	amod	21	SENT_270	[p18l1681t1726r1922b1793],
20	statin	NN	O	statin	nn	21	SENT_270	[p18l1948t1729r2140b1792],
21	pharmacogenetics	NNS	O	pharmacogenetic	pobj	4	SENT_270	[p18l9t1833r664b1923],
22	.	.	O	.	_	0	SENT_270	[p18l9t1833r664b1923],

1	By	IN	O	by	_	0	SENT_271	[p18l708t1834r806b1922],
2	choosing	VBG	O	choose	prepc_by	20	SENT_271	[p18l842t1833r1158b1922],
3	genes	NNS	O	gene	dobj	2	SENT_271	[p18l1195t1859r1388b1922],
4	implicated	VBN	O	implicate	partmod	3	SENT_271	[p18l1430t1833r1801b1923],
5	in	IN	O	in	_	0	SENT_271	[p18l1840t1836r1908b1898],
6	statin	NN	O	statin	nn	7	SENT_271	[p18l1949t1836r2141b1899],
7	pharmacology	NN	O	pharmacology	prep_in	4	SENT_271	[p18l9t1939r512b2029],
8	and	CC	O	and	_	0	SENT_271	[p18l541t1939r669b2005],
9	SNPS	NN	O	snp	conj_and	7	SENT_271	[p18l703t1939r900b2005],
10	that	WDT	O	that	nsubjpass	12	SENT_271	[p18l933t1939r1074b2005],
11	were	VBD	O	be	auxpass	12	SENT_271	[p18l1100t1965r1267b2005],
12	known	VBN	O	know	rcmod	3	SENT_271	[p18l1299t1939r1540b2005],
13	to	TO	O	to	aux	15	SENT_271	[p18l1571t1956r1639b2005],
14	be	VB	O	be	cop	15	SENT_271	[p18l1670t1939r1751b2005],
15	functional	JJ	O	functional	xcomp	12	SENT_271	[p18l1783t1939r2141b2005],
16	in	IN	O	in	_	0	SENT_271	[p18l10t2048r78b2110],
17	prior	JJ	O	prior	amod	18	SENT_271	[p18l118t2048r292b2135],
18	studies	NNS	O	study	prep_in	15	SENT_271	[p18l333t2045r570b2111],
19	we	PRP	O	we	nsubj	20	SENT_271	[p18l610t2071r708b2111],
20	limited	VBD	O	limit	_	0	SENT_271	[p18l748t2045r1001b2111],
21	the	DT	O	the	det	22	SENT_271	[p18l1042t2045r1152b2111],
22	number	NN	O	number	dobj	20	SENT_271	[p18l1195t2045r1469b2111],
23	of	IN	O	of	_	0	SENT_271	[p18l1509t2045r1589b2111],
24	statistical	JJ	O	statistical	amod	25	SENT_271	[p18l1619t2045r1947b2111],
25	tests	NNS	O	test	prep_of	22	SENT_271	[p18l1986t2062r2139b2111],
26	being	VBG	O	be	auxpass	27	SENT_271	[p18l8t2151r206b2240],
27	performed	VBN	O	perform	partmod	25	SENT_271	[p18l251t2151r621b2240],
28	and	CC	O	and	_	0	SENT_271	[p18l670t2151r797b2217],
29	the	DT	O	the	det	30	SENT_271	[p18l844t2151r954b2217],
30	risk	NN	O	risk	conj_and	25	SENT_271	[p18l1003t2151r1133b2217],
31	of	IN	O	of	_	0	SENT_271	[p18l1178t2151r1257b2217],
32	ﬁnding	VBG	O	ﬁnding	prepc_of	30	SENT_271	[p18l1293t2151r1548b2240],
33	a	DT	O	a	det	37	SENT_271	[p18l1596t2177r1630b2217],
34	false	JJ	O	false	amod	37	SENT_271	[p18l1677t2151r2140b2241],
35	—	NN	O	—	nn	37	SENT_271	[p18l1677t2151r2140b2241],
36	positive	JJ	O	positive	amod	37	SENT_271	[p18l1677t2151r2140b2241],
37	result	NN	O	result	dobj	32	SENT_271	[p18l10t2257r221b2323],
38	.	.	O	.	_	0	SENT_271	[p18l10t2257r221b2323],

1	For	IN	O	for	_	0	SENT_272	[p18l268t2258r393b2323],
2	example	NN	O	example	prep_for	23	SENT_272	[p18l435t2257r743b2346],
3	,	,	O	,	_	0	SENT_272	[p18l435t2257r743b2346],
4	the	DT	O	the	det	5	SENT_272	[p18l788t2257r898b2323],
5	SLCOJB	NNP	O	SLCOJB	nsubjpass	28	SENT_272	[p18l943t2260r1379b2324],
6	]	CD	NUMBER	]	num	5	SENT_272	[p18l943t2260r1379b2324],
7	*	CD	NUMBER	*	number	8	SENT_272	[p18l943t2260r1379b2324],
8	5	CD	NUMBER	5	num	9	SENT_272	[p18l943t2260r1379b2324],
9	allele	NN	O	allele	nsubjpass	13	SENT_272	[p18l1418t2257r1594b2323],
10	has	VBZ	O	have	aux	13	SENT_272	[p18l1637t2257r1750b2323],
11	been	VBN	O	be	auxpass	13	SENT_272	[p18l1791t2257r1958b2323],
12	well	RB	O	well	advmod	13	SENT_272	[p18l1996t2257r2142b2323],
13	studied	VBN	O	study	rcmod	5	SENT_272	[p18l12t2364r267b2430],
14	with	IN	O	with	_	0	SENT_272	[p18l323t2364r484b2430],
15	respect	NN	O	respect	prep_with	13	SENT_272	[p18l543t2381r790b2454],
16	to	TO	O	to	_	0	SENT_272	[p18l848t2381r916b2430],
17	leading	VBG	O	lead	prepc_to	13	SENT_272	[p18l976t2364r1235b2453],
18	to	TO	O	to	_	0	SENT_272	[p18l1293t2381r1362b2430],
19	greater	JJR	O	greater	amod	22	SENT_272	[p18l1422t2381r1667b2453],
20	statin	NN	O	statin	nn	22	SENT_272	[p18l1727t2367r1919b2430],
21	drug	NN	O	drug	nn	22	SENT_272	[p18l1980t2364r2142b2453],
22	concentrations	NNS	O	concentration	prep_to	17	SENT_272	[p18l11t2473r527b2536],
23	(	VBP	O	(	_	0	SENT_272	[p18l564t2468r834b2551],
24	11-13	CD	NUMBER	11-13	num	25	SENT_272	[p18l564t2468r834b2551],
25	)	CD	NUMBER	)	dobj	23	SENT_272	[p18l564t2468r834b2551],
26	and	CC	O	and	_	0	SENT_272	[p18l871t2470r998b2536],
27	was	VBD	O	be	auxpass	28	SENT_272	[p18l1026t2496r1155b2537],
28	identiﬁed	VBN	O	identiﬁed	conj_and	23	SENT_272	[p18l1188t2470r1526b2536],
29	as	IN	O	as	mark	36	SENT_272	[p18l1558t2496r1621b2536],
30	a	DT	O	a	det	32	SENT_272	[p18l1656t2496r1690b2536],
31	major	JJ	O	major	amod	32	SENT_272	[p18l1721t2472r1925b2559],
32	cause	NN	O	cause	nsubj	36	SENT_272	[p18l1956t2496r2140b2536],
33	of	IN	O	of	_	0	SENT_272	[p18l11t2576r91b2642],
34	simvastatin	NN	O	simvastatin	nn	35	SENT_272	[p18l113t2576r829b2642],
35	—	NN	O	—	prep_of	32	SENT_272	[p18l113t2576r829b2642],
36	induced	VBD	O	induce	advcl	28	SENT_272	[p18l113t2576r829b2642],
37	myopathy	NN	O	myopathy	nsubj	41	SENT_272	[p18l862t2576r1215b2666],
38	with	IN	O	with	_	0	SENT_272	[p18l1241t2576r1402b2642],
39	CK	NN	O	ck	nn	40	SENT_272	[p18l1436t2576r1563b2643],
40	elevations	NNS	O	elevation	prep_with	37	SENT_272	[p18l1595t2576r1939b2642],
41	(	VBP	O	(	ccomp	36	SENT_272	[p18l1977t2574r2136b2656],
42	14	CD	NUMBER	14	num	43	SENT_272	[p18l1977t2574r2136b2656],
43	)	CD	NUMBER	)	dobj	41	SENT_272	[p18l1977t2574r2136b2656],
44	.	.	O	.	_	0	SENT_272	[p18l1977t2574r2136b2656],

1	Second	RB	ORDINAL	second	advmod	17	SENT_273	[p18l14t2682r288b2763],
2	,	,	O	,	_	0	SENT_273	[p18l14t2682r288b2763],
3	our	PRP$	O	we	poss	4	SENT_273	[p18l328t2708r445b2748],
4	hypothesis	NN	O	hypothesis	nsubjpass	6	SENT_273	[p18l479t2682r852b2772],
5	was	VBD	O	be	auxpass	6	SENT_273	[p18l886t2708r1015b2748],
6	tested	VBN	O	test	parataxis	17	SENT_273	[p18l1053t2682r1260b2748],
7	within	IN	O	within	_	0	SENT_273	[p18l1292t2682r1524b2749],
8	the	DT	O	the	det	9	SENT_273	[p18l1561t2682r1671b2748],
9	context	NN	O	context	prep_within	6	SENT_273	[p18l1708t2699r1968b2748],
10	of	IN	O	of	_	0	SENT_273	[p18l2002t2682r2082b2748],
11	a	DT	O	a	det	12	SENT_273	[p18l2108t2708r2142b2748],
12	large	JJ	O	large	prep_of	9	SENT_273	[p18l9t2789r199b2878],
13	,	,	O	,	_	0	SENT_273	[p18l9t2789r199b2878],
14	prospective	JJ	O	prospective	amod	16	SENT_273	[p18l235t2792r632b2879],
15	statin	NN	O	statin	nn	16	SENT_273	[p18l669t2792r862b2855],
16	pharmacogenetics	NNS	O	pharmacogenetic	nsubj	17	SENT_273	[p18l895t2789r1530b2879],
17	challenge	VBP	O	challenge	_	0	SENT_273	[p18l1567t2789r1896b2878],
18	study	NN	O	study	dobj	17	SENT_273	[p18l1933t2789r2136b2878],
19	.	.	O	.	_	0	SENT_273	[p18l1933t2789r2136b2878],

1	The	DT	O	the	det	3	SENT_274	[p18l8t2893r154b2961],
2	main	JJ	O	main	amod	3	SENT_274	[p18l216t2898r392b2961],
3	beneﬁt	NN	O	beneﬁt	nsubj	8	SENT_274	[p18l450t2895r695b2961],
4	of	IN	O	of	_	0	SENT_274	[p18l754t2895r834b2961],
5	such	PDT	O	such	predet	7	SENT_274	[p18l883t2895r1039b2961],
6	a	DT	O	a	det	7	SENT_274	[p18l1100t2921r1135b2961],
7	trial	NN	O	trial	prep_of	3	SENT_274	[p18l1193t2895r1334b2961],
8	is	VBZ	O	be	_	0	SENT_274	[p18l1392t2898r1443b2961],
9	to	TO	O	to	aux	10	SENT_274	[p18l1504t2912r1572b2961],
10	provide	VB	O	provide	xcomp	8	SENT_274	[p18l1632t2895r1896b2985],
11	clear	JJ	O	clear	acomp	10	SENT_274	[p18l1957t2895r2138b2976],
12	,	,	O	,	_	0	SENT_274	[p18l1957t2895r2138b2976],
13	consistent	JJ	O	consistent	ccomp	8	SENT_274	[p18l11t3005r384b3083],
14	,	,	O	,	_	0	SENT_274	[p18l11t3005r384b3083],
15	a	DT	O	a	det	16	SENT_274	[p18l424t3028r458b3068],
16	priori	FW	O	priori	dep	17	SENT_274	[p18l491t3005r687b3091],
17	deﬁnitions	NNS	O	deﬁnitions	dep	8	SENT_274	[p18l723t3002r1096b3068],
18	of	IN	O	of	_	0	SENT_274	[p18l1134t3002r1214b3068],
19	the	DT	O	the	det	21	SENT_274	[p18l1237t3002r1347b3068],
20	clinical	JJ	O	clinical	amod	21	SENT_274	[p18l1384t3002r1632b3068],
21	phenotype	NN	O	phenotype	prep_of	17	SENT_274	[p18l1665t3002r2036b3092],
22	of	IN	O	of	_	0	SENT_274	[p18l2073t3002r2152b3068],
23	interest	NN	O	interest	prep_of	21	SENT_274	[p18l10t3110r274b3173],
24	in	IN	O	in	mark	27	SENT_274	[p18l325t3110r392b3172],
25	order	NN	O	order	dep	27	SENT_274	[p18l446t3107r632b3173],
26	to	TO	O	to	aux	27	SENT_274	[p18l683t3124r751b3173],
27	minimize	VB	O	minimize	dep	8	SENT_274	[p18l806t3110r1139b3173],
28	misclassiﬁcation	NN	O	misclassiﬁcation	nn	29	SENT_274	[p18l1193t3107r1767b3173],
29	error	NN	O	error	dobj	27	SENT_274	[p18l1820t3132r2007b3173],
30	.	.	O	.	_	0	SENT_274	[p18l1820t3132r2007b3173],

1	In	IN	O	in	_	0	SENT_275	[p18l2063t3108r2141b3172],
2	addition	NN	O	addition	prep_in	7	SENT_275	[p18l12t3213r325b3294],
3	,	,	O	,	_	0	SENT_275	[p18l12t3213r325b3294],
4	all	DT	O	all	det	5	SENT_275	[p18l373t3213r453b3279],
5	subjects	NNS	O	subject	nsubjpass	12	SENT_275	[p18l497t3213r768b3302],
6	were	VBD	O	be	auxpass	7	SENT_275	[p18l810t3239r976b3280],
7	followed	VBN	O	follow	_	0	SENT_275	[p18l1021t3213r1344b3294],
8	,	,	O	,	_	0	SENT_275	[p18l1021t3213r1344b3294],
9	interviewed	VBD	O	interview	parataxis	7	SENT_275	[p18l1391t3213r1819b3294],
10	,	,	O	,	_	0	SENT_275	[p18l1391t3213r1819b3294],
11	and	CC	O	and	_	0	SENT_275	[p18l1868t3213r1995b3279],
12	assessed	VBN	O	assess	conj_and	7	SENT_275	[p18l2040t3239r2138b3279, p18l12t3319r225b3385],
13	in	IN	O	in	_	0	SENT_275	[p18l253t3322r321b3384],
14	the	DT	O	the	det	16	SENT_275	[p18l349t3319r459b3385],
15	identical	JJ	O	identical	amod	16	SENT_275	[p18l489t3319r791b3385],
16	manner	NN	O	manner	prep_in	12	SENT_275	[p18l820t3345r1090b3385],
17	therefore	RB	O	therefore	advmod	18	SENT_275	[p18l1117t3319r1435b3385],
18	minimizing	VBG	O	minimize	partmod	16	SENT_275	[p18l1466t3322r1878b3408],
19	potential	JJ	O	potential	amod	20	SENT_275	[p18l1904t3336r2138b3409, p18l10t3425r121b3491],
20	biases	NNS	O	bias	dobj	18	SENT_275	[p18l150t3425r375b3491],
21	.	.	O	.	_	0	SENT_275	[p18l150t3425r375b3491],

1	Lastly	RB	O	lastly	advmod	4	SENT_276	[p18l413t3425r646b3514],
2	,	,	O	,	_	0	SENT_276	[p18l413t3425r646b3514],
3	we	PRP	O	we	nsubj	4	SENT_276	[p18l678t3451r776b3491],
4	provide	VBP	O	provide	_	0	SENT_276	[p18l809t3425r1072b3515],
5	in	FW	O	in	nn	6	SENT_276	[p18l1105t3428r1173b3490],
6	vivo	FW	O	vivo	advmod	4	SENT_276	[p18l1202t3428r1346b3491],
7	data	NNS	O	datum	dobj	4	SENT_276	[p18l1381t3425r1528b3491],
8	of	IN	O	of	_	0	SENT_276	[p18l1561t3425r1640b3491],
9	statin	NN	O	statin	nn	10	SENT_276	[p18l1662t3428r1855b3491],
10	metabolites	NNS	O	metabolite	prep_of	7	SENT_276	[p18l1888t3425r2137b3491, p18l11t3531r194b3597],
11	that	WDT	O	that	nsubj	12	SENT_276	[p18l229t3531r370b3597],
12	parallel	VBP	O	parallel	rcmod	7	SENT_276	[p18l400t3531r657b3621],
13	the	DT	O	the	det	15	SENT_276	[p18l688t3531r799b3597],
14	clinical	JJ	O	clinical	amod	15	SENT_276	[p18l833t3531r1081b3597],
15	associations	NNS	O	association	dobj	12	SENT_276	[p18l1115t3534r1547b3597],
16	.	.	O	.	_	0	SENT_276	[p18l1115t3534r1547b3597],

1	Conclusions	NNS	O	conclusion	_	0	SENT_277	[p19l10t87r527b150],

1	Overall	RB	O	overall	advmod	6	SENT_278	[p19l12t257r290b338],
2	,	,	O	,	_	0	SENT_278	[p19l12t257r290b338],
3	statins	NNS	O	statin	nsubj	6	SENT_278	[p19l333t260r555b323],
4	are	VBP	O	be	cop	6	SENT_278	[p19l597t283r697b323],
5	well	RB	O	well	advmod	6	SENT_278	[p19l733t257r1229b323],
6	—	JJ	O	—	_	0	SENT_278	[p19l733t257r1229b323],
7	tolerated	VBN	O	tolerate	dep	6	SENT_278	[p19l733t257r1229b323],
8	medications	NNS	O	medication	dobj	7	SENT_278	[p19l1268t257r1712b338],
9	,	,	O	,	_	0	SENT_278	[p19l1268t257r1712b338],
10	although	IN	O	although	_	0	SENT_278	[p19l1755t257r2068b346],
11	a	DT	O	a	det	12	SENT_278	[p19l2108t283r2142b323],
12	portion	NN	O	portion	prep_although	7	SENT_278	[p19l9t366r271b452],
13	of	IN	O	of	_	0	SENT_278	[p19l309t363r389b429],
14	patients	NNS	O	patient	nn	16	SENT_278	[p19l413t366r690b452],
15	experience	NN	O	experience	nn	16	SENT_278	[p19l730t366r1098b453],
16	AES	NN	ORGANIZATION	ae	prep_of	12	SENT_278	[p19l1134t362r1290b429],
17	that	WDT	O	that	nsubj	18	SENT_278	[p19l1329t363r1470b429],
18	limit	VBP	O	limit	rcmod	12	SENT_278	[p19l1504t363r1674b429],
19	dose	NN	O	dose	nn	20	SENT_278	[p19l1711t363r1866b429],
20	escalation	NN	O	escalation	dobj	18	SENT_278	[p19l1905t363r2138b429, p19l10t472r170b550],
21	,	,	O	,	_	0	SENT_278	[p19l1905t363r2138b429, p19l10t472r170b550],
22	statin	NN	O	statin	nn	23	SENT_278	[p19l202t472r394b535],
23	adherence	NN	O	adherence	appos	20	SENT_278	[p19l423t469r798b550],
24	,	,	O	,	_	0	SENT_278	[p19l423t469r798b550],
25	and	CC	O	and	_	0	SENT_278	[p19l829t469r956b535],
26	ultimately	RB	O	ultimately	advmod	27	SENT_278	[p19l982t469r1340b558],
27	achieving	VBG	O	achieve	dep	6	SENT_278	[p19l1366t469r1699b558],
28	target	NN	O	target	nn	30	SENT_278	[p19l1724t486r1928b558],
29	LDL	NN	O	ldl	nn	30	SENT_278	[p19l1955t470r2140b534],
30	Voora	NNP	O	Voora	nsubj	32	SENT_278	[p19l1484t571r1647b623],
31	et	FW	O	et	nn	32	SENT_278	[p19l1676t573r1733b623],
32	al.	FW	O	al.	xcomp	27	SENT_278	[p19l1754t571r1821b623],
33	1615	CD	DATE	1615	dep	32	SENT_278	[p19l1996t571r2140b623],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_279	[p19l668t660r1191b722],
2	of	IN	O	of	_	0	SENT_279	[p19l1216t659r1272b712],
3	Statin	NN	O	statin	nn	6	SENT_279	[p19l1294t659r1460b712],
4	Side	NN	O	side	nn	6	SENT_279	[p19l1486t659r1608b712],
5	Eﬁects	NN	O	eﬁects	nn	6	SENT_279	[p19l1636t659r1822b712],
6	levels	NNS	O	level	prep_of	1	SENT_279	[p19l9t882r216b948],
7	.	.	O	.	_	0	SENT_279	[p19l9t882r216b948],

1	We	PRP	O	we	nsubj	2	SENT_280	[p19l244t883r374b949],
2	report	VBP	O	report	_	0	SENT_280	[p19l402t899r617b971],
3	here	RB	O	here	advmod	2	SENT_280	[p19l642t882r792b948],
4	that	IN	O	that	complm	22	SENT_280	[p19l820t882r961b948],
5	carriers	NNS	O	carrier	nsubj	22	SENT_280	[p19l987t885r1239b948],
6	of	IN	O	of	_	0	SENT_280	[p19l1269t882r1349b948],
7	the	DT	O	the	det	8	SENT_280	[p19l1363t882r1473b948],
8	SLCOZB	NNP	O	SLCOZB	prep_of	5	SENT_280	[p19l1504t885r1861b949],
9	]	CD	NUMBER	]	num	8	SENT_280	[p19l1504t885r1861b949],
10	*	CD	NUMBER	*	number	11	SENT_280	[p19l1873t885r1939b948],
11	5	CD	NUMBER	5	num	12	SENT_280	[p19l1873t885r1939b948],
12	allele	NN	O	allele	nsubj	13	SENT_280	[p19l1964t882r2139b948],
13	are	VBP	O	be	rcmod	8	SENT_280	[p19l12t1016r112b1056],
14	at	IN	O	at	_	0	SENT_280	[p19l138t1008r201b1056],
15	a	DT	O	a	det	18	SENT_280	[p19l224t1017r258b1056],
16	2-fold	JJ	O	2-fold	amod	18	SENT_280	[p19l278t991r499b1057],
17	relative	JJ	O	relative	amod	18	SENT_280	[p19l521t991r774b1056],
18	risk	NN	O	risk	prep_at	13	SENT_280	[p19l798t991r929b1056],
19	of	IN	O	of	_	0	SENT_280	[p19l949t991r1028b1056],
20	mild	JJ	O	mild	amod	21	SENT_280	[p19l1040t991r1201b1056],
21	statin	NN	O	statin	prep_of	18	SENT_280	[p19l1225t994r1417b1056],
22	induced	VBD	O	induce	ccomp	2	SENT_280	[p19l1440t991r1720b1056],
23	side	JJ	O	side	amod	24	SENT_280	[p19l1745t991r1878b1056],
24	effects	NNS	O	effect	dobj	22	SENT_280	[p19l1903t991r2138b1071],
25	,	,	O	,	_	0	SENT_280	[p19l1903t991r2138b1071],
26	the	DT	O	the	det	27	SENT_280	[p19l10t1098r120b1164],
27	majority	NN	O	majority	nsubj	30	SENT_280	[p19l154t1100r451b1187],
28	of	IN	O	of	_	0	SENT_280	[p19l480t1098r560b1164],
29	which	WDT	O	which	prep_of	27	SENT_280	[p19l576t1098r793b1165],
30	had	VBD	O	have	rcmod	24	SENT_280	[p19l825t1098r954b1164],
31	normal	JJ	O	normal	amod	33	SENT_280	[p19l987t1098r1238b1164],
32	CK	NN	O	ck	nn	33	SENT_280	[p19l1271t1098r1398b1165],
33	levels	NNS	O	level	dobj	30	SENT_280	[p19l1426t1098r1634b1165],
34	.	.	O	.	_	0	SENT_280	[p19l1426t1098r1634b1165],

1	These	DT	O	these	det	2	SENT_281	[p19l1667t1096r1883b1164],
2	results	NNS	O	result	nsubj	4	SENT_281	[p19l1916t1098r2138b1164],
3	could	MD	O	could	aux	4	SENT_281	[p19l11t1206r202b1272],
4	have	VB	O	have	_	0	SENT_281	[p19l244t1206r402b1272],
5	potential	JJ	O	potential	amod	6	SENT_281	[p19l444t1206r760b1295],
6	implications	NNS	O	implication	dobj	4	SENT_281	[p19l801t1206r1233b1295],
7	for	IN	O	for	_	0	SENT_281	[p19l1277t1206r1378b1272],
8	clinical	JJ	O	clinical	amod	9	SENT_281	[p19l1420t1206r1668b1272],
9	practice	NN	O	practice	prep_for	6	SENT_281	[p19l1708t1209r1982b1295],
10	because	IN	O	because	mark	21	SENT_281	[p19l2023t1206r2137b1272, p19l11t1341r195b1381],
11	the	DT	O	the	det	13	SENT_281	[p19l240t1315r350b1381],
12	vast	JJ	O	vast	amod	13	SENT_281	[p19l391t1332r529b1381],
13	majority	NN	O	majority	nsubj	21	SENT_281	[p19l572t1316r869b1404],
14	of	IN	O	of	_	0	SENT_281	[p19l910t1315r989b1381],
15	patients	NNS	O	patient	prep_of	13	SENT_281	[p19l1020t1318r1297b1404],
16	who	WP	O	who	nsubj	18	SENT_281	[p19l1339t1315r1491b1381],
17	are	VBP	O	be	cop	18	SENT_281	[p19l1538t1340r1638b1381],
18	intolerant	JJ	O	intolerant	rcmod	15	SENT_281	[p19l1683t1315r2029b1381],
19	of	IN	O	of	_	0	SENT_281	[p19l2073t1315r2152b1381],
20	statins	NNS	O	statin	prep_of	13	SENT_281	[p19l12t1425r234b1488],
21	have	VBP	O	have	advcl	4	SENT_281	[p19l274t1422r432b1489],
22	mild	JJ	O	mild	amod	23	SENT_281	[p19l471t1422r632b1488],
23	symptoms	NNS	O	symptom	dobj	21	SENT_281	[p19l670t1439r1027b1512],
24	Without	IN	O	without	_	0	SENT_281	[p19l1063t1422r1343b1489],
25	associated	VBN	O	associate	amod	27	SENT_281	[p19l1381t1422r1733b1488],
26	CK	NN	O	ck	nn	27	SENT_281	[p19l1771t1422r1898b1489],
27	elevations	NNS	O	elevation	prep_without	21	SENT_281	[p19l1934t1422r2137b1488, p19l10t1534r200b1597],
28	.	.	O	.	_	0	SENT_281	[p19l1934t1422r2137b1488, p19l10t1534r200b1597],

1	For	IN	O	for	_	0	SENT_282	[p19l245t1532r370b1597],
2	these	DT	O	these	det	3	SENT_282	[p19l407t1531r586b1597],
3	patients	NNS	O	patient	prep_for	7	SENT_282	[p19l625t1534r923b1620],
4	,	,	O	,	_	0	SENT_282	[p19l625t1534r923b1620],
5	our	PRP$	O	we	poss	6	SENT_282	[p19l966t1557r1083b1597],
6	ﬁndings	NNS	O	ﬁndings	nsubj	7	SENT_282	[p19l1120t1531r1403b1620],
7	suggest	VBP	O	suggest	_	0	SENT_282	[p19l1445t1548r1702b1620],
8	that	IN	O	that	complm	21	SENT_282	[p19l1740t1531r1880b1597],
9	pravastatin	NN	O	pravastatin	nsubj	21	SENT_282	[p19l1916t1557r2138b1620, p19l12t1643r224b1721],
10	,	,	O	,	_	0	SENT_282	[p19l1916t1557r2138b1620, p19l12t1643r224b1721],
11	instead	RB	O	instead	_	0	SENT_282	[p19l279t1640r529b1706],
12	of	IN	O	of	_	0	SENT_282	[p19l581t1640r660b1706],
13	simvastatin	NN	O	simvastatin	prep_instead_of	9	SENT_282	[p19l701t1643r1116b1720],
14	,	,	O	,	_	0	SENT_282	[p19l701t1643r1116b1720],
15	may	MD	O	may	aux	21	SENT_282	[p19l1172t1666r1320b1729],
16	be	VB	O	be	cop	21	SENT_282	[p19l1366t1640r1446b1706],
17	a	DT	O	a	det	21	SENT_282	[p19l1500t1666r1534b1706],
18	reasonable	JJ	O	reasonable	amod	21	SENT_282	[p19l1584t1640r1953b1706],
19	first	JJ	ORDINAL	first	amod	21	SENT_282	[p19l2005t1640r2142b1706],
20	choice	NN	O	choice	nn	21	SENT_282	[p19l11t1747r233b1813],
21	statin	NN	O	statin	ccomp	7	SENT_282	[p19l268t1750r461b1813],
22	for	IN	O	for	_	0	SENT_282	[p19l493t1747r594b1813],
23	carriers	NNS	O	carrier	prep_for	21	SENT_282	[p19l626t1750r879b1813],
24	of	IN	O	of	_	0	SENT_282	[p19l914t1747r994b1813],
25	the	DT	O	the	det	29	SENT_282	[p19l1015t1747r1125b1813],
26	SLCOZBZ	NNP	O	SLCOZBZ	nn	29	SENT_282	[p19l1161t1750r1596b1814],
27	*	CD	NUMBER	*	num	29	SENT_282	[p19l1161t1750r1596b1814],
28	5	CD	NUMBER	5	amod	29	SENT_282	[p19l1161t1750r1596b1814],
29	allele	NN	O	allele	prep_of	23	SENT_282	[p19l1627t1747r1824b1827],
30	,	,	O	,	_	0	SENT_282	[p19l1627t1747r1824b1827],
31	whereas	IN	O	whereas	mark	34	SENT_282	[p19l1856t1747r2139b1813],
32	women	NNS	O	woman	nsubj	34	SENT_282	[p19l7t1881r269b1921],
33	may	MD	O	may	aux	34	SENT_282	[p19l307t1881r455b1944],
34	beneﬁt	VB	O	beneﬁt	dep	29	SENT_282	[p19l487t1855r732b1921],
35	from	IN	O	from	_	0	SENT_282	[p19l767t1855r937b1921],
36	increased	VBN	O	increase	amod	37	SENT_282	[p19l975t1855r1302b1921],
37	surveillance	NN	O	surveillance	prep_from	34	SENT_282	[p19l1340t1855r1746b1921],
38	for	IN	O	for	_	0	SENT_282	[p19l1784t1855r1885b1921],
39	symptoms	NNS	O	symptom	prep_for	37	SENT_282	[p19l1922t1881r2138b1944, p19l10t1981r201b2029],
40	.	.	O	.	_	0	SENT_282	[p19l1922t1881r2138b1944, p19l10t1981r201b2029],

1	However	RB	O	however	advmod	26	SENT_283	[p19l246t1965r587b2044],
2	,	,	O	,	_	0	SENT_283	[p19l246t1965r587b2044],
3	further	JJ	O	further	amod	4	SENT_283	[p19l630t1964r875b2029],
4	studies	NNS	O	study	nsubj	26	SENT_283	[p19l915t1964r1153b2029],
5	of	IN	O	of	_	0	SENT_283	[p19l1195t1964r1274b2029],
6	the	DT	O	the	det	7	SENT_283	[p19l1302t1964r1412b2029],
7	role	NN	O	role	nn	24	SENT_283	[p19l1452t1964r1583b2029],
8	of	IN	O	of	_	0	SENT_283	[p19l1625t1964r1704b2029],
9	this	DT	O	this	det	10	SENT_283	[p19l1732t1964r1859b2029],
10	variant	JJ	O	variant	prep_of	7	SENT_283	[p19l1897t1967r2142b2029],
11	and	CC	O	and	_	0	SENT_283	[p19l12t2072r139b2138],
12	gender	NN	O	gender	nn	24	SENT_283	[p19l195t2072r437b2161],
13	in	IN	O	in	_	0	SENT_283	[p19l492t2075r560b2138],
14	statin	NN	O	statin	nn	15	SENT_283	[p19l619t2075r811b2138],
15	adherence	NN	O	adherence	prep_in	12	SENT_283	[p19l871t2072r1225b2138],
16	and	CC	O	and	_	0	SENT_283	[p19l1284t2072r1412b2138],
17	prognosis	NN	O	prognosis	conj_and	15	SENT_283	[p19l1467t2075r1826b2162],
18	,	,	O	,	_	0	SENT_283	[p19l1467t2075r1826b2162],
19	and	CC	O	and	_	0	SENT_283	[p19l1888t2072r2016b2138],
20	of	IN	O	of	conj_and	7	SENT_283	[p19l2073t2072r2153b2138],
21	statin	NN	O	statin	nn	22	SENT_283	[p19l12t2218r502b2307],
22	—	NN	O	—	pobj	20	SENT_283	[p19l12t2218r502b2307],
23	speciﬁc	JJ	O	speciﬁc	amod	24	SENT_283	[p19l12t2218r502b2307],
24	effects	NNS	O	effect	prep_of	4	SENT_283	[p19l535t2218r748b2284],
25	are	VBP	O	be	cop	26	SENT_283	[p19l784t2244r885b2284],
26	necessary	JJ	O	necessary	_	0	SENT_283	[p19l920t2244r1263b2307],
27	.	.	O	.	_	0	SENT_283	[p19l920t2244r1263b2307],

1	Reprint	JJ	MISC	reprint	amod	2	SENT_284	[p19l12t2459r272b2539],
2	requests	NNS	O	request	_	0	SENT_284	[p19l292t2473r566b2539],
3	and	CC	O	and	_	0	SENT_284	[p19l590t2457r712b2518],
4	correspondence	NN	O	correspondence	conj_and	2	SENT_284	[p19l735t2457r1278b2539],
5	:	:	O	:	_	0	SENT_284	[p19l735t2457r1278b2539],
6	Dr.	NNP	O	Dr.	nn	9	SENT_284	[p19l1305t2459r1410b2518],
7	Geoffrey	NNP	PERSON	Geoffrey	nn	9	SENT_284	[p19l1439t2458r1716b2538],
8	S.	NNP	PERSON	S.	nn	9	SENT_284	[p19l1738t2458r1792b2518],
9	Ginsburg	NNP	PERSON	Ginsburg	dep	2	SENT_284	[p19l1821t2458r2138b2538],
10	,	,	O	,	_	0	SENT_284	[p19l1821t2458r2138b2538],
11	Institute	NNP	ORGANIZATION	Institute	appos	9	SENT_284	[p19l10t2557r280b2615],
12	for	IN	ORGANIZATION	for	_	0	SENT_284	[p19l323t2556r414b2615],
13	Genome	NNP	ORGANIZATION	Genome	nn	14	SENT_284	[p19l457t2556r731b2615],
14	Sciences	NNPS	ORGANIZATION	Sciences	prep_for	11	SENT_284	[p19l778t2556r1041b2615],
15	&	CC	ORGANIZATION	&	rcmod	14	SENT_284	[p19l1086t2557r1155b2615],
16	.	.	O	.	_	0	SENT_284	[p19l1086t2557r1155b2615],

1	Policy	NN	O	policy	_	0	SENT_285	[p19l1191t2556r1403b2636],
2	,	,	O	,	_	0	SENT_285	[p19l1191t2556r1403b2636],
3	Center	NNP	O	Center	appos	1	SENT_285	[p19l1450t2556r1671b2615],
4	for	IN	O	for	_	0	SENT_285	[p19l1711t2556r1802b2615],
5	Genomic	JJ	ORGANIZATION	genomic	amod	6	SENT_285	[p19l1845t2556r2141b2615],
6	Medicine	NN	ORGANIZATION	medicine	prep_for	3	SENT_285	[p19l9t2654r331b2727],
7	,	,	O	,	_	0	SENT_285	[p19l9t2654r331b2727],
8	2117	CD	DATE	2117	num	9	SENT_285	[p19l365t2656r524b2714],
9	CIEMAS	NNP	O	CIEMAS	appos	1	SENT_285	[p19l558t2653r897b2727],
10	,	,	O	,	_	0	SENT_285	[p19l558t2653r897b2727],
11	101	CD	NUMBER	101	num	13	SENT_285	[p19l936t2657r1045b2714],
12	Science	NN	O	science	nn	13	SENT_285	[p19l1085t2654r1320b2714],
13	Drive	NNP	O	Drive	appos	1	SENT_285	[p19l1353t2655r1550b2727],
14	,	,	O	,	_	0	SENT_285	[p19l1353t2655r1550b2727],
15	Duke	NNP	ORGANIZATION	Duke	nn	19	SENT_285	[p19l1585t2654r1761b2714],
16	University	NNP	ORGANIZATION	University	nn	19	SENT_285	[p19l1792t2655r2138b2734],
17	,	,	O	,	_	0	SENT_285	[p19l1792t2655r2138b2734],
18	DUMC	NNP	O	DUMC	appos	19	SENT_285	[p19l10t2754r268b2813],
19	Box	NNP	O	Box	appos	1	SENT_285	[p19l319t2754r445b2812],
20	3382	CD	NUMBER	3382	num	19	SENT_285	[p19l493t2757r667b2825],
21	,	,	O	,	_	0	SENT_285	[p19l493t2757r667b2825],
22	Durham	NNP	LOCATION	Durham	nn	25	SENT_285	[p19l718t2754r1008b2825],
23	,	,	O	,	_	0	SENT_285	[p19l718t2754r1008b2825],
24	North	NNP	LOCATION	North	appos	25	SENT_285	[p19l1059t2754r1255b2812],
25	Carolina	NNP	LOCATION	Carolina	appos	1	SENT_285	[p19l1306t2754r1582b2813],
26	27708	CD	NUMBER	27708	num	25	SENT_285	[p19l1628t2755r1843b2813],
27	.	.	O	.	_	0	SENT_285	[p19l1628t2755r1843b2813],

1	E	NN	O	e	nn	3	SENT_286	[p19l1897t2754r2137b2812],
2	—	CD	NUMBER	—	num	3	SENT_286	[p19l1897t2754r2137b2812],
3	mail	NN	O	mail	_	0	SENT_286	[p19l1897t2754r2137b2812],
4	:	:	O	:	_	0	SENT_286	[p19l1897t2754r2137b2812],
5	geofFrey.ginsburg@duke.edu	NN	O	geoffrey.ginsburg@duke.edu	dep	3	SENT_286	[p19l9t2850r929b2930],
6	.	.	O	.	_	0	SENT_286	[p19l9t2850r929b2930],

1	REFERENCES	NNS	O	reference	_	0	SENT_287	[p19l11t3148r400b3192],

1	1	LS	NUMBER	1	_	0	SENT_288	[p19l49t3303r93b3354],
2	.	.	O	.	_	0	SENT_288	[p19l49t3303r93b3354],

1	Baigent	NNP	PERSON	Baigent	nn	2	SENT_289	[p19l135t3301r355b3372],
2	C	NNP	O	C	_	0	SENT_289	[p19l397t3300r462b3365],
3	,	,	O	,	_	0	SENT_289	[p19l397t3300r462b3365],
4	Keech	NNP	PERSON	Keech	nn	5	SENT_289	[p19l508t3301r682b3354],
5	A	NNP	O	A	appos	2	SENT_289	[p19l722t3299r790b3365],
6	,	,	O	,	_	0	SENT_289	[p19l722t3299r790b3365],
7	Kearney	NNP	PERSON	Kearney	nn	8	SENT_289	[p19l837t3301r1070b3372],
8	PM	NNP	O	PM	appos	2	SENT_289	[p19l1109t3301r1235b3366],
9	,	,	O	,	_	0	SENT_289	[p19l1109t3301r1235b3366],
10	et	FW	O	et	nn	11	SENT_289	[p19l1280t3314r1331b3354],
11	al.	FW	O	al.	appos	2	SENT_289	[p19l1373t3301r1432b3354],
12	.	.	O	.	_	0	SENT_289	[p19l1373t3301r1432b3354],

1	Efficacy	NN	O	efficacy	_	0	SENT_290	[p19l1479t3301r1701b3372],
2	and	CC	O	and	_	0	SENT_290	[p19l1741t3301r1844b3354],
3	safety	NN	O	safety	conj_and	1	SENT_290	[p19l1886t3300r2047b3372],
4	of	IN	O	of	_	0	SENT_290	[p19l2087t3300r2151b3354],
5	cholesterol	NN	O	cholesterol	nn	8	SENT_290	[p19l136t3383r718b3454],
6	—	CD	NUMBER	—	num	8	SENT_290	[p19l136t3383r718b3454],
7	lowering	NN	O	lowering	nn	8	SENT_290	[p19l136t3383r718b3454],
8	treatment	NN	O	treatment	prep_of	1	SENT_290	[p19l737t3397r1027b3436],
9	:	:	O	:	_	0	SENT_290	[p19l737t3397r1027b3436],
10	prospective	JJ	O	prospective	amod	13	SENT_290	[p19l1050t3386r1367b3454],
11	meta	NN	O	meta	nn	13	SENT_290	[p19l1389t3383r1771b3454],
12	—	NN	O	—	nn	13	SENT_290	[p19l1389t3383r1771b3454],
13	analysis	NN	O	analysis	dep	1	SENT_290	[p19l1389t3383r1771b3454],
14	of	IN	O	of	_	0	SENT_290	[p19l1793t3383r1857b3436],
15	data	NNS	O	datum	prep_of	13	SENT_290	[p19l1868t3383r1986b3436],
16	from	IN	O	from	_	0	SENT_290	[p19l2005t3383r2141b3436],
17	90,056	CD	NUMBER	90,056	num	18	SENT_290	[p19l136t3464r326b3528],
18	participants	NNS	O	participant	prep_from	15	SENT_290	[p19l359t3466r689b3535],
19	in	IN	O	in	_	0	SENT_290	[p19l722t3466r776b3516],
20	14	CD	NUMBER	14	num	22	SENT_290	[p19l812t3467r877b3516],
21	randomised	JJ	O	randomised	amod	22	SENT_290	[p19l908t3464r1240b3516],
22	trials	NNS	O	trial	prep_in	18	SENT_290	[p19l1271t3464r1407b3516],
23	of	IN	O	of	_	0	SENT_290	[p19l1440t3464r1505b3516],
24	statins	NNS	O	statin	prep_of	22	SENT_290	[p19l1528t3466r1721b3516],
25	.	.	O	.	_	0	SENT_290	[p19l1528t3466r1721b3516],

1	Lancet	NNP	O	Lancet	_	0	SENT_291	[p19l1758t3465r1953b3516],
2	2005	CD	DATE	2005	num	1	SENT_291	[p19l1982t3464r2138b3528],
3	;	:	O	;	_	0	SENT_291	[p19l1982t3464r2138b3528],
4	366:1267	CD	NUMBER	366:1267	number	5	SENT_291	[p19l136t3547r520b3599],
5	-78	CD	NUMBER	-78	dep	1	SENT_291	[p19l136t3547r520b3599],
6	.	.	O	.	_	0	SENT_291	[p19l136t3547r520b3599],

1	2	LS	NUMBER	2	_	0	SENT_292	[p20l44t23r93b74],
2	.	.	O	.	_	0	SENT_292	[p20l44t23r93b74],

1	Ho	NNP	O	Ho	nn	2	SENT_293	[p20l136t21r227b73],
2	PM	NNP	O	PM	_	0	SENT_293	[p20l253t21r378b85],
3	,	,	O	,	_	0	SENT_293	[p20l253t21r378b85],
4	Magid	NNP	PERSON	Magid	nn	5	SENT_293	[p20l404t21r593b91],
5	DJ	NNP	O	DJ	appos	2	SENT_293	[p20l617t21r711b87],
6	,	,	O	,	_	0	SENT_293	[p20l617t21r711b87],
7	Shetterly	NNP	PERSON	Shetterly	nn	8	SENT_293	[p20l741t20r995b91],
8	SM	NNP	O	SM	appos	2	SENT_293	[p20l1019t20r1138b85],
9	,	,	O	,	_	0	SENT_293	[p20l1019t20r1138b85],
10	et	FW	O	et	nn	11	SENT_293	[p20l1165t34r1216b73],
11	al.	FW	O	al.	appos	2	SENT_293	[p20l1240t21r1299b73],
12	.	.	O	.	_	0	SENT_293	[p20l1240t21r1299b73],

1	Medication	NN	O	medication	nn	2	SENT_294	[p20l1325t21r1655b73],
2	nonadherence	NN	O	nonadherence	nsubjpass	4	SENT_294	[p20l1680t21r2074b73],
3	is	VBZ	O	be	auxpass	4	SENT_294	[p20l2099t23r2139b73],
4	associated	VBN	O	associate	_	0	SENT_294	[p20l136t101r418b154],
5	with	IN	O	with	_	0	SENT_294	[p20l447t101r576b154],
6	a	DT	O	a	det	8	SENT_294	[p20l609t122r637b154],
7	broad	JJ	O	broad	amod	8	SENT_294	[p20l666t101r829b154],
8	range	NN	O	range	prep_with	4	SENT_294	[p20l860t122r1014b172],
9	of	IN	O	of	_	0	SENT_294	[p20l1048t101r1112b154],
10	adverse	JJ	O	adverse	amod	11	SENT_294	[p20l1136t101r1340b154],
11	outcomes	NNS	O	outcome	prep_of	8	SENT_294	[p20l1373t115r1640b154],
12	in	IN	O	in	_	0	SENT_294	[p20l1674t104r1728b153],
13	patients	NNS	O	patient	prep_in	4	SENT_294	[p20l1760t104r1981b172],
14	with	IN	O	with	_	0	SENT_294	[p20l2012t101r2141b154],
15	coronary	JJ	O	coronary	amod	17	SENT_294	[p20l136t203r383b254],
16	artery	NN	O	artery	nn	17	SENT_294	[p20l408t196r569b254],
17	disease	NN	O	disease	prep_with	13	SENT_294	[p20l593t182r802b235],
18	.	.	O	.	_	0	SENT_294	[p20l593t182r802b235],

1	Am	VBP	O	be	dep	2	SENT_295	[p20l830t181r939b235],
2	HeartJ	JJ	O	heartj	_	0	SENT_295	[p20l967t183r1179b250],
3	2008	CD	DATE	2008	tmod	2	SENT_295	[p20l1204t182r1680b247],
4	;	:	O	;	_	0	SENT_295	[p20l1204t182r1680b247],
5	155:772	CD	NUMBER	155:772	dep	2	SENT_295	[p20l1204t182r1680b247],
6	-9	CD	NUMBER	-9	dep	5	SENT_295	[p20l1204t182r1680b247],
7	.	.	O	.	_	0	SENT_295	[p20l1204t182r1680b247],

1	3	LS	NUMBER	3	_	0	SENT_296	[p20l46t267r93b318],
2	.	.	O	.	_	0	SENT_296	[p20l46t267r93b318],

1	Jacobson	NNP	PERSON	Jacobson	nn	2	SENT_297	[p20l127t265r385b333],
2	TA	NNP	O	TA	_	0	SENT_297	[p20l404t263r520b318],
3	.	.	O	.	_	0	SENT_297	[p20l404t263r520b318],

1	Toward	IN	O	toward	quantmod	2	SENT_298	[p20l542t263r768b318],
2	“	CD	NUMBER	“	num	5	SENT_298	[p20l789t265r1095b337],
3	pain-free	JJ	O	pain-free	amod	5	SENT_298	[p20l789t265r1095b337],
4	”	NN	O	”	nn	5	SENT_298	[p20l789t265r1095b337],
5	statin	NN	O	statin	_	0	SENT_298	[p20l1118t267r1272b318],
6	prescribing	VBG	O	prescribe	partmod	5	SENT_298	[p20l1291t265r1620b337],
7	:	:	O	:	_	0	SENT_298	[p20l1291t265r1620b337],
8	clinical	JJ	O	clinical	amod	9	SENT_298	[p20l1645t265r1844b318],
9	algorithm	NN	O	algorithm	dep	5	SENT_298	[p20l1865t265r2140b336],
10	for	IN	O	for	_	0	SENT_298	[p20l135t346r215b399],
11	diagnosis	NN	O	diagnosis	prep_for	9	SENT_298	[p20l242t347r500b417],
12	and	CC	O	and	_	0	SENT_298	[p20l530t347r631b399],
13	management	NN	O	management	prep_for	9	SENT_298	[p20l658t360r1025b417],
14	of	IN	O	of	_	0	SENT_298	[p20l1051t346r1115b399],
15	myalgia	NN	O	myalgium	prep_of	9	SENT_298	[p20l1133t347r1365b417],
16	.	.	O	.	_	0	SENT_298	[p20l1133t347r1365b417],

1	Mayo	NNP	O	Mayo	nn	3	SENT_299	[p20l1394t347r1558b417],
2	Clin	NNP	O	Clin	nn	3	SENT_299	[p20l1587t346r1711b399],
3	Proc	NNP	O	Proc	_	0	SENT_299	[p20l1738t347r1867b399],
4	2008	CD	DATE	2008	num	3	SENT_299	[p20l1893t349r2137b411],
5	;	:	O	;	_	0	SENT_299	[p20l1893t349r2137b411],
6	83	CD	NUMBER	83	num	8	SENT_299	[p20l1893t349r2137b411],
7	:	:	O	:	_	0	SENT_299	[p20l1893t349r2137b411],
8	687-700	CD	NUMBER	687-700	dep	3	SENT_299	[p20l136t428r395b480],
9	.	.	O	.	_	0	SENT_299	[p20l136t428r395b480],

1	4	LS	NUMBER	4	_	0	SENT_300	[p20l45t511r93b562],
2	.	.	O	.	_	0	SENT_300	[p20l45t511r93b562],

1	Nichols	NNP	ORGANIZATION	Nichols	nn	2	SENT_301	[p20l135t509r353b562],
2	GA	NNP	ORGANIZATION	GA	_	0	SENT_301	[p20l377t508r499b574],
3	,	,	O	,	_	0	SENT_301	[p20l377t508r499b574],
4	Koro	NNP	PERSON	Koro	nn	5	SENT_301	[p20l525t509r665b562],
5	CE	NNP	O	CE	appos	2	SENT_301	[p20l689t509r802b562],
6	.	.	O	.	_	0	SENT_301	[p20l689t509r802b562],

1	Does	VBZ	O	do	_	0	SENT_302	[p20l827t509r971b562],
2	statin	NN	O	statin	nn	4	SENT_302	[p20l995t511r1149b562],
3	therapy	NN	O	therapy	nn	4	SENT_302	[p20l1170t509r1384b580],
4	initiation	NN	O	initiation	nsubj	5	SENT_302	[p20l1403t511r1663b562],
5	increase	VBP	O	increase	ccomp	1	SENT_302	[p20l1684t511r1908b562],
6	the	DT	O	the	det	7	SENT_302	[p20l1930t509r2018b562],
7	risk	NN	O	risk	dobj	5	SENT_302	[p20l2039t509r2144b562],
8	for	IN	O	for	_	0	SENT_302	[p20l135t590r215b643],
9	myopathy	NN	O	myopathy	prep_for	7	SENT_302	[p20l241t590r545b661],
10	?	.	O	?	_	0	SENT_302	[p20l241t590r545b661],

1	’	RB	O	’	advmod	4	SENT_303	[p20l241t590r545b661],
2	an	DT	O	a	det	4	SENT_303	[p20l574t611r639b643],
3	observational	JJ	O	observational	amod	4	SENT_303	[p20l666t590r1039b643],
4	study	NN	O	study	_	0	SENT_303	[p20l1066t590r1217b661],
5	of	IN	O	of	_	0	SENT_303	[p20l1241t590r1304b643],
6	32,225	CD	NUMBER	32,225	prep_of	4	SENT_303	[p20l1322t590r1512b654],
7	diabetic	JJ	O	diabetic	amod	10	SENT_303	[p20l1542t590r1762b643],
8	and	CC	O	and	_	0	SENT_303	[p20l1789t590r1891b643],
9	nondia	JJ	O	nondia	amod	10	SENT_303	[p20l1918t590r2138b643],
10	—	NN	O	—	dep	4	SENT_303	[p20l1918t590r2138b643],
11	betic	JJ	O	betic	amod	12	SENT_303	[p20l133t671r270b724],
12	patients	NNS	O	patient	dep	10	SENT_303	[p20l295t673r532b743],
13	.	.	O	.	_	0	SENT_303	[p20l295t673r532b743],

1	Clin	NNP	O	Clin	nn	2	SENT_304	[p20l564t671r687b724],
2	Ther	NNP	O	Ther	_	0	SENT_304	[p20l711t669r855b724],
3	2007	CD	DATE	2007	num	2	SENT_304	[p20l879t672r1390b736],
4	;	:	O	;	_	0	SENT_304	[p20l879t672r1390b736],
5	29:1761	CD	NUMBER	29:1761	number	6	SENT_304	[p20l879t672r1390b736],
6	—	CD	NUMBER	—	dep	2	SENT_304	[p20l879t672r1390b736],
7	70	CD	NUMBER	70	dep	6	SENT_304	[p20l879t672r1390b736],
8	.	.	O	.	_	0	SENT_304	[p20l879t672r1390b736],

1	5	CD	NUMBER	5	_	0	SENT_305	[p20l46t753r93b806],
2	.	.	O	.	_	0	SENT_305	[p20l46t753r93b806],

1	Bays	NNS	O	bay	nsubj	13	SENT_306	[p20l135t754r264b824],
2	H.	NNP	O	H.	nn	4	SENT_306	[p20l290t754r362b806],
3	Statin	NNP	O	Statin	nn	4	SENT_306	[p20l393t753r558b806],
4	safety	NN	O	safety	dep	1	SENT_306	[p20l584t753r756b824],
5	:	:	O	:	_	0	SENT_306	[p20l584t753r756b824],
6	an	DT	O	a	det	7	SENT_306	[p20l784t774r849b806],
7	overview	NN	O	overview	dep	1	SENT_306	[p20l873t756r1122b806],
8	and	CC	O	and	_	0	SENT_306	[p20l1145t753r1246b806],
9	assessment	NN	O	assessment	dep	1	SENT_306	[p20l1271t767r1578b806],
10	of	IN	O	of	_	0	SENT_306	[p20l1601t753r1665b806],
11	the	DT	O	the	det	12	SENT_306	[p20l1679t754r1767b806],
12	data	NNS	O	datum	prep_of	7	SENT_306	[p20l1793t753r2137b807],
13	—	VBP	O	—	_	0	SENT_306	[p20l1793t753r2137b807],
14	2005	CD	DATE	2005	dobj	13	SENT_306	[p20l1793t753r2137b807],
15	.	.	O	.	_	0	SENT_306	[p20l1793t753r2137b807],

1	Am	NNP	O	Am	nn	3	SENT_307	[p20l133t833r242b886],
2	J	NNP	O	J	nn	3	SENT_307	[p20l262t835r290b901],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_307	[p20l317t834r532b887],
4	2006	CD	DATE	2006	num	3	SENT_307	[p20l555t834r1066b898],
5	;	:	O	;	_	0	SENT_307	[p20l555t834r1066b898],
6	97:6	CD	NUMBER	97:6	num	7	SENT_307	[p20l555t834r1066b898],
7	C	NN	O	c	dep	3	SENT_307	[p20l555t834r1066b898],
8	—	CD	NUMBER	—	num	9	SENT_307	[p20l555t834r1066b898],
9	26C	NN	O	26c	dep	7	SENT_307	[p20l555t834r1066b898],
10	.	.	O	.	_	0	SENT_307	[p20l555t834r1066b898],

1	6	CD	NUMBER	6	_	0	SENT_308	[p20l47t918r93b968],
2	.	.	O	.	_	0	SENT_308	[p20l47t918r93b968],

1	Hermann	NNP	PERSON	Hermann	nn	2	SENT_309	[p20l136t916r411b968],
2	M	NNP	PERSON	M	_	0	SENT_309	[p20l432t916r516b980],
3	,	,	O	,	_	0	SENT_309	[p20l432t916r516b980],
4	Bogsrud	NNP	O	Bogsrud	nn	5	SENT_309	[p20l541t916r778b986],
5	MP	NNP	O	MP	appos	2	SENT_309	[p20l799t916r926b980],
6	,	,	O	,	_	0	SENT_309	[p20l799t916r926b980],
7	Molden	NNP	PERSON	Molden	nn	8	SENT_309	[p20l950t916r1177b968],
8	E	NNP	O	E	appos	2	SENT_309	[p20l1201t916r1262b980],
9	,	,	O	,	_	0	SENT_309	[p20l1201t916r1262b980],
10	et	FW	O	et	nn	11	SENT_309	[p20l1288t929r1338b968],
11	al.	FW	O	al.	appos	2	SENT_309	[p20l1361t916r1420b968],
12	.	.	O	.	_	0	SENT_309	[p20l1361t916r1420b968],

1	Exposure	NN	O	exposure	nsubj	5	SENT_310	[p20l1448t916r1711b987],
2	of	IN	O	of	_	0	SENT_310	[p20l1735t916r1799b968],
3	atorvastatin	NN	O	atorvastatin	prep_of	1	SENT_310	[p20l1813t918r2141b968],
4	is	VBZ	O	be	cop	5	SENT_310	[p20l135t999r175b1049],
5	unchanged	JJ	O	unchanged	_	0	SENT_310	[p20l205t996r515b1067],
6	but	CC	O	but	_	0	SENT_310	[p20l542t996r637b1049],
7	lactone	NN	O	lactone	nn	10	SENT_310	[p20l664t996r866b1049],
8	and	CC	O	and	_	0	SENT_310	[p20l897t996r999b1049],
9	acid	NN	O	acid	nn	10	SENT_310	[p20l1029t996r1141b1049],
10	metabolites	NNS	O	metabolite	nsubjpass	12	SENT_310	[p20l1170t996r1493b1049],
11	are	VBP	O	be	auxpass	12	SENT_310	[p20l1525t1017r1605b1049],
12	increased	VBN	O	increase	conj_but	5	SENT_310	[p20l1635t996r1897b1049],
13	severalfold	RB	O	severalfold	advmod	12	SENT_310	[p20l1927t996r2139b1049, p20l135t1077r245b1129],
14	in	IN	O	in	_	0	SENT_310	[p20l271t1079r325b1129],
15	patients	NNS	O	patient	prep_in	12	SENT_310	[p20l350t1079r572b1148],
16	with	IN	O	with	_	0	SENT_310	[p20l596t1077r725b1129],
17	atorvastatin-induced	JJ	O	atorvastatin-induced	amod	18	SENT_310	[p20l752t1077r1336b1129],
18	myopathy	NN	O	myopathy	prep_with	15	SENT_310	[p20l1362t1077r1656b1148],
19	.	.	O	.	_	0	SENT_310	[p20l1362t1077r1656b1148],

1	Clin	NNP	O	Clin	nn	3	SENT_311	[p20l1687t1077r1811b1129],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_311	[p20l1837t1077r2141b1129],
3	Ther	NNP	O	Ther	_	0	SENT_311	[p20l133t1156r276b1210],
4	2006	CD	DATE	2006	num	3	SENT_311	[p20l300t1158r740b1222],
5	;	:	O	;	_	0	SENT_311	[p20l300t1158r740b1222],
6	79:532	CD	NUMBER	79:532	number	7	SENT_311	[p20l300t1158r740b1222],
7	—	CD	NUMBER	—	dep	3	SENT_311	[p20l300t1158r740b1222],
8	9	CD	NUMBER	9	dep	7	SENT_311	[p20l300t1158r740b1222],
9	.	.	O	.	_	0	SENT_311	[p20l300t1158r740b1222],

1	7	CD	NUMBER	7	_	0	SENT_312	[p20l47t1239r93b1291],
2	.	.	O	.	_	0	SENT_312	[p20l47t1239r93b1291],

1	Gotto	NNP	O	Gotto	nsubj	2	SENT_313	[p20l136t1238r305b1291],
2	=	JJ	O	=	_	0	SENT_313	[p20l334t1237r499b1306],
3	6	CD	NUMBER	6	dobj	2	SENT_313	[p20l334t1237r499b1306],
4	+	CC	O	+	_	0	SENT_313	[p20l334t1237r499b1306],
5	Statins	NNS	O	statin	dobj	2	SENT_313	[p20l540t1238r747b1303],
6	,	,	O	,	_	0	SENT_313	[p20l540t1238r747b1303],
7	cardiovascular	JJ	O	cardiovascular	amod	8	SENT_313	[p20l785t1238r1183b1291],
8	disease	NN	O	disease	conj_+	3	SENT_313	[p20l1217t1238r1427b1303],
9	,	,	O	,	_	0	SENT_313	[p20l1217t1238r1427b1303],
10	and	CC	O	and	_	0	SENT_313	[p20l1466t1238r1567b1291],
11	drug	NN	O	drug	nn	12	SENT_313	[p20l1602t1238r1732b1310],
12	safety	NN	O	safety	conj_and	5	SENT_313	[p20l1767t1238r1939b1310],
13	.	.	O	.	_	0	SENT_313	[p20l1767t1238r1939b1310],

1	Am	VBP	O	be	dep	2	SENT_314	[p20l1976t1237r2085b1291],
2	J	NN	O	j	_	0	SENT_314	[p20l2112t1239r2141b1306],

1	Cardiol	NNP	O	Cardiol	_	0	SENT_315	[p20l136t1321r351b1373],
2	2006	CD	DATE	2006	num	1	SENT_315	[p20l374t1321r783b1385],
3	;	:	O	;	_	0	SENT_315	[p20l374t1321r783b1385],
4	97	CD	NUMBER	97	dep	1	SENT_315	[p20l374t1321r783b1385],
5	:	:	O	:	_	0	SENT_315	[p20l374t1321r783b1385],
6	S3-5	NN	O	s3-5	dep	4	SENT_315	[p20l374t1321r783b1385],
7	.	.	O	.	_	0	SENT_315	[p20l374t1321r783b1385],

1	8	CD	NUMBER	8	_	0	SENT_316	[p20l48t1404r93b1455],
2	.	.	O	.	_	0	SENT_316	[p20l48t1404r93b1455],

1	Thompson	NNP	PERSON	Thompson	nn	2	SENT_317	[p20l133t1400r448b1473],
2	PD	NN	O	pd	_	0	SENT_317	[p20l472t1402r585b1466],
3	,	,	O	,	_	0	SENT_317	[p20l472t1402r585b1466],
4	Clarkson	NNP	PERSON	Clarkson	nn	5	SENT_317	[p20l613t1401r868b1455],
5	PM	NNP	O	PM	appos	2	SENT_317	[p20l891t1402r1017b1466],
6	,	,	O	,	_	0	SENT_317	[p20l891t1402r1017b1466],
7	Rosenson	NNP	PERSON	Rosenson	nn	8	SENT_317	[p20l1044t1402r1316b1454],
8	RS	NN	O	r	appos	5	SENT_317	[p20l1341t1401r1440b1455],
9	.	.	O	.	_	0	SENT_317	[p20l1341t1401r1440b1455],

1	An	DT	O	a	det	2	SENT_318	[p20l1465t1400r1555b1454],
2	assessment	NN	O	assessment	_	0	SENT_318	[p20l1579t1415r1886b1454],
3	of	IN	O	of	_	0	SENT_318	[p20l1909t1401r1973b1454],
4	statin	NN	O	statin	nn	5	SENT_318	[p20l1987t1404r2141b1454],
5	safety	NN	O	safety	prep_of	2	SENT_318	[p20l136t1483r297b1554],
6	by	IN	O	by	_	0	SENT_318	[p20l318t1483r388b1554],
7	muscle	NN	O	muscle	nn	8	SENT_318	[p20l411t1483r604b1536],
8	experts	NNS	O	expert	prep_by	2	SENT_318	[p20l632t1497r843b1555],
9	.	.	O	.	_	0	SENT_318	[p20l632t1497r843b1555],

1	Am	NNP	O	Am	nn	3	SENT_319	[p20l871t1482r980b1535],
2	J	NNP	O	J	nn	3	SENT_319	[p20l1000t1484r1028b1551],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_319	[p20l1056t1483r1270b1536],
4	2006	CD	DATE	2006	num	6	SENT_319	[p20l1293t1483r1782b1548],
5	;	:	O	;	_	0	SENT_319	[p20l1293t1483r1782b1548],
6	97	CD	NUMBER	97	dep	3	SENT_319	[p20l1293t1483r1782b1548],
7	:	:	O	:	_	0	SENT_319	[p20l1293t1483r1782b1548],
8	S69	CD	NUMBER	s69	number	9	SENT_319	[p20l1293t1483r1782b1548],
9	—	CD	NUMBER	—	dep	3	SENT_319	[p20l1293t1483r1782b1548],
10	76	CD	NUMBER	76	dep	9	SENT_319	[p20l1293t1483r1782b1548],
11	.	.	O	.	_	0	SENT_319	[p20l1293t1483r1782b1548],

1	9	CD	NUMBER	9	_	0	SENT_320	[p20l47t1568r93b1619],
2	.	.	O	.	_	0	SENT_320	[p20l47t1568r93b1619],

1	Frudakis	NNP	PERSON	Frudakis	nn	2	SENT_321	[p20l135t1566r380b1619],
2	TN	NN	O	tn	nsubjpass	25	SENT_321	[p20l411t1564r533b1630],
3	,	,	O	,	_	0	SENT_321	[p20l411t1564r533b1630],
4	Thomas	NNP	PERSON	Thomas	nn	5	SENT_321	[p20l565t1564r800b1619],
5	MJ	NNP	PERSON	MJ	appos	2	SENT_321	[p20l832t1566r939b1633],
6	,	,	O	,	_	0	SENT_321	[p20l832t1566r939b1633],
7	Ginjupalli	NNP	PERSON	Ginjupalli	nn	8	SENT_321	[p20l975t1565r1262b1637],
8	SN	NNP	O	SN	appos	2	SENT_321	[p20l1296t1565r1402b1630],
9	,	,	O	,	_	0	SENT_321	[p20l1296t1565r1402b1630],
10	Handelin	NNP	PERSON	Handelin	nn	11	SENT_321	[p20l1437t1566r1705b1619],
11	B	NNP	PERSON	B	appos	2	SENT_321	[p20l1737t1566r1797b1631],
12	,	,	O	,	_	0	SENT_321	[p20l1737t1566r1797b1631],
13	Gabriel	NNP	PERSON	Gabriel	nn	14	SENT_321	[p20l1832t1565r2045b1619],
14	R	NNP	PERSON	R	appos	2	SENT_321	[p20l2078t1566r2138b1630],
15	,	,	O	,	_	0	SENT_321	[p20l2078t1566r2138b1630],
16	Gomez	NNP	PERSON	Gomez	appos	2	SENT_321	[p20l136t1647r346b1700],
17	*	CD	NUMBER	*	number	18	SENT_321	[p20l391t1648r486b1714],
18	6	CD	NUMBER	6	dep	16	SENT_321	[p20l391t1648r486b1714],
19	+	CC	O	+	_	0	SENT_321	[p20l391t1648r486b1714],
20	CYP2D6	CD	NUMBER	cyp2d6	number	21	SENT_321	[p20l537t1647r865b1700],
21	*	CD	NUMBER	*	appos	2	SENT_321	[p20l537t1647r865b1700],
22	4	CD	NUMBER	4	num	23	SENT_321	[p20l537t1647r865b1700],
23	polymorphism	NN	O	polymorphism	dep	21	SENT_321	[p20l909t1647r1322b1718],
24	is	VBZ	O	be	auxpass	25	SENT_321	[p20l1369t1649r1409b1699],
25	associated	VBN	O	associate	_	0	SENT_321	[p20l1457t1647r1739b1699],
26	with	IN	O	with	_	0	SENT_321	[p20l1782t1647r1911b1700],
27	statininduced	JJ	O	statininduced	amod	29	SENT_321	[p20l1958t1649r2138b1699, p20l135t1729r359b1781],
28	muscle	NN	O	muscle	nn	29	SENT_321	[p20l385t1729r578b1781],
29	effects	NNS	O	effect	prep_with	25	SENT_321	[p20l605t1729r792b1781],
30	.	.	O	.	_	0	SENT_321	[p20l605t1729r792b1781],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_322	[p20l822t1729r1265b1799],
2	Genomics	NNP	O	Genomics	_	0	SENT_322	[p20l1291t1729r1578b1781],
3	2007	CD	DATE	2007	num	2	SENT_322	[p20l1605t1729r2116b1793],
4	;	:	O	;	_	0	SENT_322	[p20l1605t1729r2116b1793],
5	17:695	CD	NUMBER	17:695	number	6	SENT_322	[p20l1605t1729r2116b1793],
6	-707	CD	NUMBER	-707	dep	2	SENT_322	[p20l1605t1729r2116b1793],
7	.	.	O	.	_	0	SENT_322	[p20l1605t1729r2116b1793],

1	10	CD	NUMBER	10	_	0	SENT_323	[p20l13t1812r93b1862],
2	.	.	O	.	_	0	SENT_323	[p20l13t1812r93b1862],

1	Kameyama	NNP	PERSON	Kameyama	nn	2	SENT_324	[p20l137t1810r451b1880],
2	Y	NN	PERSON	y	_	0	SENT_324	[p20l478t1810r541b1873],
3	,	,	O	,	_	0	SENT_324	[p20l478t1810r541b1873],
4	Yamashita	NNP	PERSON	Yamashita	nn	5	SENT_324	[p20l572t1809r874b1862],
5	K	NNP	PERSON	K	appos	2	SENT_324	[p20l906t1810r968b1873],
6	,	,	O	,	_	0	SENT_324	[p20l906t1810r968b1873],
7	Kobayashi	NNP	LOCATION	Kobayashi	nn	8	SENT_324	[p20l1004t1809r1295b1880],
8	K	NNP	LOCATION	K	appos	2	SENT_324	[p20l1328t1810r1390b1873],
9	,	,	O	,	_	0	SENT_324	[p20l1328t1810r1390b1873],
10	Hosokawa	NNP	PERSON	Hosokawa	nn	11	SENT_324	[p20l1424t1809r1723b1862],
11	M	NNP	O	M	appos	2	SENT_324	[p20l1752t1810r1836b1873],
12	,	,	O	,	_	0	SENT_324	[p20l1752t1810r1836b1873],
13	Chiba	NNP	O	Chiba	nn	16	SENT_324	[p20l1871t1809r2045b1862],
14	K.	NNP	O	K.	nn	16	SENT_324	[p20l2077t1810r2137b1861],
15	Functional	JJ	O	functional	amod	16	SENT_324	[p20l135t1890r453b1942],
16	characterization	NN	O	characterization	appos	2	SENT_324	[p20l505t1890r973b1942],
17	of	IN	O	of	_	0	SENT_324	[p20l1025t1890r1091b1942],
18	SLCO1B1	NN	O	slco1b1	nn	20	SENT_324	[p20l1135t1890r1448b1943],
19	(	CD	NUMBER	(	num	20	SENT_324	[p20l1507t1888r1840b1954],
20	OATP-C	NN	O	oatp-c	prep_of	16	SENT_324	[p20l1507t1888r1840b1954],
21	)	CD	NUMBER	)	num	22	SENT_324	[p20l1507t1888r1840b1954],
22	variants	NNS	O	variant	dep	16	SENT_324	[p20l1893t1892r2138b1954],
23	,	,	O	,	_	0	SENT_324	[p20l1893t1892r2138b1954],
24	SLCO1B1	NN	O	slco1b1	appos	2	SENT_324	[p20l138t1971r522b2036],
25	*	CD	NUMBER	*	number	26	SENT_324	[p20l138t1971r522b2036],
26	5	CD	NUMBER	5	dep	24	SENT_324	[p20l138t1971r522b2036],
27	,	,	O	,	_	0	SENT_324	[p20l138t1971r522b2036],
28	SLCO1B1	NN	O	slco1b1	appos	2	SENT_324	[p20l558t1971r960b2024],
29	*	CD	NUMBER	*	number	30	SENT_324	[p20l558t1971r960b2024],
30	15	CD	NUMBER	15	dep	28	SENT_324	[p20l558t1971r960b2024],
31	and	CC	O	and	_	0	SENT_324	[p20l995t1972r1096b2024],
32	SLCO1B1	NN	O	slco1b1	conj_and	28	SENT_324	[p20l1130t1971r1862b2036],
33	*	CD	NUMBER	*	number	34	SENT_324	[p20l1130t1971r1862b2036],
34	15	CD	NUMBER	15	dep	32	SENT_324	[p20l1130t1971r1862b2036],
35	+	CC	O	+	_	0	SENT_324	[p20l1130t1971r1862b2036],
36	C1007G	NN	O	c1007g	conj_+	28	SENT_324	[p20l1130t1971r1862b2036],
37	,	,	O	,	_	0	SENT_324	[p20l1130t1971r1862b2036],
38	by	IN	O	by	_	0	SENT_324	[p20l1894t1972r1963b2042],
39	using	VBG	O	use	prepc_by	36	SENT_324	[p20l1990t1974r2142b2042],
40	transient	JJ	O	transient	amod	42	SENT_324	[p20l135t2054r384b2104],
41	expression	NN	O	expression	nn	42	SENT_324	[p20l410t2054r702b2123],
42	systems	NNS	O	system	dobj	39	SENT_324	[p20l730t2066r941b2123],
43	of	IN	O	of	_	0	SENT_324	[p20l970t2052r1034b2104],
44	HeLa	NN	O	helum	nn	47	SENT_324	[p20l1051t2053r1218b2104],
45	and	CC	O	and	_	0	SENT_324	[p20l1244t2052r1346b2104],
46	HEK293	NN	O	hek293	conj_and	44	SENT_324	[p20l1373t2053r1634b2105],
47	cells	NNS	O	cell	prep_of	42	SENT_324	[p20l1664t2052r1797b2104],
48	.	.	O	.	_	0	SENT_324	[p20l1664t2052r1797b2104],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_325	[p20l1827t2052r2139b2104, p20l134t2147r289b2204],
2	Genomics	NNP	O	Genomics	_	0	SENT_325	[p20l316t2134r602b2186],
3	2005	CD	DATE	2005	num	2	SENT_325	[p20l629t2134r767b2187],
4	;	:	O	;	_	0	SENT_325	[p20l775t2134r856b2198],
5	15	CD	NUMBER	15	number	6	SENT_325	[p20l775t2134r856b2198],
6	:5	CD	NUMBER	:5	dep	2	SENT_325	[p20l865t2134r910b2186],
7	13-22	CD	NUMBER	13-22	dep	6	SENT_325	[p20l919t2136r1105b2187],
8	.	.	O	.	_	0	SENT_325	[p20l919t2136r1105b2187],

1	11	CD	NUMBER	11	_	0	SENT_326	[p20l13t2217r93b2267],
2	.	.	O	.	_	0	SENT_326	[p20l13t2217r93b2267],

1	Pasanen	NNP	PERSON	Pasanen	nn	2	SENT_327	[p20l135t2215r367b2267],
2	MK	NNP	O	MK	nsubj	15	SENT_327	[p20l405t2215r539b2278],
3	,	,	O	,	_	0	SENT_327	[p20l405t2215r539b2278],
4	Neuvonen	NNP	O	Neuvonen	nn	5	SENT_327	[p20l580t2215r872b2267],
5	M	NNP	O	M	appos	2	SENT_327	[p20l909t2215r994b2279],
6	,	,	O	,	_	0	SENT_327	[p20l909t2215r994b2279],
7	Neuvonen	NNP	PERSON	Neuvonen	nn	8	SENT_327	[p20l1035t2215r1327b2267],
8	PJ	NNP	PERSON	PJ	npadvmod	14	SENT_327	[p20l1366t2215r1446b2281],
9	,	,	O	,	_	0	SENT_327	[p20l1366t2215r1446b2281],
10	Niemi	NNP	PERSON	Niemi	nn	12	SENT_327	[p20l1486t2215r1666b2267],
11	M.	NNP	O	M.	nn	12	SENT_327	[p20l1703t2215r1786b2267],
12	SLCO1B1	NNP	O	SLCO1B1	appos	8	SENT_327	[p20l1831t2214r2137b2267],
13	polymorphism	NN	O	polymorphism	dep	12	SENT_327	[p20l134t2295r546b2366],
14	markedly	RB	O	markedly	advmod	15	SENT_327	[p20l581t2295r844b2365],
15	affects	VBZ	O	affect	_	0	SENT_327	[p20l876t2295r1046b2347],
16	the	DT	O	the	det	17	SENT_327	[p20l1081t2295r1169b2347],
17	pharmacokinetics	NNS	O	pharmacokinetic	dobj	15	SENT_327	[p20l1203t2295r1700b2366],
18	of	IN	O	of	_	0	SENT_327	[p20l1735t2295r1799b2347],
19	simvastatin	NN	O	simvastatin	nn	20	SENT_327	[p20l1824t2297r2141b2347],
20	acid	NN	O	acid	prep_of	17	SENT_327	[p20l136t2377r262b2429],
21	.	.	O	.	_	0	SENT_327	[p20l136t2377r262b2429],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_328	[p20l293t2377r735b2447],
2	Genomics	NNP	O	Genomics	_	0	SENT_328	[p20l761t2376r1048b2429],
3	2006	CD	DATE	2006	num	2	SENT_328	[p20l1075t2378r1515b2441],
4	;	:	O	;	_	0	SENT_328	[p20l1075t2378r1515b2441],
5	16:873	CD	NUMBER	16:873	number	6	SENT_328	[p20l1075t2378r1515b2441],
6	—	CD	NUMBER	—	dep	2	SENT_328	[p20l1075t2378r1515b2441],
7	9	CD	NUMBER	9	dep	6	SENT_328	[p20l1075t2378r1515b2441],
8	.	.	O	.	_	0	SENT_328	[p20l1075t2378r1515b2441],

1	12	CD	NUMBER	12	_	0	SENT_329	[p20l13t2460r93b2510],
2	.	.	O	.	_	0	SENT_329	[p20l13t2460r93b2510],

1	Pasanen	NNP	PERSON	Pasanen	nn	2	SENT_330	[p20l135t2458r367b2509],
2	MK	NNP	O	MK	_	0	SENT_330	[p20l386t2458r521b2521],
3	,	,	O	,	_	0	SENT_330	[p20l386t2458r521b2521],
4	Fredrikson	NNP	PERSON	Fredrikson	nn	13	SENT_330	[p20l544t2457r853b2509],
5	H	NNP	PERSON	H	nn	13	SENT_330	[p20l873t2458r947b2521],
6	,	,	O	,	_	0	SENT_330	[p20l873t2458r947b2521],
7	Neuvonen	NNP	ORGANIZATION	Neuvonen	appos	13	SENT_330	[p20l969t2458r1262b2509],
8	PJ	NNP	ORGANIZATION	PJ	nn	13	SENT_330	[p20l1282t2458r1362b2524],
9	,	,	O	,	_	0	SENT_330	[p20l1282t2458r1362b2524],
10	Niemi	NNP	PERSON	Niemi	appos	13	SENT_330	[p20l1384t2458r1564b2509],
11	M.	NNP	O	M.	nn	13	SENT_330	[p20l1583t2458r1666b2509],
12	Different	NNP	O	Different	nn	13	SENT_330	[p20l1690t2457r1948b2509],
13	effects	NNS	O	effect	appos	2	SENT_330	[p20l1968t2457r2139b2509],
14	of	IN	O	of	_	0	SENT_330	[p20l136t2539r199b2591],
15	SLCO1B1	NN	O	slco1b1	nn	16	SENT_330	[p20l219t2539r525b2591],
16	polymorphism	NN	O	polymorphism	prep_of	13	SENT_330	[p20l555t2539r967b2609],
17	on	IN	O	on	_	0	SENT_330	[p20l995t2559r1064b2591],
18	the	DT	O	the	det	19	SENT_330	[p20l1091t2539r1179b2591],
19	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	13	SENT_330	[p20l1206t2539r1703b2609],
20	of	IN	O	of	_	0	SENT_330	[p20l1731t2539r1795b2591],
21	atorvastatin	NN	O	atorvastatin	prep_of	13	SENT_330	[p20l1813t2541r2141b2591],
22	and	CC	O	and	_	0	SENT_330	[p20l136t2619r238b2672],
23	rosuvastatin	NN	O	rosuvastatin	prep_of	13	SENT_330	[p20l264t2622r615b2672],
24	.	.	O	.	_	0	SENT_330	[p20l264t2622r615b2672],

1	Clin	NNP	O	Clin	nn	3	SENT_331	[p20l647t2619r771b2672],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_331	[p20l797t2619r1102b2672],
3	Ther	NNP	O	Ther	_	0	SENT_331	[p20l1125t2618r1269b2672],
4	2007	CD	DATE	2007	num	3	SENT_331	[p20l1292t2621r1645b2683],
5	;	:	O	;	_	0	SENT_331	[p20l1292t2621r1645b2683],
6	82:726	CD	NUMBER	82:726	number	7	SENT_331	[p20l1292t2621r1645b2683],
7	-33	CD	NUMBER	-33	dep	3	SENT_331	[p20l1657t2622r1777b2672],
8	.	.	O	.	_	0	SENT_331	[p20l1657t2622r1777b2672],

1	13	CD	NUMBER	13	_	0	SENT_332	[p20l13t2703r93b2752],
2	.	.	O	.	_	0	SENT_332	[p20l13t2703r93b2752],

1	Niemi	NNP	PERSON	Niemi	nn	2	SENT_333	[p20l135t2701r314b2752],
2	M	NNP	O	M	_	0	SENT_333	[p20l334t2701r418b2764],
3	,	,	O	,	_	0	SENT_333	[p20l334t2701r418b2764],
4	Pasanen	NNP	PERSON	Pasanen	nn	5	SENT_333	[p20l443t2701r675b2752],
5	MK	NNP	O	MK	appos	2	SENT_333	[p20l695t2701r829b2764],
6	,	,	O	,	_	0	SENT_333	[p20l695t2701r829b2764],
7	Neuvonen	NNP	O	Neuvonen	nn	8	SENT_333	[p20l853t2701r1145b2752],
8	PJ	NNP	O	PJ	appos	5	SENT_333	[p20l1167t2701r1246b2767],
9	.	.	O	.	_	0	SENT_333	[p20l1167t2701r1246b2767],

1	SLCOIB1	NN	O	slcoib1	nn	2	SENT_334	[p20l1274t2700r1579b2752],
2	polymorphism	NN	O	polymorphism	nsubj	5	SENT_334	[p20l1604t2700r2016b2771],
3	and	CC	O	and	_	0	SENT_334	[p20l2040t2700r2141b2752],
4	sex	NN	O	sex	nsubj	5	SENT_334	[p20l136t2802r220b2835],
5	affect	VBP	O	affect	_	0	SENT_334	[p20l246t2781r393b2835],
6	the	DT	O	the	det	7	SENT_334	[p20l417t2782r505b2835],
7	pharmacokinetics	NNS	O	pharmacokinetic	dobj	5	SENT_334	[p20l530t2782r1027b2853],
8	of	IN	O	of	_	0	SENT_334	[p20l1055t2781r1119b2835],
9	pravastatin	NN	O	pravastatin	prep_of	7	SENT_334	[p20l1133t2784r1442b2853],
10	but	CC	O	but	_	0	SENT_334	[p20l1466t2782r1560b2835],
11	not	RB	O	not	_	0	SENT_334	[p20l1585t2795r1679b2835],
12	ﬂuvastatin	NN	O	ﬂuvastatin	nn	15	SENT_334	[p20l1703t2780r2137b2846],
13	[	CD	NUMBER	[	num	15	SENT_334	[p20l1703t2780r2137b2846],
14	ast	NN	O	ast	nn	15	SENT_334	[p20l1703t2780r2137b2846],
15	]	NN	O	]	conj_negcc	7	SENT_334	[p20l1703t2780r2137b2846],
16	.	.	O	.	_	0	SENT_334	[p20l1703t2780r2137b2846],

1	Clin	NNP	O	Clin	nn	3	SENT_335	[p20l136t2863r260b2916],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_335	[p20l287t2863r592b2916],
3	Ther	NNP	O	Ther	_	0	SENT_335	[p20l615t2862r758b2916],
4	2006	CD	DATE	2006	num	3	SENT_335	[p20l782t2863r1275b2927],
5	;	:	O	;	_	0	SENT_335	[p20l782t2863r1275b2927],
6	80:356	CD	NUMBER	80:356	number	7	SENT_335	[p20l782t2863r1275b2927],
7	—	CD	NUMBER	—	dep	3	SENT_335	[p20l782t2863r1275b2927],
8	66	CD	NUMBER	66	dep	7	SENT_335	[p20l782t2863r1275b2927],
9	.	.	O	.	_	0	SENT_335	[p20l782t2863r1275b2927],

1	14	CD	NUMBER	14	_	0	SENT_336	[p20l13t2947r93b2997],
2	.	.	O	.	_	0	SENT_336	[p20l13t2947r93b2997],

1	Link	NN	O	link	nn	2	SENT_337	[p20l136t2945r275b2996],
2	E	NN	O	e	_	0	SENT_337	[p20l303t2945r364b3009],
3	,	,	O	,	_	0	SENT_337	[p20l303t2945r364b3009],
4	Parish	NNP	O	Parish	nn	5	SENT_337	[p20l397t2945r574b2997],
5	S	NNP	O	S	appos	2	SENT_337	[p20l607t2945r657b3009],
6	,	,	O	,	_	0	SENT_337	[p20l607t2945r657b3009],
7	Armitage	NNP	PERSON	Armitage	nn	8	SENT_337	[p20l687t2944r957b3015],
8	J	NNP	PERSON	J	appos	2	SENT_337	[p20l981t2945r1025b3012],
9	,	,	O	,	_	0	SENT_337	[p20l981t2945r1025b3012],
10	et	FW	O	et	nn	11	SENT_337	[p20l1059t2958r1109b2997],
11	al.	FW	O	al.	appos	2	SENT_337	[p20l1140t2945r1199b2997],
12	.	.	O	.	_	0	SENT_337	[p20l1140t2945r1199b2997],

1	SLCOIB1	NN	O	slcoib1	nn	2	SENT_338	[p20l1236t2945r1541b2997],
2	variants	NNS	O	variant	nsubj	6	SENT_338	[p20l1573t2947r1793b2997],
3	and	CC	O	and	_	0	SENT_338	[p20l1825t2945r1927b2997],
4	statininduced	JJ	O	statininduced	amod	5	SENT_338	[p20l1958t2947r2138b2997, p20l135t3025r359b3078],
5	myopathy	NN	O	myopathy	nsubj	6	SENT_338	[p20l390t3025r772b3096],
6	—	VBD	O	—	_	0	SENT_338	[p20l390t3025r772b3096],
7	a	DT	O	a	det	9	SENT_338	[p20l390t3025r772b3096],
8	genomewide	JJ	O	genomewide	amod	9	SENT_338	[p20l801t3025r1159b3096],
9	study	NN	O	study	dobj	6	SENT_338	[p20l1192t3025r1354b3096],
10	.	.	O	.	_	0	SENT_338	[p20l1192t3025r1354b3096],

1	N	NN	O	n	nn	2	SENT_339	[p20l1389t3026r1441b3077],
2	EnglJ	NN	O	englj	nsubj	3	SENT_339	[p20l1475t3025r1663b3096],
3	Med	VBD	O	med	_	0	SENT_339	[p20l1692t3025r1828b3078],
4	2008	CD	DATE	2008	dobj	3	SENT_339	[p20l1857t3025r2137b3089],
5	;	:	O	;	_	0	SENT_339	[p20l1857t3025r2137b3089],
6	359	CD	NUMBER	359	dep	4	SENT_339	[p20l1857t3025r2137b3089],
7	:	:	O	:	_	0	SENT_339	[p20l1857t3025r2137b3089],

1	1616	CD	DATE	1616	num	2	SENT_340	[p20l13t3186r158b3238],
2	Voora	NNP	O	Voora	_	0	SENT_340	[p20l326t3186r490b3238],
3	et	FW	O	et	nn	4	SENT_340	[p20l513t3188r570b3238],
4	al.	FW	O	al.	dep	2	SENT_340	[p20l585t3186r652b3238],
5	.	.	O	.	_	0	SENT_340	[p20l585t3186r652b3238],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_341	[p20l330t3275r854b3337],
2	of	IN	O	of	_	0	SENT_341	[p20l873t3274r929b3327],
3	Statin	NN	O	statin	nn	5	SENT_341	[p20l945t3274r1111b3327],
4	Side	NN	O	side	nn	5	SENT_341	[p20l1131t3274r1254b3327],
5	Elfects	NNS	O	elfect	prep_of	1	SENT_341	[p20l1275t3274r1462b3327],

1	Voora	NN	O	voora	nn	2	SENT_342	[p21l133t87r307b140],
2	D	NN	O	d	_	0	SENT_342	[p21l336t87r407b151],
3	,	,	O	,	_	0	SENT_342	[p21l336t87r407b151],
4	Shah	NNP	PERSON	Shah	nn	5	SENT_342	[p21l442t86r583b140],
5	SH	NNP	O	SH	appos	2	SENT_342	[p21l616t86r726b152],
6	,	,	O	,	_	0	SENT_342	[p21l616t86r726b152],
7	Reed	NNP	ORGANIZATION	Reed	nn	8	SENT_342	[p21l760t86r903b140],
8	CR	NN	ORGANIZATION	cr	appos	2	SENT_342	[p21l934t86r1048b152],
9	,	,	O	,	_	0	SENT_342	[p21l934t86r1048b152],
10	et	FW	O	et	nn	11	SENT_342	[p21l1081t100r1132b140],
11	al.	FW	O	al.	appos	2	SENT_342	[p21l1162t87r1222b140],
12	.	.	O	.	_	0	SENT_342	[p21l1162t87r1222b140],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_343	[p21l1255t87r1746b158],
2	predictors	NNS	O	predictor	nsubj	5	SENT_343	[p21l1774t87r2056b158],
3	of	IN	O	of	_	0	SENT_343	[p21l2088t86r2151b140],
4	statin	NN	O	statin	prep_of	2	SENT_343	[p21l134t169r288b220],
5	mediated	VBD	O	mediate	_	0	SENT_343	[p21l316t166r578b220],
6	LDLC	JJ	ORGANIZATION	ldlc	amod	7	SENT_343	[p21l605t167r784b220],
7	reduction	NN	O	reduction	dobj	5	SENT_343	[p21l811t167r1081b220],
8	and	CC	O	and	_	0	SENT_343	[p21l1109t167r1211b220],
9	dose	NN	O	dose	nn	10	SENT_343	[p21l1239t167r1363b220],
10	response	NN	O	response	dobj	5	SENT_343	[p21l1391t187r1648b238],
11	.	.	O	.	_	0	SENT_343	[p21l1391t187r1648b238],

1	Circ	NNP	PERSON	Circ	nn	3	SENT_344	[p21l1681t166r1803b220],
2	Cardiovasc	NNP	PERSON	Cardiovasc	nn	3	SENT_344	[p21l1831t166r2143b220],
3	Genet	NNP	PERSON	Genet	_	0	SENT_344	[p21l134t246r311b299],
4	2008	CD	DATE	2008	num	3	SENT_344	[p21l335t249r757b311],
5	;	:	O	;	_	0	SENT_344	[p21l335t249r757b311],
6	1:100	CD	NUMBER	1:100	number	7	SENT_344	[p21l335t249r757b311],
7	-6	CD	NUMBER	-6	dep	3	SENT_344	[p21l335t249r757b311],
8	.	.	O	.	_	0	SENT_344	[p21l335t249r757b311],

1	Klein	NNP	PERSON	Klein	nn	2	SENT_345	[p21l135t325r286b379],
2	TE	NNP	O	TE	_	0	SENT_345	[p21l325t324r439b391],
3	,	,	O	,	_	0	SENT_345	[p21l325t324r439b391],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_345	[p21l484t325r676b397],
5	JT	NNP	O	JT	appos	2	SENT_345	[p21l708t324r802b393],
6	,	,	O	,	_	0	SENT_345	[p21l708t324r802b393],
7	Cho	NNP	PERSON	Cho	nn	8	SENT_345	[p21l847t325r968b379],
8	MK	NNP	O	MK	appos	2	SENT_345	[p21l1009t326r1144b391],
9	,	,	O	,	_	0	SENT_345	[p21l1009t326r1144b391],
10	et	FW	O	et	nn	11	SENT_345	[p21l1187t339r1239b379],
11	al.	FW	O	al.	appos	2	SENT_345	[p21l1279t326r1338b379],
12	.	.	O	.	_	0	SENT_345	[p21l1279t326r1338b379],

1	Integrating	VBG	O	integrate	amod	2	SENT_346	[p21l1383t326r1702b397],
2	genotype	NN	O	genotype	_	0	SENT_346	[p21l1741t339r1997b397],
3	and	CC	O	and	_	0	SENT_346	[p21l2041t325r2142b379],
4	phenotype	NN	O	phenotype	nn	5	SENT_346	[p21l132t405r429b477],
5	information	NN	O	information	conj_and	2	SENT_346	[p21l478t405r832b459],
6	:	:	O	:	_	0	SENT_346	[p21l478t405r832b459],
7	an	DT	O	a	det	8	SENT_346	[p21l885t426r949b459],
8	overview	NN	O	overview	dep	2	SENT_346	[p21l999t408r1248b459],
9	of	IN	O	of	_	0	SENT_346	[p21l1294t405r1358b459],
10	the	DT	O	the	det	12	SENT_346	[p21l1397t406r1485b459],
11	PharmGKB	NN	O	pharmgkb	nn	12	SENT_346	[p21l1535t405r1879b459],
12	project	NN	O	project	prep_of	8	SENT_346	[p21l1930t407r2138b477],
13	.	.	O	.	_	0	SENT_346	[p21l1930t407r2138b477],

1	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	_	0	SENT_347	[p21l133t486r647b557],
2	Research	NNP	ORGANIZATION	Research	nn	3	SENT_347	[p21l678t486r931b539],
3	Network	NNP	ORGANIZATION	Network	dep	1	SENT_347	[p21l959t486r1213b539],
4	and	CC	O	and	_	0	SENT_347	[p21l1239t486r1340b539],
5	Knowledge	NNP	O	Knowledge	nn	6	SENT_347	[p21l1370t486r1688b557],
6	Base	NNP	O	Base	dep	1	SENT_347	[p21l1716t486r1861b539],
7	.	.	O	.	_	0	SENT_347	[p21l1716t486r1861b539],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	_	0	SENT_348	[p21l1892t486r2140b539, p21l134t568r463b637],
2	J	NNP	O	J	dep	1	SENT_348	[p21l483t566r512b633],
3	2001	CD	DATE	2001	num	2	SENT_348	[p21l537t567r977b631],
4	;	:	O	;	_	0	SENT_348	[p21l537t567r977b631],
5	1:167	CD	NUMBER	1:167	number	6	SENT_348	[p21l537t567r977b631],
6	—	CD	NUMBER	—	dep	1	SENT_348	[p21l537t567r977b631],
7	70	CD	NUMBER	70	dep	6	SENT_348	[p21l537t567r977b631],
8	.	.	O	.	_	0	SENT_348	[p21l537t567r977b631],

1	Mangravite	NNP	O	Mangravite	nn	2	SENT_349	[p21l132t646r460b717],
2	LM	NNP	O	LM	_	0	SENT_349	[p21l499t646r629b711],
3	,	,	O	,	_	0	SENT_349	[p21l499t646r629b711],
4	Thorn	NNP	O	Thorn	nn	5	SENT_349	[p21l667t644r852b699],
5	CF	NN	O	cf	appos	2	SENT_349	[p21l892t645r999b711],
6	,	,	O	,	_	0	SENT_349	[p21l892t645r999b711],
7	Krauss	NNP	PERSON	Krauss	nn	8	SENT_349	[p21l1042t646r1228b699],
8	RM	NN	O	rm	appos	5	SENT_349	[p21l1269t646r1399b699],
9	.	.	O	.	_	0	SENT_349	[p21l1269t646r1399b699],

1	Clinical	JJ	O	clinical	amod	2	SENT_350	[p21l1442t645r1664b699],
2	implications	NNS	O	implication	_	0	SENT_350	[p21l1701t646r2047b717],
3	of	IN	O	of	_	0	SENT_350	[p21l2088t646r2151b699],
4	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	2	SENT_350	[p21l132t725r680b797],
5	of	IN	O	of	_	0	SENT_350	[p21l710t725r774b779],
6	statin	NN	O	statin	nn	7	SENT_350	[p21l793t728r948b779],
7	treatment	NN	O	treatment	prep_of	2	SENT_350	[p21l976t739r1266b779],
8	.	.	O	.	_	0	SENT_350	[p21l976t739r1266b779],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_351	[p21l1298t726r1852b797],
2	J	NNP	O	J	dep	1	SENT_351	[p21l1874t726r1902b793],
3	2006	CD	DATE	2006	num	2	SENT_351	[p21l1929t728r2138b791],
4	;	:	O	;	_	0	SENT_351	[p21l1929t728r2138b791],
5	6	CD	NUMBER	6	num	7	SENT_351	[p21l1929t728r2138b791],
6	:	:	O	:	_	0	SENT_351	[p21l1929t728r2138b791],
7	360-74	CD	NUMBER	360-74	dep	1	SENT_351	[p21l133t807r367b858],
8	.	.	O	.	_	0	SENT_351	[p21l133t807r367b858],

1	Barrett	NNP	PERSON	Barrett	nn	2	SENT_352	[p21l133t885r333b938],
2	JC	NNP	O	JC	_	0	SENT_352	[p21l369t884r466b952],
3	,	,	O	,	_	0	SENT_352	[p21l369t884r466b952],
4	Fry	NNP	O	Fry	nn	5	SENT_352	[p21l513t885r611b956],
5	B	NNP	O	B	appos	2	SENT_352	[p21l653t885r713b949],
6	,	,	O	,	_	0	SENT_352	[p21l653t885r713b949],
7	Maller	NNP	PERSON	Maller	nn	8	SENT_352	[p21l758t884r949b938],
8	J	NNP	PERSON	J	appos	2	SENT_352	[p21l985t885r1029b952],
9	,	,	O	,	_	0	SENT_352	[p21l985t885r1029b952],
10	Daly	NNP	PERSON	Daly	nn	11	SENT_352	[p21l1076t885r1214b956],
11	p	NN	O	p	appos	2	SENT_352	[p21l1255t885r1361b952],
12	+	CC	O	+	_	0	SENT_352	[p21l1255t885r1361b952],
13	Haploview	NN	O	haploview	conj_+	11	SENT_352	[p21l1410t885r1731b956],
14	:	:	O	:	_	0	SENT_352	[p21l1410t885r1731b956],
15	analysis	NN	O	analysis	dep	2	SENT_352	[p21l1781t885r1993b956],
16	and	CC	O	and	_	0	SENT_352	[p21l2040t884r2142b938],
17	visualization	NN	O	visualization	dep	2	SENT_352	[p21l130t965r486b1018],
18	of	IN	O	of	_	0	SENT_352	[p21l527t964r591b1018],
19	LD	NN	O	ld	nn	22	SENT_352	[p21l623t965r723b1017],
20	and	CC	O	and	_	0	SENT_352	[p21l766t965r868b1018],
21	haplotype	NN	O	haplotype	conj_and	19	SENT_352	[p21l908t964r1185b1036],
22	maps	NNS	O	map	prep_of	15	SENT_352	[p21l1227t985r1388b1036],
23	.	.	O	.	_	0	SENT_352	[p21l1227t985r1388b1036],

1	Bioinformatics	NNS	O	bioinformatic	_	0	SENT_353	[p21l1433t964r1853b1018],
2	2005	CD	DATE	2005	num	1	SENT_353	[p21l1893t964r2138b1030],
3	;	:	O	;	_	0	SENT_353	[p21l1893t964r2138b1030],
4	21	CD	NUMBER	21	num	6	SENT_353	[p21l1893t964r2138b1030],
5	:	:	O	:	_	0	SENT_353	[p21l1893t964r2138b1030],
6	263-5	CD	NUMBER	263-5	dep	1	SENT_353	[p21l131t1043r323b1096],
7	.	.	O	.	_	0	SENT_353	[p21l131t1043r323b1096],

1	Gauderman	NNP	PERSON	Gauderman	nn	5	SENT_354	[p21l134t1122r472b1176],
2	VVJ	NNP	O	VVJ	nn	5	SENT_354	[p21l495t1123r610b1190],
3	,	,	O	,	_	0	SENT_354	[p21l495t1123r610b1190],
4	Morrison	NNP	PERSON	Morrison	appos	5	SENT_354	[p21l637t1123r1039b1190],
5	QUANTO	NNP	O	QUANTO	_	0	SENT_354	[p21l1070t1121r1393b1190],
6	1.1	CD	NUMBER	1.1	num	5	SENT_354	[p21l1424t1125r1522b1176],
7	:	:	O	:	_	0	SENT_354	[p21l1424t1125r1522b1176],
8	a	DT	O	a	det	10	SENT_354	[p21l1554t1143r1581b1176],
9	computer	NN	O	computer	nn	10	SENT_354	[p21l1607t1136r1877b1194],
10	program	NN	O	program	dep	5	SENT_354	[p21l1901t1143r2142b1194],
11	for	IN	O	for	_	0	SENT_354	[p21l133t1203r213b1257],
12	power	NN	O	power	nn	16	SENT_354	[p21l259t1224r433b1275],
13	and	CC	O	and	_	0	SENT_354	[p21l481t1204r583b1257],
14	sample	NN	O	sample	nn	16	SENT_354	[p21l631t1203r825b1275],
15	size	NN	O	size	nn	16	SENT_354	[p21l874t1206r975b1257],
16	calculations	NNS	O	calculation	prep_for	10	SENT_354	[p21l1024t1204r1352b1257],
17	for	IN	O	for	_	0	SENT_354	[p21l1401t1203r1481b1257],
18	genetic-epidemiology	JJ	O	genetic-epidemiology	amod	19	SENT_354	[p21l1526t1203r2145b1275],
19	studies	NNS	O	study	prep_for	10	SENT_354	[p21l134t1284r342b1349],
20	,	,	O	,	_	0	SENT_354	[p21l134t1284r342b1349],
21	2006	CD	DATE	2006	appos	19	SENT_354	[p21l365t1286r521b1337],
22	.	.	O	.	_	0	SENT_354	[p21l365t1286r521b1337],

1	Available	JJ	O	available	_	0	SENT_355	[p21l545t1282r810b1337],
2	at	IN	O	at	advmod	1	SENT_355	[p21l835t1297r898b1337],
3	:	:	O	:	_	0	SENT_355	[p21l835t1297r898b1337],
4	http://hydra.usc.edu/gxe	NN	O	http://hydra.usc.edu/gxe	dep	1	SENT_355	[p21l924t1283r1637b1355],
5	.	.	O	.	_	0	SENT_355	[p21l924t1283r1637b1355],

1	Accessed	VBN	O	access	_	0	SENT_356	[p21l1661t1282r1921b1337],
2	June	NNP	DATE	June	tmod	1	SENT_356	[p21l1936t1284r2068b1351],
3	4	CD	DATE	4	num	2	SENT_356	[p21l2090t1286r2139b1349],
4	,	,	DATE	,	_	0	SENT_356	[p21l2090t1286r2139b1349],
5	2009	CD	DATE	2009	num	2	SENT_356	[p21l132t1366r287b1416],
6	.	.	O	.	_	0	SENT_356	[p21l132t1366r287b1416],

1	Singh	NNP	PERSON	Singh	nn	2	SENT_357	[p21l136t1442r299b1514],
2	R	NNP	PERSON	R	_	0	SENT_357	[p21l320t1443r380b1508],
3	,	,	O	,	_	0	SENT_357	[p21l320t1443r380b1508],
4	Ting	NNP	O	Ting	nn	5	SENT_357	[p21l399t1441r542b1514],
5	JG	NNP	O	JG	appos	2	SENT_357	[p21l552t1442r654b1510],
6	,	,	O	,	_	0	SENT_357	[p21l552t1442r654b1510],
7	Pan	NNP	O	Pan	nn	8	SENT_357	[p21l675t1443r784b1496],
8	Y	NN	O	y	appos	5	SENT_357	[p21l799t1443r863b1508],
9	,	,	O	,	_	0	SENT_357	[p21l799t1443r863b1508],
10	Teh	NN	LOCATION	teh	nn	11	SENT_357	[p21l882t1441r1000b1496],
11	LK	NN	LOCATION	lk	appos	5	SENT_357	[p21l1020t1443r1130b1508],
12	,	,	O	,	_	0	SENT_357	[p21l1020t1443r1130b1508],
13	Ismail	NNP	PERSON	Ismail	nn	14	SENT_357	[p21l1150t1442r1326b1496],
14	R	NNP	PERSON	R	appos	5	SENT_357	[p21l1345t1443r1406b1508],
15	,	,	O	,	_	0	SENT_357	[p21l1345t1443r1406b1508],
16	Ong	NNP	O	Ong	nn	17	SENT_357	[p21l1429t1442r1557b1514],
17	CE	NNP	O	CE	appos	5	SENT_357	[p21l1576t1442r1688b1496],
18	.	.	O	.	_	0	SENT_357	[p21l1576t1442r1688b1496],

1	Functional	JJ	O	functional	amod	2	SENT_358	[p21l1711t1442r2019b1496],
2	role	NN	O	role	_	0	SENT_358	[p21l2036t1442r2141b1496],
3	of	IN	O	of	_	0	SENT_358	[p21l134t1522r197b1576],
4	Ile264	NN	O	ile264	prep_of	2	SENT_358	[p21l232t1522r412b1576],
5	in	IN	O	in	_	0	SENT_358	[p21l458t1525r512b1575],
6	CYP2C8	NN	O	cyp2c8	prep_in	2	SENT_358	[p21l559t1522r837b1577],
7	:	:	O	:	_	0	SENT_358	[p21l559t1522r837b1577],
8	mutations	NNS	O	mutation	nsubj	9	SENT_358	[p21l887t1525r1169b1576],
9	affect	VBP	O	affect	dep	2	SENT_358	[p21l1217t1522r1365b1576],
10	haem	NN	O	haem	nn	11	SENT_358	[p21l1409t1523r1562b1576],
11	incorporation	NN	O	incorporation	dobj	9	SENT_358	[p21l1608t1525r1993b1594],
12	and	CC	O	and	_	0	SENT_358	[p21l2040t1522r2142b1576],
13	catalytic	JJ	O	catalytic	amod	14	SENT_358	[p21l134t1602r364b1674],
14	activity	NN	O	activity	dobj	9	SENT_358	[p21l391t1605r606b1674],
15	.	.	O	.	_	0	SENT_358	[p21l391t1605r606b1674],

1	Drug	NN	O	drug	nn	3	SENT_359	[p21l637t1603r788b1674],
2	Metab	NNP	O	Metab	nn	3	SENT_359	[p21l811t1603r998b1656],
3	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_359	[p21l1026t1603r1459b1656],
4	2008	CD	DATE	2008	num	3	SENT_359	[p21l1482t1603r1959b1668],
5	;	:	O	;	_	0	SENT_359	[p21l1482t1603r1959b1668],
6	23:165	CD	NUMBER	23:165	number	7	SENT_359	[p21l1482t1603r1959b1668],
7	-74	CD	NUMBER	-74	dep	3	SENT_359	[p21l1482t1603r1959b1668],
8	.	.	O	.	_	0	SENT_359	[p21l1482t1603r1959b1668],

1	Zhao	NNP	PERSON	Zhao	nn	2	SENT_360	[p21l134t1683r283b1736],
2	JJ	NN	PERSON	jj	_	0	SENT_360	[p21l306t1683r373b1750],
3	,	,	O	,	_	0	SENT_360	[p21l306t1683r373b1750],
4	Rogers	NNP	ORGANIZATION	Rogers	nn	5	SENT_360	[p21l406t1683r600b1754],
5	JD	NNP	ORGANIZATION	JD	appos	2	SENT_360	[p21l622t1683r723b1750],
6	.	.	O	.	_	0	SENT_360	[p21l622t1683r723b1750],

1	Proceedings	NNP	O	Proceedings	_	0	SENT_361	[p21l756t1682r1098b1754],
2	of	IN	O	of	_	0	SENT_361	[p21l1129t1682r1193b1736],
3	the	DT	O	the	det	6	SENT_361	[p21l1212t1683r1300b1736],
4	47th	JJ	ORDINAL	47th	amod	6	SENT_361	[p21l1328t1683r1459b1736],
5	ASMS	NNP	MISC	ASMS	nn	6	SENT_361	[p21l1485t1681r1683b1736],
6	Conference	NN	MISC	conference	prep_of	1	SENT_361	[p21l1715t1682r2042b1736],
7	on	IN	MISC	on	_	0	SENT_361	[p21l2072t1703r2142b1736],
8	Mass	JJ	MISC	mass	amod	9	SENT_361	[p21l132t1763r280b1816],
9	Spectrommetry	NN	MISC	spectrommetry	prep_on	6	SENT_361	[p21l310t1762r761b1834],
10	;	:	O	;	_	0	SENT_361	[p21l310t1762r761b1834],
11	June	NNP	DATE	June	dep	1	SENT_361	[p21l783t1763r915b1830],
12	13-17	CD	DATE	13-17	num	11	SENT_361	[p21l945t1764r1133b1828],
13	,	,	DATE	,	_	0	SENT_361	[p21l945t1764r1133b1828],
14	1999	CD	DATE	1999	num	11	SENT_361	[p21l1165t1765r1317b1828],
15	;	:	O	;	_	0	SENT_361	[p21l1165t1765r1317b1828],
16	Dallas	NNP	LOCATION	Dallas	nn	18	SENT_361	[p21l1346t1762r1540b1828],
17	,	,	O	,	_	0	SENT_361	[p21l1346t1762r1540b1828],
18	TX	NNP	LOCATION	TX	dep	11	SENT_361	[p21l1566t1761r1680b1816],
19	.	.	O	.	_	0	SENT_361	[p21l1566t1761r1680b1816],

1	Benjamini	NNP	MISC	Benjamini	nn	2	SENT_362	[p21l133t1843r427b1914],
2	Y	NN	O	y	_	0	SENT_362	[p21l460t1843r523b1908],
3	,	,	O	,	_	0	SENT_362	[p21l460t1843r523b1908],
4	Hochberg	NNP	PERSON	Hochberg	appos	2	SENT_362	[p21l563t1842r864b1914],
5	,	,	O	,	_	0	SENT_362	[p21l563t1842r864b1914],
6	Y.	NNP	O	Y.	nn	7	SENT_362	[p21l900t1843r962b1896],
7	Controlling	NNP	O	Controlling	appos	2	SENT_362	[p21l1004t1842r1338b1914],
8	the	DT	O	the	det	11	SENT_362	[p21l1373t1843r1461b1896],
9	false	JJ	O	false	amod	11	SENT_362	[p21l1498t1842r1621b1896],
10	discovery	NN	O	discovery	nn	11	SENT_362	[p21l1659t1842r1921b1914],
11	rate	NN	O	rate	dep	7	SENT_362	[p21l1954t1856r2074b1896],
12	:	:	O	:	_	0	SENT_362	[p21l1954t1856r2074b1896],
13	a	DT	O	a	det	17	SENT_362	[p21l2115t1863r2143b1896],
14	practical	JJ	O	practical	amod	17	SENT_362	[p21l132t1923r371b1994],
15	and	CC	O	and	_	0	SENT_362	[p21l402t1922r504b1976],
16	powerful	JJ	O	powerful	conj_and	14	SENT_362	[p21l533t1922r784b1994],
17	approach	NN	O	approach	dep	2	SENT_362	[p21l815t1923r1073b1994],
18	to	TO	O	to	_	0	SENT_362	[p21l1103t1936r1158b1976],
19	multiple	JJ	O	multiple	amod	20	SENT_362	[p21l1190t1922r1424b1994],
20	testing	NN	O	testing	prep_to	17	SENT_362	[p21l1455t1925r1660b1994],
21	.	.	O	.	_	0	SENT_362	[p21l1455t1925r1660b1994],

1	J	NN	O	j	nn	5	SENT_363	[p21l1687t1923r1715b1990],
2	R	NN	O	r	nn	5	SENT_363	[p21l1747t1923r1795b1975],
3	Stat	NN	O	stat	nn	5	SENT_363	[p21l1826t1922r1936b1976],
4	Soc	NN	O	soc	nn	5	SENT_363	[p21l1969t1922r2068b1976],
5	B	NN	O	b	_	0	SENT_363	[p21l2098t1923r2138b1975],
6	1995	CD	DATE	1995	dep	5	SENT_363	[p21l136t2002r652b2066],
7	;	:	O	;	_	0	SENT_363	[p21l136t2002r652b2066],
8	57:289	CD	NUMBER	57:289	num	9	SENT_363	[p21l136t2002r652b2066],
9	-300	CD	NUMBER	-300	dep	5	SENT_363	[p21l136t2002r652b2066],
10	.	.	O	.	_	0	SENT_363	[p21l136t2002r652b2066],

1	JACC	NNP	O	JACC	nn	2	SENT_364	[p21l1482t2093r1597b2144],
2	Vol	NNP	O	Vol	_	0	SENT_364	[p21l1618t2094r1700b2144],
3	.	.	O	.	_	0	SENT_364	[p21l1618t2094r1700b2144],

1	54	CD	NUMBER	54	_	0	SENT_365	[p21l1725t2094r1798b2153],
2	,	,	O	,	_	0	SENT_365	[p21l1725t2094r1798b2153],
3	No.	NN	O	no.	appos	1	SENT_365	[p21l1824t2094r1896b2144],
4	17	CD	NUMBER	17	num	3	SENT_365	[p21l1922t2094r1994b2153],
5	,	,	O	,	_	0	SENT_365	[p21l1922t2094r1994b2153],
6	2009	CD	DATE	2009	num	7	SENT_365	[p21l2019t2093r2142b2144],
7	October	NNP	DATE	October	appos	1	SENT_365	[p21l1480t2182r1660b2233],
8	20	CD	DATE	20	num	7	SENT_365	[p21l1680t2182r1753b2241],
9	,	,	O	,	_	0	SENT_365	[p21l1680t2182r1753b2241],
10	2009:1609	CD	NUMBER	2009:1609	number	11	SENT_365	[p21l1778t2182r2142b2233],
11	—	CD	NUMBER	—	appos	1	SENT_365	[p21l1778t2182r2142b2233],
12	16	CD	NUMBER	16	dep	11	SENT_365	[p21l1778t2182r2142b2233],

1	Selvin	NNP	PERSON	Selvin	nn	3	SENT_366	[p21l137t2402r306b2456],
2	S.	NNP	O	S.	nn	3	SENT_366	[p21l335t2402r383b2456],
3	Statistical	NNP	O	Statistical	_	0	SENT_366	[p21l415t2402r689b2456],
4	Analysis	NN	O	analysis	dep	3	SENT_366	[p21l712t2401r949b2474],
5	of	IN	O	of	_	0	SENT_366	[p21l977t2402r1041b2456],
6	Epidemiologic	NNP	O	Epidemiologic	nn	7	SENT_366	[p21l1058t2403r1475b2474],
7	Data	NNP	O	Data	prep_of	4	SENT_366	[p21l1500t2403r1653b2456],
8	.	.	O	.	_	0	SENT_366	[p21l1500t2403r1653b2456],

1	New	NNP	LOCATION	New	nn	2	SENT_367	[p21l1682t2403r1818b2456],
2	York	NNP	LOCATION	York	_	0	SENT_367	[p21l1838t2403r1996b2468],
3	,	,	O	,	_	0	SENT_367	[p21l1838t2403r1996b2468],
4	NY	NNP	O	NY	appos	2	SENT_367	[p21l2024t2403r2139b2456],
5	:	:	O	:	_	0	SENT_367	[p21l2024t2403r2139b2456],
6	Oxford	NNP	ORGANIZATION	Oxford	nn	8	SENT_367	[p21l135t2482r340b2536],
7	University	NNP	ORGANIZATION	University	nn	8	SENT_367	[p21l365t2483r660b2554],
8	Press	NNP	ORGANIZATION	Press	dep	2	SENT_367	[p21l684t2483r845b2548],
9	,	,	O	,	_	0	SENT_367	[p21l684t2483r845b2548],
10	1991	CD	DATE	1991	appos	8	SENT_367	[p21l877t2485r1028b2536],
11	.	.	O	.	_	0	SENT_367	[p21l877t2485r1028b2536],

1	Frankel	NNP	PERSON	Frankel	nn	2	SENT_368	[p21l134t2563r351b2616],
2	DS	NN	O	d	_	0	SENT_368	[p21l370t2562r480b2627],
3	,	,	O	,	_	0	SENT_368	[p21l370t2562r480b2627],
4	Meigs	NNP	ORGANIZATION	Meigs	nn	5	SENT_368	[p21l500t2563r677b2634],
5	JB	NNP	ORGANIZATION	JB	appos	2	SENT_368	[p21l690t2563r781b2631],
6	,	,	O	,	_	0	SENT_368	[p21l690t2563r781b2631],
7	Massaro	NNP	PERSON	Massaro	nn	8	SENT_368	[p21l802t2563r1040b2616],
8	JM	NN	O	jm	appos	2	SENT_368	[p21l1054t2563r1167b2630],
9	,	,	O	,	_	0	SENT_368	[p21l1054t2563r1167b2630],
10	et	FW	O	et	nn	11	SENT_368	[p21l1190t2576r1241b2616],
11	al.	FW	O	al.	appos	2	SENT_368	[p21l1261t2563r1320b2616],
12	.	.	O	.	_	0	SENT_368	[p21l1261t2563r1320b2616],

1	Von	NNP	PERSON	Von	nn	3	SENT_369	[p21l1343t2563r1464b2616],
2	Willebrand	NN	PERSON	willebrand	nn	3	SENT_369	[p21l1480t2562r1807b2616],
3	factor	NN	O	factor	_	0	SENT_369	[p21l1826t2562r2003b2628],
4	,	,	O	,	_	0	SENT_369	[p21l1826t2562r2003b2628],
5	type	NN	O	type	nn	8	SENT_369	[p21l2025t2576r2142b2634],
6	2	CD	NUMBER	2	num	8	SENT_369	[p21l133t2645r165b2696],
7	diabetes	NN	O	diabetes	nn	8	SENT_369	[p21l195t2642r421b2696],
8	mellitus	NN	O	mellitus	appos	3	SENT_369	[p21l451t2643r691b2708],
9	,	,	O	,	_	0	SENT_369	[p21l451t2643r691b2708],
10	and	CC	O	and	_	0	SENT_369	[p21l722t2642r823b2696],
11	risk	NN	O	risk	conj_and	3	SENT_369	[p21l850t2643r955b2696],
12	of	IN	O	of	_	0	SENT_369	[p21l980t2642r1044b2696],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_369	[p21l1062t2643r1461b2696],
14	disease	NN	O	disease	prep_of	11	SENT_369	[p21l1487t2642r1696b2696],
15	:	:	O	:	_	0	SENT_369	[p21l1487t2642r1696b2696],
16	The	DT	O	the	det	19	SENT_369	[p21l1725t2641r1843b2696],
17	Framingham	NNP	O	Framingham	nn	19	SENT_369	[p21l1872t2643r2141b2714, p21l134t2723r257b2776],
18	Offspring	NNP	O	Offspring	nn	19	SENT_369	[p21l285t2722r556b2794],
19	Study	NNP	O	Study	dep	3	SENT_369	[p21l584t2722r759b2794],
20	.	.	O	.	_	0	SENT_369	[p21l584t2722r759b2794],

1	Circulation	NN	O	circulation	_	0	SENT_370	[p21l791t2722r1112b2776],
2	2008	CD	DATE	2008	num	1	SENT_370	[p21l1137t2723r1649b2787],
3	;	:	O	;	_	0	SENT_370	[p21l1137t2723r1649b2787],
4	118:2533	CD	NUMBER	118:2533	number	5	SENT_370	[p21l1137t2723r1649b2787],
5	-9	CD	NUMBER	-9	dep	1	SENT_370	[p21l1137t2723r1649b2787],
6	.	.	O	.	_	0	SENT_370	[p21l1137t2723r1649b2787],

1	Cziraky	NNP	O	Cziraky	nn	2	SENT_371	[p21l135t2802r359b2874],
2	MJ	NNP	O	MJ	_	0	SENT_371	[p21l399t2803r507b2870],
3	,	,	O	,	_	0	SENT_371	[p21l399t2803r507b2870],
4	Willey	NNP	PERSON	Willey	nn	5	SENT_371	[p21l551t2803r746b2874],
5	VJ	NNP	O	VJ	appos	2	SENT_371	[p21l788t2803r875b2870],
6	,	,	O	,	_	0	SENT_371	[p21l788t2803r875b2870],
7	McKenney	NNP	PERSON	McKenney	nn	8	SENT_371	[p21l921t2803r1240b2874],
8	JM	NN	O	jm	appos	2	SENT_371	[p21l1275t2803r1389b2870],
9	,	,	O	,	_	0	SENT_371	[p21l1275t2803r1389b2870],
10	et	FW	O	et	nn	11	SENT_371	[p21l1437t2816r1488b2856],
11	al.	FW	O	al.	appos	2	SENT_371	[p21l1532t2803r1592b2856],
12	.	.	O	.	_	0	SENT_371	[p21l1532t2803r1592b2856],

1	Statin	NN	O	statin	nn	2	SENT_372	[p21l1643t2802r1810b2856],
2	safety	NN	O	safety	_	0	SENT_372	[p21l1856t2802r2028b2874],
3	:	:	O	:	_	0	SENT_372	[p21l1856t2802r2028b2874],
4	an	DT	O	a	det	5	SENT_372	[p21l2078t2823r2143b2856],
5	assessment	NN	O	assessment	dep	2	SENT_372	[p21l135t2896r443b2936],
6	using	VBG	O	use	partmod	5	SENT_372	[p21l479t2885r631b2954],
7	an	DT	O	a	det	10	SENT_372	[p21l669t2903r733b2936],
8	administrative	JJ	O	administrative	amod	10	SENT_372	[p21l773t2883r1174b2936],
9	claims	NNS	O	claim	nn	10	SENT_372	[p21l1214t2883r1389b2936],
10	database	NN	O	database	dobj	6	SENT_372	[p21l1429t2883r1682b2936],
11	.	.	O	.	_	0	SENT_372	[p21l1429t2883r1682b2936],

1	Am	NNP	O	Am	nn	3	SENT_373	[p21l1722t2881r1831b2935],
2	J	NNP	O	J	nn	3	SENT_373	[p21l1862t2883r1890b2950],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_373	[p21l1930t2882r2144b2936],
4	2006	CD	DATE	2006	num	3	SENT_373	[p21l133t2963r586b3028],
5	;	:	O	;	_	0	SENT_373	[p21l133t2963r586b3028],
6	97	CD	NUMBER	97	num	8	SENT_373	[p21l133t2963r586b3028],
7	:	:	O	:	_	0	SENT_373	[p21l133t2963r586b3028],
8	S61	CD	NUMBER	s61	dep	3	SENT_373	[p21l133t2963r586b3028],
9	—	CD	NUMBER	—	number	10	SENT_373	[p21l133t2963r586b3028],
10	8	CD	NUMBER	8	dep	8	SENT_373	[p21l133t2963r586b3028],
11	.	.	O	.	_	0	SENT_373	[p21l133t2963r586b3028],

1	Skottheim	NNP	O	Skottheim	nn	2	SENT_374	[p21l137t3042r431b3096],
2	IB	NNP	O	IB	_	0	SENT_374	[p21l454t3043r540b3108],
3	,	,	O	,	_	0	SENT_374	[p21l454t3043r540b3108],
4	Gedde	NNP	PERSON	Gedde	appos	2	SENT_374	[p21l567t3042r931b3096],
5	.	.	O	.	_	0	SENT_374	[p21l567t3042r931b3096],

1	—	NN	O	—	_	0	SENT_375	[p21l567t3042r931b3096],
2	.	.	O	.	_	0	SENT_375	[p21l567t3042r931b3096],

1	Dahl	NNP	PERSON	Dahl	nn	2	SENT_376	[p21l567t3042r931b3096],
2	A	NNP	O	A	nsubj	13	SENT_376	[p21l950t3041r1018b3108],
3	,	,	O	,	_	0	SENT_376	[p21l950t3041r1018b3108],
4	Hejazifar	NNP	O	Hejazifar	nn	5	SENT_376	[p21l1044t3042r1308b3114],
5	S	NNP	O	S	appos	2	SENT_376	[p21l1332t3042r1381b3108],
6	,	,	O	,	_	0	SENT_376	[p21l1332t3042r1381b3108],
7	Hoel	NNP	PERSON	Hoel	nn	8	SENT_376	[p21l1406t3042r1549b3096],
8	K	NNP	PERSON	K	appos	2	SENT_376	[p21l1573t3043r1634b3108],
9	,	,	O	,	_	0	SENT_376	[p21l1573t3043r1634b3108],
10	Asberg	NNP	LOCATION	Asberg	nn	12	SENT_376	[p21l1657t3041r1862b3114],
11	A.	NNP	O	A.	nn	12	SENT_376	[p21l1881t3041r1947b3096],
12	Statin	NNP	O	Statin	appos	2	SENT_376	[p21l1977t3042r2143b3096],
13	induced	VBD	O	induce	_	0	SENT_376	[p21l134t3122r359b3176],
14	myotoxicity	NN	O	myotoxicity	dobj	13	SENT_376	[p21l380t3125r726b3194],
15	:	:	O	:	_	0	SENT_376	[p21l380t3125r726b3194],
16	The	DT	O	the	det	18	SENT_376	[p21l749t3121r866b3176],
17	lactone	NN	O	lactone	nn	18	SENT_376	[p21l888t3122r1090b3176],
18	forms	NNS	O	form	nsubj	21	SENT_376	[p21l1112t3122r1273b3176],
19	are	VBP	O	be	cop	21	SENT_376	[p21l1297t3143r1378b3176],
20	more	RBR	O	more	advmod	21	SENT_376	[p21l1401t3143r1544b3176],
21	potent	JJ	O	potent	parataxis	13	SENT_376	[p21l1565t3136r1751b3194],
22	than	IN	O	than	_	0	SENT_376	[p21l1771t3123r1898b3176],
23	the	DT	O	the	det	25	SENT_376	[p21l1919t3123r2008b3176],
24	acid	NN	O	acid	nn	25	SENT_376	[p21l2031t3122r2143b3176],
25	forms	NNS	O	form	prep_than	21	SENT_376	[p21l134t3202r294b3255],
26	in	IN	O	in	_	0	SENT_376	[p21l338t3205r393b3254],
27	human	JJ	O	human	amod	30	SENT_376	[p21l435t3202r633b3255],
28	skeletal	JJ	O	skeletal	amod	30	SENT_376	[p21l677t3203r885b3255],
29	muscle	NN	O	muscle	nn	30	SENT_376	[p21l927t3202r1119b3255],
30	cells	NNS	O	cell	prep_in	25	SENT_376	[p21l1164t3203r1280b3255],
31	in	FW	O	in	nn	32	SENT_376	[p21l1324t3205r1379b3254],
32	vitro	FW	O	vitro	advmod	21	SENT_376	[p21l1418t3205r1565b3255],
33	.	.	O	.	_	0	SENT_376	[p21l1418t3205r1565b3255],

1	Eur	NNP	O	Eur	nn	4	SENT_377	[p21l1612t3203r1720b3255],
2	J	NNP	O	J	nn	4	SENT_377	[p21l1753t3203r1782b3270],
3	Pharm	NNP	O	Pharm	nn	4	SENT_377	[p21l1825t3203r2015b3255],
4	Sci	NNP	O	Sci	_	0	SENT_377	[p21l2061t3202r2143b3255],
5	2008	CD	DATE	2008	num	4	SENT_377	[p21l133t3282r645b3346],
6	;	:	O	;	_	0	SENT_377	[p21l133t3282r645b3346],
7	33:317	CD	NUMBER	33:317	number	8	SENT_377	[p21l133t3282r645b3346],
8	-325	CD	NUMBER	-325	dep	4	SENT_377	[p21l133t3282r645b3346],
9	.	.	O	.	_	0	SENT_377	[p21l133t3282r645b3346],

1	Cardiovascular	NNP	O	Cardiovascular	_	0	SENT_378	[p21l135t3360r557b3414],
2	disease	NN	O	disease	nn	6	SENT_378	[p21l582t3361r776b3414],
3	and	CC	O	and	_	0	SENT_378	[p21l804t3360r907b3414],
4	steroid	NN	O	steroid	nn	6	SENT_378	[p21l933t3360r1124b3414],
5	hormone	NN	O	hormone	nn	6	SENT_378	[p21l1150t3361r1406b3414],
6	contraception	NN	O	contraception	dep	1	SENT_378	[p21l1433t3363r1836b3432],
7	.	.	O	.	_	0	SENT_378	[p21l1433t3363r1836b3432],

1	Report	NNP	O	Report	_	0	SENT_379	[p21l1868t3361r2063b3432],
2	of	IN	O	of	_	0	SENT_379	[p21l2089t3360r2153b3414],
3	a	DT	O	a	prep_of	1	SENT_379	[p21l135t3461r163b3494],
4	WHO	WP	ORGANIZATION	who	dep	6	SENT_379	[p21l203t3440r395b3494],
5	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	6	SENT_379	[p21l445t3440r706b3494],
6	Group	NNP	ORGANIZATION	Group	rcmod	3	SENT_379	[p21l751t3440r952b3512],
7	.	.	O	.	_	0	SENT_379	[p21l751t3440r952b3512],

1	World	NNP	MISC	World	nn	6	SENT_380	[p21l998t3441r1188b3494],
2	Health	NNP	MISC	Health	nn	6	SENT_380	[p21l1233t3441r1431b3494],
3	Organ	NN	MISC	organ	nn	6	SENT_380	[p21l1477t3440r1658b3512],
4	Tech	NNP	MISC	Tech	nn	6	SENT_380	[p21l1701t3439r1849b3494],
5	Rep	NNP	MISC	Rep	nn	6	SENT_380	[p21l1895t3441r2006b3512],
6	Ser	NNP	DATE	Ser	_	0	SENT_380	[p21l2055t3440r2145b3494],
7	1998	CD	DATE	1998	num	9	SENT_380	[p21l137t3522r556b3585],
8	;	:	O	;	_	0	SENT_380	[p21l137t3522r556b3585],
9	877	CD	NUMBER	877	dep	6	SENT_380	[p21l137t3522r556b3585],
10	:	:	O	:	_	0	SENT_380	[p21l137t3522r556b3585],
11	i-vii	NN	O	i-vii	dep	6	SENT_380	[p21l137t3522r556b3585],
12	,	,	O	,	_	0	SENT_380	[p21l137t3522r556b3585],
13	1-89	CD	NUMBER	1-89	appos	11	SENT_380	[p21l588t3523r747b3573],
14	.	.	O	.	_	0	SENT_380	[p21l588t3523r747b3573],

1	Cannon	NNP	O	Cannon	nn	2	SENT_381	[p21l135t3599r364b3652],
2	CP	NNP	O	CP	_	0	SENT_381	[p21l407t3599r516b3664],
3	,	,	O	,	_	0	SENT_381	[p21l407t3599r516b3664],
4	Braunwald	NNP	PERSON	Braunwald	nn	5	SENT_381	[p21l560t3600r868b3652],
5	E	NNP	O	E	appos	2	SENT_381	[p21l910t3600r971b3664],
6	,	,	O	,	_	0	SENT_381	[p21l910t3600r971b3664],
7	McCabe	NNP	PERSON	McCabe	nn	8	SENT_381	[p21l1014t3599r1261b3652],
8	CH	NN	O	ch	appos	2	SENT_381	[p21l1306t3599r1431b3664],
9	,	,	O	,	_	0	SENT_381	[p21l1306t3599r1431b3664],
10	et	FW	O	et	nn	11	SENT_381	[p21l1476t3613r1527b3652],
11	al.	FW	O	al.	appos	2	SENT_381	[p21l1569t3599r1628b3652],
12	.	.	O	.	_	0	SENT_381	[p21l1569t3599r1628b3652],

1	Intensive	JJ	O	intensive	_	0	SENT_382	[p21l1673t3600r1931b3652],
2	versus	CC	O	versus	prep	1	SENT_382	[p21l1971t3620r2142b3652],
3	moderate	JJ	O	moderate	amod	4	SENT_382	[p21l135t3679r399b3733],
4	lipid	NN	O	lipid	dep	2	SENT_382	[p21l426t3680r555b3751],
5	lowering	VBG	O	lower	partmod	1	SENT_382	[p21l582t3680r830b3751],
6	with	IN	O	with	_	0	SENT_382	[p21l854t3680r983b3733],
7	statins	NNS	O	statin	prep_with	5	SENT_382	[p21l1012t3682r1191b3733],
8	after	IN	O	after	_	0	SENT_382	[p21l1221t3679r1349b3733],
9	acute	JJ	O	acute	amod	11	SENT_382	[p21l1377t3693r1521b3733],
10	coronary	JJ	O	coronary	amod	11	SENT_382	[p21l1551t3700r1799b3751],
11	syndromes	NNS	O	syndrome	prep_after	5	SENT_382	[p21l1825t3679r2140b3751],
12	.	.	O	.	_	0	SENT_382	[p21l1825t3679r2140b3751],

1	N	NN	O	n	nn	3	SENT_383	[p22l134t21r187b73],
2	Englj	NNP	O	Englj	nn	3	SENT_383	[p22l215t21r399b92],
3	Med	NNP	O	Med	_	0	SENT_383	[p22l424t20r560b74],
4	2004	CD	DATE	2004	num	3	SENT_383	[p22l585t20r1168b86],
5	;	:	O	;	_	0	SENT_383	[p22l585t20r1168b86],
6	350:1495	CD	NUMBER	350:1495	num	7	SENT_383	[p22l585t20r1168b86],
7	—	NN	O	—	dep	3	SENT_383	[p22l585t20r1168b86],
8	504	CD	NUMBER	504	dep	7	SENT_383	[p22l585t20r1168b86],
9	.	.	O	.	_	0	SENT_383	[p22l585t20r1168b86],

1	29	CD	NUMBER	29	_	0	SENT_384	[p22l8t103r92b154],
2	.	.	O	.	_	0	SENT_384	[p22l8t103r92b154],

1	Pfeffer	NNP	PERSON	Pfeffer	nn	2	SENT_385	[p22l134t100r321b154],
2	MA	NNP	PERSON	MA	_	0	SENT_385	[p22l355t99r492b166],
3	,	,	O	,	_	0	SENT_385	[p22l355t99r492b166],
4	Keech	NNP	PERSON	Keech	nn	5	SENT_385	[p22l533t100r708b154],
5	A	NNP	O	A	appos	2	SENT_385	[p22l743t99r810b166],
6	,	,	O	,	_	0	SENT_385	[p22l743t99r810b166],
7	Sacks	NNP	O	Sacks	nn	8	SENT_385	[p22l853t100r1005b154],
8	FM	NNP	O	FM	appos	2	SENT_385	[p22l1044t101r1169b165],
9	,	,	O	,	_	0	SENT_385	[p22l1044t101r1169b165],
10	et	FW	O	et	nn	11	SENT_385	[p22l1209t114r1260b154],
11	al.	FW	O	al.	appos	2	SENT_385	[p22l1297t101r1356b154],
12	.	.	O	.	_	0	SENT_385	[p22l1297t101r1356b154],

1	Safety	NN	O	safety	_	0	SENT_386	[p22l1399t100r1572b172],
2	and	CC	O	and	_	0	SENT_386	[p22l1608t100r1710b154],
3	tolerability	NN	O	tolerability	conj_and	1	SENT_386	[p22l1746t101r2054b172],
4	of	IN	O	of	_	0	SENT_386	[p22l2088t100r2152b154],
5	pravastatin	NN	O	pravastatin	prep_of	1	SENT_386	[p22l133t183r442b252],
6	in	IN	O	in	_	0	SENT_386	[p22l463t183r517b233],
7	long	JJ	O	long	amod	11	SENT_386	[p22l537t181r824b252],
8	—	JJ	O	—	amod	11	SENT_386	[p22l537t181r824b252],
9	term	NN	O	term	nn	11	SENT_386	[p22l537t181r824b252],
10	clinical	JJ	O	clinical	amod	11	SENT_386	[p22l846t180r1045b234],
11	trials	NNS	O	trial	prep_in	5	SENT_386	[p22l1064t181r1216b234],
12	:	:	O	:	_	0	SENT_386	[p22l1064t181r1216b234],
13	Prospective	JJ	O	prospective	amod	17	SENT_386	[p22l1241t181r1565b252],
14	Pravastatin	NNP	O	Pravastatin	nn	17	SENT_386	[p22l1587t181r1901b234],
15	Pooling	NNP	O	Pooling	nn	17	SENT_386	[p22l1922t180r2144b252],
16	(	CD	NUMBER	(	num	17	SENT_386	[p22l136t259r305b325],
17	PPP	NNP	ORGANIZATION	PPP	dep	1	SENT_386	[p22l136t259r305b325],
18	)	CD	NUMBER	)	num	19	SENT_386	[p22l136t259r305b325],
19	project	NN	O	project	dep	17	SENT_386	[p22l334t262r542b332],
20	.	.	O	.	_	0	SENT_386	[p22l334t262r542b332],

1	Circulation	NN	O	circulation	_	0	SENT_387	[p22l574t260r895b314],
2	2002	CD	DATE	2002	num	1	SENT_387	[p22l920t261r1441b325],
3	;	:	O	;	_	0	SENT_387	[p22l920t261r1441b325],
4	105:2341	CD	NUMBER	105:2341	number	5	SENT_387	[p22l920t261r1441b325],
5	-6	CD	NUMBER	-6	dep	1	SENT_387	[p22l920t261r1441b325],
6	.	.	O	.	_	0	SENT_387	[p22l920t261r1441b325],

1	Key	NN	O	key	nn	2	SENT_388	[p22l11t419r126b490],
2	Words	NNS	O	word	dep	20	SENT_388	[p22l147t418r367b472],
3	:	:	O	:	_	0	SENT_388	[p22l147t418r367b472],
4	hydroxyrnethylglutaryl-CoA	NN	O	hydroxyrnethylglutaryl-coa	dep	8	SENT_388	[p22l397t417r1208b490],
5	reductase	NN	O	reductase	nn	6	SENT_388	[p22l1233t419r1495b472],
6	inhibitors	NNS	O	inhibitor	dep	4	SENT_388	[p22l1523t419r1795b472],
7	I	PRP	O	I	dep	8	SENT_388	[p22l1831t431r1860b459],
8	pharrnacogenetics	NNS	O	pharrnacogenetic	dep	20	SENT_388	[p22l8t500r517b571],
9	I	PRP	O	I	dep	8	SENT_388	[p22l553t512r581b540],
10	single	JJ	O	single	amod	12	SENT_388	[p22l617t499r778b571],
11	nucleotide	NN	O	nucleotide	nn	12	SENT_388	[p22l806t500r1098b553],
12	polymorphisms	NNS	O	polymorphism	dep	16	SENT_388	[p22l1124t500r1562b571],
13	I	PRP	O	I	dep	12	SENT_388	[p22l1598t512r1626b540],
14	adverse	JJ	O	adverse	amod	15	SENT_388	[p22l1663t500r1867b553],
15	events	NNS	O	event	dep	16	SENT_388	[p22l1894t513r2067b553],
16	I	PRP	O	I	dep	20	SENT_388	[p22l2103t512r2132b540],
17	clinical	JJ	O	clinical	amod	18	SENT_388	[p22l10t580r209b633],
18	trial	NN	O	trial	dep	16	SENT_388	[p22l234t580r347b633],
19	I	PRP	O	I	nsubj	20	SENT_388	[p22l381t592r409b620],
20	myopathy	VBP	O	myopathy	_	0	SENT_388	[p22l445t580r739b651],
21	.	.	O	.	_	0	SENT_388	[p22l445t580r739b651],

